CA2391491A1 - Very large scale immobilized peptide synthesis - Google Patents

Very large scale immobilized peptide synthesis Download PDF

Info

Publication number
CA2391491A1
CA2391491A1 CA 2391491 CA2391491A CA2391491A1 CA 2391491 A1 CA2391491 A1 CA 2391491A1 CA 2391491 CA2391491 CA 2391491 CA 2391491 A CA2391491 A CA 2391491A CA 2391491 A1 CA2391491 A1 CA 2391491A1
Authority
CA
Canada
Prior art keywords
substrate
light
different
nucleic acid
different nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2391491
Other languages
French (fr)
Inventor
J. Leighton Read
Stephen P. A. Fodor
Lubert Stryer
Michael C. Pirrung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymetrix Inc
Original Assignee
Affymetrix, Inc.
J. Leighton Read
Stephen P. A. Fodor
Lubert Stryer
Michael C. Pirrung
Affymax N.V.
Affymax Technologies N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27001838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2391491(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Affymetrix, Inc., J. Leighton Read, Stephen P. A. Fodor, Lubert Stryer, Michael C. Pirrung, Affymax N.V., Affymax Technologies N.V. filed Critical Affymetrix, Inc.
Publication of CA2391491A1 publication Critical patent/CA2391491A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00Heating or cooling apparatus; Heat insulating devices
    • B01L7/52Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/045General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers using devices to improve synthesis, e.g. reactors, special vessels
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/06Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14Peptides being immobilised on, or in, an inorganic carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B80/00Linkers or spacers specially adapted for combinatorial chemistry or libraries, e.g. traceless linkers or safety-catch linkers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/251Colorimeters; Construction thereof
    • G01N21/253Colorimeters; Construction thereof for batch operation, i.e. multisample apparatus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6452Individual samples arranged in a regular 2D-array, e.g. multiwell plates
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/26Processing photosensitive materials; Apparatus therefor
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/26Processing photosensitive materials; Apparatus therefor
    • G03F7/265Selective reaction with inorganic or organometallic reagents after image-wise exposure, e.g. silylation
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/26Processing photosensitive materials; Apparatus therefor
    • G03F7/38Treatment before imagewise removal, e.g. prebaking
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11CSTATIC STORES
    • G11C13/00Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
    • G11C13/0002Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
    • G11C13/0009RRAM elements whose operation depends upon chemical change
    • G11C13/0014RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11CSTATIC STORES
    • G11C13/00Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
    • G11C13/0002Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
    • G11C13/0009RRAM elements whose operation depends upon chemical change
    • G11C13/0014RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
    • G11C13/0019RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material comprising bio-molecules
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L25/00Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof
    • H01L25/50Multistep manufacturing processes of assemblies consisting of devices, each device being of a type provided for in group H01L27/00 or H01L29/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00313Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315Microtiter plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00427Means for dispensing and evacuation of reagents using masks
    • B01J2219/00432Photolithographic masks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00427Means for dispensing and evacuation of reagents using masks
    • B01J2219/00434Liquid crystal masks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00436Maskless processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00457Dispensing or evacuation of the solid phase support
    • B01J2219/00459Beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00457Dispensing or evacuation of the solid phase support
    • B01J2219/00459Beads
    • B01J2219/00468Beads by manipulation of individual beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00457Dispensing or evacuation of the solid phase support
    • B01J2219/00475Sheets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/005Beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • B01J2219/00529DNA chips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • B01J2219/00531Sheets essentially square
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00585Parallel processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/0059Sequential processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00596Solid-phase processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00608DNA chips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/0061The surface being organic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00612Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614Delimitation of the attachment areas
    • B01J2219/00617Delimitation of the attachment areas by chemical means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614Delimitation of the attachment areas
    • B01J2219/00617Delimitation of the attachment areas by chemical means
    • B01J2219/00619Delimitation of the attachment areas by chemical means using hydrophilic or hydrophobic regions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614Delimitation of the attachment areas
    • B01J2219/00621Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00623Immobilisation or binding
    • B01J2219/00626Covalent
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00632Introduction of reactive groups to the surface
    • B01J2219/00637Introduction of reactive groups to the surface by coating it with another layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00639Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00646Making arrays on substantially continuous surfaces the compounds being bound to beads immobilised on the solid supports
    • B01J2219/00648Making arrays on substantially continuous surfaces the compounds being bound to beads immobilised on the solid supports by the use of solid beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00659Two-dimensional arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068Means for controlling the apparatus of the process
    • B01J2219/00686Automatic
    • B01J2219/00689Automatic using computers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068Means for controlling the apparatus of the process
    • B01J2219/00695Synthesis control routines, e.g. using computer programs
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00709Type of synthesis
    • B01J2219/00711Light-directed synthesis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00725Peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11Compounds covalently bound to a solid support
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
    • G01N15/1433
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2924/00Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
    • H01L2924/0001Technical content checked by a classifier
    • H01L2924/0002Not covered by any one of groups H01L24/00, H01L24/00 and H01L2224/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/968High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/969Multiple layering of reactants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/973Simultaneous determination of more than one analyte
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809Multifield plates or multicontainer arrays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31971Of carbohydrate
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575Volumetric liquid transfer

Abstract

A method and device for preparing desired sequences on a substrate at known locations. Known locations (10) of a substrate (2) are irradiated by way of a mask (8) so as to activate a material (4) for binding. The substrate is then exposed to a first material (12) for binding thereto. Second locations (14) are then irradiated through a mask and exposed to a second material (16). A variety of sequences may be formed through selective irradiation of the substrate followed by application of selected materials. A reactor system and fluorescence detection system are also dis-closed.

Description

1' VERY LARGE SCALE IMMOBILIZED PEPTIDE SYNTHESIS
COPYRIGHT NOTICE
A portion of the disclosure of this patent document contains material which is subject to copyright protection.
The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure as it appears in'the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.
This application is a divisional application of Canadian Application No: 2,054;70 filed on June 7, 1990. A second divisional application, Canadian Application No. 2;278,883 was filed on August 17, 1999.
BACKGROUND OF THE INVENTION
The present invention relates to the synthesis and replacement materials at known locations. In particular, one embodiment of the invention provides a method and associated apparatus for preparing diverse chemical sequences at known locations on a single substrate surface. The inventions may be applied, for example, in the field of preparation of oligomer, peptide, nucleic acid, oligosaechari.de, phospholipid, polymer, or drug congener preparation; especially to create sources of chemical diversity for use in screening for biological activity.

'la The relationship betwEen structure and activity of molecules is a fundamental issue in the study of biological systems. Structure-activity relationships are important in understanding, for example; the function of enzymes, the ways in which cells communicate with each other, as well as cellular control and feedback systems.
Certain macromolecules are known to interact and bind to other molecules having a very specific three-dimensional spatial and electronic distribution. Any large molecule having such specificity can be considered a receptor, whether it is an enzyme catalyzing hydrolysis of a metabolic intermediate, a cell-surface protein mediating membrane transport of ions, a glycoprotein serving to identify a particular cell to its neighbors, an IgG-class antibody circslat:ng in the plasma, an alidcnucleotide saque.~.ce of DNA in the nucleus, o~ t:ne like. The various molecules whicz receptors.seect.ivelv bind are known as ligands.
Many assays are available for measuring the binding affinity of known receators and ligands, but the information which can be gained from such exper~.men~s is often limited by the number and type of ligancs which ale available. Novel ligands are sometimes discovered by c=Dance or by application of new technirues for t:~e elucidation o' molecular structure, incjuding x-ray crystallographic analysis and recombinant gene~.ic tec hricues f or pr o rains Small peptides are an exemplary syste:.~. ~cr explcr ing the relationship between s tructure and f~~.~.c ~:cn in bio.icgy: A peptide is a sza_uence of amino acids.
When the twenty naturally occurring amino acids are condensed into polymeric molecules they form a wide variety of three-dimensional configurations, each resulting from a particular amino acid sequence and solvent condition. The number of possible pentapeptides of the 20 naturally occurring amino acids, for example, is 20' or 3.2_million;different peptides. The likelihood than molecules of this size might be useful in recep'or-binding studies is supported by epitope analysis s.udies showing that some antibodies recognize sequences as shcr~
as a few amino acids with high speci~ici y. Furthe:.-.~,iore, the average molecular'weight of amino acids puts s:aall peptides in the size range of many currently useful pharmaceutical products.
Phar:uaceutical drug discavery is one type of research which relies on such a study of structure-acti~rity relationships. In most cases, contemporary pharmaceutical research can be desc:ibed as the process of discovering novel ligands with desirable patterns c~
specificity for biologica2ly important receptors.

Another example is research to niscover new compouncs for use in agriculture, such :as pesticides and herbicides.
Sometimes; the solution to a rational process of designing ligands is difficult or unyielding. .Prior methods of preparing large numbers of different polymers have been painstaking3y slow when used 'at a scale sufficient to permit effective rational or random screening. For example, the "Merrifi~ld" method (J. Ar,.
them. Soc. (2963) 85:2149-2154 has been used to synthesize peptides on a solid support. In the Merrifield method, an amino acid is covalently bonded to a support made of ~n insoluble polymer. Another amino acid with an alpha protected group is reacted wzth to covalently banded amino acid to for: a dipeptide. A°tew washing, the protective group '1s removed and a thin;
amino acid with an alpha protective group is added to t::e dipeptide. This process is continued until a peptide c~
a desired length and sequence is obtained. Using the Merrifield method, it is not economically practical ~o synthesize more than a handful of peptide seguences in a day.
To synthesize larger numbers of polymer sequences, it has also been prayosed to use a series o~
reaction vessels for polymer synthesis. For example, a tubular reactor syste~a'may be used to synthesize a linear polymer on a solid phase support by automated sec_uer.tia' addition of reagents. This method still does not enable the synthesis of a sufficiently large number of polymer sequences for effective economical screening.
Methods of preparing a plurality of polyner sequences are also known 2n which a foraminous container encloses a known quantity of reactive particles, the particles being larger in size than foramina of the 3c container. The contyiners may be selectively reacted with desired materials to synthesize desired sequences c~
product molecules. As with other'methods known in the art, this method cannot practically be used to synthesize a sufficient variety of polypeptides for effective screening.
Other techniques have also been described.
These methods include the synthesis of peptides on 96 plastic pins which fit the Format of standard microtiter plates. Unfortunately, while these tzchnicues have been somewhat useful, substantia3 problems remain. ror example, these methods continue to be limited in the I0 diversity of sequences which can be economically synthesized and screened:
From the above; it is seen that an improved method and apparatus for synthesizing a variety of chemical sequences at known locations is desired.
SUI~B~iA,RY OF THE INVENTION
An improved method and apparatus for the preparation of a variety of polymers is disclosed.
In one preferred embodiment, linker molecules are provided on a substrate. A fierminal end of the linker molecules is provided with a reactive functional group protected with a photoremovable protective grcup.
Using lithographic methbds, the photoremovable protective group is exposed to light and removed from the linker molecules in first selected regions. The substrate is then washed or otherwise contacted with a first monomer that reacts with exposed functional groups on the linker molecules. In a preferred embodiment, the monomer is an amiwo acid containing a photoremovable protective group at its amino or carboxy terminus and the linker molecule terminates in an amino or carboxy acid group bearing a photoremovable protective group.
A second set of selected regions is, thereafter, exposed to light and the photoremovable ;5 protective group on the linker molecule/protected aui~to acid is removed at the second set of regions. The substrate is then contacted with a second monomer containing a photpremovable protective group for raacticn with exposed functional groups: This process is rape3ted to selective)y app3y menomers until polymers of a desired length and desired chemical sequence are obtained..
Photolabile groups are then optionally removed and the sequence is, thereafter, optionally capped. Side chain protective graups, if present; are also removed.
By using the!lithographic technigues disclosed herein, it is possible to direct light to relatively small and precisely known locations on the substrate.
2t is, therefore, possible to synthesize polymers of a known chemical sequence at known.locations on the substrate.
The resu2ting substrate w'xll have a variety of uses incyuding; for example, screening large numi~ers of polymers for biological activity, To screen for biological activity, the substrate is exposed to one or more receptors such; as antibody whole cells, receptors on vesicles, lipids, or any one of a variety of other receptors. The receptors are preferably labeled with, for example, a fluorescent marker; radioactive marker, or a labeled antibody reactive with the receptor. The location of the marker on the substrate is.detected with, for example, photon detection or autoradiogranric techniques. Through knowledge of the sequence of the material at the location where binding is detected, it is possible to quickly determine which sequence binds with the receptor and, therefore; the technique can be used to screen large numbers of peptides. Other possible applications of the inventions herein include-diagnos;.ics in which various antibodies for particular receptors would be placed on a substrate and, for example, blood sera would be screened fo= immune deficiencies. Still further applications include, for example, selective "doping" of organic materia3s in semiconductor devices, and the like:

In connection with one aspect of the invention an improved reactor system,for synthesizing polymers is also dis-closed. The reactor system ine3udes a substrata mount which engages a sub trate around a periphery thereof. The substrate mount provides for a reactor space between the substrate and the mount through or into which reaction fluids are ptuaped or flowed. A mask is placed on or focused on~the substrate and illuminated so as to deprotect selected regions of the substrate in the reactor space. A monomer is pumped through the reactor space or otherwise contacted with the substrate and reacts with the deprotected regions., Hy se3.ectivel.y deprotecting regions on the substrate and flowing predeter~ained monomers through the reactor space, desired polymers at known locations may be synthesized.
Imprcved detection apparatus and methods are also disclosed. The detection method and apparatus utilize a substrate having a large variety of potymer sequences at known locations on a surface thereof. The substrate is exposed to a fluorescently labeled receptor which binds o one or more of the polymer sequences. The substrate is placed in a microscope detection apparatus for identification of locations where binding takes place. The mxcroscope;detection apparatus includes a monochromatic or polychromatic light source for directing light at the substrate, means for detecting fluoresced light from the substrate, and means for determining a location of the fluoresced light. The means for detecting light f3uoresced on the substrate may in some embodiments include a photon counter. The means for determining a .location of thefluoresced light may include an x/y translat~:on table for the substrate.
Translation of the slide and data coT3ection are recorded and managed by an appropriately programmed digital computer.

Therefore, in accordance with the invention of the present divisional application there is provided apparatus for detection of fluoreseently marked regions on a substrate comprising: a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, each of said different polymer sequences being coupled in a different known location of said surface, each of said known location having an area of 102 em2 or less; b) a light source for directing light at said surface of said substrate; c) a means for deteetW g light fluoresced from a fluorescent label bound to the polymer sequences on said surface in response to said light source; d) means for translating said substrate from a first position to a second position relative to said'light source and/or said means for detecting light; and e) means for storing fluoresced light intensity as a function of location on said substrate, said means for storing connected to said means for translating and said means for detecting.
The invention also provides a system for determining binding of a fluorescently labeled receptor to a ligand comprising: a) a substrate bearing a plurality of different polymer sequences 'coupled to a surface of said substrate, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of l0-2 cm2 or less b) means for applying light to said surface of said substrate, said means for;appl.ying light providing simultaneous illumination at a plurality of said known locations; and c) an array of detectors for detecting light fluoresced at said plurality of known locations upon binding of a fluorescently labeled receptor to said polymer sequences.

7a The invention also provides an apparatus for detection of fluorescently marked locations on a substrate comprising: a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, wherein said plurality of different polymer sequences comprises a plurality of :different nucleic acid sequences, each of said different polymer sequence being coupled in a different known location 'of said surface, each of said known locations having an area of 10~Z cm2 or less; b) a light source for directing, light at a surface of said substrate;
c) a detector for detecting light fluoresced from a fluorescent label bound to the polymer sequences on said surface in response to said light source; d) a translator for translating said substrate relative to said light source; and e) a data storage system for storing fluoresced light intensity as a function of location on said substrate, said data storage system connected to said translator and said detector.
The invention ai.so,provides an apparatus for detection of fluorescently marked locations on a surface of a substrate, comprising: °a point light source for generating an excitation light; a substrate bearing a plurality of different polymers coupled to a surface of said substrate, wherein said plurality of different polymers comprises a plurality of different nucleic acid sequences, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less; an objective lens for focusing said point light source at said surface of said substrate, whereby locations, upon binding of a fluorescent label to the polymer sequences coupled therein, emit a fluoresced light in response to said excitation light; an x-y translation stage for moving said substrate 7b relative to said excitation light,~ a dichroic mirror for reflecting light having a wavelength of said excitation light and passing light having a wavelength of said fluoresced light; a photomultiplier and photon counter for detecting said fluoresced light; and an appropriately programmed computer for recordingsaid fluoresced light as a function of a position on said surface of said substrate from which said fluoresced light was emitted.
The invention also provides a method of detecting the presence of a fluorescent marker on a surface of a substrate, the method comprising: directing an excitation light at the surface of the substrate; and detecting light fluoresced from the surface of the substrate; wherein said surface of said substrate!bears a plurality of different nucleic acids covalently bound thereto, each of said different nucleic acids being bound at a different known location on the substrate; each of said known locations having an area of less than l0-2 cm2 and said fluorescent marker comprises a fluorescently labeled target nucleic acid that is capable of hybridizing with'one or mare of said plurality of different nucleic acids.
The invention also provides a method of determining whether a fluorescently labeled ligand binds to one or more of a plurality of different polymer sequences, wherein said fluorescently labeled ligand comprises a fluorescently labeled target nucleic acid, and said plurality of different polymer sequences on the surface of a substrate comprises a plurality of different nucleic acids, comprising: providing a plurality of different polymer sequences covalently bound to a surface of a substrate, each of said different polymer sequences being bound at a known location on the surface of the substrate, each of said known locations having an area of less than 10-2 cm2; contacting the surface of the substrate with the fluorescently labeled ligand; washing the surface to remove unbound fluorescently labeled ligand from the surface of the substrate; and detecting binding between the fluorescently labeled ligand and the one or more polymer sequences, said detecting step comprising directing an excitation light at the surface of the substrate, and detecting light fluoresced from the surface of the substrate:
The invention also provides a nucleic acid analysis apparatus comprising: a substrate bearing a plurality of different: nucleic acids; each of said different nucleic acids being attached to a different known location of the surface of said substrate, each of said known locations having an area of l0-2 cm2 or less, said substrate comprising more than l0 of such nucleic acids, at least some of said nucleic acids coupled to fiuorescently labeled target molecules; a light source for directing light at a surface of said substrates a detector for detecting light fluoresced from said surface in response to said light source; a translator for -translating said substrate relative to said light source; and a data storage system for storing fluoresced light intensity as a function of location on said substrate, said data storage system coupled to said translator and said detector.
The invention also provides an apparatus for detection of labeled locations on a substrate comprising:
a) a light source capable!of directing light at a surface of a substrate, said subs rate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences occupying a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less, and at least one of the polymers capable of being coupled to a labeled 7d receptor; b) a detector to detect light emitted from said surface in response to said light source to indicate which polymers) are coupled to the labeled receptor.
The invention also provides a method of detecting the presence of a fluorescent marker on a surface of a substrate, the method comprising: (1) directing an excitation light at a surface of a substrate, said substrate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences- occupying a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less, and at least one of the polymers capable of being coupled to a fluorescently labeled receptor; and (2) detecting light fluoresced from the surface of the substrate.
Our copending Canadian Application No. 2,278,883, also divided out of parent'Application No. 2,054,706 provides a reactor for facilitating reaction of chemical compounds, said reactor comprising: a body having a sealed cavity therein, said cavity being less than about 1,000 um deep; and an inlet port and an outlet port, said inlet pbrt and said outlet port being in fluid communication with said cavity for flowing fluid comprising nucleosides into and through said cavity.
The parent application, Canadian Application No.
2,054,706, provides a method of forming an array of diverse polymers on a substrate, a surface of said substrate comprising at least first and second known locations having polymer molecules thereon, said polymer molecules comprising a protective group at an active site, said method comprising the iC
steps of: removing said:protective group from polymer molecules in said first known location of said substrate to expose said active site, but not rerciosring said protect.i:ve group from polymer molecules in said second known location; exposing said first and second known locations of said surface to first selected monomer molecules, to couple said first selected monomer molecules in said firs known location but not said second known location, said first selected monomer molecules comprising a protective group at an active site; removing a protective group from at least a portion of said first selected monomer molecules in said first known location to expose an active site on said at least a portion of said first selected monomer molecules; and exposing said first and said second known location to second selected monomer molecules, forming polymer molecules in said first known location having a different monomer sequence than monomers in said second known location.
Furthermore, another embodiment of the invention of the parent application provides an apparatus for investigating by receptorlligand binding a nucleotide sequence, which apparatus .., comprises a substrate with a surface, said surface comprising at least 103 known locations, said known locations containing different polynucleotide sequences thereon, said known locations each occupying an area of less than 2.5 x 10'3 cm2.

Ir A further understanding of the nature and advantages of the inventions of the divisional applications and the parent application herein may be realized by reference to the remaining portions of t:~e specification and the attached S drawings.
BRIEF DESCRIPTION OF THE FTGURES
Fig. 1 illustrates masking and irradiation of a substrate at a first location. The substrate is shown in cross-sect~.an;
Fig. 2 illustrates t:3e substrate after application of a monomer "A" ;
Fig. 3 illustrates irradiation of the substrates at a second location;
Fig. 9 illustrates trie substrate after application of monomer "B" ;
Fig. 5 illustrates i:r'radiation of the "A" monomer;
Fig. 6 illustrates the substrate after a second application of "B" ;
Fig. ~ illustrates a completed substrate;
Figs. 8A end 8B illustrate alternative embodiments of a reactor system for forming;a glurality of polymers on a substrate;
Fig. 9 illustrates a detection apparatus for locating fluorescent markers on thz substrate;
Figs: l0A-lOM illustrates the method as it is applied to the production of the trimers of monomers "A" and "B":

Figs. 11A, 11S and I~C arp fluorescence traces fcr standard fluorescent beads;
Figs. 12A and 12B are fluorescence curves for NVOC slides not exposed and erposed to light respectively;
E"igs. 13A and 13B illustrate formation of a slide with a checkerboard pattern of Y~GFL and GGFL exposed to labeled Herz antibody; and $ .
Figs. 14A and 14B illustrate the mapping of szxteen sec_uences synthesized on two different glass slides.
DE'_T'AILED DESCRIPTION OF THE P:~.EFERRED EMBODIi~NTS
GONTEH'TS
I. Glossary II. General la III. Polymer Synthesis ZV. Details of One Embodiment of a Reactor System V: Details of One Embodiment of a Fluorescent Detection Device 13 VI. Determination of Relative Binding Strength of Receptors VII. Examples A. Slide Preparation 20 B. synthesis of Eight Trimers of ~~Au and ~gf~

C: Synthesis of a Dimer of an Aminopropyl Group and a Fluorescent Group D. emonstration of Signal Capabzlzty E. Determination of the Number of Molecules Per Unit Area F. Removal of NVOC and Attachment of a Fluorescent Marker 30 G: U.se of a Mask in Removal of NVOC

H: Attachment of YGGFL and Subsequent Exposure to Here Antibody and Goat Apt in~ous a I. Monomer-by-Monomer Formation of YGGFL and Sub equent Exposure to 'S Labeled Antibody CONTENTS
(Coat'd) J. Monomerby-Monomer Synthesis of YGGiL and PGGFL
K. Monomer-by Monomer Synthesis of YGGFI~ and YPGGFL
L. Synthesis of an Array of Sixteen Different Amino Acid Sequences and Estimation of Relative Binding Affiniay to Herz Antibody 1~ VII2.. Illustrative Alaernative Embodiment Ix. Conclusion I. Glossa~-v The following terns are intended to nave the following general meanings as they are used herein':
1. Complementary: Refers to the Lopvlogical compatibility or matching together of interacting surfaces of a ligand molecule and its receptor.
Thus, the receptor and its ligand can be described as complementary; and furthermore, the contact surface characteristics are complementary to each other.
'r 2. ypitone: The portion of an antigen molecule which is delineated by~the area of interaction with the subclass of receptors-known as antibodies.
3. ' and: A ligand is a molecule that is recocnized by a particular receptor: Examples of ligands that can be investigated by this invention include, but are not-restricted to, agon'2sts and antagonists fog cell meanbrane receptors, toxins and venoms, viral epitopes, hornones (e. g., opiates, steroids, etc.), hormone receptors, peptides, enzymes, enzyme Substrates, cofactors, drltgs, lectins, sugars, oligonucleotides, Nucleic acids, oligosaccharides, proteins, and monocianal antibodies.
4. ~ionomer~. A member of the set of small molecules which can be joined together to form a polymer. The set of monomers includes but is not restricted to, .
far example, the set of common L-amino acids, the set of D-amino acids,. the set of synthetic amino acids, the set of nucleotides and the set o:
10 pentoses and h~xoses. As used herein, monoae_s refers to any member of a basis set for synthesis of a polymer. For example; dimers of L-amino acids form a basis set of 40o monomers for synthesis of polypeptides: Different basis sets of monomers may be used at successive steps in the synthesis of a polymer.
a t' e: A polymer in which the monomers are aloha amino acids and which are joined together through a amide bonds and alternatively referred to as a polypeptide. In the context of this specification it should be appreciated that the amino acids may be the L-optical iso~aer or the D-optical isomer.
Peptides a.a more than t;~o amino acid monomers long, and often more than 20 amino acid monomers long.
Standard abbreviations for amino acids are used (e.c., P for proline:). These abbreviations are included in 8tr~ter;,Biochemstrv, Third Ed., 1988 6. Radiation: Energy which may be selectively applied including energy having a wavelength of between 10w4 and l0' meters including, for example, electron bear radiation, gammai radiation, x-ray radiation, ultra-vielet radiationy, visible light, infrared radiation, microwave radiation, and radio waves. "Irradiatie::"
refers to the appl~c3ticn of radiation to a surface.
7. Recsotor: A molecule,that has an affinity for a given ligand. Receptors may be naturally-occuring or manmade molecules. Also, they can be employed in their unaltered state or as aggregates with other species. Receptors may be attached, covalently or noncovalently; to a binding member, either directly or via a specific bending substance. Examples of receptors which can be employed by this invention include, but are not restricted to, antibodies, cell membrane re;c~ptor~, monoclonal antibodies and antisera reactive with specific antigenic determinants (such as on viruses, cell s or other materials), drug , polynucleotides, nucleic acids, peptides, cofactors, lectins, sugars, polysaccharides, cel3s, cellular membranes, and organelles. Receptors are sometimes referred to in the art as anti-ligands. As the terra receptors is used herein, no difference in meaning is intended.
A "Ligand Receptor Pair'! is formed when two macromolecules have combined through molecular recognition to form a complex.
Other examples of receptors which can be investigated by this invention include but are nct restricted to:
a) Microoraani~m r~ceators:, Determination of ligands which bind to receptors, such as specific transport proteins or enzymes essential t~ survival of mieroorganisms, is useful in a new class of antibiotics. Of particular value wouldbe antibiotics against opportunistic fungi, protozoa, and those bacteria resistant'to the antibiotics in current use.

b) Enzymes: For instances; the binding site of enzymes such as the enzymes responsible for cleaving neurotransatitters; determination of ligands whic:~ bind to certain receptors~to modulate the action of the enzymes which cleave the different neurotransmitters is useful in the development of drugs which can be used in the treatment of disorders of neurotransmission.

14 c) Artibcdies: Fcr instance, the inveht~on may be useful in investigating the liganc-binding site on the antibody molecule which combines with the epitope of an antigen of interest;

determining a s~cruence that mimics an antigenic 15 epitoce may lead to the development cf vaccines of which the immunogen is based on one or more of such sequences or Lead to the development of relatEd diagnostic agents or campounds useful in therapeutic treatments such as for auto-immune diseases (e. g., by blocking the binding of the "sel " antibodies).

d) Nucleic Acids: Sequences of nucleic acids may be synthesized to establish DNA or RNA binding sequences:

Z3 a) Cata~.ytic Polvuetti~ies: Polymers, preferably polypegtides, which are capable of promoting a chemical reaction involving the conversion of one or more reactants to one or more products.

Such polypeptides generally include a binding 30 site specific for at least one reactant or reaction intermediate and an active functionality proximate to the binding site, which functionality is capable of chemically modifying the bound reactant.

f) F~ormone receptors: For instance, the receptors far insulin and growy-~h hormone. Determination of the ligands which bind with high affinity to a receptor is useful in the development of, for example, an oral replacement of the daily inj~ctiors which diabetics must take to re?ieve the svmptons cf dabetss, and ir. the cthe;
case; a replacement for the scarce human growth hornone which can only be obtained from cadavers or by recombinant DNA technology.
Other examples are_the vasoconstrictive hormone receptors: deterainat'ion of those ligands yhich bind to a receptor may lead to t:~e development of drugs to c~ntrol,blood pressure.
g) Oviate receata=s: Determination of ligards which bind to the opiate receptors in the brain is useful in the development of less-addictive replacements for morphine and related drugs.
8. Substrate: A material having a rigid or semi-rigid surface. In many embodments, at least- one surface of the substrate will, be substantially flat, although in some embodiments it maybe desirable to physically separate,synthesis regions for different polymers with, for example, wells, raised regions, etched trenches, or the like. According to other embodiments, smal3 beads may be provided on the surface which may be released upon completion of the syntr.es is .
9. Protective G~c~ut: A material which 3s bound to a monomer unit and which may be spatially removed upon selective exposure to an activator such as electromagnetic radiation.. Examples of protective groups with utility herein include Nitroveratryloxy 14 .
carbonyl, Ni robenzyloxy carbonyl,. Dimethyl dimethoxybenzyloxy carbonyl, 5-3romo-7-nitroindolinyl, o-Fiydroxy-a-methyl cinnamoyl, and 2-Oxymethylene anthraquinone. Other examples of activators include icn beams, electric fields, magnetic fields; electron beams, x-ray, and the like.
10. Predefined Region: A predefined region is a IO localized area on a surface Which is, was, or is intended to be activated for formation of a pclvmer.
The predefined region may have any convenient shape, e.g:, circular, rectangular, elliptical, wedge-shaped, etc. For the sake of brevity herein, "predefined regions" are sometimes referred to simply as "regions."
11. Substantially Pure: A polymer is considered to be ~~substantialLy pure" within a predefined region of a substrate when it exhibits characteristics that distinguish it from other predefined regions.
Typically, purity will be measured in terms of biological activity or function as a result of uniform sequence. Such characteristics will typically be measured by way of binding with a selected ligand or receptaz.
II. Ge a a The present invention provides methods and apparatus for the preparation and use of a substrate having a plurality of polymer ser~uences in predefined regions. The invention is desczibed herein primarily with regard to the preparation of molecules containing sequences of amino acids, but, could readily be applied in the preparation of other polymers. Such polymers include, for example; both linear and cyclic polymers of nucleic acids, polysaccharides, phospholipids, and i~
peptides having either a-, p-, or w-amino acids, hetare-polymers in which a kncwn drug is covalently bound to a.~.y of the above, polyurethanes, polyesters, polycarbcnates, poiyureas, polyamides; polyethyleneiraines, polyarylene S sulfides, polysiloxanes, polyimides, polyacetates, cr other polymers which will be apparent upon review cf this disclosure. In a preferred embodiment, the inventicn herein is used in the synthesis of peptides.
The prepared substrate may, for example, be 1~ used in screening a variety of polymers as ligands for binding with a recepto=, although it will be apparent that the invention cou3d be used for the synthesis of a receptor for binding with a ligand. The substrate disclosed herein will have a wide variety of other uses.
1S Merely by way of example; the invention herein can be used in detenaining peptide, and nucleic acid seQUences which bind to proteins, finding seguence-specific binding drugs, identifying ep.itopes recogni2ed by antibodies, and evaluation of a variety of drugs for clinical and 20 diagnostic applications, as well as combinations of the above.
The invention preferably provides for the use of a substrate "S" with a surface. Linker molecules "L"
are optionally provided on a surface of the substrate.
23 The purpose of the linker: molecules, in some embodiments;
is to facilitate receptor recognition of the synthesized polymers.
Optionally, the linker molecules may be chemically protected for storage purposes. A chemical 30 storage protective group such as t-3oC (t-butaxycarbonyl) maybe used in some embodiments. Such chemcal protective group would be chemically removed upon exposure to, for example; acidic solution and °;aould serve to protect the surface during storage and be 3S removed prior to polymer preparation.
On the substrate or a distal end of the linker molecules, a functional group with a protective group P

is provided.: The protective greup Po may be remcved upcn expcsure to radiation, electric fields, electric currents, or ether activators to expose the functional group.
In a preferred embodiment, the radiation i:s ultraviolet (W), infrared (IR;, or visible light. As more fully described below, the protective g=oun may altzrnatively bean electrochemically-sensitive group which may be removed in the presence of an electric field. In still further a-lternative embodiments, ion beams, electron beams, or the like may be used fcr deprotection.
In some embod'lmentg,, the exposed regions and, therefore, the area upon which each distinct polymer sequence is synthesized are- smaller than about 1 cm2 cr less than 1 mmz. Ln preferred emoodiments the exposed area is less than about 10,000 ~cmz or, more preferably, less than 100 ~,m2 and may, in some embodiments, encompass the binding site for as few as a single molecule. Within these regions, each polymer is preferably synthesized in a substantially pure form:
Concurrently or after exposure of a known region of the substrate to light, the surface is contacted with a first monomer unit M, which reacts with the functional group which has been expo ed by the deprotection step. The first monomer includes a protective group P1. PI may or may not be the same as Po.
Accordingly, after a first cycle, known first regions of the surfacemay comprise the sequence:
S-L-Mi'pi while remaining regions of the,surface comprise the sequence:
S-L-Po .

i7 Thereafter, second regions of the surface (which may include the first region) are exposed to light and con-tacted with a second monomer M2 (which may or may not be the same as M1) having a protective group P2. P~,mav or may not be the same as Po and PI. After this second cycle, different regions of the substrate may ccznprzse one or more of the following sequences:
S'L_Mi'~'f z-Pz S-Ia-Mz-P~
S-L-Mi-pi and/or S-L-Po .
Tre above process is repeated until the substrate includes desired po3ymers of desired lengths. 3y controlling the locations of the substrate exposed to light and the reagents exposed to the substrate following exposure, the location of each sequence will be known.
. Thereafter, the,pzotective groups are removed from some or all of the substrate and the sequences are, optionally, capped with a capping unit C. The process results in a substrate having a surface with a plurality of polymers of the following general formula:
S-(L)-(Mi)-(M~)-(Mk) ... (Mx)-(C~
where square brackets indicate optional gr3ups, and Mi...M~ indicates any sequence of monomers. The number of monomers could cover a wide variety of values, but in a preferred. embodiment they will range from 2 to 100.
Zn some embodiments a plura3:ity of locations on the substrate polymers'are to contain a common monomer subsequence. For examcle, it may be desired to synthe-size a seguence S-MI-Mz'-M3 at first locations and a sequence S-M,~-Mz-M3 at second locations. The process would commence with irradiation of the first locations followed by c~ntac'ing with Ml-P, resulting in the sequence S-MI-P at the first location. The second locs-tions would then be iradiated and contacted with M4-P, resulting in the sequence S-?~4-P at the second locations.
Thereafter both the first and'second locations would be irradiated and contacted with the direr M2-?~3, resulti~g in the sequence S-Ml-Zri2-M3 at the first locaticns and S-M~-M2-M3 at the second locations. Of course, common subsequences of any length could be utilized including those in a range of 2 or-more monomers, 2 to 100 monomers, 2 to 20 monomers, and a mcst preferred range of 2 to 3 monomers.
According to other.smbodiments, a set of masks is used for the fiast monomer layer and, thereafter, is varied light wavelengths-are used for selective deprotection. For examp~:e, in the: process discussed above, first regions are first exposed through a mask and reacted with a first monomer having a first protective graup PI, whic:~ is, removable upon exposure to a first wavelength of light (e.g., IR). Second regions are masked and reacted with a second monomer having a second protecive group PZ, which is removable upon exposure to a second wavelength of light (e. g:, W). Thereafter; masks become unnecessary in the synthesis because the entire substrate may be exposed alternatively to the first and secand wavelengths of 'light in the deprotection cycle.
The polymers prepared on a substrate according to the above methods will have a variety of uses includ ing, for example, sc=eening for biological activity. In such screening activities, the substrate containing the seruences is expesed to an unlabeled or 3.abeled receptor such as an antibody, receptor on a cell, phospholipid vesicle, or any one of a variety of other receptors. In one preferred embodiment the polymers- are exposed to a first, unlabeled receptor of interest and, thereafter, exposed to a labeled receptor-specific recognition element, which is, for example, an antibody. This prvcass will provide signal amplification in the detection stage.
The reeeator molec~;xles gay bind with one o.
more polymers on the'substrate. The presence of~the labeled receptor and; therefore, the presence of a sequence which binds whh the receptor is detecte~, in a preferred embodiment through the use of autozadiography, detection of fluorescence with a charge-coupled device, fluorescence micrascopy, or the like. The sequence of the polymer at the locations where the receptor binding is detected may be used to determine all or part of a sequence which is complementary to the receptor.
Use of the inventy~n herein is illustra;.ed primarily with reference to screening for biological activity. The invention will; however, find many othe-r uses. For example, the invention may be used in infcz:nation storage ('e.g., on optical disks), production of molecular electronic devices, production of stationary phases in separation sciences, production of dyes and brightening agents, :photography, and in immobilization of cells, proteins, hectins; nucleic acids, polysaccharides and the like in patterns on a surface via molecular recognition of specific polymer sequences. By synthesizing the same compound in adjacent, progressively differing concentrations, a gradient will be established to control chemotaxis or to develop diagnostic dipsticks which, for example, titrate an antibody against an increasing amount of antigen. By synthesizing sev< ~al catalyst molecules in close proximity, more efficient multistep conversions may be achieved by ~~coordinate immobilization." Coordinate immobilization also may be used for e3ectron transfer systems, as well as to provide both structural integrity and other desirable properties to materials such as lubrication, wetting, etc.
According to alternative embodiments; molecular bindistribution or pha=macokinetic progerties may be examined. For example, to assess resistance to intestinal or serum,proteases, polymers may be capped with a fluorescent tag and exposed to biological fluids of interest.
~~I. P,id~,E?r SVZlthe515 Fig. l illustrates one embodiment of the invention disclosed herein in which a substrate 2 is shown in cross-section. Essentially, any conceivable substrate may be employed in the invention. The l~ substrate may be biological, nonbiological, organic, inorganic, or a combination of any of these, existing as particles, strands, precipitates, gels, sheets, tubing, spheres, containers, capillaries; pads, slices, filers, plates, slides, etc. The substrate may have any ,5 convenient shape, such as a dis;., square, sphere; circle, etc. The substrate is preferably flat but may take on a variety of alternative surface configurations. For , example, the substrata may contain raised or depressed regions on which the synthesis takes place. The 2p substrate and its surface preferably form a rigid support on which to carry out the reactions described herein.
The substrate and its surface is also chosen to prcvide appropriate light-absorbing characteristics. ror instance, the substrate may be a po3ymerized Langmui~
25 Blodgett film, functionalized glass, Si, Ge, GaAs, GaP, Si02, SiN4, modified silicon, or any one of a wide variety of gels or polymers such as (poly)tetraflucro-ethylene, (poly)viny3idenedifluoride; polystyrene, poiycarbonate, or combinations thereof. other substrate 3p materials will be readily apparent to those of skill in the art upon review of'this disclosure. In a preferre3 embodiment the substrata is flat glass or single-crystal silicon with surface relief features of less than 10 A.
According to some embodiments, the surface of 35 the substrate is etched using we31 known techniczues to provide for desired surface faatures. For example, by way of he formation of trenches, v-grooves mesa st.~,:ctures, or the like, the synthesis regions aay be more closely placed within the focus point of impingi.~.7 light, be provided with reflective "mirror" str~,:ctures far maximization of light collection from fluorescent v sources, or the hike.
Surfaces on the solid substrate will usually, though not always, be composed of tie same material as the substrate. Thus, the surface may be composed of any of a wide variety of materials, for example; polymers, plastics, resins, polysaccharides, silica or siliea-based materials, car:~on, metals; inorganic glasses, membranes, or any of the above-listed substrate materials. In some embodiments the surface may provide for the use of caged binding members which are attached fircly to the surace is of the substrate, Prieferabiy, the surface will contain reactive groups, which could be carboxyl, amino, hydroxyl, or the like: Most preferably, the surface will 2Q be optically transparent and will have surface Si-OH
functicnalities, such as, are found on silica surfaces.
The surface 4 of the substrate is preferably provided with a layer of linker molecules 6, although it will be understood that the linker molecules are not re 25 quired elements of the invention. The linker molecules are preferably of sufficient length to permit polymers in a completed substrate to into=act freely with molecules exposed to the substrate. The linker molecules should be 6-50 atoms long to provide sufficient exposure. The 30 life= molecules may be, for example, aryl acetylene, ethylene glycol oligomers captaining 2-l0 monomer uni s, diamines, diacids; amino acids, or combinations thereof.
Other linker molecules may be used in light of this disclsoure.
;S According to alternative embodiments, the linker molecules are selected based upon their hydrophilic/hydrophobic-properties to improve presentation of ynthesized polymers to certain receptors: For example, in the case of a hydrophilic receptor, hydrophilic linker molecules wi.Il be preferred so as to pex-mit the receptor to more closely approach the synthesi2ed polymer:
According to another alternative embcdiment, linker molecules are also provided with a photocleavabls group at an intermediate position. The photocleavable group is prefe=ably cleavable at a wavelength different from the protective group. This enables removal of the various polymers following completion of the synthesis by way of exposure to the different wavelengths of light.
The linker molecules can be attached to the substrate via carbon-carbon bonds using, for example, 35 (Poly)trifluorochloroethylene surfaces, or preferably, by siloxane bonds (using;:foz example, glass or silicon oxide ssrfaces). Siloxane bonds with the surface of the substrate may be formed in one embodiment via reactions of linker molecules bearing trichlorosilyl groups. The linker molecules may optionally be attached in an ordered array, i.e., as parts of the head groups in a polymerized Langmuir Blodgett film. In alternative embodiments, the linker molecules are adsorbed to the surface of the substrate.
The linker molecules and monomers used herein are provided with a functional group to which is bound a protective group. Preferably, the protective group is on the distal or terminal end of the linker molecule opposite the substrate. The protective group may be either a negative protective group (i.e.,,the p=otective group renders the linker molecules less reactive with a monomer upon exposure) or a positive protective group (i.e., the protective group renders the linker molecules more reactive with a monomer upon exposure). In the case of negative protective groups an additional step of reactivation will be reqtai=ed: In some embodiments, this will be done by heating.

The prctective group on the linker .~"oiecules may be selected from a.wide variety of positive night-reactive groups preferably -including vitro aromatic compounds such as o-nitrobenzyl derivatives or benzylsul-fonyl. In a preferred embodiment, s-nitrove=atryloxy-ca=bonyl (NVOC), 2-niarobenzyloxycarbonyl (NBOC) or r~,a-dimethyl-dimethoxybenzyioxycarbonyl (DDZ) is used:
In one embodiment, a vitro aromatic compound containing a benz~~' is hydr age:i ortho to t.:e vitro group is usad, i . a . , a c:~emical o f the f ora R~ RS O

H O ...
15 Rz ~ ~NO2 where RI is alkoxy, alkyl, halo, aryl, alkenyl, or hydrogen: RZ is alkoxy, alkyl, halo, azyl; vitro, or' 20 hydrogen: R3 is alkoxy, alkyl; halo; vitro, aryl, or hydrogen: Rs iS alkoxy,'alkyl, hydrogen, aryl, halo, or vitro; and RS is-alkyl, alkynyl, cyano, alkoxy, hydrogen, halo, ary3, or alkenyl. Other materials whicz may be used include o-hydroxy-a-methyl cinnamoyl der watives:
25 photoremovable protective gsoups are described in; fvr example, Patchornik, J: Fpm. Chem. Soc. (1910) 92:6333 and Amit et al., J. ora. Chem. (1974y ~.9:192a In an alternative embodiment the pcsitive 30 reactive group is activated for reaction with reagents in solution. For example, a, 5-bromo-7-nitre indoline group, when bound to a carbonyl, undergoes reaction upon exposure to light at 420 nm:
In a second aLternativ~ embodiment, the reactive group on the Tinker molecule is selected from a wide variety of'negatiVe light-reactive groups including a cinammate group.

Alternatively; the reactive group is activated or deactivated by electrcn beam lithography, x-ray lithography, or any other radiation. Suitable reac;.ive groups for el~ctran beam lithography include su?fonyl.
other methods may be used inc3uding, for example., expo-sure to a currant source. Other reactive groups and methods of activation may be used in light of this disclosure.
As shown in Fig. 1, the linking molecules ire pr-'e~abiy exposzd to; for example, light throuch a suitable mask 8 using photolithographic techniaues cf the type known in the semiconductor industry and described in, for example, Sze, VLSI Technoloav, McGraw-Hill (3983), and Mead et a-?., Introduce=cn tc zorc-Systems, Addison-Wesley (1880).
The 1 i-gh ~ may be directed at either the surface containing the g~otec~we groups or at the bac3c of the substrate, so long as the substrate is transparent to the wavelength of light needed for removal of the protective groups. In the embodiment shown in Fig: 1, light is directed at tie surface of the substrate captaining the protective groups. Fig. l illustrates the use of such masking techniczues as they are applied to a positive reactive group so as to activate linking molecules and expose functional groups in areas 10a and 10b:
The mask 8 !is in one embodiment a transparent support material selectively coated with a layer of opaque material. Portions of the opaque material are removed, leaving opaque>mat~rial in the precise pattern desired on the substrate surface. The mask is brought into cJ:ose proximity with, imaged on, or brought directly into contact with the substrate surface as shown in Fig. 1. "flpenings'! in the mask correspond to locations on the substrate where it is desired to remove photoremovable protective-groups from the substrate.
Alignment may be pe=formed using conventional alignment z5 techniques in which alignment r~ayks (not shown) ara used to accurately overlay successive masks with previous patterning steps, Or more sophisticated techniuaes ~av be used. For example; inteyferorsetis tec:~niques such as the one described.in Flanders et a~., "A New Interf erometric Alignment Technique," Apo. phvs. Lptt.
(1977) 31:426-428. may be used.
To e:lhanc~ contrast cf lig, t acolied to 1Q the substrata, it is desira5le to provide contrast enhancement mate=ials between the mask and the suysrrate according tc, some embodiments . This cont; as t enhznce:~er, t layer may comoris~ a molecule which. is deco:aposad by Light suc:~ as cuinone diazid or a material whic:, is 1 ~ tr ans ier. tlv bleac:~ed a t ~~e wave l eng th o f inter es ;: .
Transient bleaching cf materials will allow grea~c=
penetration where light is~applied,hereby enr;anci~c contrast. Alternatively, contrast enhancement mzv be provided by way of a cladded fiber optic bundle.
20 The light may be~f.~om a conventional incandescent source, a laser; a lase-r diode, or the like.
If non-colli~ate~ sources of light are used it may be desirable to provide a thick- or mufti-layered bask to prevent spreading of the fight onto the substrate. it may, further, be desirable in some embodimentsto ~:t;li~e groups which are sensitive to different wavelengths tc control synthesis. For example, by using grou~s.whic:-:
are sensitive to different ~;ravelength5, it is possible to select branch positions in'the synthesis of a polymer c~
30 eliminate certain masking steps. several reactive g~eu~s along crith their corresponding wavelengths for deprotec~ion are provided in Table 1.

Table 1 Approximate Group ' Denrotzction Wave~encth Nitrove=atryloxy carbonyl (NVOC) W (300-40o nm) Nitrobenzyloxy carbonyl (NBOC) W (300-350 n:i) Dimethyl dimethoxybenzyloxy carbonyl W (280-300 nm) 5-Bromo-7-nitroindolinyl W (420 nm) o-Hydroxy-a-methyl c'innamoyl UV (300-350 nm) 2-oxymethylene anthraqu.none UV (35e nm) While the invention is illustrated primarily herein by way of the use of a mask to iiiuminata selected regions the substrate, other techniques may also be used.
For example, the substrate may be translated under a modulated laser or diode light source. Such technicues are discussed in, for example, U.S. Patent No. 4,7I9,6?5 _ ,. (Feyrer et al.), In alternative embodiments a laser galvanometric scanner is utilize. In other embodiments, the synthesis may take place on yr in contact with a conventional liquid crystal (referred to herein as a "light valve") o= fiber optic light sources. By appropriately modulating liquid c:ystals, Light may be selectively controlled so: as to permit light to contact selected regions of the ubstrate: Alternatively, synthesis may take place on the end of a series of optical fibers to which light is selectively applied.
Other means of controlling the location of light exposure will be apparent to those- of skirl in the art:
The substrate;may be irradiated either in contact or not in contact with a solution (not shown) and is, preferably, irradiated in contact with a 35 Solution. The solution'conta'1ns reagents to prevent the by-products formed by irradiation from interfering with synthesis of the polymer according to some embodiments.
Such by-products might include, ~or example, carbon Z' dioxide, nitrosacarbonyl compounds, styrene der.vatives, indoie derivatives, and products of their photochemical reactions. Alternatively, the solution may contain reagents used to match the index of refraction of t:~e substrate. Reagents added to t'~e solution may further include, for example; acidic or basic buffers, thiols, substituted hydrazines and hydroxylamines, reducing agents~(e.g:, NADH) or reagents known to react with a given functional group (e, g., aryl nitroso + glyoxylic acid ~» aryl formhydroxamate + Co2).
Either concurrently with or after the irradiation step, the linker molecules are washed or otherwise contacted with a fltst monomer, illustrated by "A" in regions 12a and 12b in Fig. 2. Tha first Monomer reacts with the activated functional groups of the linkage molecules which have been exposed to light.
The first monomer, which is preferably an amino acid, is also provided with a photaprotective group. The photoprotective g=oup on the monomer may be the same as or different than the protective group used in.the linkage molecules; and may be selected from any of the above-described protective groups. In one embodiment, the protective groups for the A monomer is selected from the group NBOC and NVOC.
As shown in Fig: 3, the process of irradiating is thereafter repeated, with a mask repositioned so as to remove linkage protective groups and expose functional groups in regions 14a and 14b which are illustrated as being regions which were protectea in the previous masking step. As an alternative to repositioning of the first mask, in many embodiments a second mask will be utilized. In other alternative embodiments, same steps may provide fo-r illuminating a common region in successive steps: As shown in Fig. 3, it may be desirable to provide separation between irradiated regions. For example, separation of about 1-5 um may be appropriate to account for alignment tolerances.

As shown in Fig. 4, the subsgate is then exposed to a second protzctad monomer "B," producing B regions 15a and 16b. Thereafter, the substrate is again masked so as to remove the protectlY2 groums a:~d expose reactive groups on A region 12a and B region 16b.
The substrate is again exposed to monomer B, resulting in the foraation of the structure shown in Fig. 6. The dimers B-A and B-B have been produced cn the substrate.
A subsequent series of masking and contacting steps similar to those described above with A (not shown) provides the strscture shown in Fig. 7. The process provides all possible dimers of B and A, i.e:, B-A, A-B, A-A, and H-B:
The substrate, the area of synthesis, and the lc area for synthesis of each individual polymer could be of any size or shape. For example, squares, ellipsoids, rectangles, triangles, circles; or portions thereof, along with irregular geometric shapes, may be utilized.
Duplicate synthesis areas may a3so be applied to a single substrate for purposes of redundancy.
In one embodiment the regions 12 and 16 on the substrate will have a surface area of between about 1 c:n2 and 10-1° cm2. In some embodiments the regions l2 and 16 have areas of less than about 10-j cm2; 10-2 cmz; 10-3 cmZ, IO-4 cm2, 10-5 cmz, I0-6 cm2; i0-~ cm2; 10-8 cmZ, or lOwo cm2.
In a preferred embodiment, the regions 12 and 16 are between about 10x10 ~Cm and 500x500 ~cm.
In some embodiments a single substrate supports more than about 10 differ=ent monomer sequences and perferably more than about IOO different monomer seguences, although in some embodiments more than about 103, TOj, 105, 10b, 101, or 108 different sequences are provided on a substrate. Of course, within a region of the substrate in which a monomer sequence is synthesized; it is preferred that the monomer sequence be substantially pure: Ln some embodiments, regions of the substrate contain polymer sequences which are at least about l%, 5%, 10%, 15%; 20%, .~.5%, 30%, 35%, ~0%, 45%, 50%, 60%, 70$, 80%, 90%, 95%, 96%, 97%, 98g, or 99% pure.
According to same embodiments, several.
sequences are intentiona3ly provided within a single region so as to provide an initial screening for biological activity, after which materials within rec:cns exhibiting significant binding are further evaluatec.
q IV. Details of One Eriboc~iment of a Reactor System Fig. 8A schematically illustrates a preferred embodiment of a reactor system l00 for synthesizing polymers an the prepared sub,~trate in accordance wit:: one aspect of the invention: The reactor system induces a body 102 with a cavity 104 on a surface thereof. In preferred embodiments the cavity 104 is between about 50 and 1000 ~cm deep with a depth of about 500 ~cm preferred.
The bottom of the cavity is preferably provided with an array of ridges 106 Which extend laoth into the 20 plane of the:Figure and parallel to the plane of the Figure. The ridges are preferably about 50 to 200 ~m deep and spaced at about 2 to 3mm. The purpose of the ridges is to generate turbulent flow for better mixir.G.
The bottom surtace of the cavity is preferably light ~5 absorbing so as to prevent reflection of impinging light.
A substrate 11:2 is mounted above the cavity 104. The substrate is provided along its bottom surface 114 with a photoremovable protective group such as NVOC
with or without an intervening linker molecule . The p substrate is preferably transparent to a wide spectrum of light; but in same embodiments is transparent only at a wavelength at which the protective group may be removed (such as UV in the case of NVOC). The substrate in some embodiments is a conventional microscope glass slide or cover slip. The substrate is preferably as thin as possible; while still providing adequate physica3 support: Preferably, the substrate is less than about 1 mm thick, more preferably less than 0.5 mm thick, :yore preferably less than 0.1 mm trick, and most preferably less than o.05 mm thick: In alternative preferred embodiments, the substrate is quartz or silicon.
The substrate and the body serve to seal the cavity except for an inlet fort 108 and an outlet port 110. The body and the substrate may be mated for sealing in some embodiments with one or more gaskets. According to a preferred embodiment, the body is provided wit:. two i0 concentric gas~sts and the intarvening space i,s held at vacuum to ensure mating of the substrate to the gaskets.
Fluid is pumz~ed through the inlet port into the cavity by way of a pump 116 ~thich may be, for example, a model no. H-120-S made by Elder Laboratories. Selected fluids are circulated into the cavity by the pump, through the cavity, and out the outlet for reei~culation or disposal. The reactor may be subjected to ultrasonic radiation and/or heated to aid in agitation in some embodiments.
Above the Substrate i12, a lent 120 is provided which may be, for example, a 2" lOOmm focal length fined silica lens. For the sake of a compact system, a reflective mirror l22 may be provided for directing light from a light source 124 onto the substrate. ~,igr~t source 124 may be, for example, a Xe(Hg) light source manufactured by Oriel and having~model no. 66024. A
second lens 12fi may be provided for the purpose of projectirc a mask image onto the substrate in combination with lens 120. This for~.a of lithography is referred to herein as projection'printing. As will be apparent from this disclosure, proximity printing and the like may also be used according to ame embodiments.
Light from the bight source is permitted to reach only selected locations on-the substrate as a result of mask 128. Mask IZ8 maybe, for example, a glass slide having etched chrome thereon. The mask 128 in one embodiment is provided with a grid of transparent locations andopaque'locations. Such masks may be manufactured by, for exaixple, Photo Sciences, Inca Ligh passes freely through the transparent regions of the mask, but is. reflected from or absorbed by other regions.
Therefore, only selected regions of the substrate are expo ed to light.
As discussed above, light valves (LCD's}
may be used as an alternative to conventional masks to selectively expose regions of the substrate.
Alt~raatively, fiber opt.ic'faceplates such as those available from Schott Glass, Inc, may be used for the, purpose of contrast enhancement of the mask or as the sale means of restricting th~.region to which light is applied. Such f3caplates would be placed directly above IS or on the sub trate in the reactor shown in Fig. 8A: Ia still further embodiments; flys-dye lenses, tapered =fiber optic faceplates, or the like; may be used for contrast enhancement.
In order to provide for illumination of regicns smaller than a wavelength of light, more elaborate techniques may be utilized. For example, according to one preferred embodiment, light is directed at the substrata by way of molecular microcrysta~.s on the t~p of, for example, micropipettes. Such devices are 25 disclosed in 'Lieherman ,e~ a~., "A Light Source Smaller Than the Optical Wavelength;" Science (1990) 247;59-61>
In operation, the substrate i5 placed on the fl cavity and sealed thereto. A11 operations in the process cf preparing the substrate are carried out in a room lit primarily or entirely by light of a Wavelength outside of the light range at which the protective group is removed.
For example, in the case of NVOC, the room should be lit 35 With a.conventional darkroom light which provides little or no UV light. A11 operations are preferably conducted at about room temperature.

A first, deprotection fluid (Without a monomer;
is circulated through the cavity. The solution preferably is of 5 mM sulfuric acid in dioxane solution which serves to keea exposed amino groups protonated and decreases their reactivity with photolysis by-products.
Absorptive materia3:s such as N;N-diethylamino 2,4-dinitrobenzene, for example, may be included in the deprotection f3uid which serves to absorb light and prevent reflection and unwanted photolysis.
1Q The slide is, thereafter, positioned in a light raypath fram the mask such that first locations or, the substrate are illuminated and, therefore, deprotected.
In preferred embodi-~ents the substrate is illuminated for between about l and 15 minutes with a preferred 15 illumination time of about l0 minutes at 10-20 mW/c~n= wit'.~.
365 nm light. The slides are neutralized (i..e., brought to a pH of about 7) after photolysis with, for example, a.
solution of di-isopropylethylamine (DIEA) in methylene chloride for about 5 minutes.
The first monomer is then placed at the first locations on the substrate. After irradiation, the slide is removed, treated in bulk, and then reinstalled in the flow cell. Rlternatively, a fluid containing the first monomer ,preferably also protected by a protective group, is circulated through the cavity by way of pump 116. Lf, for example, it is: de fired to attach the amino acid Y to the substrate at the first locations; the amino acid Y
(bearing a p:otective group on its a-nitrogen), along with reagents used to render the monomer reactive, and/or p a carier, is circulated from a s orage container 11s, through the pump, through the cavity, and back to the inlet of the pump.
The monomer carrier aoiution is, in a preferred embodiment; formed b~ mixing of a first solution 3S (referred to herein as solution "A") and a second solution (raferrsd to herein as solution "H"): Table 2 provides an illustration of a mixture which :nay : a used for sarution A.
Tab3,e 2 reap t . ~ Ve t- arri er p: ti n ttA n LOO mg NVOC amino protected amino acid 37 mg Ii08T (1-Hydroxybenzotriazole) 250 ~1 DMF (D:i.methylformamzde) 86 u1 DIEA (Diisopropylethylamine) The compo ition of solution B is illus~razs~: in Table 3. Solutions A and H are mixed and allowec to react at soo:a temperature for about 8 minutes, t!~en diluted with 2 m1 of DMF, and 500 ~c1 are applied to the surface of the slide or the solution is circulated through the reactor system and allowed to react far about 0 2 hours at room temperature: The slide is then washed with DMF, methylene chloride and ethanol.
Reore ent~tive MQ;p;omer Carrier Sol~ut~ an 250 ~l DMF
111 mg BQP (Benzotriazolyl-n-oxy-tris(dimethylaminc) phosphoniumhexafluorophosphate) As the solution containing the monomer to be attached is circulated through the cavity the amino acid or other monomer will react at its carboxy teranus with amino groups on the regions of the substrate which have been deprotectad. Of course, while the invention is illustrated by way of circulation of the monomer through the cavity, the invention cou3d be practiced by way o' removing tae slide frcm the reactor and submersing i~.. in an appropriate monomer solution.
After addition of the first monomer, the solution containing the first amino acid is then purged from the system. Aftzr circulation of a sufficient amount of the DMF/methylene chloride Such. that removal of the amino acid can be assured (e.g., about 50x times the volume of the cavity and carrier lines), the mask or substrate is repositioned, or a new mask is utilized such la that second regions on the substrate will be exposed to light and the light l24 is engaged for a second expcsure.
This will deprotect second regions on the substrate and the process is repeated until the desired polymer sequences have been ynthesized. .
15 The entire derivatized substrate is then exposed to a receptor of interest, preferably labeled with, for example, a fluorescent marker, by circ~~laticn of a solution or suspension of the receptor thrbugh the.
cavity yr by contacting the surface of the slide in bulk.
The receptor will prefez8ntially bind. to certain regions of the substrate which contain complementary seguences.
Antibodies are typically suspended in what is commonly referred to as: "supercacktail,": whic:~ may be, for example, a solution of about I~ BSA (bovine seru:.~, albumin), o:5% T'ween'~in PHS (phosphate buffered sa?iney buffer. The antibodies are diluted into the supercacktail buffer to a final concentration of, for example, about 0.3. to 4 ~sg/ml.
Fig. 88 illustrates an alterna rive prat erred 3Q embodiment of the reactor shown in Fig. 8A. According to this embodi.went, the mask 128 is placed directly in contact with the substrate. Preferably, the etched portion of the mask is placed face down so as to reduce the effects of light dispersion: According to this 35 embodiment; the imaging lenses'120 and iZ6 are not necessari because the mask is brought into close proximity with the substrate.
* trade-mark j5 Fog pur~oses of increasing the signal -to-noise ratio of the tech.~.ique; some embodyments of the invention provide for exposure of the substrata to a first labeled or u~~.labeiec recsp~~r fllowed by exposure of a labeled, second receptor (e. g:, an antibody) which bfinds~at multirle sites or. she first receptor. If, for example, the first receptor is an antibody derived from a first species of an animal, t.'~e second receptor is an antibody derived from a second species directed to epitopes associated with the fist species. In the case of a mouse antibody, for example, fluorescently labeled goat antibody or antiserum which is antimouse may be used to hind at multiple sites an the mouse antibody, providing several times the fluor~scencs compared to the attachme.~.~
of a single mouse antfibody at each binding site. This process may be reaeate3 again with additional antibodies (e.g., goat-mouse-goat, etc.) for further signal amplification.
In preferred embodiments an ordered sequence of 2~y masks is utilized. Tn soiae embodiments it is possible to use as few as a single mask to synthesize all of the possible polymers of a given monomer set.
If, for example, it is desired to synthesiza all 16 dinuc3eotides from-four bases, a l cm scuare synthesis region is divided conceptually into 16 boxes, each 0.25 c~ wide: Denote the four monomer units by A, B, C, and D. The first reactions are carried out in four vent=cal columns, each 0.25 cm wide. The first mask exposes the legt~bost column of boxes, where A is 30 oouPled. The second mask exposes the next column;
where 8 is coupled; followed-by a third mask, for the C column: and a f::nal mask that exposes the right-most column, for D. The first, second, third, and fourth masks may be a single mask translated to different 35 locations.

The process is repeated in the horizontal directicn for the second unit of the dimer. This time, the masks allow exposure of horizontal rows, acain 0.25 cm wide. A, B; C, and D are sequentially coupled using masks that expose horizontal fourths of the reaction area. The resulting substrate contains all 16 dinucleotides of four bases:
The eight masks used to synthesize the dinucieotide are related to one another by trans?at.on c.
rotation. In fact, one mask can be used in all eight steps if it is: suitably rotated and translated. :or example, in the example above, a mask with a single transparent region could be sequentially used to expose each of the vertical columns, translated 90', and then ,s sequentially used to allow exposure of the horizontal rows.
Tables 4 and 5 provide a simple computer program in Quick Basic for planning a masking program and a sample output; respectively, for the synthesis of a p°lYmer chain of three monomers ("residues") having three-diffe=ent monomers in the first Ieyel, four different monomers in the second level, and five different monomers in the third le~ei in a striped pattern. The -output of t:~e program is the nurber of cells, the number of "stripes" (light regions) on each mask, and the amount of translation required far each exposure of the mask.

a 1e 4 Ma k ~t-ra~,egv Pro.~rar~.
DE:INT A-Z
DIM b(20), w(20), 1(500) F $ - "I:PT1: "
OPEN f$ FAR OUTPUT AS #1 jmax - 3 'Number of residues b(i) - 3: b(2) - 4: b(3) - 5 'Number of building blacks zor res 1,2,3 g - I: lmax(I) - l FOR j - 1 TO j max : g- g * b ( ~ ) : ' NEXT j w(0) - 0: w(1) - g / b(1) PRINT ~1, "M.ASK2 . BAS " DAT~$ , TI?YiE$ : PRINT #1, PRINT T1, USING ":lumber of residues:" ; fax FOR j ~ 1 TO jmax ?P,INT w l , USING " Residue ~ =~ building blocks" ; j ; b ( j ) NEXT j PRINT ,=1, "
PRINT T, L!SING "Number of cells-~x"; g: PRINT #l, FOR j - 2 TO jmax lmax(j) - lmax(j - 1) * b(j - 1) w(j ) - w(j - 1) / b(3 ) NEXT j FOR j - 1 TO j max PRT_NT #1; USING "Mask for residue ~"; j: PRINT #1, PRINT #L, USING " Numcer of stripes-"; lmax(j) PRINT =I, USING " Wfdth of each stripe-~a"; w(j) FOR 1 - 1 TO lmax(j) a - 1 + (1 - 1) * w(j - 1) ae - a + w(j) ~ I
PRINT ~1, USING " St:i;pe ~e begins at location and ends at ~"~ 1; a; ae PRINT =1, PRINT ~1, USING " For each of os# building blocks, translate mask by ~~
cells)"; b(j); w(j), .
PRINT #1, . PRINT #1, . PRINT #I, NEXT j m Copyright 1990, Affymax N.V.

Tab a Masking StrateQV Output 'lumber of residues- 3 Residue 1 3 building blocks Residue 2 4 building blocks Residue 3 5 building blocks Number of cells- 60 Mask for residue 1 Number o= stripes- 1 Width of each stripe- 20 Str~pe l begins at location 1 and ends at 20 For each of 3 building Mocks, translate mask by 20 cells) ::ask for residue 2 Number of stripes- 3 Width of each stripe- S
Stripe l begins at location 1 and ends at 5 Stripe 2 begins at location 21 and ends at 25 Stripe 3 begins at location 4l and ends at 45 For each of 4 building blocks; cransiate mask by 5 cells) Mask for residue 3 Number of stripes- 12 Width of each stripe- I
Stripe 1 begins at location I and ends at 1 S;.ipe 2 begins at location 6 and ends at 6 Stripe 3 begins at location I1 and ends at 11 Stripe 4 begins at location I6 and ends at 16 Stripe 5 begins at location 21 and ends at 2I
Stripe 6 begins at location 26 and ends at 26 Stripe 7 begins at location 31 and ends at 3I
Stripe 8 begins at location 36 and ends at 36 Stripe 9 begins at location 41 and ends at 4I
Stripe 1O begins at location 46 and ends at 46 Stripe 1l begins at location 51 and ends at 51 Stripe 12 begins at location 56 and ends at 56 For each of 5 building blocks, translate mask by l cells) ~ Copyrigh 1990, Affymax N.V:

V. Details of ~~e ~ ~odime.~.~ of A Fluor=_scfl.~.t -Detection Device Fig. 9 illustrates a fl~:orescent 'detectic;.
device far detecting fluorescantl:: ?abeied receptors on a substrate: A substrate 112 is placed on an x/_~
translation table 202. In a preferred e~odi:~2nz t'.-.=_ x/y transiaticn table i5 a model. no . ~ M5 0 0-yl man4f actor ;d by Newport Corporation. The x/y ~_anslaticn table connected to and controlled by an aapratriatev i0 Programmed digital camputer 204 which may be, =ar example, an apprapriately program.~ed LB:~ PC/Aor A
compatible coma~ter. Of cau=se, other ;:omputa= sys~_:~s, special purpose hardware, of the l;ke c:.;:ld reacilv ~' substituted for tie ~T. com~u,;.er used herein for 15 illus tra ripe . Computer sof triare f :,r the tr ars=a tic-and data coilac~ion functions described :~erei:: can ~~
provided based on commerciaz :.y ava~.l ~bi~ sof t.:are including, for example, "Lab Windc~rs~~ licensee by National Inst~ents':
The substrate and x/y translation table a.-=
planed under a microscape 206 which includes one or pore objectives 208. Light '(abo4t 488 em) fram a Laser 2=0, which in some embodiments is a model no. 2020-05 arccn ion laser manufactured by.Spectrapysics, is direcz=c at the substrate by a dichroic mirrc~ 207 which gasses greater than about 520 em i~ght bLt ref'ects ~38 em light. Dic:~roic mirror 207 may be; for example, a w~del no. FT510 manuzacturad by Carl Zeiss. Light reflec==:
from the mir;or then enters the m=croscope 206 whic:: :aay be, for example, a model no. Axioscov 20 manufactured by Carl Zeiss. Fluorescein-harked materials on the substrate will =luoresce >488 em light, and t::e fluflresced light will be co?lected by t:':e micrcsc,~,pe 3c and passed through the mirror. T:~e fluoresce~c lic::=
from the substrate is then directe3 thr;.ugh a ;~avele.-.gt:~
filter 209 and, thereafter throng:. an aperture plate 2I1.
* trade-mark wavelength filter 209 may be, for example, a model no. 0G~30 manufactured by Melles Griot and aperture plats 211 may be, for example, a model no. 477352/:~a7380 manufactured by Cari Zeiss.
The fluoresced lfight then enters a photomultipli~r tube 212 which in some embcdi:aents is a model no. 8943-02 manufactured by Hamamatsu, the sicnal is amplified in preamplifier 214 and~photons are counted by photon counter 216: The number of photons is recorded as a function of the location in t:~e computer 204.
Pre-Amp 2Z4 may be, for example, a model no. SR440 manufactured by Stanford Research Systems and photon counter 2I5 may be a model no. SR4D0 manufactured by Stanford Research Systems. The substrate is then moved to a subseauent location and the process is repeated.
In preferred embodiments the data are acquired every 1 to 100 ~cm with a data collection diameter of about 0:8 to 10 ~cm preferred. In embodiments with sufficiently high fluorescence, a CCD detector with broadfield illumination is utilized:
By counting the number of photons generated in a given area in response to the laser, it is possible to determine where fluorescent marked molecules are located on the substrate. Consequently, for a slide wh.ic:~ has a matrix of poiypeptidesfor example, synthesized on the surface hereof, it is possible to determine which of the polypeptides is complementary to a fluorescently marked receptor.
According to preferred embodiments, the intensity and duration of the light applied to the substrate is controlled by varying the laser power and scan stage rate foz improved signal-to-noise ratio by maximizing fluorescence emission-and minimizing background noise.
35 While the detection apparatus has been illustrated primarily herein with regard to t!~e detection of marked receptors, the invention will find application ~1 in other areas. For example, the detactian apparatus discicsed herein could be used in the fields of catalysis, DNA or protein gel scanning, and t:~e like.
VI . DeteT-mination of Rel ati.VA
~indincr Strength of ~,ecettors The signal=to-noise ratio of the present invention is sufficient?y high that not only can the presence or absence of a redeptor on a ligand be detected, but also the relative binding affini~~y of receptors to a variety of sequences can be deter";inec.
In practice it is found that a receator will bind to several peptide sequences in an array, but will bind muc:z more strongly; to some secxuences than others.
Strong binding affinity will be evidenced herein. by a strong fluorescent or radiographic signal since many receptor molecules will bind in a region of a strongly bound ligand. Conversely, a weak binding affinity will be evidenced by a weak fluorescent or radiographic signal due to the relatively small number of receptor molecules which bind in a particular region of a substrate having a ligand with a weak binding affinity, for the receptor.
Consat~uently; it becomes possible to determine =elative binding avidity (or affinity in the case of univalent l~ interactions) of a ligand herein by way of the intensify of a fluorescent or radiographic signal in a region containing that ligand.
Semiquantitative data on affinities might also be obtained by varying washing conditions and concentrations of the receptor. Thz would be done by comparison to known ligand receptor pairs, for example.
VII. Exam~Ies The following examples are provided t~
illustrate the efficacy of the inventions here n. All operations were conducted at about ambient temneratu=es and pressures unless indicated to the contrarv.

A. Slide Prpnaration Before attachment of reactive groups it is preferred to clean the substrate wrich is, in a preferred emi~cdiment a glass substrate such. as a microscope slide or cover slip. according to one embodiment the slide is soaked in an alkaline bath consisting of, for example, 1 liter of 95% ethanol with 120 ml of water ard:120 grams of sodium hydroxide for L2 hours. The slides are then washed under running water and allowed to air dry, anc i0 rinsed once with a solu~icn of 95% ethanol.
The slides are then aminated with, for exa:~ple, aminopropyitriethoxysilane for the purpose of attaching amino groups to the glass surface on linker molecules, although any omega funct~onalized silane could also be 1~ used for this purpose. in one embodiment 0.10 aminopropyltriethoxysilane is utilized, although solutions with concentrations from l0-'% to l0% may be used, with about IO-3% to 2% preferred. A 0:1% mixture is prepared by adding to 100 ml of a 95% ethanol/5% water 20 mixture, 10O microliters (~l) of aminopropyltriethoxy-silane. The mixture is agitated at about ambient temperature on a rotary shaker for about 5 minutes.
500 u1 of thismixture is then applied to the surface of one side of each cleaned slide. After 4 minutes, the 25 slides are decanted of this solution and rinsed three times by dipping in, for example, 100% ethanol.
After the plates dry, they are placed in a 110-120'C vacuum oven for about 20 minutes, and then allowed to cure at room temperature for about l2 hours 30 in an argon environment. The slides are then dipped into DMF (dimethylformamide) solution, followed by a thorough washing with methylene chloride:
The aminated surface of the Tide is then exposed to about 500 u1 of, for example; a 30 milli:~olar 25 (mM) solution of NVDC-GAGA (gamma amino butyric acid) NhS
(N-hydroxysuc~ini~ide) in DMF for attachment of a NVOC-GABA to each of the amino groups.

The surface is washed :pith, fir example, ~MF, methylene chloride, and etzanal.
Any u~rsacted a~inoprcpyl siiane on the surface--that is, these amino grcu~s which have nc:.':ad the NVOC-GAGA attached--are now capped with acct 1 ~r Y' ~ ours (to preventfurther'reaction) by exposure to a 1:3 mixture of acetic anhydride in pyridine for 1 hour.
other materials whicmay perform this residual capping function include tri;luorcacetic anhydride; formicacetic a~Ydride, or other reactive acyiating agents. Fi.~.ally, the slides are washed again with DMF, methylene c::'_~ride, and ethanol.
r T..;~.~,r.s Cr ttpn and tmt~
g. Svn~hesis of E_a;
F:ig. 10 illustrates a possible synthesis of the eight trimers of the t:ao-:~onc~z~r set: gly, phe (represented by ttAtt and t3, ~n respectively) . A gla=_5 slide bearing silane groups terminating in 6-nitre-veratryloxycarboxamide (NVOC-NH) residues is prepared as a substrate. Active esters (pentafluorophenyl, OBt, etc:) of gly and phe pratectad at the amino group ;pith NVOC are prepared as reagents:: While not pertiner~ to this example, if side chain protecting gsoups are rpcuired for the monomer set, these must not be 23 photoreactive at the wave?ength of light used to protect the primary chain.
For a monomer set of size n, n x E cycles are required to synthesize all possible sequences of length t. A cycle consists of:
30 1. Irradiation through ,an appropriate »:ask to expose t:'~e- amino groups at the si;.es where the next residue is to be added, with appropriate washes to remove t'.~.e by-products o~ the deprotection.
35 2. Addition of a single activated and protected (with t::e same phot~chem:cally-removablegroup) monomer, which wil'_ react only at the sites addressed in step 1; ::~th appropriate washes to remove the excess reagent f i ~m the surf ace .
The above cycle is repeated for.eacn member of the monomer set unti-1 each location on the surface has been extended by one residue i:~ one embodiment. In ct:~er embodiments, save-ral residues are sequentially added a~
one location before moving on to t2~.e next location:
Cycle times wil? generally be limitzd by the coupling reaction rate, now as short as 20 min in autematea peptide synthesizers. This step is optionally followed by addition of a protecting group to stabilize the ar=ay for later testing. For some types of polymers (e. g., peptides), a final deprotection of the entire ,5 surface (removal of photoprotective side chain groups) may be reauired.
More particularly, as shown in Fig. 20A, she glas 20 is provided with regions 22, 24, 26, 23, 30, 32, 34, and 36. Regions 30, 32, 34, and 36 are masked, as shown in Fig: 108 and the glass is irradiated and ex-posed to a reagent containg "A" (e.g., gly), with t~.e resulting structure shown in Fig. lQC. Thereafter, regions 22, 24; 26, and 28 are masked, the glass is irradiated (as shown in Fig. lOD~ and exposed to a 5 reagent containing "H" (e. g., phe), with the result_.a structure shown in Fig. IOE: The process pr4ceeds, consecutively masking and exposing the sections as s;~own until the structure shown in Fig. lOM is obtained. The glass is irradiated and the terminal groups are, optionally, capped by acetylation. As shown, all possible trimers of gly/phe are obtained.
In this example, no side chain protective group removal is necessary. If it is des iced, side chain deprotection may be accomplished by treatment with ethanedithiol and trifluoroacetic acid.
In general, the number of steps needed to obtain a particular polymer chain is defined by:

n x E (1) where:
n = the numrae~ of monomers i~ the basis set of monomers, and L = the number ~of monomer units in a pclymer chain.
Conversely; tie synthesi2ed number of szauences of length E will be:
nc. (2) Of course, greater diversity is obtained b_J
.- using masking strategies which will also include the synthesis of polymers having a length of less than E.
If, in the extreme case, all polymers having a lengt:: , less than or equal to E are synthesized, the number of polymers synthesized will be:
nt + nt:. + . . . + n1 : ( 3 ) The maximum number of lithographic steps needed will generally be n for'each "layer" of monomers, i.e., the total number of masks (and, therefore, t:~e number of lithographic steps) needed will be n x E. The size of the transparent mask regions will vary in accardanea with the area of the substrate availab3e for synthesis and the number of sequences to be formed. In general; the size 0 of the synthesis areas will be:
size of synthesis areas _ (A)/(S) where:
35 ,A is the total area available for synthesis;
and S is the number of sequences desired in to area.
I t will be aDarec'iated by those of skit 1 i~
the art that the above method could readily be used to simultaneously produca thousands or millions oz oligcmers on a substrate using the photolithographic tec:~nicues disclosed herein. Consea_uently, the methcd rssult in the ability to practically test large numi~ers of, for example, dl, ti, tetra; penta, hexa, hepta, octapeptides, dodecapeatides, er larger polypeptides (or coriespondinrly, polynucleotides).
The above examale has illustrated the me~::cd by ~aav of a manual example. It will of course be appreciated that autoaate:- ~r semi-automated methcds cou?d be used. The substrate would be mounted in a flow cell for automated addition and removal of reage.~.as, to minimize the volume of reagents needed, and to more carefully control reaction condit.ons. Successive masks Q . could be applied manually or automatically.
~, C. Synthesis of a Dimer of an Aminoaroavl Groua and a Fluorescent Groub In synthesizing the dim~r of an amiroar pyl group and a fluorescent-group, a functionalizec durapore*
membrane was used as a substrate: The duraaare me~~rane was a polyviny2idine difluoride with aminopropyl Groups.
The aminoprapyl groups were protected with the DDZ group by reaction of the carbonyl chloride with the amino groups, a reaction readily known to t,.'~ose of skill in the art. The surface bearing these groups was placee in a solution of THF and contacted with a mask bearing a checkerboard pattern of 1 mm opacrue and transparent regions. The mask was exposesi to ultraviolet light having a wavelength down to at least about 280 nm yor about 5 minutes at ambient temperature, although a wide range of exposure times and temperatures may be * trade-mark apcr cpr late in var ions embodiments of the inver. tio.~. , For example, iZ one ebbodiment, an exposure time of between about 1 and 5000 seco.~ds may be used at process temz~eratures of betwee:~ -70 and -~50 ~ C.
In one pref ery ed emnodianent , exposure times c f between about l and 500 seecnds at about ambient pressure are used. In some preferred embodiments, presssre above ambient is used to prevent evaporation.
Tre surface of the membrane was then washed fcr about l hour with a fluorescent label which irciuded an active ester bound to a chelate of a lanthanide. wash times will vary over a wide range of values frc:,i about a few minutes to a few hours. .These materials fluoresce in the red and the green visible region. Afte.'he reaction with the active ester in the fluoronhcre was complete, the locations in which the fluorophore was bound could be visualized by exposing them to ultraviolet light and observing-the-red and the green fluoresce.~.ce.
It was observed that the derivatized regions of the substrate closely corresponded to the original pattern of the mask.
D. Demonstration of Signal Canabilitv Signal detection capability was c3emcnstraZed I5 using a low-level standard fluorescent bead kit manufactured by Flow Cytomet~y Standards and having :~edel no. 824. This kit includes 5:8 ~cm diameter beads, each impregnated with a known number of fluorescein molecules.
One of the beads was placed in the illumination field on the scan stage as shown in Fig. 9 in a field of a laser spot which was initially shuttered. Alter being po itioned in the illumination field, the photon detection equipment was turned on;. The laser beam was unblocked and it interacted with the particle bead, which then fluoresced. Fluorescence curves of beads impregnated with 7,000 and 29,000 fluorescein r.:olecules, are shown in Figs: 11A and 1L3, respectively. On each curve, traces for beads without fluorescein molecules aye also shown. These experiments were performed wish 4$3 r.:a excitation, with 100 I~W of laser power. The light was focused throuch a 40 power 0.75 NA objective.
The fluorescence intensity in all cases'started off at a high valise and then decreased exponentially.
The fall-off in intensity is due to photableaching o the fluorescein molecules: The traces of beads without fluorescein molecules are used for background subtraction. The difference in the initial exponential decay between labeled and noniabe~;ed beads is integrated to give the total number of photcn counts, and this :number is related to the number of noiecules per bead.
Therefore; it is possible to deduce the number cf photcrs per fluorescein molecule that can be detected. :or t:e curves illust~at~ed in Fig. 1l, this calculation indicates the radiation of about 40 to SO photons per fluorescein molecule are detected.
p ~. Determination of the Number of Molecules Per Unit-Area Aminoprop~lated glass microscope slides pre~ared according to the methods discussed above were utilized in order to establish the density of labeling c_' the slides. The free amino termini of the slides were reacted with FITC (fluorescein isothiocyanatP) which forms a covalent linkage with the amino group. The slide is then Scanned to count the number of fluorescent photons generated in a region which, using the estimated 30 40-SO photons per fluorescent molecule, enables the calculation of the number of molecules which are on the surface per unit area.
A slide with aminaprapyl silane on its surface was immersed in a l mM solution of FITC in DMF for 35 1 hour at about ambient temperature. After reaction, the slide was washed twice with DMF and then washed with ethanol, water, and then ethanol again. It was then drie3 anci stored in the dark until it was react' to ~=
examined.
Through the use of curves similar to thcs2 shown in Fig. L1, and by integrating the fluoreseer~
G counts under the exponentially decaying signs:, the number of free amino groups on the surface after deri:vitization was determined. Z t was determined t'.-.at slides wit.' labeling densities of 1 fluoroscein per 103x103 to ~2x2 nm could be reproducibly made as the canc~ntration of aminopropyltriethoxysilane varied _=om IO-5% to 10-1% .
F, removal of NVOG and Attachment of A Fluorescent Marker NVOC-BABA groups were attached as descri'cec above. The entire surface of one slide was e,coos2c to light so as to expose a'free amino group at the enc of the gamma amino butyric acid. This slide, and a duplicate which was not exposed, were then exposed 20 to fluo~escein isothiocyanate:(FZTC).
Fig. 12A illustrates the slide whic:: was ::ot exposed to light, but which was exposed to FITC. T~:e units of the x axis are time and the units of the y axis 'are counts. The trace contains a certain amount of background fluoresc8nce. The duplicate slide was extosec to 35O nm broaaband illumination for about l ninut= .
(12 mW/cm2, -350 nm illumination), washed and react=d with FZTC. The fluorescence curves for this slide a~-e shown in Fig. 1ZH. A large increase in the level c=
p fluorescence is observed, which indicates photolysi_=
has expo ed a number of amino graups on the surface of the slides for attachment of a fluorescent marker.

G. Use of a Masl~ in Removal of NVOC' The next experiment was performed wit:: a C.1%
ami.~.corcpylated slide. Light from a Hg-Xe are lamp was imaged onto the subs rate through a laser-ablated chrome-on-glass mask in direct contact wi~,:h the substrate.
This slide was illuminated for approximately 5 minutes, with 12 mW of 350 nm broadband light and then eacted with the l mM FITC solution. It was put on the IO laser detection scanning.stage and a graph was plotted as a two-dimensional representation of position color-coded for fluorescence intensi y. The experiment was repeated a number of times through various masks. The fluorescence patterns for a 100x100 ~m mask; a 50 um 15 mask, a 20 ~cm mask, and a 10 um mask indicate that the mask pattern is distinct down to at least about l0 um squares using this lithographic technique.
H. Attachment of'YGGFL and Subsecruent ~xDOSUrp to 20 Herz'Antibodv and Goat A~ntimouse Zn order-to establish that receptors to a particular polypeptide sequence would bind to a surface-bound peptide and be defected; Leu enkephalin was coupled to the surface and recognized by an antibody. A slide was derivatized with0:1% amino-propyl-tr~ethoxysilane and protected with NVOC. A 500 ~m checkerboard mask was used to expose the slide in a flow cell using backside contact printing. The Leu enkephalin sequence (HZN-tyrosine,glycine,glycine,phenylalanine,leucine-CO=H, 30 o~erwise refer=ed to herein as YGGFL) was attached via its carboxy end to the exposed amino groups on the surfaceof theslide. The peptide was added in DMF
solution with the 80P/HDHT/D3EA coupling reagents and recirculat~d through the flow cell for 2 hours at room 35 temperature.
A'first antibody, known as the Herz antibody, was applied tb the surface of the slide for 45 minutes at 2 ug/ml in a sup~rcocktail (cAntaining I% BSA and 1% ova~.bumin a?so in this case). A second antibcdy, goat anti-mouse fluorescein canjugate,.was then adde3 at 2 ~cg/ml in the supercacktail buffer, and allowed to incubate for 2 hours.
The results of this experiment were plctted as fluorescence intensity as a function of position. This image was taken at IO um steps and showed that not only can deprot2ction be carried out in a well deffined pattern, but also that (1) the method provided for successful coupl:.ng of peptides to the surface of the substrate, (2) the surface of a bound,peptide was available for binding with a~, antibody, arid (3) that the detection apparatus capabilities were suf;icient 15- to detect binding of a receptor.
3. Manamer-by-Monomer Fornation of YGGFT and Sub,~eauent Exvosure to Labeled Ant~,~odv Monomer-by-monomer synthesis of YGGFL and GGFL
in alternate squares was performed on a slide in a checkerboard pattern and the resulting slide was exposed to the Herz antibody. This experimentis illustrated in Figs. I3A and i3H.
In Fig: 13A, a slide is shown which is derivatized with the aminopropyi group, protec.ed in this case with t-BOC (t-butoxycarbonyl), The elide was treated with TFA:to remove the t-HOC protecting group.
E-aminocaproic acid-, which was t-BOC protected at its ami:~o group, was then coupled onto the aminopropyl 0 groups. The aminocaproic acid serves as a spacer between the aminopropyl group and the peptide to be synthesized.
The amino end of the spacer was deprotected and coupled to NVOC-leucine: The entire slide was then illuminated with I2 mW of 325 nm broadband illumination. The slida 35 was then coupled with NttOC-phenylalanine and washed. The entire slide was again illuminated, then coup3ed to NVOC-glycine and washed. The slide was again illuminated and coupled to NVOC-g'.:y cine to fore the seauence shown i~
the last portion of Fig. 13A.
As shown in Fig. 138, altdrnating regions of the slide were then illuminated using a projecticn print using a 500x500 ~um checkerboard mask: thus, the amirc group of glycine was exposed only in the lighted areas.
When the next coupling chemistr-~r step was carried cut, NVOC-tyrosine was added; and it coupled only at those spots which had received illumination: The entire slide was then illuminated to remove all the NVOC groups, leaving a checkerboard of YGGFL in the lighted areas and in the other areas, GGFL. The Herz antibody (which recognizes the YGGr~L~ but not GGFL) was then added, followed by goat anti-mouse fluorescein conjugate.
,~ The resulting fluorescence scan showed dark areas containing the tetrapeptide GGF~L, which is not reccgrized by the Herz antibody (and thus there is nc binding of the goat anti-mouse antibody with fluorescein conjugate), and red areas in which YGGFL was present.
The YGGFL pentapeptide is recognized by the Herz antibcdy and, therefore; there is antibody in the lighted regions for the fluorescein-conjugated goat anti-rouse to recognize.
Similar patterns for a 50 ~,m mask used in G3 direct contact ("proximity print") with the substra;.e provided a pattern which was more distinct and the corners of the checkerboard pattern were touching as a result of the mask being placed in direct contact with the substrate (which reflects the increase in rasolLt~cn using this technique)., J. Monomer-bv-Monomer Synthesis of YGGFL and PGGFL
A synthesis using a 50 ~m checkerboard mask similar to that shorn in Fig. 13 was conducted. However, P was added to the GGFL sites on the substrate through an additional coupling step. P.was added by exposing protected GGFL to light through a mask, and subseguence exposure to P in the manner set forth above. Therefore, half of the regions on t.'~e substrato contained YGGFL and the remaining half contained PGGFL.
The fluorescence plot for this experimen;.
showed the regions are again readily discernable~bet-,aeen those in which binding did and d:d not occur. This experiment demonstrated that antibcdies are able to recognize a specific sec_uenc~ and that the re.ccgnition is not length-dependent.
'0 K. Monomer-bv-Monomer ~vnthesis of vGGFL and vpGG~'~
In order to further demonstrate t:~e cperability of the invention, a 50 ~;m checkerboard pattern of ,~ alternating YGGCL and YPGGFL was synthesized cn a substrate using technicues like-those set forth above.
The resulting fluorescence plot showed that the ant_bccv was clearly able to recognize the YGGFL sequence and did not bind significantly at the YPGGFL regions:
L. Synthesi of an Arrav of Sixteen Differ~nt Amino Acid Secruences and ~'stimation of Rep ativ~
Bindincr Affinity to HeTz Antibody Using techniques similar to those set forth above, an array of 16 different amino acid sacuences (replicated four times) was synthesized on eacof two glass substrates. The sequences were synthesized by attaching the sequence NVOC-GFL across the entire surface of the slides: Using;a series of masks, two layers of amino acids were then selectively applied to the substrate. Each region had dimensions of 0.25 cm x 0.0625 cm. The first slide ccn ained amino acid sequences containing only L amino acids while the second slide contained selected D amino acids. Figs. 14A
and 14B illustrate a map of the various regions on the first and second s ides, respectively. The patterns shown in Figs. i4A and 14B were duplicated four times on each slide. The slides were then, exposed to the rier~
antibody and fluorescein-labeled goat anti-:house.
A fluarescencs plat of the first slide, whic contained only L amino acids snowed red areas (indicating strong binding, i.e., 14,9,000 courts or more) and black areas (indicating little or no binding of the Herz antibody, i.e., 20;000 counts or less). The secruen,ce YGGFL was clearly most strongly recognized. The sequences YAGFL and YSGFL also exhibited strong recognition of he antibody. By contrast, most of t::e remaining sequences howed little or no binding. The four duplicate portions of the slide were extremely consistent in the amount of binding shown therein.
A fluorescence plat of the D amino acic slide indicated that strongest binding was exhibited by the YGGFL sequence. Significant binding was also detec;.ec to YaGFL, YsGFL, and YpGFL: The-remaining sequences snowed less binding with the antibody. Low binding efficiency of the sequence yGGFL was observed:
Table 6 fists the various sequences tested in order of relative fluorescence, which provides information regarding relative binding affinity.
~5 Table 6 Apaa~ent 8indina to I~erz Ab a.a. ce D_a:a'' get L -YGGFh ' YGGFL ' YAGF L YaGFL

YSGFL YsGFL

LGGFh YpGFL

FGGF L fGGFL

YFGF L yGGF L

I~IGi L f 3GFL

FAGFL wGGFL

wGGFL yaGFL

fpGF:

waGF L

VIII. Ill ustrative Alternative Embodiment According tc an alternative embodiment of t::e invention; the methods provide for attaching to the surface a caged binding member which in its caged fog has a relatively low aff;pity for other potentially binding species, such ~s receptors and speci~:c bir.;~g substances.

Accor3ing to this alternative embodi~ert, t:~e invention provides methods for forming predef ;ned regicns on a surface of a solid support, wherein the oredef_ned regions are capable of'immobiliting receptors. The methods make use of caged binding members attached ~~ the surface to enable selective activation of the prede==ned ~5 regions. The caged binding members are liberated t:, act as binding members ultimately capable of binding receptors upon se? ective act~.vation of the predefine reaiors: The activated binding members are then used to immobilize specific molecules such as receptors on the predefined region of the surface. The above procedure is repeated at'the same Qr different sites on the surface so as to provide a surface prepared with a piurali.ty of regions on the surface contain'lng; for example, the sa:~e or different receptors, when receators immobilized in this way have a differential affinity for one or more ligands, screenings and assays for the ligands can be conducted in the regions of the surface containing the receators.
The alternative embodiment may maKe use of novel caged binding members attached to the substrate.
CaCed (unactivated),meiabers have a relatively low 1~ affinit;r for receptors of substances that specifically bind to uncaged binding members when compared with the corresponding affinities of activated binding members.
Thus, the binding; members are protected from reaction until a suitable source of energy is applied to the regions of the surface desired to be activated. Upon applicationof a suitable'energy source, the caging groups labilize, thereby presenting the activated binding member. A typical energy source will be light.
Once the binding members on the surface are activated they maybe attached to a receptor: The receptor chosen may be a monoclonal antibody, a nucleic acid sequence, a drug receptor, etc. The receptor will usually, though not always, be prepared so as to permit attaching it; directly or indirectly, to abinding member. For example, a specific binding substance having a strong binding affinity for the binding member and a strong affinity for the receptor or a conjugate of the receptor may be used to act as a bridge between bindi~g members and receptors if desired. The method uses a ;5 receptor prepared such that the receptor retains its activity towar3 a particular ligand:

Preferably, the caged binding member attached to the solid substrate will be a photoactiJatable biotin complex, i.e., a biotin molecule that has been chemically, modified with photoactivatable protectirig.groups so that it has a significantly reduced binding affinity for avidin or avidin analogs than does natural biotin: In a preferred embodiment, the protecting groups localized in a predefined region of the surface will be removed upon application of a suitable source of radiation to give bindingmembers, that are biotin or a functionally analogous compound having substantially the same binding affinity for avidin or a'vidin analogs as does biotin.
In another preferred. embodiment, avidin or an avidin analog is incubated with activated binding members on the surface until the avidin binds strongly to the binding members.
The avid:in so immobilized on predefined regions of the surface can then be incubated with a desired receptor or conjugate of a desired receptor . The receptor will preferably be bi.otinylated, e.g., a biotinylated antibody, when avidin is immobilized on the predefined regions of the surface.
Alternatively, a preferred embodiment will present an av:idin/bi.otinylated receptor complex, which has been previously prepared, to activated binding members on the surface.

Il. Conclusion The inventions of the present application and related Canadian Application Nos: 2,27f,883 and 2,054,706 provide greatly improved methods and apparatus for synthesis of S polymers on substrates. Lt is to be understood that the above description is intended to be, illustrative and not restrictive.
Many embodiments will be apparent to those of skill in the art upon reviewing the above description. By way of example, the invention has been described primarily with reference to the use of photoremovable protective groups, but it will be readily recognized by those of skill in the art that sources of radiation other than light could also be used. For example, in some embodiments it may be de irable to use protective groups which are sensitive to electron beam irradiation, x-ray irradiation, in combination with electron beam lithograph, or x-ray lithography techniques: Alternatively, the group could be removed by exposure to an electric current. The scope of the inventions of the present application and related Canadian Application Nos: 2,278,883 and 2,054,706, should, therefore, be determined not with reference to the above description, but should instead be determined with reference to the appended claims; along with the full scope of equivalents to which such claims are entitlsd.

Claims (52)

1. Apparatus for detection of fluorescently marked regions on a substrate comprising:

a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, each of said different polymer sequences being coupled in a different known location of said surface, each of said known location having an area of 10-2 cm2 or less;

b) a light source for directing light at said surface of said substrate;

c) a means for detecting light fluoresced from a fluorescent label bound to the polymer sequences on said surface in response to said light sources;

d) means for translating said substrate from a first position to a second position relative to said light source and/or said means for detecting light; and e) means for storing fluoresced light intensity as a function of location on said substrate, said means for storing connected to said means for translating and said means for detecting.
2. A system for determining binding of a fluorescently labeled receptor to a ligand comprising:

a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less;

b) means for applying light to said surface of said substrate, said means for applying light providing simultaneous illumination at a plurality of said known locations; and c) an array of detectors for detecting light fluoresced at said plurality of known locations upon binding of a fluorescently labeled receptor to said polymer sequences.
3. A system as recited in claim 2, wherein said means for applying light comprises a point light source and a cylindrical lens for focusing said point light source along a substantially linear path.
4. A system as recited in claim 2, wherein said array of detectors comprises a linear array.
5. A system as recited in claim 2, wherein said array of detectors comprises a linear CCD array.
6. An apparatus for detection of fluorescently marked locations on a substrate comprising:

a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, wherein said plurality of different polymer sequences comprises a plurality of different nucleic acid sequences, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less;

b) a light source for directing light at a surface of said substrate;

c) a detector for detecting light fluoresced from a fluorescent label bound to the polymer sequences on said surface in response to said light source;

d) a translator for translating said substrate relative to said light source; and e) a data storage system for storing fluoresced light intensity as a function of location on said substrate, said data storage system connected to said translator and said detector.
7. The apparatus as recited in claim 6, wherein said plurality of different nucleic acid sequences comprises greater than 10 different nucleic acid sequences on a surface of said substrate.
8. The apparatus as recited in claim 6, wherein said plurality of different nucleic acid sequences comprises at least 100 different nucleic acid sequences on a surface of said substrate.
9. The apparatus as recited in claim 6, wherein said plurality of different nucleic acid sequences comprises at least 1,000 different nucleic acid sequences on a surface of said substrate.
10. The apparatus as recited in claim 6, wherein said plurality of different nucleic acid sequences comprises greater than 10,000 different nucleic acid sequences on a surface of said substrate.
11. The apparatus a recited in claim 6, wherein said plurality or different nucleic acid sequences comprises greater than 100,000 different nucleic acid sequences on a surface of said substrate.
12. The apparatus as recited in claim 6, wherein each of said different nucleic acid sequences is in a known location on a surface of said substrate, said known location having an area of less than 10,000 µm2.
13. An apparatus for detecting fluorescently marked locations on a surface of a substrate, comprising:

a point light source for generating an excitation light;
a substrate bearing: a plurality of different polymers coupled to a surface of said substrate, wherein said plurality of different polymers comprises a plurality of different nucleic acid sequences, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less;

an objective lens for focusing said point light source at said surface of said substrate, whereby locations, upon binding of a fluorescent label to the polymer sequences coupled therein, emit a fluoresced light in response to said excitation light;

an x-y translation stage for moving said substrate relative to said excitation light;

a dichroic mirror for reflecting light having a wavelength of said excitation light and passing light having a wavelength of said fluoresced light;

a photomultiplier and photon counter for detecting said fluoresced light; and an appropriately programmed computer for recording said fluoresced light as a function of a position on said surface of said substrate from which said fluoresced light was emitted.
14. The apparatus as recited in claim 13, wherein said plurality of different nucleic acid sequences comprises greater than 10 different nucleic acid sequences on a surface of said substrate.
15. The apparatus as recited in claim 13, wherein said plurality of different nucleic acid sequences comprises at least 100 different nucleic acid sequences on a surface of said substrate.
16. The apparatus as recited in claim 13, wherein said plurality of different nucleic acid sequences Comprises a least 1,000 different nucleic acid sequences on a surface of said substrate.
17. The apparatus as recited in claim 13, wherein said plurality of different: nucleic acid sequences comprises greater than 10,000 different nucleic acid sequences on a surface of said substrate.
18. The apparatus as recited in claim 13, wherein said plurality of different nucleic acid sequences comprises greater than 100,000 different nucleic acid sequences on a surface of said substrate.
19. The apparatus as recited in claim 13, wherein each of said different nucleic acid sequences is in a known location on a surface of said substrate, said known location having an area of less than 10,000 µm2.
20. A method of detecting the presence of a fluorescent marker on a surface of a substrate, the method comprising:

directing an excitation light at the surface of the substrate: and detecting light fluoresced from the surface of the substrate;

wherein said surface of said substrate bears a plurality of different nucleic acids covalently bound thereto, each of said different nucleic acids being bound at a different known location on the substrate, each of said known locations having an area of less than 10 -2 cm2 and said fluorescent marker comprises a fluorescently labeled target nucleic acid that is capable of hybridizing with one or more of said plurality of different nucleic acids.
21. A method of determining whether a fluorescently labeled ligand binds to one or more of a plurality of different polymer sequences, wherein said fluorescently labeled ligand comprises, a fluorescently labeled target nucleic acid, and said plurality of different polymer sequences on the surface of a substrate comprises a plurality of different nucleic acids, comprising:

providing a plurality of different polymer sequences covalently bound to a surface of a substrate, each of said different polymer sequences being bound at a known location on the surface of the substrate, each of said known locations having an area of less than 10 -2 cm2;

contacting the surface of the substrate with the fluorescently labeled ligand;

washing the surface to remove unbound fluorescently labeled ligand from the surface of the substrate; and detecting binding between the fluorescently labeled ligand and the one or more polymer sequences, said detecting step comprising directing an excitation light at the surface of the substrate, and detecting light fluoresced from the surface of the substrate.
22. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises greater than different nucleic acids on a surface of said substrate.
23. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises at least 100 different nucleic acids on a surface of said substrate.
24. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises at least 1,000 different nucleic acids on a surface of said substrate.
25. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises greater than 10,000 different nucleic acids on a surface of said substrate.
26. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises greater than 100,000 different nucleic acids on a surface of said substrate.
27. The method as recited in claim 21, wherein each of the different nucleic acid sequences is in a known location on a surface of said substrate, said known location having an area of less than 10,000 µm2.
28. A nucleic acid analysis apparatus comprising:
a substrate bearing a plurality of different nucleic acids; each of said different nucleic acids being attached to a different known location of the surface of said substrate, each of said known locations having an area of 10-2 cm2 or less, said substrate comprising more than 10 of such nucleic acids, at least some of said nucleic acids coupled to fluorescently labeled target molecules;

a light source for directing light at a surface of said substrate;

a detector for detecting light fluoresced from said surface in response to said light source;

a translator for translating said substrate relative to said light source; and a data storage system for storing fluoresced light intensity as a function of location on said substrate, said data storage system coupled to said translator and said detector.
29. An apparatus for detection of labeled locations on a substrate comprising:
a) a light source capable of directing light at a surface of a substrate, said substrate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences occupying a different known location of said surface, each of sand known locations having an area of 10 -2 cm2 or less, and at least one of the polymers capable of being coupled to a labeled receptor;

b) a detector to detect light emitted from said surface in response to said light source to indicate which polymer(s) are coupled to the labeled receptor.
30. The apparatus of claim 29, further comprising a translator to translate said substrate relative to said light source.
31. The apparatus of claim 29, wherein the receptor is fluorescently labeled and the emitted light is fluoresced light.
32. The apparatus of claim 31 further comprising a data storage system to store fluoresced light intensity as a function of location on said substrate.
33. The apparatus of any one of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises greater than 10 different nucleic acid sequences on a surface of said substrate.
34. The apparatus of any one of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises at least 100 different nucleic acid sequences on a surface of said substrate.
35. The apparatus of any one of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises at least 1,000 different nucleic acid sequences on a surface of said substrate.
36. The apparatus as recited in any one of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises greater than 10,000 different nucleic acid sequences on a surface of said substrate.
37. The apparatus as recited in anyone of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises greater than 100,000 different nucleic acid sequences on a surface of said substrate.
38. The apparatus as recited in any one of claims 29 to 37, wherein each of said different nucleic acid sequences is in a known location on a surface of said substrate; said known location having an area of less than 10 -4 cm2.
39. The apparatus of any one of preceding claims 29 to 38, wherein the light source is a point light source that directs an excitation light;

the translator is an x-y translation stage;

the detector comprises a photomultiplier and photon counter to detect said fluoresced light;

the data storage system comprises an appropriately programmed computer to record said fluoresced light as a function of a position on said surface of said substrate from which said fluoresced light was emitted;

and the apparatus further comprises:

an objective lens and a dichroic mirror to reflect light from the light source having a wavelength of said excitation light and to pass light having a wavelength of said fluoresced light to the detector.
40. The apparatus of claim 39, wherein the appropriately programmed computer further comprises a video display to display the recorded fluoresced light as a function of position.
41. The apparatus of claim 39 or 40, wherein the light source is a laser.
42. The apparatus of claim 39 ar 40, wherein the polymers are nucleic acids and the receptor is a labeled polynucleotide.
43. A method of detecting the presence of a fluorescent marker on a surface of a substrate, the method comprising:
(1) directing excitation light at a surface of a substrate, said substrate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences occupying a different known location of said surface, each of said known locations having an area of 10 -2 cm2 or less, and at least one of the polymers capable of being coupled to a fluorescently labeled receptor; and (2) detecting light fluoresced from the surface of the substrate.
44. The method of claim 43 further comprising:

(1) translating the substrate relative to the light source; and (2) repeating, step (1).
45. A method of determining whether one or more of a plurality of different polymer sequences binds to a fluorescently labeled receptor, comprising:

(1) providing an apparatus comprising:

a) a substrate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences occupying a different known location of said surface, each of said known locations having an area of 10 -2 cm2 or less;

b) a light source to direct light at a surface of said substrate;

c) a detector to detect light fluoresced from said surface in response to said light source; and d) a translator to translate said substrate relative to said light source;

(2) contacting the surface of the substrate with the fluorescently labeled receptor; and (3) detecting binding between the fluorescently labeled receptor and one or more different polymer sequences by directing an excitation light at the surface of the substrate, and detecting light fluoresced from the surface of the substrate.
46. The method of claim 45, further comprising washing the surface to remove unbound fluorescently labeled receptor from the surface of the substrate.
47. The method of claim 46, wherein the polymers are nucleic acids and he receptor is a fluorescently labeled nucleic acid.
48. The method as recited in claim 46, wherein the apparatus is as described in any one of claims 31 to 42.
49. The method as recited in any one of claims 20 to 27 and 43 to 48, further comprising recording the fluoresced light and storing the data therefrom in an appropriately programmed computer.
50. The method as recited in claim 49, wherein the method further comprises displaying the data derived from the method.
51. The apparatus of claim 1, wherein said polymer sequences on said substrate have a density of at least 1,000/cm2.
52. The apparatus of claim 6, wherein said polymer sequences on said substrate have a density of at least 1,000/cm2.
CA 2391491 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis Abandoned CA2391491A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36290189A 1989-06-07 1989-06-07
US362,901 1989-06-07
US07/492,462 US5143854A (en) 1989-06-07 1990-03-07 Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US492,462 1990-03-07
CA 2278878 CA2278878C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA 2278878 Division CA2278878C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis

Publications (1)

Publication Number Publication Date
CA2391491A1 true CA2391491A1 (en) 1990-12-13

Family

ID=27001838

Family Applications (4)

Application Number Title Priority Date Filing Date
CA 2391491 Abandoned CA2391491A1 (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis
CA 2054706 Expired - Lifetime CA2054706C (en) 1989-06-07 1990-06-07 Very large scale immobilized polymer synthesis
CA 2278883 Expired - Lifetime CA2278883C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis
CA 2278878 Expired - Lifetime CA2278878C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis

Family Applications After (3)

Application Number Title Priority Date Filing Date
CA 2054706 Expired - Lifetime CA2054706C (en) 1989-06-07 1990-06-07 Very large scale immobilized polymer synthesis
CA 2278883 Expired - Lifetime CA2278883C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis
CA 2278878 Expired - Lifetime CA2278878C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis

Country Status (22)

Country Link
US (19) US5143854A (en)
EP (4) EP0902034A3 (en)
JP (5) JP3759161B2 (en)
KR (2) KR970001578B1 (en)
AT (2) ATE110738T1 (en)
AU (2) AU651795B2 (en)
BR (1) BR9007425A (en)
CA (4) CA2391491A1 (en)
DE (3) DE69012119T2 (en)
DK (2) DK0619321T3 (en)
ES (2) ES2129101T3 (en)
FI (1) FI109130B (en)
GB (1) GB2248840B (en)
HK (2) HK61395A (en)
HU (1) HU223462B1 (en)
IL (1) IL94551A (en)
NL (1) NL191992C (en)
NO (1) NO301233B1 (en)
NZ (1) NZ233886A (en)
SG (1) SG13595G (en)
TW (1) TW434254B (en)
WO (1) WO1990015070A1 (en)

Families Citing this family (3506)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US7811751B2 (en) 1988-05-03 2010-10-12 Oxford Gene Technology Limited Analysing polynucleotide sequences
US6054270A (en) * 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US6919211B1 (en) * 1989-06-07 2005-07-19 Affymetrix, Inc. Polypeptide arrays
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US6379895B1 (en) 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6955915B2 (en) * 1989-06-07 2005-10-18 Affymetrix, Inc. Apparatus comprising polymers
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5925525A (en) * 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5242974A (en) * 1991-11-22 1993-09-07 Affymax Technologies N.V. Polymer reversal on solid surfaces
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5527681A (en) * 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5547839A (en) * 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US5424186A (en) * 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5871928A (en) * 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US6506558B1 (en) 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
US5252296A (en) * 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
DE4027675C2 (en) * 1990-08-31 1997-05-07 Biotechnolog Forschung Gmbh Process for the parallel production of carrier-bound or free peptides, carrier-bound peptides and their use
EP0834576B1 (en) * 1990-12-06 2002-01-16 Affymetrix, Inc. (a Delaware Corporation) Detection of nucleic acid sequences
ATE244065T1 (en) * 1990-12-06 2003-07-15 Affymetrix Inc METHODS AND REAGENTS FOR VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS
US5658728A (en) * 1991-06-19 1997-08-19 Gosney, Jr.; William Milton Templates for nucleic acid molecules
GB2258236B (en) * 1991-07-30 1995-03-22 Hitachi Europ Ltd Molecular synthesis
WO1993002992A1 (en) * 1991-08-07 1993-02-18 H & N Instruments, Inc. Synthesis of chain chemical compounds
US5449754A (en) * 1991-08-07 1995-09-12 H & N Instruments, Inc. Generation of combinatorial libraries
JPH05206017A (en) * 1991-08-09 1993-08-13 Internatl Business Mach Corp <Ibm> Lithographic exposure system and its method
US6589726B1 (en) 1991-09-04 2003-07-08 Metrigen, Inc. Method and apparatus for in situ synthesis on a solid support
US6921636B1 (en) * 1991-09-04 2005-07-26 Metrigen, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5846717A (en) 1996-01-24 1998-12-08 Third Wave Technologies, Inc. Detection of nucleic acid sequences by invader-directed cleavage
DK0604552T3 (en) * 1991-09-18 1997-08-04 Affymax Tech Nv Process for the synthesis of different assemblies of oligomers
US5639603A (en) * 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5733731A (en) * 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US6051380A (en) 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
US6569382B1 (en) * 1991-11-07 2003-05-27 Nanogen, Inc. Methods apparatus for the electronic, homogeneous assembly and fabrication of devices
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US6652808B1 (en) * 1991-11-07 2003-11-25 Nanotronics, Inc. Methods for the electronic assembly and fabrication of devices
US6017696A (en) 1993-11-01 2000-01-25 Nanogen, Inc. Methods for electronic stringency control for molecular biological analysis and diagnostics
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US5849486A (en) 1993-11-01 1998-12-15 Nanogen, Inc. Methods for hybridization analysis utilizing electrically controlled hybridization
US6048690A (en) * 1991-11-07 2000-04-11 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US5556961A (en) * 1991-11-15 1996-09-17 Foote; Robert S. Nucleosides with 5'-O-photolabile protecting groups
US5846708A (en) * 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection
IL103674A0 (en) * 1991-11-19 1993-04-04 Houston Advanced Res Center Method and apparatus for molecule detection
CA2124087C (en) * 1991-11-22 2002-10-01 James L. Winkler Combinatorial strategies for polymer synthesis
US5324633A (en) * 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
US6943034B1 (en) 1991-11-22 2005-09-13 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
US5550215A (en) * 1991-11-22 1996-08-27 Holmes; Christopher P. Polymer reversal on solid surfaces
US6468740B1 (en) 1992-11-05 2002-10-22 Affymetrix, Inc. Cyclic and substituted immobilized molecular synthesis
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5412087A (en) * 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
EP1382386A3 (en) * 1992-02-19 2004-12-01 The Public Health Research Institute Of The City Of New York, Inc. Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
US5359115A (en) * 1992-03-26 1994-10-25 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5541061A (en) * 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
US5643873A (en) * 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US5648458A (en) * 1992-05-06 1997-07-15 Affymax Technologies N.V. Peptides and compounds that bind to ELAM-1
US5728802A (en) * 1992-05-06 1998-03-17 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
US5849545A (en) * 1992-05-11 1998-12-15 Evotec Biosystems Gmbh Substrate material for simultaneously binding genotypic and phenotypic substances
JPH0622798A (en) * 1992-07-07 1994-02-01 Hitachi Ltd Method for determining base sequence
US5585275A (en) * 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
US5591646A (en) * 1992-09-02 1997-01-07 Arris Pharmaceutical Method and apparatus for peptide synthesis and screening
US5420328A (en) * 1992-09-11 1995-05-30 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5877278A (en) * 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5324483B1 (en) * 1992-10-08 1996-09-24 Warner Lambert Co Apparatus for multiple simultaneous synthesis
US5714127A (en) * 1992-10-08 1998-02-03 Warner-Lambert Company System for multiple simultaneous synthesis
US5702672A (en) * 1992-10-08 1997-12-30 Warner-Lambert Company Apparatus and method for multiple simultaneous synthesis
US5567391A (en) * 1992-10-08 1996-10-22 Warner-Lambert Company Apparatus for multiple simultaneous synthesis
US5554501A (en) * 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
AU5449094A (en) * 1992-11-02 1994-05-24 Affymax Technologies N.V. Novel photoreactive protecting groups
HUT73150A (en) * 1992-11-06 1996-06-28 Chiron Mimotopes Pty Ltd Modular polymer and support for the synthesis thereof
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
IL108748A0 (en) * 1993-02-23 1994-08-26 Univ Princeton Solution and solid-phase formation of glycosidic linkages
US6864048B2 (en) * 1993-04-28 2005-03-08 Affymetrix, Inc. Factorial chemical libraries
US6632613B1 (en) * 1993-06-02 2003-10-14 University Of Utah Research Foundation Compositions and kits for fluorescence polarization assay of large molecules
US6008058A (en) * 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
US6153379A (en) * 1993-06-22 2000-11-28 Baylor College Of Medicine Parallel primer extension approach to nucleic acid sequence analysis
US7001722B1 (en) 1993-06-22 2006-02-21 Baylor College Of Medicine Parallel primer extension approach to nucleic acid sequence analysis
US5858659A (en) * 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5861242A (en) * 1993-06-25 1999-01-19 Affymetrix, Inc. Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same
US7115364B1 (en) 1993-10-26 2006-10-03 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US6027880A (en) * 1995-08-02 2000-02-22 Affymetrix, Inc. Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis
DE69431719T2 (en) 1993-06-25 2003-09-18 Affymetrix Inc N D Ges D Staat HYBRIDIZATION AND SEQUENCING OF NUCLEIC ACIDS
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US20030134291A1 (en) * 1993-06-25 2003-07-17 Affymetrix, Inc. Polymorphism detection
AU7551094A (en) 1993-07-23 1995-02-20 Hyseq, Inc. Method for screening unknown organisms
US6401267B1 (en) 1993-09-27 2002-06-11 Radoje Drmanac Methods and compositions for efficient nucleic acid sequencing
JPH0798276A (en) * 1993-09-28 1995-04-11 Hitachi Electron Eng Co Ltd Determining device for appangement of dna base
US6180239B1 (en) 1993-10-04 2001-01-30 President And Fellows Of Harvard College Microcontact printing on surfaces and derivative articles
US6776094B1 (en) * 1993-10-04 2004-08-17 President & Fellows Of Harvard College Kit For Microcontact Printing
US5512131A (en) * 1993-10-04 1996-04-30 President And Fellows Of Harvard College Formation of microstamped patterns on surfaces and derivative articles
US5776748A (en) 1993-10-04 1998-07-07 President And Fellows Of Harvard College Method of formation of microstamped patterns on plates for adhesion of cells and other biological materials, devices and uses therefor
US5900160A (en) * 1993-10-04 1999-05-04 President And Fellows Of Harvard College Methods of etching articles via microcontact printing
WO1995010296A1 (en) * 1993-10-12 1995-04-20 Glycomed Incorporated A library of glyco-peptides useful for identification of cell adhesion inhibitors
US6045996A (en) * 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US6156501A (en) * 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
US6309823B1 (en) * 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
US20060229824A1 (en) * 1993-10-26 2006-10-12 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes
US7375198B2 (en) * 1993-10-26 2008-05-20 Affymetrix, Inc. Modified nucleic acid probes
US20120329677A9 (en) * 1993-10-26 2012-12-27 Cronin Maureen T Arrays of nucleic acid probes for detecting cystic fibrosis
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US20030232361A1 (en) * 1993-10-26 2003-12-18 Affymetrix, Inc. Nucleic acid array preparation using purified phosphoramidites
US6893816B1 (en) * 1993-10-28 2005-05-17 Houston Advanced Research Center Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
DK0725682T3 (en) * 1993-10-28 2002-07-15 Houston Advanced Res Ct Micro-made, porous pass-through apparatus for discrete detection of bonding reactions
US5429807A (en) * 1993-10-28 1995-07-04 Beckman Instruments, Inc. Method and apparatus for creating biopolymer arrays on a solid support surface
US5922545A (en) * 1993-10-29 1999-07-13 Affymax Technologies N.V. In vitro peptide and antibody display libraries
US5965452A (en) * 1996-07-09 1999-10-12 Nanogen, Inc. Multiplexed active biologic array
US6331274B1 (en) 1993-11-01 2001-12-18 Nanogen, Inc. Advanced active circuits and devices for molecular biological analysis and diagnostics
US6225059B1 (en) 1993-11-01 2001-05-01 Nanogen, Inc. Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics
US6309602B1 (en) 1993-11-01 2001-10-30 Nanogen, Inc. Stacked, reconfigurable system for electrophoretic transport of charged materials
US7314708B1 (en) * 1998-08-04 2008-01-01 Nanogen, Inc. Method and apparatus for electronic synthesis of molecular structures
US6319472B1 (en) 1993-11-01 2001-11-20 Nanogen, Inc. System including functionally separated regions in electrophoretic system
US7582421B2 (en) * 1993-11-01 2009-09-01 Nanogen, Inc. Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip
US6315953B1 (en) * 1993-11-01 2001-11-13 Nanogen, Inc. Devices for molecular biological analysis and diagnostics including waveguides
US6726880B1 (en) 1993-11-01 2004-04-27 Nanogen, Inc. Electronic device for performing active biological operations and method of using same
US6129828A (en) 1996-09-06 2000-10-10 Nanogen, Inc. Apparatus and methods for active biological sample preparation
US20040077074A1 (en) * 1993-11-01 2004-04-22 Nanogen, Inc. Multi-chambered analysis device
US6306348B1 (en) * 1993-11-01 2001-10-23 Nanogen, Inc. Inorganic permeation layer for micro-electric device
US7172864B1 (en) 1993-11-01 2007-02-06 Nanogen Methods for electronically-controlled enzymatic reactions
US6638482B1 (en) 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
US7101661B1 (en) 1993-11-01 2006-09-05 Nanogen, Inc. Apparatus for active programmable matrix devices
US6375899B1 (en) 1993-11-01 2002-04-23 Nanogen, Inc. Electrophoretic buss for transport of charged materials in a multi-chamber system
US6254827B1 (en) 1993-11-01 2001-07-03 Nanogen, Inc. Methods for fabricating multi-component devices for molecular biological analysis and diagnostics
US6068818A (en) * 1993-11-01 2000-05-30 Nanogen, Inc. Multicomponent devices for molecular biological analysis and diagnostics
US6287517B1 (en) 1993-11-01 2001-09-11 Nanogen, Inc. Laminated assembly for active bioelectronic devices
US6165778A (en) * 1993-11-02 2000-12-26 Affymax Technologies N.V. Reaction vessel agitation apparatus
US5503805A (en) * 1993-11-02 1996-04-02 Affymax Technologies N.V. Apparatus and method for parallel coupling reactions
US7034110B2 (en) * 1994-01-05 2006-04-25 Arqule, Inc. Method of identifying chemical compounds having selected properties for a particular application
GB9401833D0 (en) * 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US6741344B1 (en) * 1994-02-10 2004-05-25 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US6090555A (en) * 1997-12-11 2000-07-18 Affymetrix, Inc. Scanned image alignment systems and methods
US20030017081A1 (en) * 1994-02-10 2003-01-23 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
GB9404709D0 (en) * 1994-03-11 1994-04-27 Multilyte Ltd Binding assay
US6015880A (en) * 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5502246A (en) * 1994-03-22 1996-03-26 Eli Lilly And Company Solid-phase synthesis utilizing photochemical carbon-sulfur bond cleavage of thioethers
WO1995025737A1 (en) * 1994-03-23 1995-09-28 The Penn State Research Foundation Method for identifying members of combinatorial libraries
US5871918A (en) * 1996-06-20 1999-02-16 The University Of North Carolina At Chapel Hill Electrochemical detection of nucleic acid hybridization
US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
DE69527585T2 (en) * 1994-06-08 2003-04-03 Affymetrix Inc Method and device for packaging chips
US6287850B1 (en) * 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US7323298B1 (en) * 1994-06-17 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Microarray for determining the relative abundances of polynuceotide sequences
US7615368B1 (en) 1994-06-17 2009-11-10 The Board Of Trustees Of The Leland Stanford Junior University Microarrays of polypeptides
US7378236B1 (en) 1994-06-17 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Method for analyzing gene expression patterns
US5525734A (en) * 1994-06-22 1996-06-11 Affymax Technologies N.V. Methods for synthesizing diverse collections of pyrrolidine compounds
US5525735A (en) * 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
AU689924B2 (en) * 1994-06-23 1998-04-09 Affymax Technologies N.V. Photolabile compounds and methods for their use
US5679773A (en) * 1995-01-17 1997-10-21 Affymax Technologies N.V Reagants and methods for immobilized polymer synthesis and display
US6379897B1 (en) * 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US6071394A (en) * 1996-09-06 2000-06-06 Nanogen, Inc. Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
US7857957B2 (en) 1994-07-07 2010-12-28 Gamida For Life B.V. Integrated portable biological detection system
US6403367B1 (en) 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
US5710000A (en) * 1994-09-16 1998-01-20 Affymetrix, Inc. Capturing sequences adjacent to Type-IIs restriction sites for genomic library mapping
US6558633B1 (en) * 1994-09-21 2003-05-06 Isis Pharmaceuticals, Inc. Chemical reaction apparatus and methods
US6327031B1 (en) * 1998-09-18 2001-12-04 Burstein Technologies, Inc. Apparatus and semi-reflective optical system for carrying out analysis of samples
US5695934A (en) * 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
US5604097A (en) 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
USRE43097E1 (en) 1994-10-13 2012-01-10 Illumina, Inc. Massively parallel signature sequencing by ligation of encoded adaptors
US6004617A (en) * 1994-10-18 1999-12-21 The Regents Of The University Of California Combinatorial synthesis of novel materials
US6121048A (en) * 1994-10-18 2000-09-19 Zaffaroni; Alejandro C. Method of conducting a plurality of reactions
US5985356A (en) 1994-10-18 1999-11-16 The Regents Of The University Of California Combinatorial synthesis of novel materials
US7767627B1 (en) 1994-10-18 2010-08-03 Symyx Solutions, Inc. Combinatorial synthesis of inorganic or composite materials
US6974666B1 (en) * 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US8236493B2 (en) 1994-10-21 2012-08-07 Affymetrix, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6600996B2 (en) 1994-10-21 2003-07-29 Affymetrix, Inc. Computer-aided techniques for analyzing biological sequences
US5795716A (en) 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5486633A (en) * 1994-11-10 1996-01-23 Duke University Photochemically-removable silyl protecting groups
AU705351B2 (en) * 1994-11-10 1999-05-20 Orchid Biosciences, Inc. Liquid distribution system
US5603351A (en) * 1995-06-07 1997-02-18 David Sarnoff Research Center, Inc. Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device
SE9404166D0 (en) * 1994-11-30 1994-11-30 Pharmacia Biotech Ab Multifunctional surfaces
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5622826A (en) * 1994-12-22 1997-04-22 Houston Advanced Research Center Method for immobilization of molecules on platinum solid support surfaces
US5712171A (en) 1995-01-20 1998-01-27 Arqule, Inc. Method of generating a plurality of chemical compounds in a spatially arranged array
US6239273B1 (en) 1995-02-27 2001-05-29 Affymetrix, Inc. Printing molecular library arrays
US5599695A (en) * 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5959098A (en) 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process
US5908926A (en) * 1995-03-16 1999-06-01 Duke University 5'to 3' nucleic acid synthesis using 3'-photoremovable protecting group
US6428955B1 (en) 1995-03-17 2002-08-06 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US7803529B1 (en) * 1995-04-11 2010-09-28 Sequenom, Inc. Solid phase sequencing of biopolymers
US6025129A (en) * 1995-04-25 2000-02-15 Irori Remotely programmable matrices with memories and uses thereof
US5751629A (en) 1995-04-25 1998-05-12 Irori Remotely programmable matrices with memories
US6017496A (en) 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US6100026A (en) * 1995-04-25 2000-08-08 Irori Matrices with memories and uses thereof
US6416714B1 (en) * 1995-04-25 2002-07-09 Discovery Partners International, Inc. Remotely programmable matrices with memories
US6331273B1 (en) 1995-04-25 2001-12-18 Discovery Partners International Remotely programmable matrices with memories
US5741462A (en) * 1995-04-25 1998-04-21 Irori Remotely programmable matrices with memories
US6329139B1 (en) 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US5925562A (en) * 1995-04-25 1999-07-20 Irori Remotely programmable matrices with memories
US5874214A (en) 1995-04-25 1999-02-23 Irori Remotely programmable matrices with memories
US6284459B1 (en) 1995-04-25 2001-09-04 Discovery Partners International Solid support matrices with memories and combinatorial libraries therefrom
US5961923A (en) * 1995-04-25 1999-10-05 Irori Matrices with memories and uses thereof
US5624711A (en) * 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5830655A (en) 1995-05-22 1998-11-03 Sri International Oligonucleotide sizing using cleavable primers
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US6720149B1 (en) 1995-06-07 2004-04-13 Affymetrix, Inc. Methods for concurrently processing multiple biological chip assays
US5958792A (en) * 1995-06-07 1999-09-28 Chiron Corporation Combinatorial libraries of substrate-bound cyclic organic compounds
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
NZ310778A (en) 1995-06-07 1999-10-28 Glaxo Group Ltd Peptides and compounds that bind to a thrombopoietin receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6361951B1 (en) 1995-06-27 2002-03-26 The University Of North Carolina At Chapel Hill Electrochemical detection of nucleic acid hybridization
US6346387B1 (en) * 1995-06-27 2002-02-12 Xanthon, Inc. Detection of binding reactions using labels detected by mediated catalytic electrochemistry
US6180346B1 (en) 1995-06-27 2001-01-30 The Universtiy Of North Carolina At Chapel Hill Electropolymerizable film, and method of making and use thereof
US5968745A (en) * 1995-06-27 1999-10-19 The University Of North Carolina At Chapel Hill Polymer-electrodes for detecting nucleic acid hybridization and method of use thereof
US6132971A (en) * 1995-06-27 2000-10-17 The University Of North Carolina At Chapel Hill Microelectronic device
US6127127A (en) * 1995-06-27 2000-10-03 The University Of North Carolina At Chapel Hill Monolayer and electrode for detecting a label-bearing target and method of use thereof
US6387625B1 (en) 1995-06-27 2002-05-14 The University Of North Carolina At Chapel Hill Monolayer and electrode for detecting a label-bearing target and method of use thereof
US20050100946A1 (en) * 1995-06-29 2005-05-12 Affymetrix, Inc. Integrated nucleic acid diagnostic device and method for in-situ confocal microscopy
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US6168948B1 (en) 1995-06-29 2001-01-02 Affymetrix, Inc. Miniaturized genetic analysis systems and methods
US20020022261A1 (en) * 1995-06-29 2002-02-21 Anderson Rolfe C. Miniaturized genetic analysis systems and methods
US5968740A (en) * 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
US6326140B1 (en) * 1995-08-09 2001-12-04 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5759779A (en) * 1995-08-29 1998-06-02 Dehlinger; Peter J. Polynucleotide-array assay and methods
US5633724A (en) * 1995-08-29 1997-05-27 Hewlett-Packard Company Evanescent scanning of biochemical array
US7026114B1 (en) * 1995-09-13 2006-04-11 Affymetrix, Inc. Methods and compositions for monitoring polymer array synthesis
US5733729A (en) 1995-09-14 1998-03-31 Affymetrix, Inc. Computer-aided probability base calling for arrays of nucleic acid probes on chips
US5843655A (en) 1995-09-18 1998-12-01 Affymetrix, Inc. Methods for testing oligonucleotide arrays
US20040086917A1 (en) * 1995-09-27 2004-05-06 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US6132580A (en) * 1995-09-28 2000-10-17 The Regents Of The University Of California Miniature reaction chamber and devices incorporating same
US20020068357A1 (en) * 1995-09-28 2002-06-06 Mathies Richard A. Miniaturized integrated nucleic acid processing and analysis device and method
US20040175718A1 (en) * 1995-10-16 2004-09-09 Affymetrix, Inc. Computer-aided visualization and analysis system for sequence evaluation
US5658734A (en) * 1995-10-17 1997-08-19 International Business Machines Corporation Process for synthesizing chemical compounds
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5763263A (en) * 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US6300063B1 (en) 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
US6953663B1 (en) * 1995-11-29 2005-10-11 Affymetrix, Inc. Polymorphism detection
US20110028350A1 (en) * 1995-12-15 2011-02-03 Affymetrix, Inc. Photocleavable protecting groups
US6022963A (en) * 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
US6147205A (en) * 1995-12-15 2000-11-14 Affymetrix, Inc. Photocleavable protecting groups and methods for their use
US6660233B1 (en) * 1996-01-16 2003-12-09 Beckman Coulter, Inc. Analytical biochemistry system with robotically carried bioarray
US7282327B2 (en) * 1996-01-23 2007-10-16 Affymetrix, Inc. Nucleic acid labeling compounds
US6864059B2 (en) * 1996-01-23 2005-03-08 Affymetrix, Inc. Biotin containing C-glycoside nucleic acid labeling compounds
US20040210045A1 (en) * 1996-01-23 2004-10-21 Mcgall Glenn Nucleic acid labeling compounds
US20010018514A1 (en) * 1998-07-31 2001-08-30 Mcgall Glenn H. Nucleic acid labeling compounds
US7291463B2 (en) * 1996-01-23 2007-11-06 Affymetrix, Inc. Nucleic acid labeling compounds
US7423143B2 (en) * 1996-01-23 2008-09-09 Affymetrix. Inc. Nucleic acid labeling compounds
EP0880598A4 (en) * 1996-01-23 2005-02-23 Affymetrix Inc Nucleic acid analysis techniques
US7468243B2 (en) 2001-03-12 2008-12-23 Affymetrix, Inc. 2-aminopyrimidin-4-one nucleic acid labeling compounds
US6965020B2 (en) 1996-01-23 2005-11-15 Affymetrix, Inc. Nucleic acid labeling compounds
US7527928B2 (en) * 1996-11-29 2009-05-05 Third Wave Technologies, Inc. Reactions on a solid surface
US6924094B1 (en) 1996-02-08 2005-08-02 Affymetrix, Inc. Chip-based species identification and phenotypic characterization of microorganisms
EP1728875A3 (en) 1996-02-08 2007-05-09 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
AU2189397A (en) 1996-02-08 1997-08-28 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
US6852487B1 (en) 1996-02-09 2005-02-08 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US20020150921A1 (en) * 1996-02-09 2002-10-17 Francis Barany Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
AU735440B2 (en) 1996-02-09 2001-07-05 Cornell Research Foundation Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US20030022184A1 (en) * 1996-02-12 2003-01-30 Oncormed. Inc. Coding sequences of the human BRCA1 gene
US6838256B2 (en) 1996-02-12 2005-01-04 Gene Logic Inc. Coding sequences of the human BRCA1 gene
US6130322A (en) * 1996-02-12 2000-10-10 Gene Logic, Inc. Coding sequences of the human BRCA1 gene
DE19609272C2 (en) * 1996-02-27 2000-05-25 Schering Ag Process for the parallel synthesis of large numbers of 2,6-disubstituted quinoline derivatives
US6063633A (en) 1996-02-28 2000-05-16 The University Of Houston Catalyst testing process and apparatus
EP0886681A1 (en) * 1996-03-04 1998-12-30 Genetrace Systems, Inc. Methods of screening nucleic acids using mass spectrometry
WO1997033169A1 (en) * 1996-03-08 1997-09-12 Smithkline Beecham Corporation A method for determining the affinity of proteins for chemical agents during screening of combinatorial libraries
US20030165931A1 (en) * 1998-03-11 2003-09-04 Bruno Tocque Qualitative differential screening
FR2775984B1 (en) 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa QUALITATIVE DIFFERENTIAL SCREENING
US6013440A (en) * 1996-03-11 2000-01-11 Affymetrix, Inc. Nucleic acid affinity columns
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
AU2320597A (en) 1996-03-19 1997-10-10 Molecular Tool, Inc. Method for determining the nucleotide sequence of a polynucleotide
US6361937B1 (en) 1996-03-19 2002-03-26 Affymetrix, Incorporated Computer-aided nucleic acid sequencing
US6528324B1 (en) * 1996-03-22 2003-03-04 Ontogen Corporation Apparatus for pre-determined mass sorting of positional-encoded solid phase synthesis supports
US6777217B1 (en) * 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US6114122A (en) 1996-03-26 2000-09-05 Affymetrix, Inc. Fluidics station with a mounting system and method of using
DE19612356B4 (en) * 1996-03-28 2007-04-26 Clondiag Chip Technologies Gmbh Optical detection of hybridization signals
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
US5733509A (en) * 1996-04-17 1998-03-31 Motorola, Inc. Method and system for synthesizing oligonucleotides using nucleotide-specific dispensing bars
AU2462497A (en) 1996-04-17 1997-11-19 Hubert Koster A combinatorial protecting group strategy for multifunctional molecules
US6706875B1 (en) * 1996-04-17 2004-03-16 Affyemtrix, Inc. Substrate preparation process
DE69737883T2 (en) * 1996-04-25 2008-03-06 Bioarray Solutions Ltd. LIGHT-REGULATED, ELECTROKINETIC COMPOSITION OF PARTICLES TO SURFACES
US6165335A (en) 1996-04-25 2000-12-26 Pence And Mcgill University Biosensor device and method
US6958245B2 (en) 1996-04-25 2005-10-25 Bioarray Solutions Ltd. Array cytometry
US7144119B2 (en) * 1996-04-25 2006-12-05 Bioarray Solutions Ltd. System and method for programmable illumination pattern generation
JP2000512744A (en) 1996-05-16 2000-09-26 アフィメトリックス,インコーポレイテッド System and method for detecting label material
US5958342A (en) * 1996-05-17 1999-09-28 Incyte Pharmaceuticals, Inc. Jet droplet device
EP0912761A4 (en) * 1996-05-29 2004-06-09 Cornell Res Foundation Inc Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6103479A (en) * 1996-05-30 2000-08-15 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US20060141539A1 (en) * 1996-05-30 2006-06-29 Taylor D L Miniaturized cell array methods and apparatus for cell-based screening
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
AU3568897A (en) * 1996-06-07 1998-01-05 Eos Biotechnology, Inc. Immobilised linear oligonucleotide arrays
US5914229A (en) * 1996-06-14 1999-06-22 Sarnoff Corporation Method for amplifying a polynucleotide
CA2258511A1 (en) * 1996-06-14 1997-12-18 Sarnoff Corporation Method for polynucleotide sequencing
US5770370A (en) * 1996-06-14 1998-06-23 David Sarnoff Research Center, Inc. Nuclease protection assays
US5912124A (en) * 1996-06-14 1999-06-15 Sarnoff Corporation Padlock probe detection
SE9602545L (en) 1996-06-25 1997-12-26 Michael Mecklenburg Method of discriminating complex biological samples
CN1230216A (en) 1996-07-08 1999-09-29 伯斯坦恩实验室股份有限公司 Cleavable signal element device and method
US6342349B1 (en) 1996-07-08 2002-01-29 Burstein Technologies, Inc. Optical disk-based assay devices and methods
US6331275B1 (en) 1996-07-08 2001-12-18 Burstein Technologies, Inc. Spatially addressable, cleavable reflective signal elements, assay device and method
US20050069923A1 (en) * 1996-07-08 2005-03-31 Mullis Kary Banks Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
US20050214827A1 (en) * 1996-07-08 2005-09-29 Burstein Technologies, Inc. Assay device and method
DE19629141A1 (en) * 1996-07-19 1998-04-16 Bayer Ag Method and device for screening molecules for their individual binding behavior to at least one predetermined ligand
US5798360A (en) * 1996-08-01 1998-08-25 Isis Pharmaceuticals, Inc. N-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic compositions
US5922872A (en) * 1996-08-01 1999-07-13 Isis Pharmaceuticals, Inc. Meta-benzylic and alpha-amido compositions and methods for preparing same
US5731438A (en) * 1996-08-01 1998-03-24 Isis Pharmaceuticals, Inc. N-(aminoalkyl)-and/or N-(amidoalkyl)-dinitrogen heterocycles
US5817489A (en) 1996-08-01 1998-10-06 Isis Pharmaceuticals, Inc. Di-nitrogen heterocycle compositions
US5858666A (en) * 1996-08-29 1999-01-12 Biotechnology Research And Development Corporation Apparatus and method of detection employing an AC frequency sensor array
US6020047A (en) * 1996-09-04 2000-02-01 Kimberly-Clark Worldwide, Inc. Polymer films having a printed self-assembling monolayer
US5965363A (en) 1996-09-19 1999-10-12 Genetrace Systems Inc. Methods of preparing nucleic acids for mass spectrometric analysis
US6391550B1 (en) 1996-09-19 2002-05-21 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
AU4428497A (en) * 1996-09-20 1998-04-14 James P. Demers Spatially addressable combinatorial chemical arrays in cd-rom format
ATE449851T1 (en) 1996-10-01 2009-12-15 Geron Corp HUMAN TELOMERASE REVERSE TRANSCRIPTASE PROMOTER
US6468806B1 (en) * 1996-10-02 2002-10-22 Symyx Technologies, Inc. Potential masking systems and methods for combinatorial library synthesis
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6136274A (en) * 1996-10-07 2000-10-24 Irori Matrices with memories in automated drug discovery and units therefor
US6738529B1 (en) * 1996-10-09 2004-05-18 Symyx Technologies, Inc. Analysis of chemical data from images
US5762881A (en) * 1996-10-29 1998-06-09 Bohdan Automation, Inc. Apparatus for multiple, simultaneous synthesis of organic compounds
US6875620B1 (en) * 1996-10-31 2005-04-05 Agilent Technologies, Inc. Tiling process for constructing a chemical array
US5780241A (en) * 1996-11-05 1998-07-14 Isis Pharmaceuticals, Inc. Complex chemical libraries
US6140053A (en) * 1996-11-06 2000-10-31 Sequenom, Inc. DNA sequencing by mass spectrometry via exonuclease degradation
US6024925A (en) 1997-01-23 2000-02-15 Sequenom, Inc. Systems and methods for preparing low volume analyte array elements
DK0937096T3 (en) 1996-11-06 2004-06-14 Sequenom Inc Method of mass spectrometry analysis
US6133436A (en) 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US7285422B1 (en) 1997-01-23 2007-10-23 Sequenom, Inc. Systems and methods for preparing and analyzing low volume analyte array elements
DE19782095T1 (en) * 1996-11-06 2000-03-23 Sequenom Inc DNA diagnosis based on mass spectrometry
US6441172B1 (en) 1996-11-07 2002-08-27 Torrey Pines Institute For Molecular Studies Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
ATE234674T1 (en) * 1996-11-14 2003-04-15 Affymetrix Inc CHEMICAL AMPLIFICATION FOR SYNTHESIS OF PATTERN ORDERS
US6887665B2 (en) * 1996-11-14 2005-05-03 Affymetrix, Inc. Methods of array synthesis
US5965719A (en) * 1996-11-15 1999-10-12 Sunsorb Biotech, Inc. Combinatorial synthesis of carbohydrate libraries
US5780603A (en) * 1996-11-15 1998-07-14 Synsorb Biotech, Inc. Combinatorial synthesis of carbohydrate libraries
US6706473B1 (en) * 1996-12-06 2004-03-16 Nanogen, Inc. Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
DE69735445T2 (en) 1996-12-10 2006-08-10 Sequenom, Inc., San Diego NON-VOLATILE, NON-VOLATILE MOLECULES FOR MASS MARKING
US5942397A (en) * 1996-12-11 1999-08-24 Tarlov; Michael J. Surface immobilization of biopolymers
IL129767A0 (en) 1996-12-12 2000-02-29 Prolume Ltd Apparatus and method for detecting and identifying infectious agents
JP2001517300A (en) * 1996-12-17 2001-10-02 アフィメトリックス・インコーポレーテッド Lithography mask design and synthesis of various probes on a substrate
US6048623A (en) * 1996-12-18 2000-04-11 Kimberly-Clark Worldwide, Inc. Method of contact printing on gold coated films
US5922550A (en) * 1996-12-18 1999-07-13 Kimberly-Clark Worldwide, Inc. Biosensing devices which produce diffraction images
CA2275541A1 (en) * 1996-12-19 1998-06-25 Yale University Bioreactive allosteric polynucleotides
EP1249705A3 (en) * 1996-12-31 2003-11-05 Genometrix Genomics Incorporated Multiplexed molecular analysis apparatus and its fabrication method
US6277563B1 (en) 1997-01-16 2001-08-21 The Regents Of The University Of California Genetic alterations associated with cancer
US7670767B1 (en) * 1997-01-16 2010-03-02 The Regents Of The University Of California Genetic alterations associated with cancer
DK0971946T3 (en) 1997-01-21 2006-10-30 Gen Hospital Corp Selection of proteins using RNA-protein fusions
US5837475A (en) * 1997-01-30 1998-11-17 Hewlett-Packard Co. Apparatus and method for scanning a chemical array
US5812272A (en) * 1997-01-30 1998-09-22 Hewlett-Packard Company Apparatus and method with tiled light source array for integrated assay sensing
US6262269B1 (en) 1997-02-04 2001-07-17 Trega Biosciences, Inc. 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries
US5773308A (en) * 1997-02-10 1998-06-30 The United States Of America As Represented By The Secretary Of The Navy Photoactivatable o-nitrobenzyl polyethylene glycol-silane for the production of patterned biomolecular arrays
CA2281205A1 (en) 1997-02-12 1998-08-13 Eugene Y. Chan Methods and products for analyzing polymers
US6187536B1 (en) 1997-02-18 2001-02-13 Thomas Jefferson University Methods of identifying and detecting pancreatic cancer
US7117098B1 (en) 1997-02-27 2006-10-03 Cellomics, Inc. Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
US6727071B1 (en) 1997-02-27 2004-04-27 Cellomics, Inc. System for cell-based screening
AU730100B2 (en) 1997-02-27 2001-02-22 Cellomics, Inc. A system for cell-based screening
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
US7622294B2 (en) 1997-03-14 2009-11-24 Trustees Of Tufts College Methods for detecting target analytes and enzymatic reactions
US20030027126A1 (en) 1997-03-14 2003-02-06 Walt David R. Methods for detecting target analytes and enzymatic reactions
US6028189A (en) * 1997-03-20 2000-02-22 University Of Washington Solvent for oligonucleotide synthesis and methods of use
US6419883B1 (en) 1998-01-16 2002-07-16 University Of Washington Chemical synthesis using solvent microdroplets
JP2001518086A (en) 1997-03-20 2001-10-09 ユニバーシティ オブ ワシントン Solvents, solvent microdroplets, and methods of use for biopolymer synthesis
US6180288B1 (en) 1997-03-21 2001-01-30 Kimberly-Clark Worldwide, Inc. Gel sensors and method of use thereof
US6753161B2 (en) * 1997-03-27 2004-06-22 Oncosis Llc Optoinjection methods
CA2284612A1 (en) 1997-04-04 1998-10-15 Michael Knapp Closed-loop biochemical analyzers
US5772855A (en) * 1997-04-17 1998-06-30 Bend Research, Inc. Preparation of bioactive compounds by plasma synthesis
US6143496A (en) 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US6558901B1 (en) * 1997-05-02 2003-05-06 Biomerieux Vitek Nucleic acid assays
US7101672B2 (en) 1998-05-05 2006-09-05 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
WO1998050403A1 (en) 1997-05-05 1998-11-12 Third Wave Technologies,Inc. Target-dependent reactions using structure-bridging oligonucleotides
US6210880B1 (en) 1997-09-19 2001-04-03 Third Wave Technologies, Inc. Polymorphism analysis by nucleic acid structure probing with structure-bridging oligonucleotides
US6194149B1 (en) 1998-03-03 2001-02-27 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
US6214545B1 (en) 1997-05-05 2001-04-10 Third Wave Technologies, Inc Polymorphism analysis by nucleic acid structure probing
US6159681A (en) * 1997-05-28 2000-12-12 Syntrix Biochip, Inc. Light-mediated method and apparatus for the regional analysis of biologic material
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
ATE464123T1 (en) * 1997-06-20 2010-04-15 Univ New York ELECTROSPRAYING SOLUTIONS FOR MASS PRODUCTION OF CHIPS AND MOLECULE LIBRARIES
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
EP0991930B1 (en) * 1997-06-26 2004-06-16 Perseptive Biosystems, Inc. High density sample holder for analysis of biological samples
IL121312A (en) * 1997-07-14 2001-09-13 Technion Res & Dev Foundation Microelectronic components, their fabrication and electronic networks comprising them
US6151123A (en) * 1997-07-14 2000-11-21 Symyx Technologies, Inc. Systems and methods for employing optical probes to characterize material properties
CN1265156A (en) 1997-07-22 2000-08-30 拉普吉恩公司 Amplification and other enzymatic reactions preformed on nucleic acid arrays
EP0996500A1 (en) 1997-07-22 2000-05-03 Rapigene, Inc. Apparatus and methods for arraying solution onto a solid support
NZ501774A (en) 1997-07-22 2002-02-01 Qiagen Genomics Inc Computer method and system for correlating known characteristics of biomolecules to molecular tags with unique molecular weights that are associated with the biomolecule
DE69823206T2 (en) 1997-07-25 2004-08-19 Affymetrix, Inc. (a Delaware Corp.), Santa Clara METHOD FOR PRODUCING A BIO-INFORMATICS DATABASE
US6420108B2 (en) * 1998-02-09 2002-07-16 Affymetrix, Inc. Computer-aided display for comparative gene expression
US6826296B2 (en) 1997-07-25 2004-11-30 Affymetrix, Inc. Method and system for providing a probe array chip design database
US7068830B2 (en) * 1997-07-25 2006-06-27 Affymetrix, Inc. Method and system for providing a probe array chip design database
WO1999006833A1 (en) * 1997-07-29 1999-02-11 Huston James S Methods for obtaining probes of peptide function
US6391655B1 (en) 1997-07-30 2002-05-21 Corning Incorporated Oxidized styrenic polymers for DNA binding
US6290685B1 (en) 1998-06-18 2001-09-18 3M Innovative Properties Company Microchanneled active fluid transport devices
US6375871B1 (en) 1998-06-18 2002-04-23 3M Innovative Properties Company Methods of manufacturing microfluidic articles
JP4313861B2 (en) * 1997-08-01 2009-08-12 キヤノン株式会社 Manufacturing method of probe array
ATE443866T1 (en) 1997-08-01 2009-10-15 Canon Kk REACTION SITE ARRAY, METHOD FOR PRODUCING IT, REACTION METHOD USING IT AND QUANTITATIVE DETERMINATION METHOD FOR A SUBSTANCE IN A SAMPLE SOLUTION USING IT
US6326489B1 (en) 1997-08-05 2001-12-04 Howard Hughes Medical Institute Surface-bound, bimolecular, double-stranded DNA arrays
US6120995A (en) * 1997-08-07 2000-09-19 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US7135333B1 (en) 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
AU9292898A (en) 1997-08-15 1999-03-08 Oncormed, Inc. Coding sequence haplotypes of the human brca2 gene
US20090269814A1 (en) * 1998-05-22 2009-10-29 Murphy Patricia D Method of Analyzing a BRCA2 Gene in a Human Subject
US6410342B1 (en) * 1997-08-19 2002-06-25 Pharmacopeia, Inc. Method and apparatus for controlled photoelution
US7252950B1 (en) 1997-09-04 2007-08-07 The Regents Of The University Of California Assays for detecting modulators of cytoskeletal function
US6432639B1 (en) 1997-09-10 2002-08-13 Dna Sciences Laboratories, Inc. Isolated CYP3A4 nucleic acid molecules and detection methods
CN100337106C (en) * 1997-09-11 2007-09-12 生物风险公司 Method of making high density arrays
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
DE19741715A1 (en) * 1997-09-22 1999-03-25 Hoechst Ag New pentopyranosyl nucleoside compounds
US7214298B2 (en) * 1997-09-23 2007-05-08 California Institute Of Technology Microfabricated cell sorter
US6492109B1 (en) 1997-09-23 2002-12-10 Gene Logic, Inc. Susceptibility mutation 6495delGC of BRCA2
US20030104481A1 (en) * 1997-09-30 2003-06-05 Symyx Technologies Potential masking systems and methods for combinatorial library synthesis
US6607878B2 (en) 1997-10-06 2003-08-19 Stratagene Collections of uniquely tagged molecules
US6485944B1 (en) 1997-10-10 2002-11-26 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
JP2001519538A (en) 1997-10-10 2001-10-23 プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ Replica amplification of nucleic acid arrays
US6511803B1 (en) * 1997-10-10 2003-01-28 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
AU8826598A (en) * 1997-10-10 1999-05-03 President And Fellows Of Harvard College Surface-bound, double-stranded dna protein arrays
US20020155495A1 (en) * 2000-04-17 2002-10-24 Millstein Larry S. Method for producing arrays and devices relating thereto
US6348322B1 (en) * 1997-10-17 2002-02-19 Duke University Method of screening for specific binding interactions
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US6156494A (en) * 1997-10-28 2000-12-05 Mosaic Technologies Serially directed combinatorial synthesis on fiber optic arrays
ATE537270T1 (en) * 1997-10-30 2011-12-15 Cold Spring Harbor Lab PROBE ARRANGEMENTS AND THEIR USES FOR DNA DISTINCTION PROCEDURES
US6322968B1 (en) 1997-11-21 2001-11-27 Orchid Biosciences, Inc. De novo or “universal” sequencing array
US6101946A (en) * 1997-11-21 2000-08-15 Telechem International Inc. Microarray printing device including printing pins with flat tips and exterior channel and method of manufacture
US6794133B1 (en) 1997-12-11 2004-09-21 The General Hospital Corporation Broad range PCR amplification techniques
US6184377B1 (en) 1997-12-15 2001-02-06 Sepracor Inc. Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
US6274383B1 (en) 1997-12-15 2001-08-14 Sepracor Inc. Methods for synthesizing libraries of dihydro-quinazolinones
US20070166741A1 (en) * 1998-12-14 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US6242246B1 (en) * 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US6060256A (en) * 1997-12-16 2000-05-09 Kimberly-Clark Worldwide, Inc. Optical diffraction biosensor
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US6458533B1 (en) 1997-12-19 2002-10-01 High Throughput Genomics, Inc. High throughput assay system for monitoring ESTs
US20100105572A1 (en) * 1997-12-19 2010-04-29 Kris Richard M High throughput assay system
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US20030039967A1 (en) * 1997-12-19 2003-02-27 Kris Richard M. High throughput assay system using mass spectrometry
US6238869B1 (en) 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
US6093302A (en) * 1998-01-05 2000-07-25 Combimatrix Corporation Electrochemical solid phase synthesis
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6265163B1 (en) 1998-01-09 2001-07-24 Lynx Therapeutics, Inc. Solid phase selection of differentially expressed genes
EP1714699B1 (en) * 1998-01-12 2010-08-18 Massachusetts Institute of Technology System for analyzing a plurality of samples
US6893877B2 (en) 1998-01-12 2005-05-17 Massachusetts Institute Of Technology Methods for screening substances in a microwell array
US6201639B1 (en) 1998-03-20 2001-03-13 James W. Overbeck Wide field of view and high speed scanning microscopy
US20020164585A1 (en) * 1998-01-16 2002-11-07 Sean Chapman Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
US6426185B1 (en) 1998-01-16 2002-07-30 Large Scale Biology Corporation Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation
US6303848B1 (en) 1998-01-16 2001-10-16 Large Scale Biology Corporation Method for conferring herbicide, pest, or disease resistance in plant hosts
US20030166169A1 (en) * 1998-01-16 2003-09-04 Padgett Hal S. Method for constructing viral nucleic acids in a cell-free manner
US6289229B1 (en) 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
WO1999036576A1 (en) * 1998-01-20 1999-07-22 Packard Bioscience Company Gel pad arrays and methods and systems for making them
DE19802576B4 (en) * 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Methods for the simultaneous identification of proteins and their binding partners
US6043294A (en) * 1998-01-29 2000-03-28 Gate Technologies International, Inc. Method of and apparatus for optically enhancing chemical reactions
US6741956B1 (en) 1998-02-03 2004-05-25 Lucent Technologies Inc. Analog computation using hybridization-capable oligomers
US6537747B1 (en) 1998-02-03 2003-03-25 Lucent Technologies Inc. Data transmission using DNA oligomers
US6150102A (en) * 1998-02-03 2000-11-21 Lucent Technologies Inc. Method of generating nucleic acid oligomers of known composition
DE69825722T2 (en) * 1998-02-04 2005-08-25 Corning Inc. Substrate for printing a matrix
WO1999040434A1 (en) 1998-02-04 1999-08-12 Invitrogen Corporation Microarrays and uses therefor
US20040265838A1 (en) * 1998-02-06 2004-12-30 Affymetrix, Inc. Method of manufacturing
US5994079A (en) 1998-02-06 1999-11-30 Digene Corporation Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
US7399589B2 (en) * 1998-02-06 2008-07-15 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
AU772531B2 (en) * 1998-02-11 2004-04-29 University Of Houston, The Method and apparatus for chemical and biochemical reactions using photo-generated reagents
US20040035690A1 (en) * 1998-02-11 2004-02-26 The Regents Of The University Of Michigan Method and apparatus for chemical and biochemical reactions using photo-generated reagents
ATE246041T1 (en) * 1998-02-11 2003-08-15 Univ Houston Office Of Technol DEVICE FOR CARRYING OUT CHEMICAL AND BIOCHEMICAL REACTIONS USING PHOTOPRODUCED REAGENTS
US6537505B1 (en) 1998-02-20 2003-03-25 Bio Dot, Inc. Reagent dispensing valve
US20020006604A1 (en) * 1998-02-21 2002-01-17 Alan W Schwabacher One dimensional compound arrays and a method for assaying them
DE69942272D1 (en) * 1998-02-23 2010-06-02 Wisconsin Alumni Res Found DERANORDNUNGEN
US20020090639A1 (en) * 1998-02-26 2002-07-11 Mcginnis Ralph Evan Two dimensional linkage study methods and related inventions
US6087103A (en) * 1998-03-04 2000-07-11 Lifespan Biosciences, Inc. Tagged ligand arrays for identifying target-ligand interactions
EP1717249A1 (en) 1998-03-12 2006-11-02 Georgetown University Peptides containing a cholesterol recognition sequence and their uses
US6185030B1 (en) 1998-03-20 2001-02-06 James W. Overbeck Wide field of view and high speed scanning microscopy
US6361942B1 (en) * 1998-03-24 2002-03-26 Boston Probes, Inc. Method, kits and compositions pertaining to detection complexes
CA2322843A1 (en) * 1998-03-27 1999-09-30 The Board Of Trustees Of The Leland Stanford, Jr. University Hypoxia-inducible human genes, proteins, and uses thereof
US6218114B1 (en) 1998-03-27 2001-04-17 Academia Sinica Methods for detecting differentially expressed genes
US6077673A (en) * 1998-03-31 2000-06-20 Clontech Laboratories, Inc. Mouse arrays and kits comprising the same
AU3217599A (en) * 1998-03-31 1999-10-18 Genzyme Corporation Methods for the diagnosis and treatment of lung cancer
US7108968B2 (en) * 1998-04-03 2006-09-19 Affymetrix, Inc. Mycobacterial rpoB sequences
AU3463699A (en) * 1998-04-03 1999-10-25 Phylos, Inc. Addressable protein arrays
US6284497B1 (en) * 1998-04-09 2001-09-04 Trustees Of Boston University Nucleic acid arrays and methods of synthesis
US6376619B1 (en) 1998-04-13 2002-04-23 3M Innovative Properties Company High density, miniaturized arrays and methods of manufacturing same
JP2002512045A (en) * 1998-04-20 2002-04-23 アフィメトリックス インコーポレイテッド Methods for reducing non-specific binding to nucleic acid probe arrays
AU3572799A (en) * 1998-04-24 1999-11-16 Genova Pharmaceuticals Corporation Function-based gene discovery
US6884626B1 (en) 1998-04-27 2005-04-26 Corning Incorporated Redrawn capillary imaging reservoir
US6355419B1 (en) 1998-04-27 2002-03-12 Hyseq, Inc. Preparation of pools of nucleic acids based on representation in a sample
US6350618B1 (en) 1998-04-27 2002-02-26 Corning Incorporated Redrawn capillary imaging reservoir
EP0955084B1 (en) 1998-04-27 2006-07-26 Corning Incorporated Method of depositing an array of biological samples using a redrawn capillary reservoir
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US20080050836A1 (en) * 1998-05-01 2008-02-28 Isabelle Guyon Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7617163B2 (en) * 1998-05-01 2009-11-10 Health Discovery Corporation Kernels and kernel methods for spectral data
US6130046A (en) * 1998-05-04 2000-10-10 Affymetrix, Inc. Techniques for synthesis integrity evaluation utilizing cycle fidelity probes
US20030203394A1 (en) * 1998-05-04 2003-10-30 Yoav Eichen Detection of a target in a sample
US6979728B2 (en) * 1998-05-04 2005-12-27 Baylor College Of Medicine Articles of manufacture and methods for array based analysis of biological molecules
US6686163B2 (en) 1998-05-06 2004-02-03 Gene Logic Inc. Coding sequence haplotype of the human BRCA1 gene
US5992226A (en) * 1998-05-08 1999-11-30 The United States Of America As Represented By The Secretary Of The Navy Apparatus and method for measuring intermolecular interactions by atomic force microscopy
US6324479B1 (en) 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US5965352A (en) 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
US20030153023A1 (en) * 1999-05-13 2003-08-14 Starzl Timothy W. Enumeration method of analyte detection
DE19823454A1 (en) * 1998-05-18 1999-11-25 Epigenomics Gmbh Photolithographic production of oligonucleotide array for manufacture of DNA chips
DE19823660C1 (en) * 1998-05-20 1999-10-07 Nanomont Ges Fuer Nanotechnolo Process and assembly to apply and fix biochemically-active micro- and nano- micro-spheres on a substrate, especially useful in biochemical analysis such as DNA, viral and genetic testing
AU4218499A (en) * 1998-05-27 1999-12-13 Syntrix Biochip Light-mediated method and apparatus for the regional analysis of biologic material
US6268210B1 (en) * 1998-05-27 2001-07-31 Hyseq, Inc. Sandwich arrays of biological compounds
US6271957B1 (en) * 1998-05-29 2001-08-07 Affymetrix, Inc. Methods involving direct write optical lithography
US6086831A (en) * 1998-06-10 2000-07-11 Mettler-Toledo Bohdan, Inc. Modular reaction block assembly with thermoelectric cooling and heating
DE19826458A1 (en) * 1998-06-13 1999-12-16 Papst Motoren Gmbh & Co Kg Arrangement with an electric motor
US6270730B1 (en) 1998-06-16 2001-08-07 Northwest Engineering Inc. Multi-well rotary synthesizer
US6872521B1 (en) 1998-06-16 2005-03-29 Beckman Coulter, Inc. Polymerase signaling assay
US6251595B1 (en) 1998-06-18 2001-06-26 Agilent Technologies, Inc. Methods and devices for carrying out chemical reactions
US6218122B1 (en) 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
US6132969A (en) * 1998-06-19 2000-10-17 Rosetta Inpharmatics, Inc. Methods for testing biological network models
ATE313548T1 (en) * 1998-06-22 2006-01-15 Affymetrix Inc REAGENT AND METHOD FOR SOLID PHASE SYNTHESIS
US6235473B1 (en) 1998-07-02 2001-05-22 Orchid Biosciences, Inc. Gene pen devices for array printing
US6762061B1 (en) 1998-07-03 2004-07-13 Corning Incorporated Redrawn capillary imaging reservoir
US6593133B1 (en) 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
WO2000003037A1 (en) * 1998-07-10 2000-01-20 The Board Of Trustees Of The Leland Stanford Junior University Screening arrays of nucleotides to determine correspondence with both sequence and physical properties of a probe
US6171794B1 (en) 1998-07-13 2001-01-09 Rosetta Inpharmatics, Inc. Methods for determining cross-hybridization
US6682942B1 (en) 1998-07-14 2004-01-27 Zyomyx, Inc. Microdevices for screening biomolecules
US6780582B1 (en) * 1998-07-14 2004-08-24 Zyomyx, Inc. Arrays of protein-capture agents and methods of use thereof
US20030138973A1 (en) * 1998-07-14 2003-07-24 Peter Wagner Microdevices for screening biomolecules
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6576478B1 (en) 1998-07-14 2003-06-10 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
US20020119579A1 (en) * 1998-07-14 2002-08-29 Peter Wagner Arrays devices and methods of use thereof
US6897073B2 (en) * 1998-07-14 2005-05-24 Zyomyx, Inc. Non-specific binding resistant protein arrays and methods for making the same
EP1098996A1 (en) 1998-07-20 2001-05-16 Yale University Method for detecting nucleic acids using target-mediated ligation of bipartite primers
EP1097378A2 (en) * 1998-07-21 2001-05-09 Burstein Laboratories Inc. Optical disc-based assay devices and methods
AU5255199A (en) * 1998-08-03 2000-02-28 California Institute Of Technology Method of determining cell or tissue type by transmembrane receptor identifiers
US20040029159A1 (en) * 1998-08-03 2004-02-12 Dreyer William J. Nucleic acid switch patterns as cell or tissue type identifiers
US6864092B1 (en) 1998-08-13 2005-03-08 Symyx Technologies, Inc. Parallel reactor with internal sensing and method of using same
US6306658B1 (en) 1998-08-13 2001-10-23 Symyx Technologies Parallel reactor with internal sensing
US6455316B1 (en) 1998-08-13 2002-09-24 Symyx Technologies, Inc. Parallel reactor with internal sensing and method of using same
US6548026B1 (en) 1998-08-13 2003-04-15 Symyx Technologies, Inc. Parallel reactor with internal sensing and method of using same
US6528026B2 (en) 1998-08-13 2003-03-04 Symyx Technologies, Inc. Multi-temperature modular reactor and method of using same
DE19836882A1 (en) * 1998-08-14 2000-02-17 Papst Motoren Gmbh & Co Kg Electric motor has characteristic field stored as digital values for associating parameter and motor speed values, and microcontroller or microprocessor
US6291190B1 (en) 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
US6271042B1 (en) * 1998-08-26 2001-08-07 Alpha Innotech Corporation Biochip detection system
AU757510C (en) * 1998-08-27 2003-09-11 Medimmune Limited Pyrrolobenzodiazepines
GB9818731D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Compounds
GB9818730D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
GB9818732D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collection of compounds
DE19940749A1 (en) 1998-08-28 2000-05-18 Febit Ferrarius Biotech Gmbh Integrated synthesis and analysis method e.g. for polymers, comprises a carrier body provided with immobilized receptors to provide respective channels before contact with sample and subsequent analysis
US6929912B2 (en) * 1998-08-31 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for evaluating the ability to metabolize pharmaceuticals
US6461812B2 (en) * 1998-09-09 2002-10-08 Agilent Technologies, Inc. Method and multiple reservoir apparatus for fabrication of biomolecular arrays
WO2000014197A1 (en) * 1998-09-09 2000-03-16 Hitachi Software Engineering Co., Ltd. Biochip and method of using biochip
AU770993B2 (en) * 1998-09-15 2004-03-11 Yale University Molecular cloning using rolling circle amplification
AU763890B2 (en) * 1998-09-15 2003-07-31 Yale University Artificial long terminal repeat vectors
US6475440B1 (en) 1998-09-16 2002-11-05 Clontech Laboratories, Inc. Applicator for use in deposition of fluid samples onto a substrate surface
KR100369694B1 (en) * 1998-09-17 2003-01-29 인터내셔널 비지네스 머신즈 코포레이션 Synthesis of Chemical Tags
US6185561B1 (en) 1998-09-17 2001-02-06 Affymetrix, Inc. Method and apparatus for providing and expression data mining database
US20070178475A1 (en) * 1998-09-17 2007-08-02 Nehls Michael C Novel human polynucleotides and polypeptides encoded thereby
US6821724B1 (en) * 1998-09-17 2004-11-23 Affymetrix, Inc. Methods of genetic analysis using nucleic acid arrays
US20040199544A1 (en) * 2000-11-02 2004-10-07 Affymetrix, Inc. Method and apparatus for providing an expression data mining database
US6146830A (en) * 1998-09-23 2000-11-14 Rosetta Inpharmatics, Inc. Method for determining the presence of a number of primary targets of a drug
US6703228B1 (en) 1998-09-25 2004-03-09 Massachusetts Institute Of Technology Methods and products related to genotyping and DNA analysis
US20090119022A1 (en) * 1998-09-25 2009-05-07 Timberlake William E Emericella Nidulans Genome Sequence On Computer Readable Medium and Uses Thereof
EP1001037A3 (en) * 1998-09-28 2003-10-01 Whitehead Institute For Biomedical Research Pre-selection and isolation of single nucleotide polymorphisms
US6203989B1 (en) 1998-09-30 2001-03-20 Affymetrix, Inc. Methods and compositions for amplifying detectable signals in specific binding assays
US6682927B2 (en) * 1998-10-05 2004-01-27 Duke University Methods and apparatus for the high through-put detection of binding interactions in vivo
WO2000020859A1 (en) * 1998-10-05 2000-04-13 Duke University METHOD AND APPARATUS FOR DETECTING BINDING INTERACTIONS $i(IN VIVO)
US6262216B1 (en) 1998-10-13 2001-07-17 Affymetrix, Inc. Functionalized silicon compounds and methods for their synthesis and use
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
US7071324B2 (en) * 1998-10-13 2006-07-04 Brown University Research Foundation Systems and methods for sequencing by hybridization
US6489096B1 (en) * 1998-10-15 2002-12-03 Princeton University Quantitative analysis of hybridization patterns and intensities in oligonucleotide arrays
WO2000023803A1 (en) * 1998-10-16 2000-04-27 Millstein Larry S Methods of making patterned arrays of analyte-binding molecules
US7199809B1 (en) 1998-10-19 2007-04-03 Symyx Technologies, Inc. Graphic design of combinatorial material libraries
FR2784751B1 (en) 1998-10-20 2001-02-02 Mesatronic HOUSING HOUSING OF AN ELECTRONIC CHIP WITH BIOLOGICAL PROBES
AU1218600A (en) * 1998-10-21 2000-05-08 Bios Group Lp Systems and methods for analysis of genetic networks
US7129043B1 (en) 1998-10-22 2006-10-31 Duke University Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6423493B1 (en) * 1998-10-26 2002-07-23 Board Of Regents The University Of Texas System Combinatorial selection of oligonucleotide aptamers
IL126776A (en) * 1998-10-27 2001-04-30 Technion Res & Dev Foundation Method for gold depositions
US6468476B1 (en) * 1998-10-27 2002-10-22 Rosetta Inpharmatics, Inc. Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
US6203987B1 (en) 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
FR2785052B1 (en) * 1998-10-27 2000-12-01 Commissariat Energie Atomique DEVICE FOR DETERMINING THE CONCENTRATION OF A SUBSTANCE MIXED WITH A FLUOROPHORE AND METHOD OF IMPLEMENTING THE DEVICE
US6950752B1 (en) 1998-10-27 2005-09-27 Rosetta Inpharmatics Llc Methods for removing artifact from biological profiles
EP1126035A4 (en) * 1998-10-30 2002-09-11 Takara Shuzo Co Method for detecting gene affected by endocrine disruptor
US6545264B1 (en) 1998-10-30 2003-04-08 Affymetrix, Inc. Systems and methods for high performance scanning
US6399299B1 (en) 1998-11-02 2002-06-04 Perkinelmer Life Sciences, Inc. Amplified array analysis system
CA2348828C (en) * 1998-11-04 2009-09-15 Genset S.A. Genomic and complete cdna sequences of apm1 and biallelic markers thereof
US6187540B1 (en) 1998-11-09 2001-02-13 Identigene, Inc. Method of newborn identification and tracking
US20110014706A2 (en) * 1998-12-14 2011-01-20 Monsanto Technology Llc Arabidopsis thaliana Genome Sequence and Uses Thereof
US7135283B1 (en) 1998-11-17 2006-11-14 Nanogen, Inc. Topoisomerase type II gene polymorphisms and their use in identifying drug resistance and pathogenic strains of microorganisms
US6309828B1 (en) 1998-11-18 2001-10-30 Agilent Technologies, Inc. Method and apparatus for fabricating replicate arrays of nucleic acid molecules
DE19853640C2 (en) * 1998-11-20 2002-01-31 Molecular Machines & Ind Gmbh Multi-vessel arrangement with improved sensitivity for optical analysis, processes for its production and its use in optical analysis processes
DE19854946C2 (en) 1998-11-27 2002-01-03 Guenter Von Kiedrowski Cloning and copying on surfaces
US6951682B1 (en) * 1998-12-01 2005-10-04 Syntrix Biochip, Inc. Porous coatings bearing ligand arrays and use thereof
AU1831700A (en) * 1998-12-01 2000-06-19 Syntrix Biochip, Inc. Methods and compositions for performing an array of chemical reactions on a support surface
AU3104300A (en) 1998-12-01 2000-06-19 Syntrix Biochip, Inc. Solvent resistant photosensitive compositions
WO2000032744A1 (en) * 1998-12-02 2000-06-08 Nanogen, Inc. Apparatus and methods for transport of charged biological materials
US6221579B1 (en) 1998-12-11 2001-04-24 Kimberly-Clark Worldwide, Inc. Patterned binding of functionalized microspheres for optical diffraction-based biosensors
US6245518B1 (en) 1998-12-11 2001-06-12 Hyseq, Inc. Polynucleotide arrays and methods of making and using the same
CN1357004A (en) * 1998-12-14 2002-07-03 德国癌症研究公共权益基金会 Method and devices for detecting optical properties, esp. luminescence reactions and refraction behavious of molecules which are directly or indirectly bound on support
US6579673B2 (en) 1998-12-17 2003-06-17 Kimberly-Clark Worldwide, Inc. Patterned deposition of antibody binding protein for optical diffraction-based biosensors
US20030032029A1 (en) * 1998-12-21 2003-02-13 Nanogen, Inc. Three dimensional apparatus and method for integrating sample preparation and multiplex assays
US6264891B1 (en) 1998-12-22 2001-07-24 Eos Biotechnology, Inc. Apparatus and method for concurrent chemical synthesis
DE19860547C1 (en) * 1998-12-23 2000-10-12 Genetrix B V I O Affinity sensor for the detection of specific molecular binding events and its use
US6453241B1 (en) 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6222093B1 (en) * 1998-12-28 2001-04-24 Rosetta Inpharmatics, Inc. Methods for determining therapeutic index from gene expression profiles
US6261431B1 (en) 1998-12-28 2001-07-17 Affymetrix, Inc. Process for microfabrication of an integrated PCR-CE device and products produced by the same
US6429027B1 (en) * 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US7612020B2 (en) 1998-12-28 2009-11-03 Illumina, Inc. Composite arrays utilizing microspheres with a hybridization chamber
US6351712B1 (en) * 1998-12-28 2002-02-26 Rosetta Inpharmatics, Inc. Statistical combining of cell expression profiles
US6370478B1 (en) 1998-12-28 2002-04-09 Rosetta Inpharmatics, Inc. Methods for drug interaction prediction using biological response profiles
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
US6087112A (en) * 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US20020103359A1 (en) * 1999-12-07 2002-08-01 Gregory Donoho Novel human membrane proteins and polynucleotides encoding the same
US6570003B1 (en) * 2001-01-09 2003-05-27 Lexion Genetics Incorporated Human 7TM proteins and polynucleotides encoding the same
ATE277065T1 (en) 1999-01-05 2004-10-15 Bio Merieux FUNCTIONALIZED COMPOUND, OPTIONALLY LABELED POLYNUCLEOTIDES AND METHOD FOR DETECTING A TARGET NUCLEIC ACID
JP4355384B2 (en) 1999-01-14 2009-10-28 キヤノン株式会社 Pattern exposure method, exposure apparatus, nucleic acid array formation method, and peptide array formation method
US6312906B1 (en) 1999-01-15 2001-11-06 Imperial College Innovations, Ltd. Immobilized nucleic acid hybridization reagent and method
US6232068B1 (en) 1999-01-22 2001-05-15 Rosetta Inpharmatics, Inc. Monitoring of gene expression by detecting hybridization to nucleic acid arrays using anti-heteronucleic acid antibodies
DE60029561T2 (en) * 1999-01-25 2007-07-19 Micronas Holding Gmbh IMMOBILIZATION OF MOLECULES ON SURFACES OVER POLYMER BRUSHES
US6320196B1 (en) 1999-01-28 2001-11-20 Agilent Technologies, Inc. Multichannel high dynamic range scanner
US6514768B1 (en) * 1999-01-29 2003-02-04 Surmodics, Inc. Replicable probe array
US20030148360A1 (en) * 1999-01-29 2003-08-07 Surmodics, Inc. Replicable probe array
US6429302B1 (en) 1999-02-02 2002-08-06 Chiron Corporation Polynucleotides related to pancreatic disease
US20060234246A1 (en) * 1999-02-02 2006-10-19 Chiron Corporation Gene products differentially expressed in cancerous cells
US6605432B1 (en) * 1999-02-05 2003-08-12 Curators Of The University Of Missouri High-throughput methods for detecting DNA methylation
AU2577700A (en) * 1999-02-10 2000-08-29 Macrogen Inc. Method and apparatus for compound library preparation using optical modulator
KR100497673B1 (en) * 1999-02-10 2005-07-01 주식회사 마크로젠 Method and Apparatus for Compound Library Preparation Using Optical Modulator
US6740875B1 (en) * 1999-02-11 2004-05-25 The Regents Of The University Of California Gamma watermarking
US6432719B1 (en) 1999-02-16 2002-08-13 Pe Corporation (Ny) Matrix storage and dispensing system
US7101510B2 (en) 1999-02-16 2006-09-05 Applera Corporation Matrix storage and dispensing system
JP2003517581A (en) 1999-02-16 2003-05-27 ピーイー コーポレイション (エヌワイ) Bead dispersion system
US20030027214A1 (en) * 1999-02-17 2003-02-06 Kamb Carl Alexander Methods for substrate-ligand interaction screening
ATE456652T1 (en) * 1999-02-19 2010-02-15 Febit Holding Gmbh METHOD FOR PRODUCING POLYMERS
US6136541A (en) * 1999-02-22 2000-10-24 Vialogy Corporation Method and apparatus for analyzing hybridized biochip patterns using resonance interactions employing quantum expressor functions
US6142681A (en) 1999-02-22 2000-11-07 Vialogy Corporation Method and apparatus for interpreting hybridized bioelectronic DNA microarray patterns using self-scaling convergent reverberant dynamics
US6245511B1 (en) * 1999-02-22 2001-06-12 Vialogy Corp Method and apparatus for exponentially convergent therapy effectiveness monitoring using DNA microarray based viral load measurements
US20040111219A1 (en) * 1999-02-22 2004-06-10 Sandeep Gulati Active interferometric signal analysis in software
EP1586645A3 (en) * 1999-02-25 2006-02-22 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US6362907B1 (en) 1999-02-26 2002-03-26 Nec Research Institute, Inc. Apparatus and method for transmitting data between VLSI chips
AU5646800A (en) * 1999-03-02 2000-09-21 Helix Biopharma Corporation Card-based biosensor device
AU2898500A (en) 1999-03-02 2000-09-21 Helix Biopharma Corporation Biosensor device and method
AU2830400A (en) 1999-03-05 2000-09-28 Mitsubishi Rayon Company Limited Carriers having biological substance
US6716578B1 (en) 1999-03-08 2004-04-06 Bioforce Nanosciences, Inc. Method for solid state genome analysis
US7005256B1 (en) 1999-03-10 2006-02-28 Cold Spring Harbor Laboratory Gene chip technology for determining memory genes
JP2002538479A (en) * 1999-03-11 2002-11-12 コンビマトリックス コーポレイション Self-assembled array
TW496775B (en) * 1999-03-15 2002-08-01 Aviva Bioscience Corp Individually addressable micro-electromagnetic unit array chips
US6296702B1 (en) 1999-03-15 2001-10-02 Pe Corporation (Ny) Apparatus and method for spotting a substrate
CN1185492C (en) 1999-03-15 2005-01-19 清华大学 Single-point strobed micro electromagnetic units array chip or electromagnetic biologic chip and application thereof
CA2367912A1 (en) * 1999-03-19 2000-09-28 Genencor International, Inc. Multi-through hole testing plate for high throughput screening
WO2000056774A1 (en) * 1999-03-19 2000-09-28 Duke University Methods of using bioelastomers
US7014994B1 (en) 1999-03-19 2006-03-21 Cornell Research Foundation,Inc. Coupled polymerase chain reaction-restriction-endonuclease digestion-ligase detection reaction process
US6403309B1 (en) 1999-03-19 2002-06-11 Valigen (Us), Inc. Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays
US6506594B1 (en) 1999-03-19 2003-01-14 Cornell Res Foundation Inc Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6764820B2 (en) * 1999-03-26 2004-07-20 Ludwig Institute For Cancer Research Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
WO2000058511A1 (en) 1999-03-26 2000-10-05 Ludwig Institute For Cancer Research Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
EP1041385A3 (en) * 1999-03-30 2004-01-02 Fuji Photo Film Co., Ltd. Method and apparatus for detecting an organism-originated substance
EP1088101A4 (en) * 1999-03-30 2004-10-20 Nanogen Inc Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips
AU4057600A (en) * 1999-03-31 2000-10-16 Rosetta Inpharmatics, Inc. Methods for the identification of reporter and target molecules using comprehensive gene expression profiles
US6582906B1 (en) 1999-04-05 2003-06-24 Affymetrix, Inc. Proportional amplification of nucleic acids
WO2000060125A2 (en) 1999-04-07 2000-10-12 Dennis Michael Connolly High resolution dna detection methods and devices
US6824866B1 (en) 1999-04-08 2004-11-30 Affymetrix, Inc. Porous silica substrates for polymer synthesis and assays
US20030133009A1 (en) * 1999-04-09 2003-07-17 Carl S Brown System and method for detecting with high resolution a large, high content field
JP2002541820A (en) * 1999-04-09 2002-12-10 ゲーペーツェー バイオテック アーゲー A novel method for identifying antimicrobial compounds
US6531302B1 (en) * 1999-04-12 2003-03-11 Nanogen/Becton Dickinson Partnership Anchored strand displacement amplification on an electronically addressable microchip
US6238868B1 (en) * 1999-04-12 2001-05-29 Nanogen/Becton Dickinson Partnership Multiplex amplification and separation of nucleic acid sequences using ligation-dependant strand displacement amplification and bioelectronic chip technology
WO2000062036A1 (en) * 1999-04-12 2000-10-19 Nanogen/Becton Dickinson Partnership Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology
US6326173B1 (en) * 1999-04-12 2001-12-04 Nanogen/Becton Dickinson Partnership Electronically mediated nucleic acid amplification in NASBA
US6235479B1 (en) 1999-04-13 2001-05-22 Bio Merieux, Inc. Methods and devices for performing analysis of a nucleic acid sample
DE19916867A1 (en) * 1999-04-14 2000-10-19 Fraunhofer Ges Forschung Making a molecular array on which molecules are immobilized, using micro-compartments or microcapillary reactors on planar substrates with sensor elements employs microelectronic production techniques
US20030166015A1 (en) * 1999-04-15 2003-09-04 Zarowitz Michael A. Multiplexed analysis of cell-substrate interactions
EP1175505A4 (en) * 1999-04-15 2005-04-20 Vitra Bioscience Inc Combinatorial chemical library supports having indicia at coding positions and methods of use
US7253435B2 (en) 1999-04-15 2007-08-07 Millipore Corporation Particles with light-polarizing codes
US20030129654A1 (en) * 1999-04-15 2003-07-10 Ilya Ravkin Coded particles for multiplexed analysis of biological samples
US20030207249A1 (en) * 1999-04-15 2003-11-06 Beske Oren E. Connection of cells to substrates using association pairs
US20030134330A1 (en) * 1999-04-15 2003-07-17 Ilya Ravkin Chemical-library composition and method
US6908737B2 (en) * 1999-04-15 2005-06-21 Vitra Bioscience, Inc. Systems and methods of conducting multiplexed experiments
US6171793B1 (en) 1999-04-19 2001-01-09 Affymetrix, Inc. Method for scanning gene probe array to produce data having dynamic range that exceeds that of scanner
US20060275782A1 (en) 1999-04-20 2006-12-07 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US20030215821A1 (en) * 1999-04-20 2003-11-20 Kevin Gunderson Detection of nucleic acid reactions on bead arrays
US20020177135A1 (en) * 1999-07-27 2002-11-28 Doung Hau H. Devices and methods for biochip multiplexing
US6174683B1 (en) 1999-04-26 2001-01-16 Biocept, Inc. Method of making biochips and the biochips resulting therefrom
DE19918956A1 (en) * 1999-04-27 2000-11-02 Studiengesellschaft Kohle Mbh Process for the automated investigation of catalytic and spectroscopic properties of the components of combinatorial libraries
US6518056B2 (en) 1999-04-27 2003-02-11 Agilent Technologies Inc. Apparatus, systems and method for assaying biological materials using an annular format
US6300137B1 (en) * 1999-04-28 2001-10-09 Agilent Technologies Inc. Method for synthesizing a specific, surface-bound polymer uniformly over an element of a molecular array
US20020110809A1 (en) * 1999-04-30 2002-08-15 Nehls Michael C. Novel human polynucleotides and polypeptides encoded thereby
DE60042922D1 (en) * 1999-05-04 2009-10-22 Kentucky Bioproc Llc Owensboro VIRAL EXPRESSION VECTORS FOR PLANTS
US6395559B1 (en) * 1999-05-04 2002-05-28 Orchid Biosciences, Inc. Multiple fluid sample processor with single well addressability
US20020095031A1 (en) * 1999-05-04 2002-07-18 Nehls Michael C. Novel human polynucleotides and polypeptides encoded thereby
WO2000066259A1 (en) * 1999-05-05 2000-11-09 Ut-Battelle, Llc Method and apparatus for combinatorial chemistry
DE19922941A1 (en) * 1999-05-14 2000-11-30 Epigenomics Gmbh Device and method for the photolithographic exposure of biological substances
JP3957118B2 (en) * 1999-05-18 2007-08-15 富士フイルム株式会社 Test piece and image information reading device from the test piece
US6638717B2 (en) 1999-05-19 2003-10-28 Aventis Pharmaceuticals, Inc. Microarray-based subtractive hybridzation
JP4598960B2 (en) 1999-05-19 2010-12-15 エッペンドルフ アレイ テクノロジーズ エスアー (エーアーテー) On-chip identification and / or quantification method of target compounds obtained from biological samples
US20030096321A1 (en) * 1999-05-19 2003-05-22 Jose Remacle Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips
US20030073250A1 (en) * 1999-05-21 2003-04-17 Eric Henderson Method and apparatus for solid state molecular analysis
US6287774B1 (en) * 1999-05-21 2001-09-11 Caliper Technologies Corp. Assay methods and system
US20020042081A1 (en) * 2000-10-10 2002-04-11 Eric Henderson Evaluating binding affinities by force stratification and force panning
EP1185711A4 (en) * 1999-05-21 2002-09-18 Invitrogen Corp Compositions and methods for labeling of nucleic acid molecules
US6573369B2 (en) 1999-05-21 2003-06-03 Bioforce Nanosciences, Inc. Method and apparatus for solid state molecular analysis
US6472141B2 (en) * 1999-05-21 2002-10-29 Caliper Technologies Corp. Kinase assays using polycations
US20030186311A1 (en) * 1999-05-21 2003-10-02 Bioforce Nanosciences, Inc. Parallel analysis of molecular interactions
CN1159454C (en) * 1999-05-21 2004-07-28 陆祖宏 Compound micro-array chip preparing process and the micro-array chip using the same
US6371370B2 (en) * 1999-05-24 2002-04-16 Agilent Technologies, Inc. Apparatus and method for scanning a surface
US6502039B1 (en) 2000-05-24 2002-12-31 Aventis Pharmaceuticals Mathematical analysis for the estimation of changes in the level of gene expression
ES2331737T3 (en) 1999-05-25 2010-01-14 Aventis Pharmaceuticals Inc. MATHEMATICAL ANALYSIS FOR ESTIMATING CHANGES AT THE LEVEL OF GENE EXPRESSION.
US6485690B1 (en) 1999-05-27 2002-11-26 Orchid Biosciences, Inc. Multiple fluid sample processor and system
US6132686A (en) * 1999-05-28 2000-10-17 Mettler-Toledo Bohdan, Inc. Pressurized reaction block
WO2000075644A1 (en) * 1999-06-05 2000-12-14 Zeptosens Ag Sensor platform and method for analysing multiple analytes
KR20010001577A (en) 1999-06-07 2001-01-05 윤종용 Process for Preparing Oligopeptidenucleotide Probe Using Polymeric Photoacid Generator
US6660479B2 (en) 1999-06-07 2003-12-09 Samsung Electronics Co., Ltd. Process for preparing peptide nucleic acid probe using polymeric photoacid generator
US6716579B1 (en) 1999-06-11 2004-04-06 Narayan Baidya Gene specific arrays, preparation and use
US7485715B2 (en) * 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
WO2000079009A2 (en) 1999-06-22 2000-12-28 Invitrogen Corporation Improved primers and methods for the detection and discrimination of nucleic acids
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
KR100379411B1 (en) 1999-06-28 2003-04-10 엘지전자 주식회사 biochip and method for patterning and measuring biomaterial of the same
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US6258593B1 (en) 1999-06-30 2001-07-10 Agilent Technologies Inc. Apparatus for conducting chemical or biochemical reactions on a solid surface within an enclosed chamber
US6399394B1 (en) 1999-06-30 2002-06-04 Agilent Technologies, Inc. Testing multiple fluid samples with multiple biopolymer arrays
US6830902B1 (en) * 1999-07-02 2004-12-14 Invitrogen Corporation Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
US6692914B1 (en) 1999-07-02 2004-02-17 Symyx Technologies, Inc. Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded thereto
US6771376B2 (en) * 1999-07-05 2004-08-03 Novartis Ag Sensor platform, apparatus incorporating the platform, and process using the platform
JP4684507B2 (en) 1999-07-05 2011-05-18 ノバルティス アーゲー How to use the sensor platform
US7223364B1 (en) 1999-07-07 2007-05-29 3M Innovative Properties Company Detection article having fluid control film
US6964847B1 (en) 1999-07-14 2005-11-15 Packard Biosciences Company Derivative nucleic acids and uses thereof
US6346423B1 (en) 1999-07-16 2002-02-12 Agilent Technologies, Inc. Methods and compositions for producing biopolymeric arrays
US7371516B1 (en) 1999-07-16 2008-05-13 Rosetta Inpharmatics Llc Methods for determining the specificity and sensitivity of oligonucleo tides for hybridization
US7013221B1 (en) 1999-07-16 2006-03-14 Rosetta Inpharmatics Llc Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays
US7479555B2 (en) * 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
US6692915B1 (en) 1999-07-22 2004-02-17 Girish N. Nallur Sequencing a polynucleotide on a generic chip
US7144700B1 (en) * 1999-07-23 2006-12-05 Affymetrix, Inc. Photolithographic solid-phase polymer synthesis
DE19935749C2 (en) * 1999-07-28 2003-06-26 Epigenomics Ag Process for the characterization of nucleic acid fragments
US6864050B2 (en) * 1999-07-30 2005-03-08 Affymetrix, Inc. Single-phase amplification of nucleic acids
WO2001012862A2 (en) 1999-08-18 2001-02-22 Illumina, Inc. Compositions and methods for preparing oligonucleotide solutions
US6909006B1 (en) 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
US20050118618A1 (en) * 1999-08-30 2005-06-02 Dale Roderic M. Method for detecting nucleic acid sequences
US7169553B1 (en) 1999-08-30 2007-01-30 Roche Diagnostics, Gmbh 2-Azapurine compounds and their use
AU2246601A (en) 1999-08-30 2001-04-10 Illumina, Inc. Methods for improving signal detection from an array
US6994964B1 (en) * 1999-09-01 2006-02-07 Affymetrix, Inc. Macromolecular arrays on polymeric brushes and methods for preparing the same
US20030166902A1 (en) * 2001-02-20 2003-09-04 Yi Hu Novel human protease and polynucleotides encoding the same
US20050153323A1 (en) * 2000-07-28 2005-07-14 Yi Hu Novel human proteases and polynucleotides encoding the same
US20020151047A1 (en) * 2001-01-08 2002-10-17 Yi Hu Novel human protease and polynucleotides encoding the same
US6448388B1 (en) 2000-08-16 2002-09-10 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same
US20080003673A1 (en) * 1999-09-02 2008-01-03 Alejandro Abuin Novel human proteases and polynucleotides encoding the same
US6716614B1 (en) * 1999-09-02 2004-04-06 Lexicon Genetics Incorporated Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
US6395483B1 (en) 1999-09-02 2002-05-28 3M Innovative Properties Company Arrays with mask layers
US20030050464A1 (en) * 2000-07-28 2003-03-13 Yi Hu Novel human proteases and polynucleotides encoding the same
US20020049312A1 (en) * 2000-05-23 2002-04-25 Turner C. Alexander Noel human thrombospondin-like proteins and polynucleotides encoding the same
CN1317291C (en) 1999-09-10 2007-05-23 杰龙公司 Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use
US6358557B1 (en) * 1999-09-10 2002-03-19 Sts Biopolymers, Inc. Graft polymerization of substrate surfaces
FR2798392B1 (en) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa GENETIC MARKERS OF TOXICITY, PREPARATION AND USES
US6692918B2 (en) 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US6743585B2 (en) 1999-09-16 2004-06-01 Agilent Technologies, Inc. Methods for preparing conjugates
FR2798673B1 (en) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa METHODS AND COMPOSITIONS FOR DETECTION OF PATHOLOGICAL EVENTS
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
US6319674B1 (en) 1999-09-16 2001-11-20 Agilent Technologies, Inc. Methods for attaching substances to surfaces
US7078167B2 (en) * 1999-09-17 2006-07-18 Agilent Technologies, Inc. Arrays having background features and methods for using the same
US7122303B2 (en) 1999-09-17 2006-10-17 Agilent Technologies, Inc. Arrays comprising background features that provide for a measure of a non-specific binding and methods for using the same
US6544790B1 (en) 1999-09-17 2003-04-08 Whitehead Institute For Biomedical Research Reverse transfection method
US20020006664A1 (en) * 1999-09-17 2002-01-17 Sabatini David M. Arrayed transfection method and uses related thereto
US6790660B1 (en) 2001-09-18 2004-09-14 Lexicon Genetics Incorporated Human kielin-like proteins and polynucleotides encoding the same
US20020107382A1 (en) * 2000-09-27 2002-08-08 Friddle Carl Johan Novel human protease inhibitor proteins and polynucleotides encoding the same
US6867291B1 (en) * 2000-09-15 2005-03-15 Lexicon Genetics Incorporated Human hemicentin proteins and polynucleotides encoding the same
US6586230B1 (en) * 2000-10-27 2003-07-01 Lexicon Genetics Incorporated Human kinase and polynucleotides encoding the same
US6511840B1 (en) 2000-06-15 2003-01-28 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
US6617147B2 (en) 2000-04-25 2003-09-09 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
US6797510B1 (en) * 2001-05-24 2004-09-28 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6734009B2 (en) 2000-12-27 2004-05-11 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6900045B2 (en) * 2000-08-31 2005-05-31 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
US6841377B1 (en) * 2001-06-13 2005-01-11 Lexicon Genetics Incorporated Human kinase and polynucleotides encoding the same
US6734010B2 (en) * 2001-05-09 2004-05-11 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US20080050809A1 (en) * 1999-09-28 2008-02-28 Alejandro Abuin Novel human kinases and polynucleotides encoding the same
US6593125B2 (en) 2000-11-20 2003-07-15 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6602698B2 (en) 1999-12-07 2003-08-05 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
US6541252B1 (en) 2000-05-19 2003-04-01 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6844151B1 (en) 1999-09-29 2005-01-18 Oligos Etc. Inc. Methods for production of arrays with modified oligonucleotide and polynucleotide compositions
US6673536B1 (en) 1999-09-29 2004-01-06 Rosetta Inpharmatics Llc. Methods of ranking oligonucleotides for specificity using wash dissociation histories
WO2001023426A2 (en) * 1999-09-30 2001-04-05 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
AU7730500A (en) * 1999-09-30 2001-04-30 Nanogen, Inc. Biomolecular attachment sites on microelectronic arrays and methods thereof
US7217573B1 (en) 1999-10-05 2007-05-15 Hitachi, Ltd. Method of inspecting a DNA chip
CA2386791A1 (en) 1999-10-08 2001-04-19 Protogene Laboratories, Inc. Method and apparatus for performing large numbers of reactions using array assembly
US6750054B2 (en) 2000-05-18 2004-06-15 Lexicon Genetics Incorporated Human semaphorin homologs and polynucleotides encoding the same
US20080213878A1 (en) * 1999-10-19 2008-09-04 Gregory Donoho Novel human membrane proteins and polynucleotides encoding the same
US6171797B1 (en) 1999-10-20 2001-01-09 Agilent Technologies Inc. Methods of making polymeric arrays
JP5064625B2 (en) 1999-10-27 2012-10-31 バイオウルフ テクノロジーズ エルエルスィー Method and machine for identifying patterns
US7364920B2 (en) * 1999-10-27 2008-04-29 Technion Research And Development Foundation Ltd. Method for gold deposition
US6958225B2 (en) 1999-10-27 2005-10-25 Affymetrix, Inc. Complexity management of genomic DNA
US6689319B1 (en) 1999-10-29 2004-02-10 Agilent Technologies, Ind. Apparatus for deposition and inspection of chemical and biological fluids
KR100339379B1 (en) 1999-10-29 2002-06-03 구자홍 biochip and apparatus and method for measuring biomaterial of the same
US6329210B1 (en) * 1999-10-29 2001-12-11 Agilent Technologies, Inc. Method and apparatus for high volume polymer synthesis
US8153367B2 (en) * 1999-10-29 2012-04-10 Perkinelmer Las, Inc. Amplified array analysis system
WO2001032935A2 (en) * 1999-11-02 2001-05-10 Celine Hu Molecular microarrays and methods for production and use thereof
US7167615B1 (en) 1999-11-05 2007-01-23 Board Of Regents, The University Of Texas System Resonant waveguide-grating filters and sensors and methods for making and using same
US6569674B1 (en) 1999-12-15 2003-05-27 Amersham Biosciences Ab Method and apparatus for performing biological reactions on a substrate surface
US6642046B1 (en) 1999-12-09 2003-11-04 Motorola, Inc. Method and apparatus for performing biological reactions on a substrate surface
US6589778B1 (en) 1999-12-15 2003-07-08 Amersham Biosciences Ab Method and apparatus for performing biological reactions on a substrate surface
US7041445B2 (en) 1999-11-15 2006-05-09 Clontech Laboratories, Inc. Long oligonucleotide arrays
WO2001036442A1 (en) * 1999-11-17 2001-05-25 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
US6583399B1 (en) 1999-11-22 2003-06-24 California Institute Of Technology Optical resonator microsphere sensor with altering Q-factor
US6446642B1 (en) 1999-11-22 2002-09-10 Agilent Technologies, Inc. Method and apparatus to clean an inkjet reagent deposition device
AU4507201A (en) 1999-11-24 2001-06-18 Incyte Genomics, Inc. Normalization controls and duplex probes for hybridization reactions
US6703480B1 (en) * 1999-11-24 2004-03-09 Palani Balu Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
WO2001038585A2 (en) * 1999-11-24 2001-05-31 The Regents Of The University Of California Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression
US6423535B1 (en) 1999-11-24 2002-07-23 Incyte Genomics, Inc. Normalization control for hybridization reactions
WO2001040454A1 (en) 1999-11-30 2001-06-07 Oncosis Method and apparatus for selectively targeting specific cells within a cell population
GB9928787D0 (en) * 1999-12-03 2000-02-02 Medical Res Council Direct screening method
GB9928789D0 (en) * 1999-12-03 2000-02-02 Medical Res Council Naive screening method
US6482638B1 (en) * 1999-12-09 2002-11-19 3M Innovative Properties Company Heat-relaxable substrates and arrays
JP2004500060A (en) 1999-12-09 2004-01-08 レキシコン・ジェネティクス・インコーポレーテッド Human ADAM-TS protease and polynucleotide encoding the same
US6716588B2 (en) 1999-12-09 2004-04-06 Cellomics, Inc. System for cell-based screening
EP2210948A3 (en) 1999-12-10 2010-10-06 Life Technologies Corporation Use of multiple recombination sites with unique specificity in recombinational cloning
CA2394976A1 (en) * 1999-12-13 2001-06-14 Lexicon Genetics Incorporated Novel human transferase proteins and polynucleotides encoding the same
US6303082B1 (en) * 1999-12-15 2001-10-16 Nanogen, Inc. Permeation layer attachment chemistry and method
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
US6902891B2 (en) 1999-12-17 2005-06-07 Bio Merieux Process for labeling a nucleic acid
US20020197656A1 (en) * 1999-12-17 2002-12-26 Ronghao Li Cell arrays and the uses thereof
US6406840B1 (en) 1999-12-17 2002-06-18 Biomosaic Systems, Inc. Cell arrays and the uses thereof
US6399295B1 (en) 1999-12-17 2002-06-04 Kimberly-Clark Worldwide, Inc. Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors
US6489114B2 (en) 1999-12-17 2002-12-03 Bio Merieux Process for labeling a ribonucleic acid, and labeled RNA fragments which are obtained thereby
US6670124B1 (en) 1999-12-20 2003-12-30 Stemcyte, Inc. High throughput methods of HLA typing
WO2001046407A1 (en) * 1999-12-22 2001-06-28 Lexicon Genetics Incorporated Polynucleotides encoding human protease homologs
CA2395247A1 (en) * 1999-12-22 2001-06-28 Lexicon Genetics Incorporated Novel human membrane proteins and polynucleotides encoding the same
DE19962803A1 (en) * 1999-12-23 2001-07-05 Basf Ag Process and device for mask-free production of biopolymers
US6929907B2 (en) 1999-12-31 2005-08-16 North Carolina State University Methods and compositions for determining the purity of chemically synthesized nucleic acids
US6800439B1 (en) 2000-01-06 2004-10-05 Affymetrix, Inc. Methods for improved array preparation
JP2004502402A (en) * 2000-01-06 2004-01-29 レキシコン・ジェネティクス・インコーポレーテッド Novel human protease and polynucleotide encoding it
US20070020662A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest
US20070021929A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays
US20050095696A9 (en) * 2000-01-07 2005-05-05 Lemmo Anthony V. Apparatus and method for high-throughput preparation and characterization of compositions
CZ20022332A3 (en) * 2000-01-07 2003-01-15 Transform Pharmaceuticals, Inc. Sample assembly
US20050118637A9 (en) * 2000-01-07 2005-06-02 Levinson Douglas A. Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds
US20040252299A9 (en) * 2000-01-07 2004-12-16 Lemmo Anthony V. Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
US20050089923A9 (en) * 2000-01-07 2005-04-28 Levinson Douglas A. Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds
US7108970B2 (en) * 2000-01-07 2006-09-19 Transform Pharmaceuticals, Inc. Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
DE10000629C5 (en) * 2000-01-10 2010-06-02 november Aktiengesellschaft, Gesellschaft für Molekulare Medizin Method of identifying a label applied to a solid
WO2001051634A1 (en) * 2000-01-12 2001-07-19 Lexicon Genetics Incorporated Human olfactory receptor and polynucleotides encoding the same
EP1248846A2 (en) 2000-01-18 2002-10-16 Lexicon Genetics Incorporated Human kinase protein and polynucleotides encoding the same
WO2003074738A1 (en) * 2000-01-18 2003-09-12 Quantom Dot Corporation Oligonucleotide-tagged semiconductor nanocrystals for microarray and fluorescence in situ hybridization
WO2001053489A1 (en) * 2000-01-18 2001-07-26 Lexicon Genetics Incorporated Human gaba receptor proteins and polynucleotides encoding the same
US6728641B1 (en) 2000-01-21 2004-04-27 General Electric Company Method and system for selecting a best case set of factors for a chemical reaction
US8143195B2 (en) * 2000-01-24 2012-03-27 Yingjian Wang Arrays for bringing two or more reagents in contact with one or more biological targets and methods for making and using the arrays
US7429466B2 (en) * 2000-01-24 2008-09-30 Hypromatrix, Inc Methods and arrays for detecting biological molecules
US20030097222A1 (en) * 2000-01-25 2003-05-22 Craford David M. Method, system, and computer software for providing a genomic web portal
EP1250435B1 (en) * 2000-01-26 2006-04-12 Lexicon Genetics Incorporated Human neurexin-like proteins and polynucleotides encoding the same
AU784615B2 (en) * 2000-01-28 2006-05-11 Lexicon Pharmaceuticals, Inc. Human membrane proteins and polynucleotides encoding the same
US20030054513A1 (en) * 2000-01-28 2003-03-20 Gregory Donoho Novel human enzymes and polynucleotides encoding the same
AU2001233043A1 (en) 2000-01-28 2001-08-07 Linden Technologies, Inc. C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support
CA2398107C (en) 2000-01-28 2013-11-19 Althea Technologies, Inc. Methods for analysis of gene expression
GB0002389D0 (en) 2000-02-02 2000-03-22 Solexa Ltd Molecular arrays
WO2001056955A1 (en) * 2000-02-03 2001-08-09 Nanoscale Combinatorial Synthesis, Inc. Nonredundant split/pool synthesis of combinatorial libraries
JP2004500083A (en) * 2000-02-04 2004-01-08 レキシコン・ジェネティクス・インコーポレーテッド Novel human enzymes and polynucleotides encoding them
AU782817B2 (en) * 2000-02-04 2005-09-01 Lexicon Pharmaceuticals, Inc. Novel human G protein coupled receptor proteins and polynucleotides encoding the same
US7955794B2 (en) * 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US8076063B2 (en) 2000-02-07 2011-12-13 Illumina, Inc. Multiplexed methylation detection methods
ATE411397T1 (en) * 2000-02-07 2008-10-15 Illumina Inc NUCLEIC ACID DETECTION METHOD WITH UNIVERSAL PRIMING
US7611869B2 (en) 2000-02-07 2009-11-03 Illumina, Inc. Multiplexed methylation detection methods
US20050214825A1 (en) * 2000-02-07 2005-09-29 John Stuelpnagel Multiplex sample analysis on universal arrays
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US6770441B2 (en) * 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
US6693033B2 (en) 2000-02-10 2004-02-17 Motorola, Inc. Method of removing an amorphous oxide from a monocrystalline surface
CA2399876A1 (en) 2000-02-11 2001-08-16 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same
US20030176385A1 (en) * 2000-02-15 2003-09-18 Jingfang Ju Antisense modulation of protein expression
AU2001238503A1 (en) * 2000-02-17 2001-08-27 Lexicon Genetics Incorporated Novel human thrombospondin repeat proteins and polynucleotides encoding the same
US20020110901A1 (en) * 2000-02-18 2002-08-15 Aspira Biosystems, Inc. Compositions and methods for surface imprinting
US20020151040A1 (en) 2000-02-18 2002-10-17 Matthew O' Keefe Apparatus and methods for parallel processing of microvolume liquid reactions
WO2001061054A2 (en) 2000-02-18 2001-08-23 Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for parallel processing of micro-volume liquid reactions
EP1265641A2 (en) 2000-02-22 2002-12-18 Biostream, Inc. Imaging agents for diagnosis of parkinson's disease
US20040014102A1 (en) * 2000-02-22 2004-01-22 Shiping Chen High density parallel printing of microarrays
WO2001062378A2 (en) 2000-02-22 2001-08-30 Genospectra, Inc. Microarray fabrication techniques and apparatus
CN1404415A (en) 2000-02-22 2003-03-19 基因谱公司 Microarray fabrication techniques and apparatus
CN1444646A (en) * 2000-02-23 2003-09-24 齐翁米克斯股份有限公司 Chips having elevated sample surfaces
EP1259610A2 (en) * 2000-02-29 2002-11-27 Lexicon Genetics Incorporated Human transporter proteins and polynucleotides encoding the same
WO2001064903A2 (en) 2000-02-29 2001-09-07 Lexicon Genetics Incorporated Novel human transferase proteins and polynucleotides encoding the same
US6627571B1 (en) 2000-03-01 2003-09-30 Symyx Technologies, Inc. Method and system for the situ synthesis of a combinatorial library of supported catalyst materials
US20030129724A1 (en) * 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
AU2001240040A1 (en) * 2000-03-03 2001-09-17 California Institute Of Technology Combinatorial array for nucleic acid analysis
AU2001247283A1 (en) * 2000-03-06 2001-09-17 Lexicon Genetics Incorporated Human transporter proteins and polynucleotides encoding the same
DE10011022A1 (en) * 2000-03-07 2001-09-27 Meinhard Knoll Apparatus for performing synthesis, analysis or transport processes with a process fluid has a reaction zone with controlled delivery of a process fluid and control fluids with inner analysis and reaction interfaces at the side walls
US6897015B2 (en) * 2000-03-07 2005-05-24 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of pathogens and biological materials
AU4352101A (en) 2000-03-10 2001-09-24 Lexicon Genetics Inc Novel human g-coupled protein receptor kinases and polynucleotides encoding the same
AU4739501A (en) * 2000-03-13 2001-09-24 Lexicon Genetics Inc Novel human phospholipases and polynucleotides encoding the same
US6489160B2 (en) 2000-03-16 2002-12-03 Kabushiki Kaisha Toshiba Method for producing nucleic acid strand immobilized carrier
US6833450B1 (en) 2000-03-17 2004-12-21 Affymetrix, Inc. Phosphite ester oxidation in nucleic acid array preparation
US20050119473A1 (en) * 2000-03-17 2005-06-02 Affymetrix, Inc. Phosphite ester oxidation in nucleic acid array preparation
US6806361B1 (en) 2000-03-17 2004-10-19 Affymetrix, Inc. Methods of enhancing functional performance of nucleic acid arrays
CA2403636A1 (en) * 2000-03-20 2001-09-27 Lexicon Genetics Incorporated Human secreted proteins and polynucleotides encoding the same
US6413722B1 (en) 2000-03-22 2002-07-02 Incyte Genomics, Inc. Polymer coated surfaces for microarray applications
EP2365096A1 (en) 2000-03-22 2011-09-14 Life Technologies Corporation Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
US7244572B1 (en) 2000-03-24 2007-07-17 Wisys Technology Foundation, Inc. One-dimensional arrays on optical fibers
US7202026B2 (en) * 2000-03-24 2007-04-10 Eppendorf Array Technologies Sa (Eat) Identification of a large number of biological (micro)organisms groups at different levels by their detection on a same array
US7205104B2 (en) 2000-03-24 2007-04-17 Eppendorf Array Technologies Sa (Eat) Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
US7829313B2 (en) * 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7875442B2 (en) * 2000-03-24 2011-01-25 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US20080085515A1 (en) * 2000-03-24 2008-04-10 Eppendorf Array Technologies Sa (Eat) Identification of multiple biological (micro) organisms by detection of their nucleotide sequences on arrays
WO2001073132A1 (en) 2000-03-27 2001-10-04 Thomas Jefferson University Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
JP2003529774A (en) * 2000-03-31 2003-10-07 ジェネンテック・インコーポレーテッド Compositions and methods for detecting and quantifying gene expression
US6884578B2 (en) * 2000-03-31 2005-04-26 Affymetrix, Inc. Genes differentially expressed in secretory versus proliferative endometrium
WO2001075108A1 (en) 2000-04-03 2001-10-11 Lexicon Genetics Incorporated Human ion channel protein and polynucleotides encoding the same
US7157564B1 (en) 2000-04-06 2007-01-02 Affymetrix, Inc. Tag nucleic acids and probe arrays
GB0008563D0 (en) * 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
JP2003532391A (en) * 2000-04-12 2003-11-05 レキシコン・ジェネティクス・インコーポレーテッド Human metalloprotease and polynucleotide encoding the protein
AU2001262943A1 (en) 2000-04-14 2001-10-30 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
JP5508654B2 (en) 2000-04-14 2014-06-04 コーネル・リサーチ・ファンデーション・インコーポレイテッド Method for designing positionable arrays for detection of nucleic acid sequence differences using ligase detection reactions
JP2003531372A (en) * 2000-04-14 2003-10-21 ツェプトゼンス アクチエンゲゼルシャフト Grating waveguide structure and its use for enhancing the excitation field
US6983233B1 (en) 2000-04-19 2006-01-03 Symyx Technologies, Inc. Combinatorial parameter space experiment design
US6667287B2 (en) * 2000-04-20 2003-12-23 Colgate-Palmolive Company Light duty cleaning composition comprising an amine oxide and polyacrylic acid homopolymer
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
CA2406063A1 (en) 2000-05-03 2001-11-08 Caliper Technologies Corporation Multi depth substrate fabrication processes
US8399383B2 (en) 2000-05-04 2013-03-19 Yale University Protein chips for high throughput screening of protein activity
US6690467B1 (en) 2000-05-05 2004-02-10 Pe Corporation Optical system and method for optically analyzing light from a sample
AU2001247853A1 (en) * 2000-05-08 2001-11-20 General Electric Company High throughput screening method and system
US7019129B1 (en) 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
US6709840B1 (en) 2000-05-11 2004-03-23 The Board Of Trustees Of The Leland Stanford Junior University Anergy associated genes
US20020110843A1 (en) * 2000-05-12 2002-08-15 Dumas David P. Compositions and methods for epitope mapping
EP1280909A2 (en) * 2000-05-12 2003-02-05 Lexicon Genetics Incorporated Human lipocalin homologs and polynucleotides encoding the same
US6492458B1 (en) 2000-05-16 2002-12-10 Arizona Chemical Company Polyalkyleneoxydiamine polyamides useful for formulating inks for phase-change jet printing
US6686188B2 (en) * 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US6656700B2 (en) * 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
US6790667B1 (en) * 2000-05-30 2004-09-14 Lexicon Genetics Incorporated Human mitochondrial proteins and polynucleotides encoding the same
US20020155471A1 (en) * 2000-05-31 2002-10-24 Nicolette Charles A. Compounds for therapy and diagnosis and methods for using same
US7005259B1 (en) 2000-06-01 2006-02-28 Affymetrix, Inc. Methods for array preparation using substrate rotation
JP4644914B2 (en) * 2000-06-02 2011-03-09 株式会社村田製作所 Solid phase substrate for probe array and probe array
US6994827B2 (en) 2000-06-03 2006-02-07 Symyx Technologies, Inc. Parallel semicontinuous or continuous reactors
US7351376B1 (en) * 2000-06-05 2008-04-01 California Institute Of Technology Integrated active flux microfluidic devices and methods
EP1162450A1 (en) * 2000-06-07 2001-12-12 F. Hoffmann-La Roche Ag Reference device for evaluating the performance of a confocal laser scanning microscope, and a method and system for performing that evaluation
WO2001094583A2 (en) * 2000-06-07 2001-12-13 Lexicon Genetics Incorporated Human transporter proteins and polynucleotides encoding the same
US20040168209A1 (en) * 2000-06-12 2004-08-26 Alejandro Abuin Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
US6455007B1 (en) * 2000-06-13 2002-09-24 Symyx Technologies, Inc. Apparatus and method for testing compositions in contact with a porous medium
US6660229B2 (en) 2000-06-13 2003-12-09 The Trustees Of Boston University Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
EP1164201A1 (en) * 2000-06-14 2001-12-19 Facultés Universitaires Notre-Dame de la Paix Reverse detection for identification and/or quantification of nucleotide target sequences on biochips
US20060166227A1 (en) * 2000-06-20 2006-07-27 Stephen Kingsmore Protein expression profiling
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
JP4744778B2 (en) 2000-06-21 2011-08-10 バイオアレイ ソルーションズ リミテッド Method for analyzing multiple analyte molecules using a specific random particle array
WO2002000938A2 (en) * 2000-06-26 2002-01-03 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
US7846733B2 (en) * 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
WO2002000720A2 (en) * 2000-06-27 2002-01-03 Lexicon Genetics Incorporated Novel human gaba receptors and polynucleotides encoding the same
US6323009B1 (en) * 2000-06-28 2001-11-27 Molecular Staging, Inc. Multiply-primed amplification of nucleic acid sequences
DE10031587A1 (en) * 2000-06-29 2002-01-10 Basf Ag Dosing of microscale suspensions for the production of material samples in combinatorial materials research and their testing
US20030118486A1 (en) * 2000-07-03 2003-06-26 Xeotron Corporation Fluidic methods and devices for parallel chemical reactions
EP2045005A3 (en) 2000-07-03 2011-12-21 Xeotron Corporation Devices and methods for carrying out chemical reactions using photogenerated reagents
US20030219816A1 (en) * 2001-07-02 2003-11-27 Keith Solomon Composite microarray slides
AU2001271720A1 (en) 2000-07-05 2002-01-14 Rosetta Inpharmatics, Inc. Methods and compositions for determining gene function
WO2002004597A2 (en) * 2000-07-07 2002-01-17 Nimblegen Systems, Inc. Method and apparatus for synthesis of arrays of dna probes
US6913879B1 (en) 2000-07-10 2005-07-05 Telechem International Inc. Microarray method of genotyping multiple samples at multiple LOCI
US6511277B1 (en) 2000-07-10 2003-01-28 Affymetrix, Inc. Cartridge loader and methods
US6380377B1 (en) 2000-07-14 2002-04-30 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
US6596490B2 (en) * 2000-07-14 2003-07-22 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
US7052659B1 (en) 2000-07-18 2006-05-30 General Electric Company Sequential high throughput screening method and system
EP1409718A2 (en) * 2000-07-21 2004-04-21 Phase-1 Molecular Toxicology Canine toxicity genes
WO2002008396A2 (en) * 2000-07-21 2002-01-31 Incyte Genomics, Inc. Human proteases
US6555946B1 (en) 2000-07-24 2003-04-29 Motorola, Inc. Acoustic wave device and process for forming the same
US6590236B1 (en) 2000-07-24 2003-07-08 Motorola, Inc. Semiconductor structure for use with high-frequency signals
DE10036174B4 (en) * 2000-07-25 2006-12-07 Axaron Bioscience Ag Method and apparatus for analyzing chemical or biological samples
US6887685B1 (en) 2000-07-25 2005-05-03 Lexicon Genetics Incorporated Human thymosin protein and polynucleotides encoding the same
DE10036457A1 (en) * 2000-07-26 2002-02-14 Giesing Michael Use of an imaging photoelectric area sensor for evaluating biochips and imaging processes therefor
EP1373889A2 (en) * 2000-07-31 2004-01-02 Maxygen, Inc. Biosensors, reagents and diagnostic applications of directed evolution
EP1356266A2 (en) 2000-08-03 2003-10-29 Perlegen Sciences, Inc. Substrate scanning apparatus
US20050181421A1 (en) * 2000-08-03 2005-08-18 Affymetrix, Inc. Methods of array synthesis
CA2416631C (en) * 2000-08-03 2011-11-22 F. Hoffmann-La Roche Ag Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US8463718B2 (en) * 2000-08-07 2013-06-11 Health Discovery Corporation Support vector machine-based method for analysis of spectral data
US6422249B1 (en) 2000-08-10 2002-07-23 Affymetrix Inc. Cartridge washing system and methods
AU2001284896A1 (en) 2000-08-14 2002-02-25 Surface Logix, Inc. Deformable stamp for patterning three-dimensional surfaces
ATE402760T1 (en) * 2000-08-15 2008-08-15 Bioforce Nanosciences Inc DEVICE FOR FORMING NANOMOLECULAR NETWORKS
US20020076780A1 (en) * 2000-08-16 2002-06-20 Turner C. Alexander Novel human ion channel proteins and polynucleotides encoding the same
US6902702B1 (en) 2000-08-16 2005-06-07 University Health Network Devices and methods for producing microarrays of biological samples
US20050106621A1 (en) * 2000-08-16 2005-05-19 Winegarden Neil A. Devices and methods for producing microarrays of biological samples
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
CA2419418A1 (en) 2000-08-17 2002-02-21 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6858590B2 (en) * 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
WO2002016435A2 (en) * 2000-08-22 2002-02-28 Lexicon Genetics Incorporated Human 7tm proteins and polynucleotides encoding the same
US6789040B2 (en) 2000-08-22 2004-09-07 Affymetrix, Inc. System, method, and computer software product for specifying a scanning area of a substrate
ATE334208T1 (en) * 2000-08-22 2006-08-15 Lexicon Genetics Inc HUMAN PROTEASES AND POLYNUCLEOTIDES ENCODING THEM
EP1573634A2 (en) 2000-08-22 2005-09-14 Affymetrix, Inc. System method, and computer software product for controlling biological microarray scanner
AU2001285219A1 (en) * 2000-08-24 2002-03-04 Aviva Biosciences Corporation Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
US6900013B1 (en) 2000-08-25 2005-05-31 Aviva Biosciences Corporation Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
US7807447B1 (en) 2000-08-25 2010-10-05 Merck Sharp & Dohme Corp. Compositions and methods for exon profiling
US6713257B2 (en) 2000-08-25 2004-03-30 Rosetta Inpharmatics Llc Gene discovery using microarrays
US20020055112A1 (en) * 2000-08-26 2002-05-09 Nila Patil Methods for reducing complexity of nucleic acid samples
US20020164634A1 (en) * 2000-08-26 2002-11-07 Perlegen Sciences, Inc. Methods for reducing complexity of nucleic acid samples
US20030190612A1 (en) * 2000-08-31 2003-10-09 Nobuko Yamamoto Detecting method and detection substrate for use therein
JP3467004B2 (en) * 2000-08-31 2003-11-17 キヤノン株式会社 Analysis method of nucleic acid base sequence
JP2002071687A (en) * 2000-08-31 2002-03-12 Canon Inc Screening method for variant gene
US7229790B2 (en) * 2000-09-01 2007-06-12 Lexicon Pharmaceuticals, Inc. Human GABA transporter protein and polynucleotides encoding the same
EP1327135B1 (en) * 2000-09-04 2010-02-24 Bayer Technology Services GmbH Multianalyte determination system and methods
US7108969B1 (en) 2000-09-08 2006-09-19 Affymetrix, Inc. Methods for detecting and diagnosing oral cancer
AU2001292142A1 (en) * 2000-09-11 2002-03-22 Affymetrix, Inc. Photocleavable protecting groups
US20030176344A1 (en) * 2000-09-14 2003-09-18 Decode Genetics Ehf. Human osteoporosis gene
US20040185464A1 (en) * 2000-09-15 2004-09-23 Kris Richard M. High throughput assay system
US7057704B2 (en) * 2000-09-17 2006-06-06 Bioarray Solutions Ltd. System and method for programmable illumination pattern generation
JP2004526411A (en) * 2000-09-18 2004-09-02 トマス・ジエフアーソン・ユニバーシテイ Compositions and methods for identifying and targeting gastric and esophageal cancer cells
US20020133299A1 (en) * 2000-09-20 2002-09-19 Jacob Howard J. Physiological profiling
US6780648B1 (en) 2000-09-20 2004-08-24 General Electric Company Method and system for selectively distributing luminescence material precursors
US6420178B1 (en) * 2000-09-20 2002-07-16 General Electric Company High throughput screening method, array assembly and system
US20030044803A1 (en) * 2000-09-22 2003-03-06 Pedersen Finn Skou Methods for diagnosis and treatment of diseases associated with altered expression of JAK1
US20020115058A1 (en) * 2000-09-22 2002-08-22 Pedersen Finn Skou Methods for diagnosis and treatment of diseases associated with altered expression of Pik3r1
AU2001292959A1 (en) * 2000-09-22 2002-04-02 Clontech Laboratories, Inc. Highly sensitive proteomic analysis methods and kits and systems for practicing the same
US20030077590A1 (en) * 2000-09-22 2003-04-24 Pedersen Finn Skou Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
US6613285B1 (en) 2000-09-25 2003-09-02 General Electric Company Reactor plate and method
US6808934B2 (en) 2000-09-25 2004-10-26 Picoliter Inc. High-throughput biomolecular crystallization and biomolecular crystal screening
US20020037359A1 (en) 2000-09-25 2002-03-28 Mutz Mitchell W. Focused acoustic energy in the preparation of peptide arrays
ATE315957T1 (en) 2000-09-25 2006-02-15 Picoliter Inc SOUND EXHAUST OF FLUID FROM SEVERAL CONTAINER
US6806051B2 (en) * 2000-09-25 2004-10-19 Picoliter Inc. Arrays of partially nonhybridizing oligonucleotides and preparation thereof using focused acoustic energy
US6493497B1 (en) 2000-09-26 2002-12-10 Motorola, Inc. Electro-optic structure and process for fabricating same
US6780584B1 (en) * 2000-09-27 2004-08-24 Nanogen, Inc. Electronic systems and component devices for macroscopic and microscopic molecular biological reactions, analyses and diagnostics
WO2002026980A2 (en) 2000-09-27 2002-04-04 Lexicon Genetics Incorporated Human ion-exchanger proteins and polynucleotides encoding t he same
US6496250B1 (en) 2000-09-29 2002-12-17 General Electric Company Combinatorial method foe development of optical ceramics
CN100495030C (en) * 2000-09-30 2009-06-03 清华大学 Multi-force operator and use thereof
US6777232B1 (en) 2000-10-02 2004-08-17 Lexicon Genetics Incorporated Human membrane proteins and polynucleotides encoding the same
US6638838B1 (en) 2000-10-02 2003-10-28 Motorola, Inc. Semiconductor structure including a partially annealed layer and method of forming the same
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
US20040091602A1 (en) * 2000-10-04 2004-05-13 Hwang Hyun Jin Method for immobilizing biologically active molecules
US20100261159A1 (en) * 2000-10-10 2010-10-14 Robert Hess Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
WO2002031129A2 (en) 2000-10-12 2002-04-18 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6849409B2 (en) * 2000-10-16 2005-02-01 Axxima Pharmaceuticals Ag Cellular kinases involved in Cytomegalovirus infection and their inhibition
US7001763B1 (en) 2000-10-17 2006-02-21 Lexicon Genetics Incorporated Human semaphorin proteins and polynucleotides encoding the same
DE10051396A1 (en) 2000-10-17 2002-04-18 Febit Ferrarius Biotech Gmbh An integrated synthesis and identification of an analyte, comprises particles immobilized at a carrier to be coupled to receptors in a structured pattern to give receptor arrays for biochemical reactions
US20030045005A1 (en) * 2000-10-17 2003-03-06 Michael Seul Light-controlled electrokinetic assembly of particles near surfaces
JPWO2002033068A1 (en) * 2000-10-18 2004-02-26 キヤノン株式会社 Analysis method of nucleic acid base sequence
JP2004537712A (en) * 2000-10-18 2004-12-16 バーチャル・アレイズ・インコーポレーテッド Multiple cell analysis system
AU2002241803A1 (en) * 2000-10-20 2002-06-18 The Board Of Trustees Of The Leland Stanford Junior University Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample
US6861214B1 (en) * 2000-10-23 2005-03-01 Beckman Coulter, Inc. Immobilization of biopolymers to aminated substrates by direct adsorption
US6491967B1 (en) 2000-10-24 2002-12-10 General Electric Company Plasma spray high throughput screening method and system
DE10052823B4 (en) * 2000-10-24 2014-11-20 Ruprecht-Karls-Universität Heidelberg Method for light microscopic analysis of the topology of molecular structures in grid arrangements
CA2426871A1 (en) 2000-10-24 2002-05-16 Oncosis Llc Method and device for selectively targeting cells within a three -dimensional specimen
US7118908B2 (en) * 2000-10-25 2006-10-10 Bor-Iuan Jan On-spot selectively activated hydrophobic slide and preparation thereof
EP1203945B1 (en) * 2000-10-26 2006-12-20 Agilent Technologies, Inc. (a Delaware corporation) Microarray
EP1409674A2 (en) * 2000-10-27 2004-04-21 Lexicon Genetics Incorporated Human 7tm proteins and polynucleotides encoding them
JP2004531209A (en) * 2000-10-30 2004-10-14 レキシコン・ジェネティクス・インコーポレーテッド Novel human 7TM protein and polynucleotide encoding the same
EP1332000B1 (en) 2000-10-30 2012-06-20 Sequenom, Inc. Method for delivery of submicroliter volumes onto a substrate
ATE336571T1 (en) * 2000-11-01 2006-09-15 Lexicon Genetics Inc POLYNUCLEOTIDES THAT CODE FOR HUMAN MELTRIN BETA (ADAM19) METALLOENDOPEPTIDASES
US6567751B1 (en) 2000-11-03 2003-05-20 General Electric Company Methods and computer system for combinatorial analysis of lighting phosphors
US7326563B2 (en) 2000-11-08 2008-02-05 Surface Logix, Inc. Device and method for monitoring leukocyte migration
US6699665B1 (en) * 2000-11-08 2004-03-02 Surface Logix, Inc. Multiple array system for integrating bioarrays
US6893851B2 (en) 2000-11-08 2005-05-17 Surface Logix, Inc. Method for arraying biomolecules and for monitoring cell motility in real-time
US6844184B2 (en) * 2000-11-08 2005-01-18 Surface Logix, Inc. Device for arraying biomolecules and for monitoring cell motility in real-time
US6803205B2 (en) * 2000-11-08 2004-10-12 Surface Logix, Inc. Methods of measuring enzyme activity using peelable and resealable devices
US7001740B2 (en) * 2000-11-08 2006-02-21 Surface Logix, Inc. Methods of arraying biological materials using peelable and resealable devices
US7374906B2 (en) 2000-11-08 2008-05-20 Surface Logix, Inc. Biological assays using gradients formed in microfluidic systems
US7439056B2 (en) 2000-11-08 2008-10-21 Surface Logix Inc. Peelable and resealable devices for arraying materials
US7033821B2 (en) * 2000-11-08 2006-04-25 Surface Logix, Inc. Device for monitoring cell motility in real-time
US6967074B2 (en) * 2000-11-08 2005-11-22 Surface Logix, Inc. Methods of detecting immobilized biomolecules
WO2002084302A2 (en) * 2000-11-08 2002-10-24 Burstein Technologies, Inc. Interactive system for analyzing biological samples and processing related information and the use thereof
US6864065B2 (en) * 2000-11-08 2005-03-08 Surface Logix, Inc. Assays for monitoring cell motility in real-time
US7033819B2 (en) 2000-11-08 2006-04-25 Surface Logix, Inc. System for monitoring cell motility in real-time
US7351575B2 (en) * 2000-11-08 2008-04-01 Surface Logix, Inc. Methods for processing biological materials using peelable and resealable devices
US7371563B2 (en) * 2000-11-08 2008-05-13 Surface Logix, Inc. Peelable and resealable devices for biochemical assays
US20020150887A1 (en) * 2000-11-09 2002-10-17 National Institute Of Advanced Industrial Science And Technology Methods and nucleic acid probes for molecular genetic analysis of polluted environments and environmental samples
AU2002228872A1 (en) * 2000-11-09 2002-05-21 Burstein Technologies, Inc. Disc drive system and methods for use with bio-discs
WO2002050278A2 (en) * 2000-11-15 2002-06-27 Lexicon Genetics Incorporated Novel human secreted proteins and polynucleotides encoding the same
WO2002044695A1 (en) * 2000-11-16 2002-06-06 Burstein Technologies, Inc. Methods and apparatus for detecting and quantifying lymphocytes with optical biodiscs
EP2381116A1 (en) 2000-11-16 2011-10-26 California Institute of Technology Apparatus and methods for conducting assays and high throughput screening
US7026131B2 (en) * 2000-11-17 2006-04-11 Nagaoka & Co., Ltd. Methods and apparatus for blood typing with optical bio-discs
US7087203B2 (en) * 2000-11-17 2006-08-08 Nagaoka & Co., Ltd. Methods and apparatus for blood typing with optical bio-disc
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
WO2002044425A2 (en) 2000-12-01 2002-06-06 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
US7635571B2 (en) * 2000-12-07 2009-12-22 Siemens Healthcare Diagnostics Products Gmbh Amplified signal in binding assays
EP2336368A1 (en) 2000-12-07 2011-06-22 Novartis Vaccines and Diagnostics, Inc. Endogenous retroviruses up-regulated in prostate cancer
JP3778041B2 (en) * 2000-12-08 2006-05-24 コニカミノルタホールディングス株式会社 Particle separation mechanism and particle separation apparatus
WO2002046761A2 (en) * 2000-12-08 2002-06-13 Burstein Technologies, Inc. Methods for detecting analytes using optical discs and optical disc readers
US6760298B2 (en) * 2000-12-08 2004-07-06 Nagaoka & Co., Ltd. Multiple data layer optical discs for detecting analytes
WO2002055685A2 (en) 2000-12-11 2002-07-18 Lexicon Genetics Incorporated Novel human kinase and polynucleotides encoding the same
US6596239B2 (en) * 2000-12-12 2003-07-22 Edc Biosystems, Inc. Acoustically mediated fluid transfer methods and uses thereof
AU2002232642B2 (en) * 2000-12-12 2007-02-01 Lexicon Pharmaceuticals, Inc. Novel human kinases and uses thereof
US6858413B2 (en) * 2000-12-13 2005-02-22 Nugen Technologies, Inc. Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
CA2431066C (en) * 2000-12-15 2007-05-15 Youqi Wang Methods and apparatus for designing high-dimensional combinatorial experiments
US6448387B1 (en) * 2000-12-18 2002-09-10 Monsanto Technology, Llc Polymeric arrays adapted for high expressing polynucleotides
US6583269B1 (en) 2000-12-18 2003-06-24 Lexicon Genetics Incorporated Human protease inhibitor and polynucleotides encoding the same
JP2005502307A (en) * 2000-12-20 2005-01-27 レキシコン・ジェネティクス・インコーポレーテッド Novel human ion channel protein and polynucleotide encoding the same
US6852844B1 (en) * 2000-12-20 2005-02-08 Lexicon Genetics Incorporated Human protocadherin proteins and polynucleotides encoding the same
US7645441B2 (en) 2000-12-22 2010-01-12 Sagres Discovery Inc. Compositions and methods in cancer associated with altered expression of PRLR
US20030099963A1 (en) * 2000-12-22 2003-05-29 Morris David W. Novel compositions and methods in cancer associated with altered expression of TBX21
US7820447B2 (en) 2000-12-22 2010-10-26 Sagres Discovery Inc. Compositions and methods for cancer
US20030165878A1 (en) * 2000-12-22 2003-09-04 Morris David W. Novel compositions and methods in cancer associated with altered expression of MCM3AP
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
US20030232334A1 (en) * 2000-12-22 2003-12-18 Morris David W. Novel compositions and methods for cancer
US20030087252A1 (en) * 2000-12-22 2003-05-08 Morris David W. Novel compositions and methods in cancer associated with altered expression of PRDM11
US7700274B2 (en) * 2000-12-22 2010-04-20 Sagres Discovery, Inc. Compositions and methods in cancer associated with altered expression of KCNJ9
WO2002052045A1 (en) * 2000-12-26 2002-07-04 Aviva Biosciences Active and biocompatible platforms prepared by polymerization of surface coating films
WO2002053753A2 (en) * 2001-01-05 2002-07-11 Lexicon Genetics Incorporated Novel human lipase and polynucleotides encoding the same
US7205161B2 (en) * 2001-01-10 2007-04-17 Symyx Technologies, Inc. Polymer brushes for immobilizing molecules to a surface or substrate having improved stability
WO2002056311A2 (en) * 2001-01-11 2002-07-18 Burstein Technologies Inc Optical disc analysis system including related methods for biological and medical imaging
US20020150935A1 (en) * 2001-01-12 2002-10-17 Zheng-Zheng Zhou Dotted micro-array data extraction method
ES2309175T3 (en) * 2001-01-19 2008-12-16 Centocor, Inc. ASSEMBLY DIRECTED BY COMPUTER OF A POLINUCLEOTIDE THAT CODIFIES A DIANA POLYPEPTIDE.
JP2004524835A (en) * 2001-01-23 2004-08-19 レキシコン・ジェネティクス・インコーポレーテッド Novel human kinase and polynucleotide encoding it
ATE538380T1 (en) * 2001-01-23 2012-01-15 Harvard College NUCLEIC ACID PROGRAMMABLE PROTEIN ARRAYS
US6870011B2 (en) 2001-01-24 2005-03-22 Arizona Chemical Company Hydrocarbon-terminated polyether-polyamide block copolymers and uses thereof
US20090226915A1 (en) 2001-01-24 2009-09-10 Health Discovery Corporation Methods for Screening, Predicting and Monitoring Prostate Cancer
EP1356059A1 (en) * 2001-01-24 2003-10-29 Lexicon Genetics Incorporated Human lipase and polynucleotides encoding the same
US6399713B1 (en) 2001-01-24 2002-06-04 Arizona Chemical Company Hydrocarbon-terminated polyether-polyamide block copolymers and uses thereof
US20020169562A1 (en) * 2001-01-29 2002-11-14 Gregory Stephanopoulos Defining biological states and related genes, proteins and patterns
GB0102357D0 (en) * 2001-01-30 2001-03-14 Randox Lab Ltd Imaging method
US7112305B2 (en) 2001-01-31 2006-09-26 Agilent Technologies, Inc. Automation-optimized microarray package
US20030170148A1 (en) * 2001-01-31 2003-09-11 Mcentee John F. Reaction chamber roll pump
US7166258B2 (en) * 2001-01-31 2007-01-23 Agilent Technologies, Inc. Automation-optimized microarray package
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
WO2002063002A2 (en) * 2001-02-02 2002-08-15 Lexicon Genetics Incorporated Novel human transporter protein and polynucleotides encoding the same
WO2002063270A2 (en) * 2001-02-05 2002-08-15 Board Of Regents, The University Of Texas System The use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors
CN1500144A (en) * 2001-02-06 2004-05-26 �����﹤����ʽ���� Amplified nucleic acids and immobilized products thereof
CA2436986A1 (en) * 2001-02-07 2002-08-15 Invitrogen Corporation Ter sites and ter binding proteins
US6832163B2 (en) * 2001-02-09 2004-12-14 Agilent Technologies, Inc. Methods of identifying heterogeneous features in an image of an array
US20020160527A1 (en) * 2001-02-26 2002-10-31 3M Innovative Properties Company Combinatorial library comprising pouches as packages for library members and method therefor
US6673646B2 (en) 2001-02-28 2004-01-06 Motorola, Inc. Growth of compound semiconductor structures on patterned oxide films and process for fabricating same
EP1236804A1 (en) 2001-03-02 2002-09-04 Boehringer Mannheim Gmbh A method for determination of a nucleic acid using a control
WO2002070020A2 (en) 2001-03-02 2002-09-12 University Of Western Ontario Polymer precursors of radiolabeled compounds, and methods of making and using the same
ATE497603T1 (en) 2001-03-02 2011-02-15 Gpc Biotech Ag THREE-HYBRID ASSAY SYSTEM
US20050196785A1 (en) * 2001-03-05 2005-09-08 California Institute Of Technology Combinational array for nucleic acid analysis
JP3929250B2 (en) * 2001-03-08 2007-06-13 株式会社ルネサステクノロジ Semiconductor device
GB0105787D0 (en) * 2001-03-08 2001-04-25 Expresson Biosystems Ltd Complex element micro-array and methods of use
CA2439074A1 (en) * 2001-03-09 2002-09-19 Nugen Technologies, Inc. Methods and compositions for amplification of rna sequences
EP2295971B1 (en) * 2001-03-09 2016-09-07 TrovaGene, Inc. Conjugate probes and optical detection of analytes
MXPA02012739A (en) 2001-03-09 2004-04-20 Nugen Technologies Inc Methods and compositions for amplification of rna sequences.
EP1578770A2 (en) * 2001-03-12 2005-09-28 Lexicon Genetics Incorporated Novel human egf-family proteins and polynucleotides encoding the same
AU2002252370A1 (en) * 2001-03-12 2002-09-24 Irm, Llc. Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters
AU2002252296A1 (en) * 2001-03-12 2002-09-24 Lexicon Genetics Incorporated Novel human transporter proteins and polynucleotides encoding the same
US7276580B2 (en) * 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
US20030170642A1 (en) * 2001-03-12 2003-09-11 Irm, Llc Identification of cellular targets for biologically active molecules
WO2002072603A2 (en) * 2001-03-12 2002-09-19 Lexicon Genetics Incorporated Novel human dectin proteins and polynucleotides encoding the same
WO2002072892A1 (en) 2001-03-12 2002-09-19 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
WO2002073673A1 (en) 2001-03-13 2002-09-19 Rochester Institute Of Technology A micro-electro-mechanical switch and a method of using and making thereof
US7211654B2 (en) * 2001-03-14 2007-05-01 Regents Of The University Of Michigan Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
US20030104410A1 (en) * 2001-03-16 2003-06-05 Affymetrix, Inc. Human microarray
US6994995B1 (en) * 2001-03-16 2006-02-07 Lexicon Genetics Incorporated Human synaptotagmin and polynucleotides encoding the same
WO2002074932A2 (en) 2001-03-20 2002-09-26 Lexicon Genetics Incorporated Novel human kinase and polynucleotides encoding the same
EP1370696A4 (en) * 2001-03-20 2009-04-22 Ortho Clinical Diagnostics Inc Expression profiles and methods of use
FR2822476B1 (en) 2001-03-23 2004-04-02 Aventis Pharma Sa METHODS OF PURIFICATION AND DETECTION OF TARGET SEQUENCES OF DOUBLE-STRANDED DNA BY TRIPLE-HELICE INTERACTION
US20020136772A1 (en) * 2001-03-26 2002-09-26 Tai-Nang Huang Polymer synthesis
US20020168669A1 (en) * 2001-03-26 2002-11-14 Tai-Nang Huang Patterned polymer synthesis
WO2002076401A2 (en) 2001-03-26 2002-10-03 Dana-Farber Cancer Institute, Inc. Method of attenuating reactions to skin irritants
US6596489B2 (en) 2001-03-30 2003-07-22 Applied Gene Technologies Methods and compositions for analyzing nucleotide sequence mismatches using RNase H
AU785425B2 (en) * 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
US7115726B2 (en) * 2001-03-30 2006-10-03 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
JP2004530125A (en) * 2001-04-02 2004-09-30 ツェプトゼンス アクチエンゲゼルシャフト Optical structures and their use for multiphoton excitation
US7514263B2 (en) 2001-04-02 2009-04-07 3M Innovative Properties Company Continuous process for the production of combinatorial libraries of materials
EP1384022A4 (en) 2001-04-06 2004-08-04 California Inst Of Techn Nucleic acid amplification utilizing microfluidic devices
JP2004524043A (en) * 2001-04-06 2004-08-12 レキシコン・ジェネティクス・インコーポレーテッド Novel human kinase and polynucleotide encoding the kinase
EP1383880A1 (en) * 2001-04-06 2004-01-28 Lexicon Genetics Incorporated Novel human kinase and polynucleotides encoding the same
US20060129329A1 (en) * 2001-04-09 2006-06-15 Kobylecki Ryszard J Investigating different physical and/or chemical forms of materials
US6911339B2 (en) * 2001-04-09 2005-06-28 David P. Dumas Transparent polymer support for organic synthesis
US6644173B2 (en) * 2001-04-11 2003-11-11 Keuring, Incorporated Beverage filter cartridge holder
JP3885511B2 (en) * 2001-04-11 2007-02-21 ソニー株式会社 Laser light generating apparatus and method
US7033747B2 (en) 2001-04-11 2006-04-25 Nagaoka & Co., Ltd Multi-parameter assays including analysis discs and methods relating thereto
WO2002083706A1 (en) * 2001-04-16 2002-10-24 Lexicon Genetics Incorporated Nucleic acid encoding a human adenylosuccinate synthetase
EP1390526A4 (en) 2001-04-18 2005-02-02 Perlegen Sciences Inc Methods for identifying the evolutionarily conserved sequences
US7258974B2 (en) * 2001-04-23 2007-08-21 Michael F. Chou Transcription factor network discovery methods
US6643015B2 (en) 2001-04-26 2003-11-04 Affymetrix, Inc. System, method, and product for symmetrical filtering in scanning of biological materials
US6490533B2 (en) * 2001-04-26 2002-12-03 Affymetrix, Inc. System, method, and product for dynamic noise reduction in scanning of biological materials
US6650411B2 (en) 2001-04-26 2003-11-18 Affymetrix, Inc. System, method, and product for pixel clocking in scanning of biological materials
US20020160427A1 (en) * 2001-04-27 2002-10-31 Febit Ag Methods and apparatuses for electronic determination of analytes
US20030166893A1 (en) * 2001-04-30 2003-09-04 Yi Hu Novel human nuclear transporters and polynucleotides encoding the same
ES2400448T3 (en) * 2001-04-30 2013-04-10 Ventana Medical Systems, Inc. Reagents and methods for automated in situ hybridization or microarray
US7138506B2 (en) * 2001-05-09 2006-11-21 Genetic Id, Na, Inc. Universal microarray system
US7244853B2 (en) 2001-05-09 2007-07-17 President And Fellows Of Harvard College Dioxanes and uses thereof
US6989276B2 (en) * 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
USRE44031E1 (en) 2001-05-10 2013-02-26 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
US7695919B2 (en) * 2001-05-10 2010-04-13 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
US20030119015A1 (en) * 2001-05-10 2003-06-26 Perlegen Sciences, Inc. Methods for nucleic acid analysis
USRE46351E1 (en) 2001-05-10 2017-03-28 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
US7183116B2 (en) 2001-05-14 2007-02-27 The Institute For Systems Biology Methods for isolation and labeling of sample molecules
US6552160B2 (en) 2001-05-14 2003-04-22 Arizona Chemical Company Ester-terminated poly(ester-amides) useful for formulating transparent gels in low polarity fluids
US7858385B2 (en) * 2001-05-16 2010-12-28 Los Alamos National Security, Llc Method for detecting binding events using micro-X-ray fluorescence spectrometry
US9157875B2 (en) * 2001-05-16 2015-10-13 Benjamin P. Warner Drug development and manufacturing
US20080220441A1 (en) * 2001-05-16 2008-09-11 Birnbaum Eva R Advanced drug development and manufacturing
WO2004010099A2 (en) * 2001-05-16 2004-01-29 Burstein Technologies, Inc. Variable sampling for rendering pixelization of analysis results in optical bio-disc assembly
US20050009101A1 (en) * 2001-05-17 2005-01-13 Motorola, Inc. Microfluidic devices comprising biochannels
US7083920B2 (en) * 2001-05-18 2006-08-01 Nagaoka & Co. Ltd. Surface assembly for immobilizing DNA capture probes in genetic assays using enzymatic reactions to generate signal in optical bio-discs and methods relating thereto
TW490783B (en) * 2001-05-22 2002-06-11 Hi Max Optoelectronics Corp Testing device and method built in the wafer scribe line
WO2002095057A2 (en) * 2001-05-24 2002-11-28 Genospectra, Inc. Pairs of nucleic acid probes with interactive signaling moieties and nucleic acid probes with enhanced hybridization efficiency and specificity
AU2002303827A1 (en) * 2001-05-25 2002-12-09 Invitrogen Corporation Compositions and methods for extension of nucleic acids
WO2002097095A1 (en) * 2001-05-25 2002-12-05 Lexicon Genetics Incorporated Novel human transporter proteins and polynucleotides encoding the same
US20070015144A9 (en) * 2001-05-25 2007-01-18 Genset, S.A. Human cDNAs and proteins and uses thereof
US6867025B2 (en) 2001-05-29 2005-03-15 Lexicon Genetics Incorporated Human hydroxylases and polynucleotides encoding the same
US7195393B2 (en) 2001-05-31 2007-03-27 Rochester Institute Of Technology Micro fluidic valves, agitators, and pumps and methods thereof
US7294478B1 (en) 2001-06-06 2007-11-13 Rosetta Inpharmatics Llc Microarray reaction cartridge
US20070184436A1 (en) * 2001-06-07 2007-08-09 Joel Myerson Generic capture probe arrays
AU2002312411A1 (en) * 2001-06-07 2002-12-16 Proligo Llc Microcalorimetric detection of analytes and binding events
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6824974B2 (en) * 2001-06-11 2004-11-30 Genorx, Inc. Electronic detection of biological molecules using thin layers
US20040048241A1 (en) * 2001-06-11 2004-03-11 Freeman Beverly Annette Methods for attaching molecules
US20030027301A1 (en) * 2001-06-14 2003-02-06 Yi Hu Novel human transporter proteins and polynucleotides encoding the same
CA2451074C (en) * 2001-06-18 2014-02-11 Rosetta Inpharmatics, Inc. Diagnosis and prognosis of breast cancer patients
US20030104426A1 (en) * 2001-06-18 2003-06-05 Linsley Peter S. Signature genes in chronic myelogenous leukemia
US20030096264A1 (en) * 2001-06-18 2003-05-22 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (MPHTS)
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
US20020198666A1 (en) * 2001-06-20 2002-12-26 Kabushikigaisha Dynacom System and method for computer-designing optimum oligo-nucleic acid sequences from nucleic acid base sequences, and oligo-nucleic acid array mounted with the designed oligo-nucleic acid sequences
US7262063B2 (en) 2001-06-21 2007-08-28 Bio Array Solutions, Ltd. Directed assembly of functional heterostructures
US6709989B2 (en) 2001-06-21 2004-03-23 Motorola, Inc. Method for fabricating a semiconductor structure including a metal oxide interface with silicon
EP1925672A1 (en) 2001-06-22 2008-05-28 Syngeta Participations AG Abiotic stress responsive polynucleotides and polypeptides
CA2451637C (en) 2001-06-22 2013-04-23 Stemcells, Inc. Liver engrafting cells, assays, and uses thereof
US20040166593A1 (en) * 2001-06-22 2004-08-26 Nolte David D. Adaptive interferometric multi-analyte high-speed biosensor
US7402286B2 (en) * 2001-06-27 2008-07-22 The Regents Of The University Of California Capillary pins for high-efficiency microarray printing device
US6855538B2 (en) * 2001-06-27 2005-02-15 The Regents Of The University Of California High-efficiency microarray printing device
WO2003002765A2 (en) 2001-06-27 2003-01-09 Cancer Research Technology Limited Methods for the diagnosis of cancer based on the obcam and ntm genes
EP1412752B1 (en) * 2001-06-29 2011-06-22 VERI-Q, Inc. Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids
US20040161741A1 (en) * 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9777312B2 (en) * 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
EP1412535A4 (en) * 2001-07-02 2007-08-22 Univ Leland Stanford Junior Microarrays for cell phenotyping and manipulation
US6691042B2 (en) 2001-07-02 2004-02-10 Rosetta Inpharmatics Llc Methods for generating differential profiles by combining data obtained in separate measurements
AU2002318186A1 (en) * 2001-07-03 2003-01-21 Lexicon Genetics Incorporated Novel human kielin-like proteins and polynucleotides encoding the same
US20050009022A1 (en) * 2001-07-06 2005-01-13 Weiner Michael P. Method for isolation of independent, parallel chemical micro-reactions using a porous filter
US7221632B2 (en) * 2001-07-12 2007-05-22 Burstein Technologies, Inc. Optical disc system and related detecting methods for analysis of microscopic structures
US20030013208A1 (en) * 2001-07-13 2003-01-16 Milagen, Inc. Information enhanced antibody arrays
US7297553B2 (en) * 2002-05-28 2007-11-20 Nanosphere, Inc. Method for attachment of silylated molecules to glass surfaces
WO2003006676A2 (en) 2001-07-13 2003-01-23 Nanosphere, Inc. Method for immobilizing molecules onto surfaces
CA2563510A1 (en) * 2001-07-13 2005-11-17 Nanosphere, Inc. Method for preparing substrates having immobilized molecules and substrates
EP2053406A3 (en) * 2001-07-16 2009-06-24 caprotec bioanalytics GmbH Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
US20030068691A1 (en) * 2001-07-16 2003-04-10 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002329606A1 (en) * 2001-07-17 2003-03-03 Bioforce Nanosciences, Inc. Combined molecular blinding detection through force microscopy and mass spectrometry
US6646293B2 (en) 2001-07-18 2003-11-11 Motorola, Inc. Structure for fabricating high electron mobility transistors utilizing the formation of complaint substrates
US20030143612A1 (en) * 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
US6893822B2 (en) 2001-07-19 2005-05-17 Nanogen Recognomics Gmbh Enzymatic modification of a nucleic acid-synthetic binding unit conjugate
US6693298B2 (en) 2001-07-20 2004-02-17 Motorola, Inc. Structure and method for fabricating epitaxial semiconductor on insulator (SOI) structures and devices utilizing the formation of a compliant substrate for materials used to form same
AU2002326441A1 (en) * 2001-07-20 2003-03-03 Burstein Technologies, Inc. Optical analysis disc and related drive assembly for performing interactive centrifugation
US20030022150A1 (en) * 2001-07-24 2003-01-30 Sampson Jeffrey R. Methods for detecting a target molecule
CA2452260C (en) * 2001-07-24 2011-09-06 Genset S.A. Novel variants and exons of the glyt1 transporter
US7348140B1 (en) 2001-07-25 2008-03-25 Acadia Pharmaceuticals, Inc. Clinical indications for genotyping polymorphic variants of G-protein coupled receptors
US6667196B2 (en) 2001-07-25 2003-12-23 Motorola, Inc. Method for real-time monitoring and controlling perovskite oxide film growth and semiconductor structure formed using the method
JP4265149B2 (en) * 2001-07-25 2009-05-20 セイコーエプソン株式会社 Electro-optical device and method for manufacturing electro-optical device
US20030022394A1 (en) * 2001-07-27 2003-01-30 Dumas David P. Biochips and methods of making same
WO2003083040A2 (en) * 2001-07-30 2003-10-09 Sts Biopolymers, Inc. Graft polymer matrices
US6833441B2 (en) 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
US20030027258A1 (en) * 2001-08-02 2003-02-06 Chang Fang-Tseh Frank Methods and compositions for pearl oyster cultivation
US6589856B2 (en) 2001-08-06 2003-07-08 Motorola, Inc. Method and apparatus for controlling anti-phase domains in semiconductor structures and devices
US6639249B2 (en) 2001-08-06 2003-10-28 Motorola, Inc. Structure and method for fabrication for a solid-state lighting device
US20030082596A1 (en) * 2001-08-08 2003-05-01 Michael Mittmann Methods of genetic analysis of probes: test3
IL160229A0 (en) 2001-08-10 2004-07-25 Genset Sa Polynucleotides, polypeptides encoded thereby and their use
WO2003016481A2 (en) * 2001-08-14 2003-02-27 Lexicon Genetics Incorporated Novel human collagen proteins and polynucleotides encoding the same
KR100455284B1 (en) * 2001-08-14 2004-11-12 삼성전자주식회사 High-throughput sensor for detecting biomolecules using carbon nanotubes
US6673667B2 (en) 2001-08-15 2004-01-06 Motorola, Inc. Method for manufacturing a substantially integral monolithic apparatus including a plurality of semiconductor materials
WO2003016574A1 (en) * 2001-08-16 2003-02-27 Zhifeng Shao Analysis of gene expression profiles using sequential hybridization
US20080026367A9 (en) * 2001-08-17 2008-01-31 Perlegen Sciences, Inc. Methods for genomic analysis
AU2002332598A1 (en) * 2001-08-22 2003-03-10 Shengfeng Li Compositions and methods for generating antigen-binding units
WO2003020966A2 (en) * 2001-08-27 2003-03-13 Zeptosens Ag Surface for the immobilisation of nucleic acids
US20030129665A1 (en) * 2001-08-30 2003-07-10 Selvan Gowri Pyapali Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems
US10539561B1 (en) 2001-08-30 2020-01-21 Customarray, Inc. Enzyme-amplified redox microarray detection process
US20050147984A1 (en) * 2001-08-31 2005-07-07 Clondiag Chip Technologies Gmbh Interaction detection on several probe arrays
US20050032060A1 (en) * 2001-08-31 2005-02-10 Shishir Shah Arrays comprising pre-labeled biological molecules and methods for making and using these arrays
US20030143637A1 (en) * 2001-08-31 2003-07-31 Selvan Gowri Pyapali Capture layer assemblies for cellular assays including related optical analysis discs and methods
DE10142643A1 (en) * 2001-08-31 2003-04-24 Clondiag Chip Tech Gmbh Detection of interactions on probe arrays
US20030044798A1 (en) * 2001-08-31 2003-03-06 Lefkowitz Steven M. Methods for generating ligand arrays via deposition of ligands onto olefin displaying substrates, and arrays produced thereby
US20030108972A1 (en) * 2001-12-06 2003-06-12 Zweig Stephen Eliot Tethered receptor-ligand reagent and assay
US20030113925A1 (en) * 2001-09-07 2003-06-19 Gordon John Francis Nuclear morphology based identification and quantification of white blood cell types using optical bio-disc systems
US20030054396A1 (en) * 2001-09-07 2003-03-20 Weiner Michael P. Enzymatic light amplification
US20030106492A1 (en) * 2001-09-07 2003-06-12 Douglas Levinson Apparatus and method for high-throughput preparation, visualization and screening of compositions
US6974671B1 (en) 2001-09-12 2005-12-13 Salk Institute For Biological Studies Methods for indentifying compounds that modulate gluconeogenesis through the binding of CREB to the PGC-1 promoter
EP1425696A2 (en) * 2001-09-12 2004-06-09 Burstein Technologies, Inc. Methods for differential cell counts including related apparatus and software for performing same
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20070082337A1 (en) * 2004-01-27 2007-04-12 Compugen Ltd. Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
US20060068405A1 (en) * 2004-01-27 2006-03-30 Alex Diber Methods and systems for annotating biomolecular sequences
US6900237B2 (en) * 2001-09-14 2005-05-31 Axys Pharmaceuticals, Inc. Sulfonamide compounds as protease inhibitors
US20060188875A1 (en) * 2001-09-18 2006-08-24 Perlegen Sciences, Inc. Human genomic polymorphisms
US7202028B2 (en) * 2001-09-24 2007-04-10 The University Of North Carolina At Chapel Hill Methods for the electrochemical detection of multiple target compounds
US20070098728A1 (en) * 2001-09-24 2007-05-03 Pedersen Finn S Novel compositions and methods in cancer
US7042488B2 (en) 2001-09-27 2006-05-09 Fujinon Corporation Electronic endoscope for highlighting blood vessel
JP4754746B2 (en) * 2001-09-28 2011-08-24 オリンパス株式会社 Rod-shaped carrier and cylinder reaction vessel equipped with the same
US20030068621A1 (en) * 2001-10-04 2003-04-10 Jonathan Briggs Method and device for producing oligonucleotide arrays
US20040053232A1 (en) * 2001-10-05 2004-03-18 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
DE10149684B4 (en) * 2001-10-09 2005-02-17 Clondiag Chip Technologies Gmbh Device for holding a substance library carrier
US7439346B2 (en) 2001-10-12 2008-10-21 Perkinelmer Las Inc. Nucleic acids arrays and methods of use therefor
AU2002334769A1 (en) * 2001-10-12 2003-04-28 Duke University Image analysis of high-density synthetic dna microarrays
US6993173B2 (en) * 2001-10-12 2006-01-31 Duke University Methods for estimating probe cell locations in high-density synthetic DNA microarrays
CA2463725A1 (en) 2001-10-12 2003-11-06 Spectral Genomics, Inc. Compilations of nucleic acids and arrays and methods of using them
JP4377689B2 (en) 2001-10-15 2009-12-02 バイオアレイ ソリューションズ リミテッド Combined analysis of polymorphic loci with simultaneous interrogation and enzyme-mediated detection
WO2003033718A1 (en) * 2001-10-17 2003-04-24 Global Genomics Ab Synthesis of oligonucleotides on solid support and assembly into doublestranded polynucleotides
US20030219800A1 (en) * 2001-10-18 2003-11-27 Beske Oren E. Multiplexed cell transfection using coded carriers
US20040166490A1 (en) * 2002-12-17 2004-08-26 Morris David W. Novel therapeutic targets in cancer
US20030165859A1 (en) * 2001-10-23 2003-09-04 Invitrogen Corporation Primers and methods for the detection and discrimination of nucleic acids
US20040126762A1 (en) * 2002-12-17 2004-07-01 Morris David W. Novel compositions and methods in cancer
JP2005522988A (en) 2001-10-25 2005-08-04 メディカル リサーチ カウンシル molecule
ITMI20010566U1 (en) * 2001-10-25 2003-04-25 Troletti Adriano HAIR DRYER, WITH HIGH PRACTICALITY OF USE
US7211923B2 (en) 2001-10-26 2007-05-01 Nth Tech Corporation Rotational motion based, electrostatic power source and methods thereof
US7378775B2 (en) 2001-10-26 2008-05-27 Nth Tech Corporation Motion based, electrostatic power source and methods thereof
US7292349B2 (en) * 2001-10-26 2007-11-06 University Of Rochester Method for biomolecular sensing and system thereof
WO2003098661A2 (en) * 2001-10-26 2003-11-27 Integrated Nano-Technologies, Llc Chemical and biological hazard sensor system and methods thereof
US20030082560A1 (en) * 2001-10-29 2003-05-01 Yingjian Wang Method of making interactive protein arrays
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6902921B2 (en) * 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20040259095A1 (en) * 2001-10-30 2004-12-23 Cary Stephen C Rapid high-throughput screen for detecting biological species in ballast water
US20050124022A1 (en) * 2001-10-30 2005-06-09 Maithreyan Srinivasan Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
WO2003038130A2 (en) * 2001-10-31 2003-05-08 Pfizer Products Inc. Therapeutics and diagnostics for disorders of erythropoiesis
US7175983B2 (en) * 2001-11-02 2007-02-13 Abmaxis, Inc. Adapter-directed display systems
AU2002367965A1 (en) * 2001-11-06 2003-12-31 Dermal Systems International Inc. High throughput methods and devices for assaying analytes in a fluid sample
CN100398551C (en) 2001-11-09 2008-07-02 乔治敦大学 Novel isoforms of vascular endothelial cell growth inhibitor
US20080094974A1 (en) * 2001-11-09 2008-04-24 Burstein Technologies, Inc. Optical disc system and related detecting methods for analysis of microscopic structures
WO2003051174A2 (en) * 2001-11-09 2003-06-26 Neurogenetics, Inc. Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
US20040067512A1 (en) * 2001-11-09 2004-04-08 Neurogenetics, Inc. Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
EP1451584B1 (en) * 2001-11-09 2011-05-11 3dbiosurfaces Technologies, LLC High surface area substrates for microarrays and methods to make same
US20030124599A1 (en) * 2001-11-14 2003-07-03 Shiping Chen Biochemical analysis system with combinatorial chemistry applications
DE10156467A1 (en) * 2001-11-16 2003-06-05 Micronas Gmbh Carriers for synthesis and processes for the production of biopolymers
EP1448992A4 (en) * 2001-11-20 2005-11-02 Burstein Technologies Inc Optical bio-discs and fluidic circuits for analysis of cells and methods relating thereto
WO2003046144A2 (en) * 2001-11-26 2003-06-05 Molecular Reflections, Inc. Microscale immobilization of molecules using a hydrogel and methods of use thereof
US20040023237A1 (en) * 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
US20060040262A1 (en) * 2002-12-27 2006-02-23 Morris David W Novel compositions and methods in cancer
AU2002351187A1 (en) 2001-11-30 2003-06-17 Fluidigm Corporation Microfluidic device and methods of using same
US20040180344A1 (en) * 2003-03-14 2004-09-16 Morris David W. Novel therapeutic targets in cancer
US20040197778A1 (en) * 2002-12-26 2004-10-07 Sagres Discovery, Inc. Novel compositions and methods in cancer
US20070037147A1 (en) * 2001-12-07 2007-02-15 Pablo Garcia Endogenous retrovirus polypeptides linked to oncogenic transformation
US6960298B2 (en) * 2001-12-10 2005-11-01 Nanogen, Inc. Mesoporous permeation layers for use on active electronic matrix devices
AU2002358110A1 (en) * 2001-12-10 2003-07-09 Novartis Ag Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene
US7098041B2 (en) 2001-12-11 2006-08-29 Kimberly-Clark Worldwide, Inc. Methods to view and analyze the results from diffraction-based diagnostics
US7102752B2 (en) 2001-12-11 2006-09-05 Kimberly-Clark Worldwide, Inc. Systems to view and analyze the results from diffraction-based diagnostics
EP1321768A1 (en) * 2001-12-18 2003-06-25 Roche Diagnostics GmbH Diagnosis of endometriosis from menstrual blood
US7858297B2 (en) * 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
JP2005527191A (en) * 2001-12-18 2005-09-15 アンドキューブ ソシエタ パー アクシオン シンプリフィー Novel cell death-related proteins and THAP1 and PAR4 pathways in controlling apoptosis
US20030157700A1 (en) * 2001-12-19 2003-08-21 Affymetrix, Inc. Apparatus and methods for constructing array plates
KR20050008644A (en) * 2001-12-21 2005-01-21 엘지 바이오메디컬 인스티튜트 Gene expression profiles in stomach cancer
US20030119203A1 (en) 2001-12-24 2003-06-26 Kimberly-Clark Worldwide, Inc. Lateral flow assay devices and methods for conducting assays
US8367013B2 (en) 2001-12-24 2013-02-05 Kimberly-Clark Worldwide, Inc. Reading device, method, and system for conducting lateral flow assays
EP1486561B1 (en) * 2001-12-26 2013-12-04 Canon Kabushiki Kaisha Probe medium
US7335153B2 (en) 2001-12-28 2008-02-26 Bio Array Solutions Ltd. Arrays of microparticles and methods of preparation thereof
US20040241653A1 (en) * 2001-12-31 2004-12-02 Elena Feinstein Methods for identifying marker genes for cancer
US6897025B2 (en) * 2002-01-07 2005-05-24 Perlegen Sciences, Inc. Genetic analysis systems and methods
US20030188343A1 (en) * 2002-01-09 2003-10-02 Lynx Therapeutics, Inc. Identification of genes associated with growth in plants
FR2834521B1 (en) * 2002-01-10 2004-12-17 Bio Merieux METHOD FOR DETECTION AND / OR IDENTIFICATION OF THE ORIGINAL ANIMAL SPECIES OF THE ANIMAL MATERIAL CONTAINED IN A SAMPLE
US20040246252A1 (en) * 2002-01-14 2004-12-09 Morrow Jesse James Method and apparatus for visualizing data
DE10201463B4 (en) 2002-01-16 2005-07-21 Clondiag Chip Technologies Gmbh Reaction vessel for performing array method
US20030148391A1 (en) * 2002-01-24 2003-08-07 Salafsky Joshua S. Method using a nonlinear optical technique for detection of interactions involving a conformational change
US8008012B2 (en) 2002-01-24 2011-08-30 Health Discovery Corporation Biomarkers downregulated in prostate cancer
EP1470551A2 (en) * 2002-01-28 2004-10-27 Burstein Technologies, Inc. Methods and apparatus for logical triggering
US20050002827A1 (en) * 2002-01-29 2005-01-06 Mcintyre Kevin Robert Optical discs including equi-radial and/or spiral analysis zones and related disc drive systems and methods
US20050019901A1 (en) * 2002-01-31 2005-01-27 Evgenia Matveeva Methods for synthesis of bio-active nanoparticles and nanocapsules for use in optical bio-disc assays and disc assembly including same
US7418351B2 (en) * 2002-01-31 2008-08-26 Rosetta Inpharmatics Llc Methods for analysis of measurement errors in measured signals
US7083975B2 (en) * 2002-02-01 2006-08-01 Roland Green Microarray synthesis instrument and method
EP1483720A1 (en) * 2002-02-01 2004-12-08 Rosetta Inpharmactis LLC. Computer systems and methods for identifying genes and determining pathways associated with traits
US20030149933A1 (en) * 2002-02-01 2003-08-07 Marco Falcioni Graphical design of chemical discovery processes
US6887362B2 (en) * 2002-02-06 2005-05-03 Nanogen, Inc. Dielectrophoretic separation and immunoassay methods on active electronic matrix devices
US6861523B2 (en) 2002-02-08 2005-03-01 Torrey Pines Institute For Molecular Studies 1,3,5- trisubstituted-1,3,5-triazine-2,4,6-trione compounds and libraries
US7553619B2 (en) * 2002-02-08 2009-06-30 Qiagen Gmbh Detection method using dissociated rolling circle amplification
EP1481090A4 (en) * 2002-02-15 2006-08-09 Somalogic Inc Methods and reagents for detecting target binding by nucleic acid ligands
US20030156136A1 (en) * 2002-02-15 2003-08-21 Cattell Herbert F. Method and system for visualization of results of feature extraction from molecular array data
US20030162178A1 (en) * 2002-02-25 2003-08-28 O'hagan David Variable microarray and methods of detecting one or more anlaytes in a sample
NL1020066C2 (en) * 2002-02-26 2003-08-27 Dutch Space B V Device for manufacturing a DNA test array.
US6770892B2 (en) 2002-02-28 2004-08-03 Agilent Technologies, Inc. Method and system for automated focus-distance determination for molecular array scanners
US6914229B2 (en) * 2002-02-28 2005-07-05 Agilent Technologies, Inc. Signal offset for prevention of data clipping in a molecular array scanner
US6929951B2 (en) * 2002-02-28 2005-08-16 Agilent Technologies, Inc. Method and system for molecular array scanner calibration
US20030161761A1 (en) * 2002-02-28 2003-08-28 Williams Roger O. Apparatus and method for composing high density materials onto target substrates by a rapid sequence
US7504364B2 (en) * 2002-03-01 2009-03-17 Receptors Llc Methods of making arrays and artificial receptors
US20030203384A1 (en) * 2002-03-08 2003-10-30 Chafin David R. Multiplex detection of biological materials in a sample
ES2559764T3 (en) 2002-03-11 2016-02-15 Molecular Insight Pharmaceuticals, Inc. Technetium dipyridine complexes, and methods of use thereof
US20040209255A1 (en) * 2002-03-11 2004-10-21 Hk Pharmaceuticals, Inc. Compounds and methods for analyzing the proteome
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
WO2003076464A2 (en) 2002-03-13 2003-09-18 Bayer Cropscience Sa Mutagenesis of aspergillus fungi and identification of genes essential for growth
CA2422224A1 (en) 2002-03-15 2003-09-15 Affymetrix, Inc. System, method, and product for scanning of biological materials
SE0200817D0 (en) * 2002-03-15 2002-03-15 Ulf Gyllensten Method and kit for detection of mutations in mitochondrial DNA
US20030177380A1 (en) * 2002-03-18 2003-09-18 Woods Stanley P. Devices for storing array data and methods of using the same
WO2003081211A2 (en) * 2002-03-19 2003-10-02 Cengent Therapeutics, Inc. Discrete bayesian analysis of data
WO2003080649A2 (en) * 2002-03-20 2003-10-02 Regents Of The University Of Minnesota Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
US20040006431A1 (en) * 2002-03-21 2004-01-08 Affymetrix, Inc., A Corporation Organized Under The Laws Of Delaware System, method and computer software product for grid placement, alignment and analysis of images of biological probe arrays
EP2093233A1 (en) 2002-03-21 2009-08-26 Sagres Discovery, Inc. Novel compositions and methods in cancer
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
WO2003082210A2 (en) * 2002-03-26 2003-10-09 Massachusetts Institute Of Technology Targets, methods, and reagents for diagnosis and treatment of schizophrenia
AR039102A1 (en) * 2002-03-26 2005-02-09 Lai Derhsing INTEGRATED CIRCUIT CHIP FOR BIOLOGICAL TESTS
US6916621B2 (en) 2002-03-27 2005-07-12 Spectral Genomics, Inc. Methods for array-based comparitive binding assays
US20030186279A1 (en) * 2002-03-28 2003-10-02 Affymetrix, Inc. Large scale genotyping methods
US20030186302A1 (en) * 2002-03-29 2003-10-02 Yixin Wang Colorectal cancer diagnostics
WO2003085379A2 (en) 2002-04-01 2003-10-16 Fluidigm Corporation Microfluidic particle-analysis systems
CA2480775C (en) 2002-04-04 2016-05-31 Coley Pharmaceutical Gmbh Immunostimulatory g,u-containing oligoribonucleotides
US6773888B2 (en) * 2002-04-08 2004-08-10 Affymetrix, Inc. Photoactivatable silane compounds and methods for their synthesis and use
CA2480202A1 (en) * 2002-04-10 2003-10-23 Transtech Pharma, Inc. System and method for data analysis, manipulation, and visualization
US20030195431A1 (en) * 2002-04-10 2003-10-16 Sukhatme Vikas P. Observation of effects of body fluids on indicator cells for disease diagnosis
US20030194709A1 (en) * 2002-04-10 2003-10-16 Xing Yang Hydrophobic zone device
US7687256B2 (en) 2002-04-11 2010-03-30 Spire Corporation Surface activated biochip
AU2003224978A1 (en) 2002-04-12 2003-10-27 Curators Of The University Of Missouri ECIST microarrays for dual screening of DNA hypermethylation and gene silencing
US7531305B2 (en) * 2002-04-16 2009-05-12 Autogenomics, Inc. Human Papilloma Virus detection with DNA microarray
ATE459880T1 (en) 2002-04-17 2010-03-15 Deutsches Krebsforsch METHOD FOR SCREENING A SUBSTANCE FOR MODULATING THE WNT SIGNAL CAScade.
US7226771B2 (en) 2002-04-19 2007-06-05 Diversa Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
BRPI0309391B1 (en) 2002-04-19 2018-10-30 Dsm Food Specialties B V vector comprising nucleic acid encoding phospholipase activity polypeptide, transformed cell, protein preparation, preparation method and related methods
DE10217569A1 (en) * 2002-04-19 2003-11-13 Infineon Technologies Ag Device based on partially oxidized porous silicon
AU2003221757A1 (en) * 2002-04-23 2003-11-10 Applera Corporation Nucleic acid molecules encoding human proteins, and uses thereof
US7425749B2 (en) * 2002-04-23 2008-09-16 Sharp Laboratories Of America, Inc. MEMS pixel sensor
US20030198967A1 (en) * 2002-04-23 2003-10-23 Matson Robert S. Multi-functional microarrays and methods
US6946285B2 (en) * 2002-04-29 2005-09-20 Agilent Technologies, Inc. Arrays with elongated features
US20040023275A1 (en) * 2002-04-29 2004-02-05 Perlegen Sciences, Inc. Methods for genomic analysis
CN1202266C (en) * 2002-04-30 2005-05-18 欧姆龙株式会社 Biological chip fitted with optical scanning device and reading method of said biological chip
US6791690B2 (en) * 2002-04-30 2004-09-14 Agilent Technologies, Inc. Reading dry chemical arrays
US7485453B2 (en) * 2002-05-03 2009-02-03 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7118855B2 (en) * 2002-05-03 2006-10-10 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7214530B2 (en) * 2002-05-03 2007-05-08 Kimberly-Clark Worldwide, Inc. Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
US7771922B2 (en) 2002-05-03 2010-08-10 Kimberly-Clark Worldwide, Inc. Biomolecule diagnostic device
US7223368B2 (en) 2002-05-03 2007-05-29 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
DE60323625D1 (en) * 2002-05-03 2008-10-30 Vialogy Llc METHOD FOR CHARACTERIZING THE OUTPUT SIGNALS OF A MICROARRAY
US7223534B2 (en) 2002-05-03 2007-05-29 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
AU2003241359A1 (en) * 2002-05-06 2003-11-11 Functional Genetics, Inc. Mammalian genes involed in rapamycin resistance and tumorgenesis: annexin xiii genes
US20030216870A1 (en) * 2002-05-07 2003-11-20 Wolber Paul K. Method and system for normalization of micro array data based on local normalization of rank-ordered, globally normalized data
JP2005524412A (en) 2002-05-08 2005-08-18 ノースウエスト バイオセラピューティクス, インコーポレイティド Quality assay for antigen-presenting cells
US7217512B2 (en) * 2002-05-09 2007-05-15 Corning Incorporated Reagent and method for attaching target molecules to a surface
EP1573056A4 (en) * 2002-05-17 2007-11-28 Nugen Technologies Inc Methods for fragmentation, labeling and immobilization of nucleic acids
MXPA04011424A (en) * 2002-05-17 2005-02-17 Baylor College Medicine Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance.
JP2005527904A (en) * 2002-05-20 2005-09-15 ロゼッタ インファーマティクス エルエルシー Computer system and method for subdividing complex diseases into constituent diseases
US20050033525A1 (en) * 2002-05-21 2005-02-10 Corson John F. Method and system for computing and applying a user-defined, global, multi-channel background correction to a feature-based data set obtained from reading a microarray
TWI221523B (en) * 2002-05-21 2004-10-01 Sony Corp Bioassay method, bioassay device, and bioassay substrate
US7221785B2 (en) * 2002-05-21 2007-05-22 Agilent Technologies, Inc. Method and system for measuring a molecular array background signal from a continuous background region of specified size
US20030220746A1 (en) * 2002-05-21 2003-11-27 Srinka Ghosh Method and system for computing and applying a global, multi-channel background correction to a feature-based data set obtained from scanning a molecular array
US20040126773A1 (en) * 2002-05-23 2004-07-01 Beske Oren E. Assays with coded sensor particles to sense assay conditions
US20030219755A1 (en) * 2002-05-24 2003-11-27 Nanibhushan Dattagupta Compositions and methods for performing hybridization assays using target enhanced signal amplification (TESA)
US6763308B2 (en) 2002-05-28 2004-07-13 Sas Institute Inc. Statistical outlier detection for gene expression microarray data
US20050239193A1 (en) * 2002-05-30 2005-10-27 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of microorganisms and microparticles
US7537936B2 (en) * 2002-05-31 2009-05-26 Agilent Technologies, Inc. Method of testing multiple fluid samples with multiple biopolymer arrays
US6806460B2 (en) * 2002-05-31 2004-10-19 Agilent Technologies, Inc. Fluorescence detection with increased dynamic range
JP4193421B2 (en) * 2002-06-06 2008-12-10 ソニー株式会社 Bioassay device, manufacturing method thereof, and bioassay method
EP1511569A1 (en) * 2002-06-13 2005-03-09 Millenium Biologix AG Reaction chamber
ATE545651T1 (en) * 2002-06-13 2012-03-15 Novartis Vaccines & Diagnostic VECTORS FOR EXPRESSING HML-2 POLYPEPTIDES
US7108976B2 (en) * 2002-06-17 2006-09-19 Affymetrix, Inc. Complexity management of genomic DNA by locus specific amplification
US9388459B2 (en) * 2002-06-17 2016-07-12 Affymetrix, Inc. Methods for genotyping
US20030231986A1 (en) * 2002-06-18 2003-12-18 Eastman Kodak Company Micro-array identification means
US7332273B2 (en) 2002-06-20 2008-02-19 Affymetrix, Inc. Antireflective coatings for high-resolution photolithographic synthesis of DNA arrays
US7144950B2 (en) 2003-09-17 2006-12-05 The Regents Of The University Of California Conformationally flexible cationic conjugated polymers
EP1534857B1 (en) 2002-06-20 2010-08-04 The Regents of The University of California Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
US7091049B2 (en) 2002-06-26 2006-08-15 Kimberly-Clark Worldwide, Inc. Enhanced diffraction-based biosensor devices
JP2004024203A (en) * 2002-06-28 2004-01-29 Canon Inc Method for analysis of rna by time-of-flight secondary ion mass spectrometry
JP4498132B2 (en) * 2002-06-28 2010-07-07 キヤノン株式会社 Manufacturing method of probe array
JP3658397B2 (en) * 2002-06-28 2005-06-08 キヤノン株式会社 Device information acquisition method and information acquisition device by time-of-flight secondary ion mass spectrometry
US20040137491A1 (en) * 2002-06-28 2004-07-15 Tadashi Okamoto Method of analyzing probe carrier using time-of-flight secondary ion mass spectrometry
EP1552003A4 (en) * 2002-06-28 2007-06-13 Rosetta Inpharmatics Llc Methods to assess quality of microarrays
US20040005769A1 (en) * 2002-07-03 2004-01-08 Cabot Microelectronics Corp. Method and apparatus for endpoint detection
DE10230320A1 (en) * 2002-07-05 2004-02-05 Marcel Rogalla Programmable illumination device for high resolution, massively parallel, spatial Systhese and analysis of microarrays
US20040009574A1 (en) * 2002-07-09 2004-01-15 Nanibhushan Dattagupta Compositions and methods for detecting streptococcus agalactiae capsular polysaccharide synthesis genes
USH2223H1 (en) 2002-07-11 2008-09-02 The United States Of America As Represented By The Secretary Of The Navy Patterned, micrometer-sized antibody features
US7504215B2 (en) 2002-07-12 2009-03-17 Affymetrix, Inc. Nucleic acid labeling methods
US20050185175A1 (en) * 2002-07-16 2005-08-25 Canos Avelino C. Rotary support and apparatus used for the multiple spectroscopic characterisation of samples of solid materials
CA2491023A1 (en) * 2002-07-19 2004-01-29 Althea Technologies, Inc. Strategies for gene expression analysis
AU2003258472A1 (en) * 2002-07-23 2004-02-25 Universitat Leipzig Method for selective peptide labeling
CA2492463A1 (en) * 2002-07-25 2004-02-05 Archemix Corporation Regulated aptamer therapeutics
US7601493B2 (en) * 2002-07-26 2009-10-13 Nanogen, Inc. Methods and apparatus for screening and detecting multiple genetic mutations
US20040018497A1 (en) * 2002-07-26 2004-01-29 Warden Craig H Human obesity LIPIN3 polynucleotide and polypeptide sequences and methods of use thereof
AU2003257040A1 (en) * 2002-07-29 2004-02-16 David P. Dumas Transparent polymer support for electrophoresis and electrochromatography and related methods
AU2003257082A1 (en) * 2002-08-02 2004-02-23 Rosetta Inpharmatics Llc Computer systems and methods that use clinical and expression quantitative trait loci to associate genes with traits
US7632916B2 (en) * 2002-08-02 2009-12-15 3M Innovative Properties Company Process to modify polymeric materials and resulting compositions
EP1540344A4 (en) * 2002-08-02 2007-02-21 Applera Corp Fluorescence polarization assay
WO2004013290A2 (en) * 2002-08-05 2004-02-12 Invitrogen Corporation Compositions and methods for molecular biology
US20060073475A1 (en) * 2002-08-09 2006-04-06 Nanibhushan Dattagupta Compositions and methods for detecting pathogenic bacteria expressing chaperonin proteins
WO2004020581A2 (en) * 2002-08-15 2004-03-11 Functional Genetics, Inc. Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
US20060099676A1 (en) * 2002-08-15 2006-05-11 Limin Li Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
US20050233473A1 (en) * 2002-08-16 2005-10-20 Zyomyx, Inc. Methods and reagents for surface functionalization
US20050118616A1 (en) * 2002-08-16 2005-06-02 Kawashima Tadashi R. Amplification of target nucleotide sequence without polymerase chain reaction
US7118865B2 (en) * 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
US7900836B2 (en) 2002-08-20 2011-03-08 Illumina, Inc. Optical reader system for substrates having an optically readable code
US7872804B2 (en) 2002-08-20 2011-01-18 Illumina, Inc. Encoded particle having a grating with variations in the refractive index
US7923260B2 (en) 2002-08-20 2011-04-12 Illumina, Inc. Method of reading encoded particles
US7267751B2 (en) * 2002-08-20 2007-09-11 Nanogen, Inc. Programmable multiplexed active biologic array
US7901630B2 (en) 2002-08-20 2011-03-08 Illumina, Inc. Diffraction grating-based encoded microparticle assay stick
US7164533B2 (en) 2003-01-22 2007-01-16 Cyvera Corporation Hybrid random bead/chip based microarray
US7508608B2 (en) 2004-11-17 2009-03-24 Illumina, Inc. Lithographically fabricated holographic optical identification element
US7473535B2 (en) * 2002-08-20 2009-01-06 The Institute For Systems Biology Chemical reagents and methods for detection and quantification of proteins in complex mixtures
US7619819B2 (en) 2002-08-20 2009-11-17 Illumina, Inc. Method and apparatus for drug product tracking using encoded optical identification elements
US8277753B2 (en) * 2002-08-23 2012-10-02 Life Technologies Corporation Microfluidic transfer pin
US20040038214A1 (en) * 2002-08-23 2004-02-26 Corson John F. Method and system for reading a molecular array
KR20050055717A (en) 2002-08-26 2005-06-13 더 리전츠 오브 더 유니버시티 오브 캘리포니아 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
US7314763B2 (en) 2002-08-27 2008-01-01 Kimberly-Clark Worldwide, Inc. Fluidics-based assay devices
US7285424B2 (en) 2002-08-27 2007-10-23 Kimberly-Clark Worldwide, Inc. Membrane-based assay devices
US7432105B2 (en) 2002-08-27 2008-10-07 Kimberly-Clark Worldwide, Inc. Self-calibration system for a magnetic binding assay
AU2003298412A1 (en) * 2002-09-03 2004-03-29 Zeptosens Ag Analytical platform and identification method
EP1561109A1 (en) * 2002-09-03 2005-08-10 Zeptosens AG Analytical platform and detection method with analytes which are to be detected in a sample in the form of immobilized specific binding partners
CA2497792C (en) 2002-09-06 2014-08-05 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
JP4588451B2 (en) * 2002-09-08 2010-12-01 アプライド バイオシステムズ, エルエルシー Methods, compositions and libraries for PNA dimer and PNA oligomer synthesis
EP1546404A2 (en) * 2002-09-11 2005-06-29 Exiqon A/S A population of nucleic acids including a subpopulation of lna oligomers
US20100255603A9 (en) 2002-09-12 2010-10-07 Putnam Martin A Method and apparatus for aligning microbeads in order to interrogate the same
US6889143B2 (en) * 2002-09-12 2005-05-03 Intergrated Dna Technologies, Inc. Methods and systems for estimating the melting temperature (TM) for polynucleotide molecules
US7563600B2 (en) 2002-09-12 2009-07-21 Combimatrix Corporation Microarray synthesis and assembly of gene-length polynucleotides
US7092160B2 (en) 2002-09-12 2006-08-15 Illumina, Inc. Method of manufacturing of diffraction grating-based optical identification element
WO2004024895A2 (en) * 2002-09-16 2004-03-25 Plexxikon, Inc. Crystal structure of pim-1 kinase
US7595883B1 (en) 2002-09-16 2009-09-29 The Board Of Trustees Of The Leland Stanford Junior University Biological analysis arrangement and approach therefor
US20050037381A1 (en) * 2002-09-16 2005-02-17 Receptors Llc Artificial receptors, building blocks, and methods
US7469076B2 (en) * 2003-09-03 2008-12-23 Receptors Llc Sensors employing combinatorial artificial receptors
US20040137481A1 (en) * 2002-09-16 2004-07-15 Receptors Llc Artificial receptor building blocks, components, and kits
US20050170385A1 (en) * 2002-09-16 2005-08-04 Receptors Llc Artificial receptors including gradients
US20050037429A1 (en) * 2003-03-28 2005-02-17 Receptors Llc Artificial receptors including reversibly immobilized building blocks and methods
US20060057625A1 (en) * 2002-09-16 2006-03-16 Carlson Robert E Scaffold-based artificial receptors and methods
WO2005003326A2 (en) * 2003-03-28 2005-01-13 Receptors Llc. Artificial receptors including reversibly immobilized building blocks and methods
US20050136483A1 (en) * 2003-09-03 2005-06-23 Receptors Llc Nanodevices employing combinatorial artificial receptors
US20050037428A1 (en) * 2002-09-16 2005-02-17 Receptors Llc Artificial receptors including reversibly immobilized building blocks, the building blocks, and methods
ES2781475T3 (en) 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Methods to increase the production of hematopoietic stem cells and platelets
WO2004028955A2 (en) 2002-09-25 2004-04-08 California Institute Of Technology Microfluidic large scale integration
US7169550B2 (en) * 2002-09-26 2007-01-30 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7498176B2 (en) * 2002-09-27 2009-03-03 Roche Nimblegen, Inc. Microarray with hydrophobic barriers
US7135288B2 (en) * 2002-09-27 2006-11-14 Ut-Battelle, Llc Combinatorial synthesis of ceramic materials
DE10245432A1 (en) 2002-09-27 2004-04-08 Micronas Gmbh Method and device for detecting at least one luminescent substance
AU2003282885A1 (en) * 2002-09-30 2004-04-23 Nimblegen Systems, Inc. Parallel loading of arrays
US20040110212A1 (en) * 2002-09-30 2004-06-10 Mccormick Mark Microarrays with visual alignment marks
CA2500783C (en) * 2002-10-01 2012-07-17 Nimblegen Systems, Inc. Microarrays having multiple oligonucleotides in single array features
US8871446B2 (en) 2002-10-02 2014-10-28 California Institute Of Technology Microfluidic nucleic acid analysis
US20040259105A1 (en) * 2002-10-03 2004-12-23 Jian-Bing Fan Multiplex nucleic acid analysis using archived or fixed samples
US7459273B2 (en) * 2002-10-04 2008-12-02 Affymetrix, Inc. Methods for genotyping selected polymorphism
US20040067492A1 (en) * 2002-10-04 2004-04-08 Allan Peng Reverse transcription on microarrays
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US20050003369A1 (en) * 2002-10-10 2005-01-06 Affymetrix, Inc. Method for depleting specific nucleic acids from a mixture
US20040120861A1 (en) * 2002-10-11 2004-06-24 Affymetrix, Inc. System and method for high-throughput processing of biological probe arrays
KR100508108B1 (en) * 2002-10-14 2005-08-18 학교법인 포항공과대학교 Method for formation of polymer pattern
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
EP1558737A4 (en) 2002-10-18 2008-06-11 Lg Life Sciences Ltd Gene families associated with cancers
EP1552025A4 (en) * 2002-10-18 2006-12-13 Cylene Pharmaceuticals Inc Processes for identifying quadruplex-targeted antiviral molecules
US20040219565A1 (en) 2002-10-21 2004-11-04 Sakari Kauppinen Oligonucleotides useful for detecting and analyzing nucleic acids of interest
US20040076961A1 (en) * 2002-10-21 2004-04-22 Lewis Mark A. Biomolecule retaining material and methods for attaching biomolecules to a surface
WO2004038042A1 (en) * 2002-10-24 2004-05-06 Ben Gao A 4-dimensional method and equipment of detecting nucleic acid hybrid pair on the gene chip
US7635564B2 (en) * 2002-10-25 2009-12-22 Agilent Technologies, Inc. Biopolymeric arrays having replicate elements
US6742843B2 (en) * 2002-10-25 2004-06-01 Knoll, Inc. Cable control with overload protection device
US20040115722A1 (en) * 2002-10-25 2004-06-17 Mel Kronick Biopolymeric arrays and methods of producing the same
EP1581654A4 (en) * 2002-10-28 2007-01-03 Invitrogen Corp Array oligomer synthesis and use
JP3447009B1 (en) * 2002-10-29 2003-09-16 實 平垣 Construct structure and method for producing the same
US7195908B2 (en) 2002-10-31 2007-03-27 Corning Incorporated Supports treated with triamine for immobilizing biomolecules
AU2003301825A1 (en) * 2002-10-31 2004-06-07 Pfizer Products, Inc. Panels of molecular targets differentially expressed during cd8+ t-cell priming
JP4571776B2 (en) * 2002-11-05 2010-10-27 Jx日鉱日石エネルギー株式会社 Lubricating oil composition
US20040086892A1 (en) * 2002-11-06 2004-05-06 Crothers Donald M. Universal tag assay
AU2002952696A0 (en) 2002-11-14 2002-11-28 Genomics Research Partners Pty Ltd Status determination
GB0226593D0 (en) * 2002-11-14 2002-12-24 Consultants Ltd Compounds
EP1579005A4 (en) * 2002-11-15 2007-07-25 Sangamo Biosciences Inc Methods and compositions for analysis of regulatory sequences
AU2003298655A1 (en) 2002-11-15 2004-06-15 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
WO2004046691A2 (en) * 2002-11-18 2004-06-03 Genospectra, Inc. Uncaging devices
EP1420248A3 (en) * 2002-11-18 2004-05-26 Schott Glas Validated design for microarrays
US7250289B2 (en) * 2002-11-20 2007-07-31 Affymetrix, Inc. Methods of genetic analysis of mouse
US7314750B2 (en) * 2002-11-20 2008-01-01 Affymetrix, Inc. Addressable oligonucleotide array of the rat genome
US7781172B2 (en) 2003-11-21 2010-08-24 Kimberly-Clark Worldwide, Inc. Method for extending the dynamic detection range of assay devices
MXPA05005398A (en) * 2002-11-22 2006-03-09 Univ Johns Hopkins Target for therapy of cognitive impairment.
EP2112229A3 (en) 2002-11-25 2009-12-02 Sequenom, Inc. Methods for identifying risk of breast cancer and treatments thereof
US20040101861A1 (en) * 2002-11-27 2004-05-27 Little Roger G. Resonant cavity photodiode array for rapid DNA microarray readout
EP1424599B1 (en) * 2002-11-29 2008-03-12 ASML Netherlands B.V. Lithographic apparatus and device manufacturing method
TWI255971B (en) * 2002-11-29 2006-06-01 Asml Netherlands Bv Lithographic apparatus and device manufacturing method
US20040109045A1 (en) * 2002-12-06 2004-06-10 Eastman Kodak Company Print head for micro-deposition of bio-molecules
AU2003296326A1 (en) 2002-12-09 2004-06-30 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
US20040259111A1 (en) * 2002-12-10 2004-12-23 Rosetta Inpharmatics Llc Automated system and method for preparing an assay ready biological sample
US20040115654A1 (en) * 2002-12-16 2004-06-17 Intel Corporation Laser exposure of photosensitive masks for DNA microarray fabrication
US7247500B2 (en) 2002-12-19 2007-07-24 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in membrane-based assay devices
AU2003299441A1 (en) * 2002-12-19 2004-07-14 Centre National De La Recherche Scientifique - Cnrs Nf-hev compositions and methods of use
US20040120859A1 (en) * 2002-12-20 2004-06-24 Kocher Thomas E. Biomolecular micro-deposition system
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US20060094108A1 (en) * 2002-12-20 2006-05-04 Karl Yoder Thermal cycler for microfluidic array assays
US7682565B2 (en) 2002-12-20 2010-03-23 Biotrove, Inc. Assay apparatus and method using microfluidic arrays
WO2004058946A2 (en) * 2002-12-22 2004-07-15 The Scripps Research Institute Protein arrays
US20040180368A1 (en) * 2002-12-23 2004-09-16 Affymetrix, Inc. Method for producing a high density nucleic acid array using activators
US7541152B2 (en) * 2002-12-24 2009-06-02 Agilent Technologies, Inc. Integrated light source for diagnostic arrays
US20040126766A1 (en) * 2002-12-26 2004-07-01 Amorese Douglas A. Breakaway seal for processing a subarray of an array
WO2004061616A2 (en) 2002-12-27 2004-07-22 Rosetta Inpharmatics Llc Computer systems and methods for associating genes with traits using cross species data
US6977153B2 (en) * 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
WO2004060044A2 (en) * 2003-01-02 2004-07-22 Bioforce Nanosciences, Inc. Method and apparatus for molecular analysis in small sample volumes
DE602004015932D1 (en) * 2003-01-13 2008-10-02 Univ Michigan METHOD FOR FORMING A PROTEIN MICROARRAY SYSTEM
CA2658334C (en) * 2003-01-16 2012-07-10 Caprotec Bioanalytics Gmbh Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
KR100994566B1 (en) * 2003-01-20 2010-11-15 삼성전자주식회사 An array device comprising a photoresist film having immobilization regions and a method using the same
US7996155B2 (en) 2003-01-22 2011-08-09 Microsoft Corporation ANOVA method for data analysis
WO2004067191A2 (en) 2003-01-29 2004-08-12 President And Fellows Of Harward College Alteration of surface affinities
US7575865B2 (en) * 2003-01-29 2009-08-18 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
ES2342665T3 (en) 2003-01-29 2010-07-12 454 Corporation SEQUENCING FROM TWO EXTREME.
US20050048573A1 (en) * 2003-02-03 2005-03-03 Plexxikon, Inc. PDE5A crystal structure and uses
US20040157220A1 (en) 2003-02-10 2004-08-12 Purnima Kurnool Methods and apparatus for sample tracking
EP1599165A4 (en) 2003-02-10 2010-09-08 Univ Jefferson The use of gcc ligands
EP1599609B1 (en) 2003-02-13 2009-11-11 The Regents of The University of California Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores
US7767387B2 (en) * 2003-06-13 2010-08-03 Sagres Discovery, Inc. Therapeutic targets in cancer
US20040170982A1 (en) * 2003-02-14 2004-09-02 Morris David W. Novel therapeutic targets in cancer
US20070218071A1 (en) * 2003-09-15 2007-09-20 Morris David W Novel therapeutic targets in cancer
US20070149449A1 (en) 2003-02-14 2007-06-28 Morris David W Therapeutic targets in cancer
US7192703B2 (en) * 2003-02-14 2007-03-20 Intel Corporation, Inc. Biomolecule analysis by rolling circle amplification and SERS detection
US20050014249A1 (en) * 2003-02-21 2005-01-20 Norbert Staimer Chromatographic analysis on optical bio-discs and methods relating thereto
US7759513B2 (en) * 2003-02-21 2010-07-20 Nigu Chemie Gmbh Photolabile protective groups for improved processes to prepare oligonucleotide arrays
US20040166495A1 (en) * 2003-02-24 2004-08-26 Greinwald John H. Microarray-based diagnosis of pediatric hearing impairment-construction of a deafness gene chip
EP2365095A1 (en) 2003-02-26 2011-09-14 Callida Genomics, Inc. Random array DNA analysis by hybridization
US20060183132A1 (en) * 2005-02-14 2006-08-17 Perlegen Sciences, Inc. Selection probe amplification
US20090124514A1 (en) * 2003-02-26 2009-05-14 Perlegen Sciences, Inc. Selection probe amplification
JP2007524374A (en) * 2003-02-28 2007-08-30 プレキシコン,インコーポレーテッド PYK2 crystal structure and use
EP2194133B1 (en) 2003-03-06 2015-12-02 BASF Enzymes LLC Amylases, nucleic acids encoding them and methods for making and using them
US20040235019A1 (en) * 2003-03-06 2004-11-25 Agouron Pharmaceuticals, Inc. Diagnostics and therapeutics for the gene expression signature of PPAR-gamma receptor ligand
MX295545B (en) 2003-03-07 2012-02-03 Diversa Corp Hydrolases, nucleic acids encoding them and mehods for making and using them.
US6970240B2 (en) * 2003-03-10 2005-11-29 Applera Corporation Combination reader
FR2852317B1 (en) 2003-03-13 2006-08-04 PROBE BIOPUCES AND METHODS OF USE
JP2004279196A (en) * 2003-03-14 2004-10-07 Dainippon Printing Co Ltd Substrate for bio-micro-array and bio-micro-array
US20040235022A1 (en) * 2003-03-19 2004-11-25 Ralf Mauritz Quality control method for manufacturing biopolymer arrays
US20040248287A1 (en) * 2003-03-28 2004-12-09 Qianjin Hu Multi-array systems and methods of use thereof
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US8043834B2 (en) 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
US20040191782A1 (en) * 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
EP1473085B1 (en) * 2003-03-31 2015-07-22 Canon Kabushiki Kaisha Biochemical reaction cartridge
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
EP1473084B1 (en) * 2003-03-31 2015-07-29 Canon Kabushiki Kaisha Biochemical reaction cartridge
DE10315074A1 (en) * 2003-04-02 2004-10-14 Clondiag Chip Technologies Gmbh Device for the duplication and detection of nucleic acids
US7666361B2 (en) 2003-04-03 2010-02-23 Fluidigm Corporation Microfluidic devices and methods of using same
US7604965B2 (en) 2003-04-03 2009-10-20 Fluidigm Corporation Thermal reaction device and method for using the same
US7851209B2 (en) 2003-04-03 2010-12-14 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in assay devices
US20040197819A1 (en) 2003-04-03 2004-10-07 Kimberly-Clark Worldwide, Inc. Assay devices that utilize hollow particles
MXPA05010681A (en) 2003-04-04 2005-12-15 Diversa Corp Pectate lyases, nucleic acids encoding them and methods for making and using them.
CA2463719A1 (en) * 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Nucleotide analogs with six membered rings
US7833714B1 (en) 2003-04-11 2010-11-16 Affymetrix, Inc. Combinatorial affinity selection
CA2521084A1 (en) 2003-04-14 2004-10-28 Nugen Technologies, Inc. Global amplification using a randomly primed composite primer
WO2004090161A1 (en) 2003-04-14 2004-10-21 Novartis Ag Gene expression associated with osteoblast differentiation
US20040210036A1 (en) * 2003-04-15 2004-10-21 Nanogen, Inc. Peptide substrate libraries
US8652774B2 (en) * 2003-04-16 2014-02-18 Affymetrix, Inc. Automated method of manufacturing polyer arrays
ES2328640T3 (en) 2003-04-18 2009-11-16 Biogen Idec Ma Inc. NEUBLASTIN CONJUGATED WITH A GLYCOSILATED POLYMER.
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20070042349A1 (en) * 2003-04-24 2007-02-22 Ogle Brenda M Methods for assessing biologic diversity
WO2004097371A2 (en) * 2003-04-25 2004-11-11 Board Of Regents, The University Of Texas System System and method for the detection of analytes
AU2004235298A1 (en) * 2003-04-25 2004-11-11 Janssen Pharmaceutica N.V. Preservation of RNA in a biological sample
US8435492B2 (en) * 2003-05-02 2013-05-07 University Of Western Ontario Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
GB0310270D0 (en) * 2003-05-03 2003-06-11 Univ Edinburgh Biomolecular devices
US7709610B2 (en) 2003-05-08 2010-05-04 Facet Biotech Corporation Therapeutic use of anti-CS1 antibodies
US20050136395A1 (en) * 2003-05-08 2005-06-23 Affymetrix, Inc Methods for genetic analysis of SARS virus
US20050025763A1 (en) 2003-05-08 2005-02-03 Protein Design Laboratories, Inc. Therapeutic use of anti-CS1 antibodies
WO2004101808A2 (en) * 2003-05-09 2004-11-25 Sigma-Aldrich Co. Genomic and proteomic approaches for the development of cell culture medium
US20070037140A1 (en) * 2003-05-09 2007-02-15 Capital Biochip Company, Ltd. Methods and compositions for detecting sars virus
US20090005257A1 (en) 2003-05-14 2009-01-01 Jespers Laurent S Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire
US9317922B2 (en) 2003-05-16 2016-04-19 Board Of Regents The University Of Texas System Image and part recognition technology
US8609830B2 (en) * 2003-05-16 2013-12-17 Merck Sharp & Dohme Corp. Methods and compositions for RNA interference
WO2004104922A2 (en) * 2003-05-16 2004-12-02 Board Of Regents, The University Of Texas System Image and part recognition technology
SE527896C2 (en) * 2003-05-20 2006-07-04 Aamic Ab Optical test device for biological samples, as well as a microarray for the device and the method for its use
JP3898198B2 (en) * 2003-05-22 2007-03-28 韓国科学技術院 Nanoarray fabrication method using organic supramolecular self-assembly and metal chemisorption
WO2005020784A2 (en) * 2003-05-23 2005-03-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
BRPI0410636A (en) * 2003-05-23 2006-07-18 Cold Spring Harbor Lab virtual representation of nucleotide sequences
US20040241657A1 (en) * 2003-05-28 2004-12-02 Perlegen Sciences, Inc. Liver related disease compositions and methods
US20040241659A1 (en) * 2003-05-30 2004-12-02 Applera Corporation Apparatus and method for hybridization and SPR detection
US7729864B2 (en) 2003-05-30 2010-06-01 Merck Sharp & Dohme Corp. Computer systems and methods for identifying surrogate markers
FR2855832B1 (en) * 2003-06-03 2007-09-14 Biomerieux Sa DIAGNOSTIC AND / OR PROGNOSTIC METHOD OF SEPTIC SYNDROME
KR100549103B1 (en) * 2003-06-05 2006-02-06 한국과학기술원 Method for Fabricating a Carbon Nanotube Array
US20040248323A1 (en) 2003-06-09 2004-12-09 Protometrix, Inc. Methods for conducting assays for enzyme activity on protein microarrays
CA3084542A1 (en) 2003-06-10 2005-01-06 The Trustees Of Boston University Gene expression analysis of airway epithelial cells for diagnosing lung cancer
ES2645437T3 (en) 2003-06-12 2017-12-05 Accupath Diagnostic Laboratories, Inc. Method and system for the analysis of high density cell samples
US8133670B2 (en) 2003-06-13 2012-03-13 Cold Spring Harbor Laboratory Method for making populations of defined nucleic acid molecules
US20050064462A1 (en) * 2003-06-17 2005-03-24 Bernd Stein Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
JP4367901B2 (en) * 2003-06-20 2009-11-18 キヤノン株式会社 Spotter with spot pattern encryption function and detection device that supports spot pattern encryption
US20040259100A1 (en) 2003-06-20 2004-12-23 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
US7632652B2 (en) * 2003-06-24 2009-12-15 Ventana Medical Systems, Inc. Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
US7642064B2 (en) * 2003-06-24 2010-01-05 Ventana Medical Systems, Inc. Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
EP1644184A2 (en) * 2003-06-27 2006-04-12 Nagaoka & Co., Ltd. Fluidic circuits, methods and apparatus for use of whole blood samples in colorimetric assays
JP2007528707A (en) * 2003-06-30 2007-10-18 マサチューセッツ インスティテュート オブ テクノロジー EGR gene as a target for diagnosis and treatment of schizophrenia
CN100494399C (en) * 2003-06-30 2009-06-03 清华大学 Genotype typing method based on DNA chip and use thereof
US7534563B2 (en) * 2003-06-30 2009-05-19 Agilent Technologies, Inc. Methods for producing ligand arrays
US7960148B2 (en) 2003-07-02 2011-06-14 Verenium Corporation Glucanases, nucleic acids encoding them and methods for making and using them
US20050079548A1 (en) * 2003-07-07 2005-04-14 Plexxikon, Inc. Ligand development using PDE4B crystal structures
FR2857375B1 (en) * 2003-07-10 2007-11-09 Biomerieux Sa PROCESS FOR THE DETECTION AND / OR IDENTIFICATION OF STAPHYLOCOCCUS GENE BACTERIA
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US7341841B2 (en) 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
CA2532414C (en) 2003-07-12 2017-03-14 Accelr8 Technology Corporation Sensitive and rapid biodetection
WO2005007678A2 (en) * 2003-07-14 2005-01-27 Irm Llc Methods for the preparation of rhodamine
WO2005007663A2 (en) * 2003-07-14 2005-01-27 Irm Llc Fluorogenic enzyme substrates and uses thereof
US20050019944A1 (en) * 2003-07-23 2005-01-27 Eastman Kodak Company Colorable microspheres for DNA and protein microarray
US7545494B2 (en) * 2003-07-23 2009-06-09 Bayer Technology Services Gmbh Analytical system and method for analyzing nonlinear optical signals
EP1654361B2 (en) 2003-07-25 2023-01-18 Life Technologies Corporation Methods and compositions for preparing rna from a fixed sample
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
WO2005017652A2 (en) * 2003-08-05 2005-02-24 Rosetta Inpharmatics, Llc Computer systems and methods for inferring causality from cellular constituent abundance data
US8114978B2 (en) * 2003-08-05 2012-02-14 Affymetrix, Inc. Methods for genotyping selected polymorphism
US20050100911A1 (en) * 2003-08-06 2005-05-12 Perlegen Sciences, Inc. Methods for enriching populations of nucleic acid samples
US7317415B2 (en) 2003-08-08 2008-01-08 Affymetrix, Inc. System, method, and product for scanning of biological materials employing dual analog integrators
WO2005021714A2 (en) 2003-08-11 2005-03-10 Diversa Corporation Laccases, nucleic acids encoding them and methods for making and using them
WO2005017807A2 (en) * 2003-08-13 2005-02-24 Iconix Pharmaceuticals, Inc. Apparatus and method for classifying multi-dimensional biological data
CN1580283A (en) * 2003-08-13 2005-02-16 清华大学 Method for detecting nucleic acid molecule
KR100561842B1 (en) * 2003-08-25 2006-03-16 삼성전자주식회사 A composition containing a photoacid generator monomer, a substrate coated with the composition, method for synthesizing a compound on a substrate using the composition and a microarray produced by the method
DK1675606T3 (en) * 2003-08-28 2017-06-19 Janssen Pharmaceuticals Inc Peptides and compound that bind to thrombopoietin receptors
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
US7217582B2 (en) 2003-08-29 2007-05-15 Rochester Institute Of Technology Method for non-damaging charge injection and a system thereof
US7287328B2 (en) 2003-08-29 2007-10-30 Rochester Institute Of Technology Methods for distributed electrode injection
JP3824233B2 (en) * 2003-09-01 2006-09-20 セイコーエプソン株式会社 Biosensor and biosensor manufacturing method
US20050095627A1 (en) * 2003-09-03 2005-05-05 The Salk Institute For Biological Studies Multiple antigen detection assays and reagents
EP1664762A4 (en) 2003-09-03 2008-08-13 Us Gov Health & Human Serv Methods for identifying, diagnosing, and predicting survival of lymphomas
US8131475B2 (en) 2003-09-03 2012-03-06 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods for identifying, diagnosing, and predicting survival of lymphomas
US7269517B2 (en) * 2003-09-05 2007-09-11 Rosetta Inpharmatics Llc Computer systems and methods for analyzing experiment design
US20050053949A1 (en) * 2003-09-08 2005-03-10 Silin Vitalii Ivanovich Biochip for proteomics applications
EP2325339A3 (en) 2003-09-09 2011-11-02 Integrigen, Inc. Methods and compositions for generation of germline human antibody genes
US7365179B2 (en) * 2003-09-09 2008-04-29 Compass Genetics, Llc Multiplexed analytical platform
US7824856B2 (en) * 2003-09-10 2010-11-02 Althea Technologies, Inc. Expression profiling using microarrays
GB0321295D0 (en) * 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
US20050208468A1 (en) * 2003-09-15 2005-09-22 Beske Oren E Assays with primary cells
US20050164300A1 (en) * 2003-09-15 2005-07-28 Plexxikon, Inc. Molecular scaffolds for kinase ligand development
US7488451B2 (en) * 2003-09-15 2009-02-10 Millipore Corporation Systems for particle manipulation
WO2005029705A2 (en) 2003-09-18 2005-03-31 Bioarray Solutions, Ltd. Number coding for identification of subtypes of coded types of solid phase carriers
EP1685380A2 (en) * 2003-09-18 2006-08-02 Parallele Bioscience, Inc. System and methods for enhancing signal-to-noise ratios of microarray-based measurements
US7317521B2 (en) * 2003-09-18 2008-01-08 Micron Technology, Inc. Particle detection method
WO2005040427A2 (en) * 2003-09-19 2005-05-06 Decode Genetics Ehf. Inversion on chromosome 8p23 is a risk factor for anxiety disorders, depression and bipolar
US20050233472A1 (en) * 2003-09-19 2005-10-20 Kao H P Spotting high density plate using a banded format
US20050226771A1 (en) * 2003-09-19 2005-10-13 Lehto Dennis A High speed microplate transfer
NZ546072A (en) 2003-09-22 2009-08-28 Bioarray Solutions Ltd Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
WO2005030140A2 (en) 2003-09-26 2005-04-07 Exelixis, Inc. C-met modulators and methods of use
JP4261546B2 (en) * 2003-09-26 2009-04-30 三菱レイヨン株式会社 Electrophoresis apparatus and electrophoresis method
JP4111223B2 (en) * 2003-09-26 2008-07-02 株式会社ニコン Environmental maintenance device and environmental control analyzer
KR20060120063A (en) 2003-09-29 2006-11-24 패스워크 인포메틱스 아이엔씨 Systems and methods for detecting biological features
US20070281896A1 (en) * 2003-09-30 2007-12-06 Morris David W Novel compositions and methods in cancer
FR2860518B1 (en) * 2003-10-01 2006-02-17 Biomerieux Sa METHOD FOR THE DIAGNOSIS / PROGNOSIS OF NEUROBLASTOMA
DE10346286B3 (en) 2003-10-06 2005-04-14 J. Eberspächer GmbH & Co. KG The exhaust purification device
PT2157192E (en) 2003-10-10 2013-11-28 Deutsches Krebsforsch Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins)
US20070274988A1 (en) * 2003-10-10 2007-11-29 Five Prime Therapeautics, Inc. Kiaa0779, Splice Variants Thereof, and Methods of Their Use
US20050227251A1 (en) 2003-10-23 2005-10-13 Robert Darnell Method of purifying RNA binding protein-RNA complexes
WO2005040163A1 (en) * 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
WO2005042763A2 (en) 2003-10-28 2005-05-12 Bioarray Solutions Ltd. Optimization of gene expression analysis using immobilized capture probes
EP1694859B1 (en) 2003-10-29 2015-01-07 Bioarray Solutions Ltd Multiplexed nucleic acid analysis by fragmentation of double-stranded dna
CA2544178A1 (en) * 2003-10-30 2005-05-19 Tufts-New England Medical Center Prenatal diagnosis using cell-free fetal dna in amniotic fluid
US20050095600A1 (en) * 2003-10-31 2005-05-05 Xiang Yu Methods of generating gene-specific probes for nucleic acid array detection
US20050095578A1 (en) * 2003-10-31 2005-05-05 Koller Manfred R. Method and apparatus for cell permeabilization
WO2005042716A2 (en) * 2003-10-31 2005-05-12 President And Fellows Of Harvard College Nucleic acid binding oligonucleotides
US20070212687A1 (en) * 2003-11-04 2007-09-13 Martin Dugas Method For Distinguishing Mll-Ptd-Positive Aml From Other Aml Subtypes
EP1682900A2 (en) * 2003-11-04 2006-07-26 Roche Diagnostics GmbH METHOD FOR DISTINGUISHING T(11q23)/MLL-POSITIVE LEUKEMIAS FROM T(11q23)MLL NEGATIVE LEUKEMIAS
WO2005045437A2 (en) * 2003-11-04 2005-05-19 Roche Diagnostics Gmbh Method for distinguishing immunologically defined all subtypes
US20070105118A1 (en) * 2003-11-04 2007-05-10 Martin Dugas Method for distinguishing aml subtypes with recurring genetic aberrations
WO2005043167A2 (en) * 2003-11-04 2005-05-12 Roche Diagnostic Gmbh Method for distinguishing aml subtypes with differents gene dosages
WO2005043168A2 (en) * 2003-11-04 2005-05-12 Roche Diagnostics Gmbh Method for distinguishing aml-specific flt3 length mutations from tkd mutations
US20050287668A1 (en) * 2003-11-04 2005-12-29 Cell Therapeutics, Inc. (Cti) RNA interference compositions and screening methods for the identification of novel genes and biological pathways
US20070099190A1 (en) * 2003-11-04 2007-05-03 Martin Dugas Method for distinguishing leukemia subtypes
EP1530046A1 (en) * 2003-11-04 2005-05-11 Ludwig-Maximilians-Universität München Method for distinguishing AML subtypes with aberrant and prognostically intermediate karyotypes
EP1533618A1 (en) * 2003-11-04 2005-05-25 Ludwig-Maximilians-Universität München Method for distinguishing prognostically definable AML
US20070212688A1 (en) * 2003-11-04 2007-09-13 Martin Dugas Method For Distinguishing Cbf-Positive Aml Subtypes From Cbf-Negative Aml Subtypes
WO2005047881A2 (en) * 2003-11-05 2005-05-26 Exact Sciences Corporation Repetitive reversed-field affinity electrophoresis and uses therefor
EP1694869A2 (en) * 2003-11-10 2006-08-30 Investigen, Inc. Methods of preparing nucleic acid for detection
US7169560B2 (en) * 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
WO2005049848A2 (en) * 2003-11-12 2005-06-02 Geneohm Sciences, Inc. Nucleic acid hybridization methods
US8367324B2 (en) * 2003-11-17 2013-02-05 Canon Kabushiki Kaisha Method for judging change in probe-bearing substrate, probe-bearing substrate and detecting apparatus
KR100543705B1 (en) * 2003-11-20 2006-01-20 삼성전자주식회사 A microarray comprising a substrate formed with two dimensional grating and method for detecting a target molecule by using the same
US7713748B2 (en) 2003-11-21 2010-05-11 Kimberly-Clark Worldwide, Inc. Method of reducing the sensitivity of assay devices
US20050112703A1 (en) 2003-11-21 2005-05-26 Kimberly-Clark Worldwide, Inc. Membrane-based lateral flow assay devices that utilize phosphorescent detection
US7943395B2 (en) 2003-11-21 2011-05-17 Kimberly-Clark Worldwide, Inc. Extension of the dynamic detection range of assay devices
KR100580631B1 (en) * 2003-11-22 2006-05-16 삼성전자주식회사 A substrate having an oxide layer, method for detecting a target substance using the same and optical sensor containing the same
US7456968B2 (en) * 2003-11-24 2008-11-25 General Electric Company Sensor system and methods for improved quantitation of environmental parameters
US20050112587A1 (en) * 2003-11-25 2005-05-26 Sherrill James V. Analyzing biological probes
GB2424887B (en) 2003-11-26 2008-05-21 Univ Massachusetts Sequence-specific inhibition of small RNA function
EP1709198B1 (en) 2003-11-26 2013-08-14 AdvanDx, Inc. Peptide nucleic acid probes for analysis of certain staphylococcus species
EP2287341B1 (en) 2003-12-01 2013-02-13 Life Technologies Corporation Nucleic acid molecules containing recombination sites and methods of using the same
WO2005055804A2 (en) * 2003-12-02 2005-06-23 Musc Foundation For Research Development Methods and compositions for diagnosing epithelial cell cancer
KR100695123B1 (en) * 2003-12-03 2007-03-14 삼성전자주식회사 Polynucleotide microarray comprising 2 or more groups of probe polynucleotide immobilized on a substrate in accordance with Tm and method for detecting a target polynucleotide
US20050169816A1 (en) * 2003-12-15 2005-08-04 Kirshner Brian M. Automated oligomer synthesis
JP2005173484A (en) * 2003-12-15 2005-06-30 Canon Inc Image forming apparatus and process cartridge
US20050136538A1 (en) * 2003-12-17 2005-06-23 Srikant Pathak Lithographic method for attaching biological cells to a solid substrate using a small molecule linker
KR100601936B1 (en) * 2003-12-17 2006-07-14 삼성전자주식회사 A patch for microarray reaction chamber having adhesive means support and two or more adhesion materials
US7943089B2 (en) 2003-12-19 2011-05-17 Kimberly-Clark Worldwide, Inc. Laminated assay devices
JP5138938B2 (en) 2003-12-19 2013-02-06 プレキシコン インコーポレーテッド Compounds and methods for the development of RET modulators
US20070066641A1 (en) * 2003-12-19 2007-03-22 Prabha Ibrahim Compounds and methods for development of RET modulators
EP1547678B1 (en) * 2003-12-22 2016-07-13 Affymetrix, Inc. Process for high-yield synthesis of nucleic acid arrays
EP1711618B1 (en) 2003-12-23 2010-08-04 Mount Sinai Hospital Corporation Methods for detecting markers associated with endometrial disease or phase
AU2004311882A1 (en) 2003-12-29 2005-07-21 Nugen Technologies, Inc. Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
WO2005067649A2 (en) * 2004-01-08 2005-07-28 The Ohio State University Use of databases to create gene expression microarrays
KR100580642B1 (en) * 2004-01-12 2006-05-16 삼성전자주식회사 A method for immobilizing a biomolecule to a solid substrate at a high density by using a substrate having an activated carboxyl group at the surface thereof and microarray produced using the same
EP1711517A4 (en) 2004-01-21 2008-02-13 Univ Utah Res Found MUTANT SODIUM CHANNEL NAv1.7 AND METHODS RELATED THERETO
US20080113874A1 (en) * 2004-01-23 2008-05-15 The Regents Of The University Of Colorado Gefitinib sensitivity-related gene expression and products and methods related thereto
US8017321B2 (en) * 2004-01-23 2011-09-13 The Regents Of The University Of Colorado, A Body Corporate Gefitinib sensitivity-related gene expression and products and methods related thereto
WO2005073894A2 (en) * 2004-01-26 2005-08-11 Nimblegen Systems, Inc. Computer software to assist in identifying snps with microarrays
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
EP1713936B1 (en) * 2004-02-12 2009-12-09 Population Genetics Technologies Ltd Corporation of Great Britain Genetic analysis by sequence-specific sorting
US20050272059A1 (en) * 2004-02-12 2005-12-08 Xiaolian Gao Method for providing microarrays
JP4464158B2 (en) * 2004-02-13 2010-05-19 キヤノン株式会社 Biochemical reaction cartridge
KR100580644B1 (en) 2004-02-16 2006-05-16 삼성전자주식회사 A method for noncovalently immobilizing a biomolecule on a solid substrate and a microarray produced by the same
US20060228714A1 (en) * 2004-02-17 2006-10-12 Dana Farber Cancer Institute Nucleic acid representations utilizing type IIB restriction endonuclease cleavage products
US20050191682A1 (en) 2004-02-17 2005-09-01 Affymetrix, Inc. Methods for fragmenting DNA
US7433123B2 (en) 2004-02-19 2008-10-07 Illumina, Inc. Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein
US8581308B2 (en) 2004-02-19 2013-11-12 Rochester Institute Of Technology High temperature embedded charge devices and methods thereof
WO2005080605A2 (en) 2004-02-19 2005-09-01 Helicos Biosciences Corporation Methods and kits for analyzing polynucleotide sequences
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
EP2388017B1 (en) 2004-02-24 2014-12-24 The General Hospital Corporation Catalytic radiofluorination
US20050266432A1 (en) * 2004-02-26 2005-12-01 Illumina, Inc. Haplotype markers for diagnosing susceptibility to immunological conditions
US20060046258A1 (en) * 2004-02-27 2006-03-02 Lapidus Stanley N Applications of single molecule sequencing
US7981616B2 (en) * 2004-02-27 2011-07-19 Musc Foundation For Research Development Enhanced detection of RNA using a panel of truncated gene-specific primers for reverse transcription
US20050209785A1 (en) * 2004-02-27 2005-09-22 Wells Martin D Systems and methods for disease diagnosis
EP1733055A4 (en) * 2004-02-27 2009-03-11 Harvard College Polynucleotide synthesis
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
GB0404578D0 (en) * 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
WO2005085848A1 (en) * 2004-03-04 2005-09-15 Ryoichi Imanaka Microarray and spotting apparatus
KR100590550B1 (en) * 2004-03-12 2006-06-19 삼성전자주식회사 A microarray having probe polynucleotide spots binding to a same target polynucleotide fragment maximally apart therebetween and a method of producing the same
CA2559171A1 (en) 2004-03-12 2005-09-29 Biotrove, Inc. Nanoliter array loading
US7425426B2 (en) 2004-03-15 2008-09-16 Cyntellect, Inc. Methods for purification of cells based on product secretion
JP4202391B2 (en) * 2004-03-17 2008-12-24 パナソニック株式会社 Biochip manufacturing method, probe solution, and biochip
JP4850061B2 (en) * 2004-03-18 2012-01-11 日水製薬株式会社 Antigen analyzer manufacturing method and analyzer
ES2381644T3 (en) 2004-03-24 2012-05-30 Tripath Imaging, Inc. Methods and compositions for the detection of cervical diseases
US20050269523A1 (en) * 2004-03-24 2005-12-08 Macaulay Calum E Light modulated microarray reader and methods relating thereto
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7265366B2 (en) * 2004-03-31 2007-09-04 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
ATE524561T1 (en) * 2004-04-06 2011-09-15 Sinai School Medicine METHOD FOR DETERMINING ALLERGEN RESPONSE USING MICROARRAY IMMUNOASSAY TECHNIQUES
CA2562285A1 (en) * 2004-04-08 2006-03-16 Nimblegen Systems, Inc. Comparative genomic resequencing
KR100624420B1 (en) * 2004-04-10 2006-09-19 삼성전자주식회사 A microarray having microarray identification information stored in the form of a spot, method of producing the microarray and method of using the microarray
US20050226535A1 (en) * 2004-04-13 2005-10-13 Srinka Ghosh Method and system for rectilinearizing an image of a microarray having a non-rectilinear feature arrangement
US20050260653A1 (en) * 2004-04-14 2005-11-24 Joshua Labaer Nucleic-acid programmable protein arrays
US20050239085A1 (en) * 2004-04-23 2005-10-27 Buzby Philip R Methods for nucleic acid sequence determination
US20080248465A1 (en) * 2004-04-26 2008-10-09 Uab Research Foundation Polymorphisms in the Fcgr2b Promoter and Uses Thereof
WO2006001896A2 (en) * 2004-04-26 2006-01-05 Iconix Pharmaceuticals, Inc. A universal gene chip for high throughput chemogenomic analysis
US20050244984A1 (en) * 2004-04-28 2005-11-03 Parker Russell A Methods and compositions for calibrating chemical array readers
KR100580649B1 (en) 2004-04-30 2006-05-16 삼성전자주식회사 A polynucleotide probe having enhanced binding specificity a microarray having the probe immobilized thereon and a method for designing the probe
WO2005107412A2 (en) * 2004-04-30 2005-11-17 Rosetta Inpharmatics Llc Systems and methods for reconstruction gene networks in segregating populations
US20050250108A1 (en) * 2004-05-04 2005-11-10 Jose Remacle Preparation method and use of micro-arrays supports for detection of multiple polynucleotide sequences with high sensitivity
DE102004021904B4 (en) * 2004-05-04 2011-08-18 Carl Zeiss Microlmaging GmbH, 07745 Method and device for generating an analysis arrangement with discrete, separate measurement ranges for biological, biochemical or chemical analysis
DE102005052713A1 (en) 2005-11-04 2007-05-16 Clondiag Chip Tech Gmbh Apparatus and method for detecting molecular interactions
DE102004022263A1 (en) 2004-05-06 2005-12-15 Clondiag Chip Technologies Gmbh Apparatus and method for detecting molecular interactions
JP2008503446A (en) 2004-05-06 2008-02-07 プレキシコン,インコーポレーテッド PDE4B inhibitor and use thereof
WO2005111242A2 (en) * 2004-05-10 2005-11-24 Parallele Bioscience, Inc. Digital profiling of polynucleotide populations
WO2006025879A2 (en) * 2004-05-11 2006-03-09 Wyeth Novel polynucleotides related to oligonucleotide arrays to monitor gene expression
US8135595B2 (en) 2004-05-14 2012-03-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Computer systems and methods for providing health care
JP5149622B2 (en) * 2004-05-20 2013-02-20 クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド Single label comparative hybridization
EP2093569A3 (en) 2004-05-21 2009-11-11 The Institute for Systems Biology Compositions and methods for quantification of serum glycoproteins
US20050260609A1 (en) * 2004-05-24 2005-11-24 Lapidus Stanley N Methods and devices for sequencing nucleic acids
US7476734B2 (en) 2005-12-06 2009-01-13 Helicos Biosciences Corporation Nucleotide analogs
DE602005027700D1 (en) 2004-05-25 2011-06-09 Helicos Biosciences Corp PROCESS FOR NUCLEIC ACID IMMOBILIZATION
US20090215192A1 (en) * 2004-05-27 2009-08-27 Stratos Biosystems, Llc Solid-phase affinity-based method for preparing and manipulating an analyte-containing solution
JP5422120B2 (en) * 2004-05-27 2014-02-19 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイト Methods for predicting clinical outcome for epidermal growth factor receptor inhibitors by cancer patients
EP2471922A1 (en) 2004-05-28 2012-07-04 Asuragen, Inc. Methods and compositions involving microRNA
US7302348B2 (en) 2004-06-02 2007-11-27 Agilent Technologies, Inc. Method and system for quantifying and removing spatial-intensity trends in microarray data
US7338763B2 (en) * 2004-06-02 2008-03-04 Eppendorf Array Technologies S.A. Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays
EP2270034A3 (en) 2004-06-03 2011-06-01 Athlomics Pty Ltd Agents and methods for diagnosing stress
JP3952042B2 (en) * 2004-06-07 2007-08-01 ソニー株式会社 Hybridization detection unit including an electrode having a concave portion and a DNA chip including the detection unit
US8273579B2 (en) * 2004-06-08 2012-09-25 Bizpac (Australia) Pty. Ltd. Method and apparatus for inspecting biological samples
WO2005124650A2 (en) * 2004-06-10 2005-12-29 Iconix Pharmaceuticals, Inc. Sufficient and necessary reagent sets for chemogenomic analysis
KR100634505B1 (en) * 2004-06-16 2006-10-16 삼성전자주식회사 A substrate for microarray and a microarray having a patterned thin layer and a method for producing the substrate for microarray and the microarray
ES2461857T3 (en) 2004-06-16 2014-05-21 Dsm Ip Assets B.V. Compositions and methods for enzymatic discoloration of chlorophyll
CA2570817A1 (en) * 2004-06-17 2006-01-26 Plexxikon, Inc. Azaindoles modulating c-kit activity and uses therefor
US7498342B2 (en) 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
CA2571567A1 (en) * 2004-06-18 2006-01-05 Nimblegen Systems, Inc. Variable length probe selection
WO2006002191A1 (en) * 2004-06-21 2006-01-05 Nimblegen Systems, Inc. Probe optimization methods
US8034553B2 (en) 2004-06-24 2011-10-11 Kimberly-Clark Worldwide, Inc. Biomarkers for wound healing
US7692219B1 (en) 2004-06-25 2010-04-06 University Of Hawaii Ultrasensitive biosensors
US7521226B2 (en) 2004-06-30 2009-04-21 Kimberly-Clark Worldwide, Inc. One-step enzymatic and amine detection technique
US20060003335A1 (en) * 2004-06-30 2006-01-05 Crispino John D Methods for diagnosing acute megakaryoblastic leukemia
US20060004527A1 (en) * 2004-07-01 2006-01-05 Sampas Nicholas M Methods, systems and computer readable media for identifying dye-normalization probes
EP2272987A3 (en) 2004-07-09 2012-04-11 University of Pittsburgh of the Commonwealth System of Higher Education Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma
US20060009038A1 (en) * 2004-07-12 2006-01-12 International Business Machines Corporation Processing for overcoming extreme topography
US20060014680A1 (en) * 2004-07-13 2006-01-19 Caiding Xu Peptides and compounds that bind to the IL-5 receptor
JP4756835B2 (en) * 2004-07-14 2011-08-24 キヤノン株式会社 Biochemical reaction cartridge
US7588892B2 (en) * 2004-07-19 2009-09-15 Entelos, Inc. Reagent sets and gene signatures for renal tubule injury
US20060024677A1 (en) 2004-07-20 2006-02-02 Morris David W Novel therapeutic targets in cancer
US20090226552A1 (en) * 2004-07-22 2009-09-10 Colorado State University Research Foundation Agents and methods for diagnosing osteoarthritis
EP1773860A4 (en) * 2004-07-22 2009-05-06 Sequenom Inc Methods for identifying risk of type ii diabetes and treatments thereof
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
WO2006014869A1 (en) * 2004-07-26 2006-02-09 Parallele Bioscience, Inc. Simultaneous analysis of multiple genomes
US8603824B2 (en) 2004-07-26 2013-12-10 Pfenex, Inc. Process for improved protein expression by strain engineering
FR2873697B1 (en) * 2004-07-28 2006-10-27 Commissariat Energie Atomique PHOTOLABILE PROTECTIVE GROUPING COUPLING AGENTS AND THEIR USES, IN PARTICULAR FOR THE FUNCTIONALIZATION OF SOLID SUPPORTS
EP1782315A4 (en) * 2004-07-30 2009-06-24 Rosetta Inpharmatics Llc Prognosis of breast cancer patients
US7848889B2 (en) 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
US7393903B2 (en) * 2004-08-04 2008-07-01 Guerry Grune Devices and methods for the rapid, reliable detection and determination of acrylamide concentration in food substances and prevention of acrylamide formation in the same
US20060105453A1 (en) * 2004-09-09 2006-05-18 Brenan Colin J Coating process for microfluidic sample arrays
RU2410438C2 (en) 2004-08-06 2011-01-27 Дженентек, Инк. Analyses and methods using biomarkers
JP5237638B2 (en) 2004-08-06 2013-07-17 ジェネンテック, インコーポレイテッド Assays and methods using biomarkers
EP1623996A1 (en) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved method of selecting a desired protein from a library
US20060210542A1 (en) * 2004-08-16 2006-09-21 Yurkow Edward J Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
US20090087848A1 (en) * 2004-08-18 2009-04-02 Abbott Molecular, Inc. Determining segmental aneusomy in large target arrays using a computer system
US20060057618A1 (en) * 2004-08-18 2006-03-16 Abbott Molecular, Inc., A Corporation Of The State Of Delaware Determining data quality and/or segmental aneusomy using a computer system
PT1786454E (en) * 2004-08-19 2010-08-18 Biogen Idec Inc Neublastin variants
CN101123978B (en) 2004-08-19 2012-12-12 比奥根艾迪克Ma公司 Neublastin variants
US7598080B2 (en) * 2004-08-20 2009-10-06 Carl Deirmengian Diagnostic assay for source of inflammation
KR100657896B1 (en) * 2004-08-20 2006-12-14 삼성전자주식회사 A method of storing substrate having immobilized reactive groups or probe molecules method of producing microarray using the UV film and a substrate having attached UV film
US20060046252A1 (en) * 2004-08-30 2006-03-02 Srinka Ghosh Method and system for developing probes for dye normalization of microarray signal-intensity data
US8484000B2 (en) * 2004-09-02 2013-07-09 Vialogy Llc Detecting events of interest using quantum resonance interferometry
WO2006029234A1 (en) * 2004-09-03 2006-03-16 Receptors Llc Combinatorial artificial receptors including tether building blocks
US7323308B2 (en) * 2004-09-03 2008-01-29 Affymetrix, Inc. Methods of genetic analysis of E. coli
US7312035B2 (en) * 2004-09-03 2007-12-25 Affymetrix, Inc. Methods of genetic analysis of yeast
CA2583428A1 (en) * 2004-09-03 2006-03-09 Plexxikon, Inc. Bicyclic heteroaryl pde4b inhibitors
WO2006029184A2 (en) 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
EP1789792A2 (en) * 2004-09-11 2007-05-30 Receptors LLC Combinatorial artificial receptors including peptide building blocks
KR100682891B1 (en) * 2004-09-14 2007-02-15 삼성전자주식회사 Method for designing a probe set a microarray having a substrate immobilized thereon a probe designed by the method and a computer readable medium recorded thereon a program to execute the method
FI20041204A0 (en) 2004-09-16 2004-09-16 Riikka Lund Methods for the utilization of new target genes associated with immune-mediated diseases
US20060073506A1 (en) 2004-09-17 2006-04-06 Affymetrix, Inc. Methods for identifying biological samples
EP1797881B1 (en) 2004-09-17 2009-04-15 Eisai R&D Management Co., Ltd. Medicinal composition with improved stability and reduced gelation properties
US7406391B2 (en) * 2004-09-20 2008-07-29 Affymetrix, Inc. System, method, and computer product for detection instrument calibration
US7828954B2 (en) * 2004-09-21 2010-11-09 Gamida For Life B.V. Electrode based patterning of thin film self-assembled nanoparticles
US7314542B2 (en) * 2004-09-23 2008-01-01 Nanogen, Inc. Methods and materials for optimization of electronic transportation and hybridization reactions
FR2876116B1 (en) * 2004-10-01 2007-04-06 Biomerieux Sa METHOD FOR GENERATING TRANSCRIPTS
AU2005335216A1 (en) * 2004-10-05 2007-02-15 Wyeth Probe arrays for detecting multiple strains of different species
US20060073511A1 (en) 2004-10-05 2006-04-06 Affymetrix, Inc. Methods for amplifying and analyzing nucleic acids
AU2005294150B2 (en) 2004-10-07 2011-06-16 Coimmune, Inc. Mature dendritic cell compositions and methods for culturing same
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US7571055B2 (en) * 2004-10-13 2009-08-04 Regents Of The University Of Minnesota Systemic lupus erythematosus
FR2876705B1 (en) * 2004-10-19 2008-12-12 Biomerieux Sa METHOD FOR THE DIAGNOSIS OF ASPIRIN INTOLERANCE
US7682782B2 (en) 2004-10-29 2010-03-23 Affymetrix, Inc. System, method, and product for multiple wavelength detection using single source excitation
CA2524964A1 (en) 2004-10-29 2006-04-29 Affymetrix, Inc. Automated method of manufacturing polymer arrays
US20060094024A1 (en) * 2004-11-01 2006-05-04 Pirrung Michael C Electrochemical arrays
ES2391744T3 (en) 2004-11-01 2012-11-29 George Mason University Compositions and procedures for diagnosing colon disorders
JP3927978B2 (en) * 2004-11-02 2007-06-13 キヤノン株式会社 Biochemical reaction cartridge and biochemical processing system
CA2586201A1 (en) * 2004-11-03 2006-05-11 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
EP1809765A2 (en) * 2004-11-04 2007-07-25 Roche Diagnostics GmbH Classification of acute myeloid leukemia
DE102004056735A1 (en) 2004-11-09 2006-07-20 Clondiag Chip Technologies Gmbh Device for performing and analyzing microarray experiments
WO2006060148A2 (en) * 2004-11-11 2006-06-08 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
US11105808B2 (en) 2004-11-12 2021-08-31 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer
US7785785B2 (en) 2004-11-12 2010-08-31 The Board Of Trustees Of The Leland Stanford Junior University Charge perturbation detection system for DNA and other molecules
WO2008073922A2 (en) 2006-12-08 2008-06-19 Asuragen, Inc. Functions and targets of let-7 micro rnas
EP2322616A1 (en) 2004-11-12 2011-05-18 Asuragen, Inc. Methods and compositions involving miRNA and miRNA inhibitor molecules
US20060275792A1 (en) * 2004-11-15 2006-12-07 Lee Jun E Enhancement of nucleic acid amplification using double-stranded DNA binding proteins
US20060105348A1 (en) * 2004-11-15 2006-05-18 Lee Jun E Compositions and methods for the detection and discrimination of nucleic acids
AU2005307746B2 (en) 2004-11-16 2011-05-12 Illumina, Inc. And methods and apparatus for reading coded microbeads
US20060102471A1 (en) 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer
US20060105355A1 (en) * 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer having a linker moiety
JP5026978B2 (en) 2004-11-18 2012-09-19 エッペンドルフ アレイ テクノロジーズ ソシエテ アノニム Real-time quantification of multiple targets on a microarray
DE502005003509D1 (en) * 2004-11-19 2008-05-08 Ebm Papst St Georgen Gmbh & Co ARRANGEMENT WITH ONE FAN AND ONE PUMP
DE102004056980A1 (en) * 2004-11-25 2006-06-01 Clondiag Chip Technologies Gmbh Method for the site-specific synthesis of biopolymers on solid supports
KR100695134B1 (en) * 2004-11-25 2007-03-14 삼성전자주식회사 Microarray using laminar flow and preparation method thereof
US20060252057A1 (en) * 2004-11-30 2006-11-09 Mitch Raponi Lung cancer prognostics
US7647186B2 (en) * 2004-12-07 2010-01-12 Illumina, Inc. Oligonucleotide ordering system
JP4455306B2 (en) * 2004-12-13 2010-04-21 キヤノン株式会社 Biochemical treatment method
WO2006066071A2 (en) * 2004-12-17 2006-06-22 Mayo Foundation For Medical Education And Research Prognosis of renal cell carcinoma
ATE534909T1 (en) 2004-12-22 2011-12-15 California Inst Of Techn METHOD FOR PROTEOMIC PROFILING USING NON-NATURAL AMINO ACIDS
KR100763906B1 (en) * 2004-12-23 2007-10-05 삼성전자주식회사 9 9 A primer set capable of specifically amplifying a target sequence found in 9 bacterial species and probe oligonucleotide specifically hybridizable with each target sequence of the 9 bacterial species
US20060147943A1 (en) * 2004-12-30 2006-07-06 Lewis Mark A Substrates having pendant epoxide groups for binding biomolecules and methods of making and using thereof
US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing
BRPI0519690A2 (en) * 2004-12-30 2009-03-03 Todd M Hauser compositions and methods for modulating gene expression using self-protected oligonucleotides
US8338093B2 (en) * 2004-12-31 2012-12-25 Affymetrix, Inc. Primer array synthesis and validation
US7547775B2 (en) 2004-12-31 2009-06-16 Affymetrix, Inc. Parallel preparation of high fidelity probes in an array format
CA2594458C (en) 2005-01-10 2016-08-23 The Regents Of The University Of California Cationic conjugated polymers suitable for strand-specific polynucleotide detection in homogeneous and solid state assays
US20060166224A1 (en) * 2005-01-24 2006-07-27 Norviel Vernon A Associations using genotypes and phenotypes
AU2005325716A1 (en) * 2005-01-25 2006-08-03 Sky Genetics, Inc. Nucleic acids for apoptosis of cancer cells
US20060183893A1 (en) * 2005-01-25 2006-08-17 North Don A Nucleic acids for apoptosis of cancer cells
EP1846760B1 (en) * 2005-01-27 2010-12-15 Quest Diagnostics Investments Incorporated Rapid comparative genome hybridization
US7482120B2 (en) 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
FR2881437B1 (en) 2005-01-31 2010-11-19 Biomerieux Sa METHOD FOR THE DIAGNOSIS / PROGNOSIS OF A SEPTIC SYNDROME
WO2006083751A2 (en) * 2005-01-31 2006-08-10 Pacific Biosciences Of California, Inc. Use of reversible extension terminator in nucleic acid sequencing
US7910356B2 (en) * 2005-02-01 2011-03-22 Purdue Research Foundation Multiplexed biological analyzer planar array apparatus and methods
EP2233583A1 (en) 2005-02-01 2010-09-29 AB Advanced Genetic Analysis Corporation Nucleic acid sequencing by performing successive cycles of duplex extension
WO2006083917A2 (en) * 2005-02-01 2006-08-10 Purdue Research Foundation Laser scanning interferometric surface metrology
EP2230315A1 (en) 2005-02-01 2010-09-22 AB Advanced Genetic Analysis Corporation Nucleic acid sequencing by performing successive cycles of duplex extension
US20070023643A1 (en) * 2005-02-01 2007-02-01 Nolte David D Differentially encoded biological analyzer planar array apparatus and methods
US7402730B1 (en) 2005-02-03 2008-07-22 Lexicon Pharmaceuticals, Inc. Knockout animals manifesting hyperlipidemia
US7869959B2 (en) * 2005-02-04 2011-01-11 Roche Nimblegen, Inc. Optimized probe selection method
US7407757B2 (en) * 2005-02-10 2008-08-05 Population Genetics Technologies Genetic analysis by sequence-specific sorting
US7393665B2 (en) 2005-02-10 2008-07-01 Population Genetics Technologies Ltd Methods and compositions for tagging and identifying polynucleotides
US20090068650A1 (en) * 2005-02-11 2009-03-12 Southern Illinois University Metabolic Primers for the Detection of (Per) Chlorate-Reducing Bacteria and Methods of Use Thereof
EP2377951A1 (en) 2005-02-14 2011-10-19 University of Iowa Research Foundation Methods and reagents for treatment and diagnosis of age-related macular degeneration
DK2332408T3 (en) 2005-02-17 2013-12-02 Biogen Idec Inc Treatment of neurological diseases
UA90502C2 (en) * 2005-02-18 2010-05-11 Сьёрфейс Лоджикс, Инк. Imidazotriazinone compounds and pharmaceutical composition containing thereof
WO2006089046A2 (en) 2005-02-18 2006-08-24 Monogram Biosciences, Inc. Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of hiv
JP5053867B2 (en) 2005-02-18 2012-10-24 ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー Method for detecting progression of low grade cervical dysplasia and detecting adenocarcinoma
WO2006089045A2 (en) 2005-02-18 2006-08-24 Monogram Biosciences, Inc. Methods and compositions for determining hypersusceptibility of hiv-1 to non-nucleoside reverse transcriptase inhibitors
UA95604C2 (en) * 2005-02-18 2011-08-25 Сьёрфейс Лоджикс, Инк. Method of modulating the pharmacokinetic and/or pharmacodynamic properties of a compound
WO2006089268A2 (en) * 2005-02-18 2006-08-24 The University Of North Carolina At Chapel Hill Gene and cognate protein profiles and methods to determine connective tissue markers in normal and pathologic conditions
US7795503B2 (en) * 2005-02-22 2010-09-14 Ceres, Inc. Modulating plant alkaloids
JP2006242925A (en) 2005-03-07 2006-09-14 Seiko Epson Corp Electrode substrate, detector equipped with the substrate, kit including the detector, detection method using the kit
JP2006242926A (en) * 2005-03-07 2006-09-14 Seiko Epson Corp Electrode substrate, detector equipped with the same, kit including detector, detection method using kit
KR101138864B1 (en) * 2005-03-08 2012-05-14 삼성전자주식회사 Method for designing primer and probe set, primer and probe set designed by the method, kit comprising the set, computer readable medium recorded thereon a program to execute the method, and method for identifying target sequence using the set
US20090038023A1 (en) 2005-03-10 2009-02-05 Verenium Corporation Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
US20100221186A1 (en) 2005-03-11 2010-09-02 Hueseyin Firat Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
CA2600845A1 (en) * 2005-03-11 2006-09-21 The Regents Of The University Of Colorado Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors
WO2006099421A2 (en) 2005-03-14 2006-09-21 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
AU2006227965B2 (en) 2005-03-15 2013-01-31 Bp Corporation North America Inc. Cellulases, nucleic acids encoding them and methods for making and using them
US20060211030A1 (en) * 2005-03-16 2006-09-21 Sydney Brenner Methods and compositions for assay readouts on multiple analytical platforms
EP2518161A1 (en) 2005-03-18 2012-10-31 Fluidigm Corporation Method for detection of mutant alleles
US20080241174A1 (en) * 2005-03-18 2008-10-02 The Board Of Trustees Of The Leland Stanford Junior University Production And Therapeutic Uses Of Th1-Like Regulatory T Cells
EP1863531A1 (en) 2005-03-19 2007-12-12 Medical Research Council Improvements in or relating to treatment and prevention of viral infections
CA2937005A1 (en) 2005-03-22 2006-09-28 President And Fellows Of Harvard College Treatment of protein degradation disorders
US20070092886A1 (en) * 2005-03-22 2007-04-26 Raymond Tabibiazar Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease
CN101495645B (en) 2005-03-23 2012-08-22 生物-拉德实验室公司 Method for purifying proteins
US20070034513A1 (en) 2005-03-25 2007-02-15 Combimatrix Corporation Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array
EP1871913A2 (en) * 2005-03-25 2008-01-02 Ambion, Inc. Methods and compositions for depleting abundant rna transcripts
KR20140068234A (en) 2005-03-31 2014-06-05 더 제너럴 하스피탈 코포레이션 Monitoring and modulating hgf/hgfr activity
US8309303B2 (en) 2005-04-01 2012-11-13 Qiagen Gmbh Reverse transcription and amplification of RNA with simultaneous degradation of DNA
CN101965190A (en) * 2005-04-04 2011-02-02 维里德克斯有限责任公司 Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways
US20060246576A1 (en) * 2005-04-06 2006-11-02 Affymetrix, Inc. Fluidic system and method for processing biological microarrays in personal instrumentation
CA2604885A1 (en) 2005-04-07 2006-10-19 Guoying Yu Cacna1e in cancer diagnosis, detection and treatment
JP2008535853A (en) 2005-04-07 2008-09-04 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド Cancer-related genes
US20070213293A1 (en) * 2005-04-08 2007-09-13 Nastech Pharmaceutical Company Inc. Rnai therapeutic for respiratory virus infection
US20100254945A1 (en) * 2005-04-08 2010-10-07 Nastech Pharmaceutical Company Inc. Rnai Therapeutic for Respiratory Virus Infection
EP3770278A1 (en) 2005-04-14 2021-01-27 The Trustees of Boston University Diagnostic for lung disorders using class prediction
US9394167B2 (en) 2005-04-15 2016-07-19 Customarray, Inc. Neutralization and containment of redox species produced by circumferential electrodes
US20090042736A1 (en) * 2005-04-18 2009-02-12 Johan Gerrit Bomer Biochip and process for the production of a biochip
US7312376B2 (en) * 2005-04-20 2007-12-25 Ceres, Inc. Regulatory regions from Papaveraceae
US20060240443A1 (en) * 2005-04-20 2006-10-26 Combimatrix Corporation Microarray-based single nucleotide polymorphism, sequencing, and gene expression assay method
US8351026B2 (en) 2005-04-22 2013-01-08 Affymetrix, Inc. Methods and devices for reading microarrays
US9050615B2 (en) * 2005-04-26 2015-06-09 Bayer Intellectual Property Gmbh Apparatus and method for coating substrates for analyte detection by means of an affinity assay method
US20060286571A1 (en) 2005-04-28 2006-12-21 Prometheus Laboratories, Inc. Methods of predicting methotrexate efficacy and toxicity
US7452671B2 (en) * 2005-04-29 2008-11-18 Affymetrix, Inc. Methods for genotyping with selective adaptor ligation
US20060269948A1 (en) * 2005-05-16 2006-11-30 Halloran Philip F Tissue rejection
JP2008545652A (en) * 2005-05-17 2008-12-18 プレキシコン,インコーポレーテッド Compounds that modulate c-kit and c-fms activity and uses thereof
EP1888772A1 (en) 2005-05-18 2008-02-20 Decode Genetics EHF. Variants at chr8q24.21 confer risk of cancer
JP5421590B2 (en) 2005-05-18 2014-02-19 ノバルティス アーゲー Methods for diagnosis and treatment of diseases with autoimmune and / or inflammatory components
US7666596B2 (en) * 2005-05-23 2010-02-23 University Of Alberta Tissue rejection
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
US20090087841A1 (en) * 2005-05-27 2009-04-02 Monogram Biosciences, Inc. Methods and compositions for determining resistance of hiv-1 to protease inhibitors
US8486629B2 (en) 2005-06-01 2013-07-16 Bioarray Solutions, Ltd. Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
US7550433B2 (en) 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US8324159B2 (en) * 2005-06-03 2012-12-04 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7919461B2 (en) * 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US8940143B2 (en) * 2007-06-29 2015-01-27 Intel Corporation Gel-based bio chip for electrochemical synthesis and electrical detection of polymers
WO2006133266A2 (en) 2005-06-06 2006-12-14 Monogram Biosciences, Inc. Methods for determining resistance or susceptibility to hiv entry inhibitors
US8053774B2 (en) 2005-06-06 2011-11-08 Intel Corporation Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis
US8071284B2 (en) * 2005-06-06 2011-12-06 Monogram Biosciences, Inc. Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs
WO2006132666A1 (en) 2005-06-06 2006-12-14 Decision Biomarkers, Inc. Assays based on liquid flow over arrays
EP1731620A1 (en) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for the diagnosis of immune graft tolerance
US8124839B2 (en) * 2005-06-08 2012-02-28 Ceres, Inc. Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
EP1922419A4 (en) * 2005-06-10 2010-11-17 Life Technologies Corp Method and system for multiplex genetic analysis
JP4697944B2 (en) * 2005-06-10 2011-06-08 キヤノン株式会社 Method for producing probe-immobilized carrier that reduces non-specific adsorption
US8053627B2 (en) * 2005-06-14 2011-11-08 University Of Chicago Methods for treating demyelination disorders
US7423194B2 (en) * 2005-06-14 2008-09-09 University Of Chicago Animal models for demyelination disorders
US7884260B2 (en) * 2005-06-14 2011-02-08 University Of Chicago Cell-based screen for agents useful for reducing neuronal demyelination or promoting neuronal remyelination
US7368242B2 (en) * 2005-06-14 2008-05-06 Affymetrix, Inc. Method and kits for multiplex hybridization assays
CA2611671C (en) 2005-06-15 2013-10-08 Callida Genomics, Inc. Single molecule arrays for genetic and chemical analysis
CN101238222B (en) * 2005-06-20 2013-04-10 解码遗传学私营有限责任公司 Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
ES2371397T3 (en) * 2005-06-22 2011-12-30 Plexxikon, Inc. PIRROLO DERIVATIVES [2,3-B] PIRIDINE AS INHIBITORS OF PROTEIN KINES.
US20060292576A1 (en) * 2005-06-23 2006-12-28 Quest Diagnostics Investments Incorporated Non-in situ hybridization method for detecting chromosomal abnormalities
US20060292559A1 (en) * 2005-06-23 2006-12-28 Beckman Coulter, Inc. Cell-based microarrays, and methods for their preparation and use
EP1736780A1 (en) 2005-06-24 2006-12-27 Eppendorf Array Technologies S.A. Method and means for detecting and/or quantifying hierarchical molecular change of a cell in response to an external stimulus
JP4789518B2 (en) * 2005-06-30 2011-10-12 キヤノン株式会社 Method for detecting target substance using probe-immobilized carrier with manufacturing conditions, and apparatus, kit and system therefor
AU2006265698A1 (en) 2005-07-06 2007-01-11 Biochip Innovations Pty Ltd A method and kit for analyzing a target nucleic acid sequence
EP1910565A4 (en) 2005-07-07 2009-10-28 Athlomics Pty Ltd Polynucleotide marker genes and their expression, for diagnosis of endotoxemia
WO2007016502A2 (en) 2005-08-02 2007-02-08 Wisconsin Alumni Research Foundation Synthesis of arrays of oligonucleotides and other chain molecules
US9006240B2 (en) * 2005-08-02 2015-04-14 Eisai R&D Management Co., Ltd. Method for assay on the effect of vascularization inhibitor
CN1908189A (en) * 2005-08-02 2007-02-07 博奥生物有限公司 Method of external assistant identifying intestinal-type gastric cancer and differentiation degree thereof and special reagent case
US20080219890A1 (en) * 2005-08-04 2008-09-11 Helicos Biosciences Corporation Sample loading and recovery
WO2007019479A2 (en) * 2005-08-04 2007-02-15 Helicos Biosciences Corporation Multi-channel flow cells
ATE549416T1 (en) 2005-08-05 2012-03-15 Genentech Inc METHODS AND COMPOSITIONS FOR DETECTING AUTOIMMUNE DISEASES
US20070037169A1 (en) * 2005-08-09 2007-02-15 Combimatrix Corporation Selective Dehybridization using Electrochemically-Generated Reagent on an Electrode Microarray
EP1924709A1 (en) * 2005-08-10 2008-05-28 Arena Pharmaceuticals, Inc. Methods for determining probability of an adverse or favorable reaction to a niacin receptor agonist
CN101356285A (en) * 2005-08-16 2009-01-28 梅洛根有限责任公司 Methods for identification of merle gene
CN101365951B (en) 2005-08-16 2013-09-11 健泰科生物技术公司 Apoptosis sensitivity to apo2l/trail by testing for 'galnac-t14 expression in cells/tissues
US20070047388A1 (en) * 2005-08-25 2007-03-01 Rockwell Scientific Licensing, Llc Fluidic mixing structure, method for fabricating same, and mixing method
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
WO2007028147A2 (en) * 2005-09-01 2007-03-08 Philadelphia Health & Education Corporation D.B.A. Drexel University College Of Medicin Identification of a prostatic intraepithelial neoplasia (pin)-specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer
KR100990590B1 (en) * 2005-09-01 2010-10-29 에자이 알앤드디 매니지먼트 가부시키가이샤 Method for preparation of pharmaceutical composition having improved disintegratability
WO2007030759A2 (en) * 2005-09-07 2007-03-15 Nugen Technologies, Inc. Improved nucleic acid amplification procedure
EP1762627A1 (en) 2005-09-09 2007-03-14 Qiagen GmbH Method for the activation of a nucleic acid for performing a polymerase reaction
JP2007078399A (en) * 2005-09-12 2007-03-29 Tokyo Institute Of Technology Solid support body, and dna chip
US7713689B2 (en) 2005-09-15 2010-05-11 Duke University Non-fouling polymeric surface modification and signal amplification method for biomolecular detection
US7608395B2 (en) * 2005-09-15 2009-10-27 Baylor Research Institute Systemic lupus erythematosus diagnostic assay
US7551294B2 (en) * 2005-09-16 2009-06-23 University Of Rochester System and method for brewster angle straddle interferometry
JP5405110B2 (en) 2005-09-19 2014-02-05 ベリデックス・エルエルシー Methods and materials for identifying primary lesions of cancer of unknown primary
US20070065877A1 (en) 2005-09-19 2007-03-22 Combimatrix Corporation Microarray having a base cleavable succinate linker
US20070231794A1 (en) 2005-09-21 2007-10-04 Combimatrix Corporation Process to detect binding events on an electrode microarray using enzymes
US8855955B2 (en) * 2005-09-29 2014-10-07 Custom Array, Inc. Process and apparatus for measuring binding events on a microarray of electrodes
US20100062137A1 (en) * 2005-09-30 2010-03-11 Steven Craig Bobzin Modulating plant tocopherol levels
US7763423B2 (en) * 2005-09-30 2010-07-27 Pacific Biosciences Of California, Inc. Substrates having low density reactive groups for monitoring enzyme activity
US7312079B1 (en) 2005-10-06 2007-12-25 Lexicon Pharmaceuticals, Inc. Variants of FAM3C
EP2546360A1 (en) 2005-10-07 2013-01-16 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
US7960104B2 (en) 2005-10-07 2011-06-14 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
WO2007044566A2 (en) * 2005-10-07 2007-04-19 Baylor Research Institute Diagnosis of systemic onset juvenile idiopathic arthritis through blood leukocyte microarray analysis
WO2007047408A2 (en) * 2005-10-12 2007-04-26 Pathologica, Llc. Promac signature application
US20090178160A1 (en) * 2005-10-25 2009-07-09 Joon-Hyun Park Modulation of Triterpenoid Content in Plants
EP1937849B1 (en) 2005-10-27 2019-05-29 The President and Fellows of Harvard College Methods and compositions for labeling nucleic acids
US7842823B2 (en) * 2005-10-27 2010-11-30 The Regents Of The University Of California Fluorogenic probes for reactive oxygen species
AU2005337803B2 (en) 2005-10-29 2013-04-18 Bayer Intellectual Property Gmbh Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
WO2007053732A2 (en) 2005-11-01 2007-05-10 Mayo Foundation For Medical Education And Research Promoter polymorphisms of the blys gene and use in diagnostic methods
US8075852B2 (en) 2005-11-02 2011-12-13 Affymetrix, Inc. System and method for bubble removal
US8007267B2 (en) * 2005-11-02 2011-08-30 Affymetrix, Inc. System and method for making lab card by embossing
US20070099288A1 (en) * 2005-11-02 2007-05-03 Affymetrix, Inc. Microfluidic Methods, Devices, and Systems for Fluid Handling
US20080038714A1 (en) * 2005-11-02 2008-02-14 Affymetrix, Inc. Instrument to Pneumatically Control Lab Cards and Method Thereof
US20080311585A1 (en) * 2005-11-02 2008-12-18 Affymetrix, Inc. System and method for multiplex liquid handling
WO2007056113A2 (en) * 2005-11-02 2007-05-18 Cylene Pharmaceuticals, Inc. Methods for targeting quadruplex sequences
KR101353763B1 (en) 2005-11-07 2014-01-21 에자이 알앤드디 매니지먼트 가부시키가이샤 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR
AU2006314528A1 (en) 2005-11-16 2007-05-24 Novartis Ag Biomarkers for anti-nogo-A antibody treatment in spinal cord injury
US7576037B2 (en) * 2005-11-18 2009-08-18 Mei Technologies, Inc. Process and apparatus for combinatorial synthesis
US7291471B2 (en) * 2005-11-21 2007-11-06 Agilent Technologies, Inc. Cleavable oligonucleotide arrays
WO2007061981A2 (en) * 2005-11-21 2007-05-31 Lumera Corporation Surface plasmon resonance spectrometer with an actuator-driven angle scanning mechanism
US7329860B2 (en) 2005-11-23 2008-02-12 Illumina, Inc. Confocal imaging methods and apparatus
US8076074B2 (en) 2005-11-29 2011-12-13 Quest Diagnostics Investments Incorporated Balanced translocation in comparative hybridization
US20070122842A1 (en) * 2005-11-30 2007-05-31 Rajasekaran John J Massively parallel synthesis of proteinaceous biomolecules
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US7463358B2 (en) * 2005-12-06 2008-12-09 Lumera Corporation Highly stable surface plasmon resonance plates, microarrays, and methods
US7634363B2 (en) * 2005-12-07 2009-12-15 Affymetrix, Inc. Methods for high throughput genotyping
JP2009523410A (en) 2005-12-08 2009-06-25 ノバルティス アクチエンゲゼルシャフト Effect of inhibitors of FGFR3 on gene transcription
US7994098B2 (en) * 2005-12-09 2011-08-09 Wisconsin Alumni Research Foundation Light directed DNA synthesis using inverse capping for error reduction
EP1969506A1 (en) * 2005-12-13 2008-09-17 Erasmus University Medical Center Rotterdam Genetic brain tumor markers
CN101553576A (en) * 2005-12-13 2009-10-07 罗氏宁博根有限公司 Method for identification and monitoring of epigenetic modifications
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
US20090305248A1 (en) * 2005-12-15 2009-12-10 Lander Eric G Methods for increasing accuracy of nucleic acid sequencing
US20070161031A1 (en) * 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
JP2009525946A (en) 2005-12-20 2009-07-16 デューク・ユニヴァーシティ Methods and compositions for delivering active agents with enhanced pharmacological properties
KR100738083B1 (en) 2005-12-20 2007-07-12 삼성전자주식회사 A substrate used in a microarray and a method for preparing the same
US8178495B2 (en) 2008-06-27 2012-05-15 Duke University Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide
US11306351B2 (en) 2005-12-21 2022-04-19 Affymetrix, Inc. Methods for genotyping
JP4934679B2 (en) * 2005-12-27 2012-05-16 サムスン エレクトロニクス カンパニー リミテッド Primers, probes, microarrays and methods for specifically detecting bacterial species associated with nine respiratory diseases
WO2007123579A2 (en) 2005-12-28 2007-11-01 Translational Therapeutics Translational dysfunction based therapeutics
US20070154946A1 (en) * 2005-12-29 2007-07-05 Rajasekaran John J Massively parallel synthesis of biopolymeric arrays
US7862996B2 (en) * 2005-12-29 2011-01-04 Affymetrix, Inc. Use of acid scavengers for the synthesis of standard length and long-mer nucleic acid arrays
US20070154923A1 (en) * 2005-12-29 2007-07-05 Affymetrix, Inc. Method for Gridding and Quality Control of Polymer Arrays
US20070255054A1 (en) * 2005-12-30 2007-11-01 Affymetrix, Inc. Oligonucleotide synthesis with intermittent and post synthetic oxidation
US20070198653A1 (en) * 2005-12-30 2007-08-23 Kurt Jarnagin Systems and methods for remote computer-based analysis of user-provided chemogenomic data
KR100829574B1 (en) * 2006-01-03 2008-05-14 삼성전자주식회사 Microarray substrate method of analyzing biomolecule using the microarray substrate and lab-on-a-chip including the microarray substrate
US7709227B2 (en) * 2006-01-04 2010-05-04 Phasebio Pharmaceuticals, Inc. Multimeric ELP fusion constructs
US20100137163A1 (en) 2006-01-11 2010-06-03 Link Darren R Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
EP2613147B1 (en) * 2006-01-17 2015-03-11 Somalogic, Inc. Detection methods using aptamers
US20070168197A1 (en) * 2006-01-18 2007-07-19 Nokia Corporation Audio coding
EP1991274A4 (en) 2006-01-20 2009-06-10 Women S And Children S Health Method of treatment, prophylaxis and diagnosis of pathologies of the bone
WO2007087312A2 (en) * 2006-01-23 2007-08-02 Population Genetics Technologies Ltd. Molecular counting
US20090143238A1 (en) * 2006-01-23 2009-06-04 Junghuei Chen Oligonucleotide matrix and methods of use
US20070172852A1 (en) * 2006-01-24 2007-07-26 Affymetrix, Inc. Non-destructive Quality Control Methods for Microarrays
WO2007087377A2 (en) * 2006-01-25 2007-08-02 Massachusetts Institute Of Technology Photoelectrochemical synthesis of high density combinatorial polymer arrays
WO2008100244A2 (en) 2006-01-27 2008-08-21 Athena Diagnostics, Inc. Methods of detecting mutations associated with ataxia-ocular apraxia 2 (aoa2)
US9445025B2 (en) 2006-01-27 2016-09-13 Affymetrix, Inc. System, method, and product for imaging probe arrays with small feature sizes
US8055098B2 (en) 2006-01-27 2011-11-08 Affymetrix, Inc. System, method, and product for imaging probe arrays with small feature sizes
MX2008009592A (en) 2006-01-27 2008-09-08 Tripath Imaging Inc Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor.
EP2216403A3 (en) 2006-02-02 2010-11-24 Verenium Corporation Esterases and related nucleic acids and methods
MX360595B (en) 2006-02-08 2018-11-09 Genzyme Corp Gene therapy for niemann-pick disease type a.
DK1989301T3 (en) 2006-02-10 2015-01-05 Bp Corp North America Inc Cellulolytic enzymes, nucleic acids encoding them, and methods for making and using them
WO2008091349A1 (en) * 2006-02-14 2008-07-31 The President And Fellows Of Harvard College Bifunctional histone deacetylase inhibitors
AU2007214458C1 (en) 2006-02-14 2012-12-06 Dana-Farber Cancer Institute, Inc. Histone deacetylase inhibitors
CA2638801C (en) 2006-02-14 2016-12-13 Verenium Corporation Xylanases, nucleic acids encoding them and methods for making and using them
GB0602992D0 (en) * 2006-02-15 2006-03-29 Morvus Technology Ltd Methods, genes and proteins
AU2007214427B2 (en) * 2006-02-16 2011-11-10 Ventana Medical Systems, Inc. Reagents and methods for cancer prognosis and pathological staging
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
US8460878B2 (en) 2006-02-21 2013-06-11 The Trustees Of Tufts College Methods and arrays for detecting cells and cellular components in small defined volumes
US20070199090A1 (en) * 2006-02-22 2007-08-23 Nestor Apuya Modulating alkaloid biosynthesis
SG10201405158QA (en) * 2006-02-24 2014-10-30 Callida Genomics Inc High throughput genome sequencing on dna arrays
JP5180845B2 (en) 2006-02-24 2013-04-10 カリダ・ジェノミックス・インコーポレイテッド High-throughput genomic sequencing on DNA arrays
TWI501774B (en) * 2006-02-27 2015-10-01 Biogen Idec Inc Treatments for neurological disorders
EP2004843B1 (en) 2006-02-28 2015-07-22 Montana State University Use of phenanthridium derivatives for distinguishing between intact and membrane-compromised cells using molecular nucleic acid-based techniques
US7815868B1 (en) 2006-02-28 2010-10-19 Fluidigm Corporation Microfluidic reaction apparatus for high throughput screening
EP1993590B1 (en) * 2006-03-01 2013-12-25 Biogen Idec MA Inc. Compostions and methods for administering gdnf ligand family proteins
MX2008011477A (en) 2006-03-07 2008-09-23 Cargill Inc Aldolases, nucleic acids encoding them and methods for making and using them.
EA019971B1 (en) 2006-03-07 2014-07-30 Верениум Корпорейшн Aldolases, nucleic acids encoding them and methods for making and using them
US7397546B2 (en) 2006-03-08 2008-07-08 Helicos Biosciences Corporation Systems and methods for reducing detected intensity non-uniformity in a laser beam
US20080309926A1 (en) * 2006-03-08 2008-12-18 Aaron Weber Systems and methods for reducing detected intensity non uniformity in a laser beam
EP2605018A1 (en) 2006-03-09 2013-06-19 The Trustees of the Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
EP2007874A4 (en) * 2006-03-13 2009-06-10 Veridex Llc Propagation of primary cells
US20100233350A1 (en) * 2006-03-15 2010-09-16 Boston Scientific Scimed, Inc. Drug delivery composition and methods of making same using nanofabrication
US7812206B2 (en) 2006-03-21 2010-10-12 Bp Corporation North America Inc. Apparatus and process for the separation of solids and liquids
US20070231823A1 (en) * 2006-03-23 2007-10-04 Mckernan Kevin J Directed enrichment of genomic DNA for high-throughput sequencing
US20080009552A1 (en) * 2006-03-23 2008-01-10 Craig Pennell Markers of pre-term labor
EP2389947A1 (en) 2006-03-23 2011-11-30 Novartis AG Anti-tumor cell antigen antibody therapeutics
WO2008118167A1 (en) * 2006-03-24 2008-10-02 The Regents Of The University Of Michigan Method for forming molecular sequences on surfaces
US20080045471A1 (en) * 2006-03-27 2008-02-21 North Don A Nucleic Acids For Apoptosis Of Cancer Cells
US8975216B2 (en) * 2006-03-30 2015-03-10 Pacific Biosciences Of California Articles having localized molecules disposed thereon and methods of producing same
US20080050747A1 (en) * 2006-03-30 2008-02-28 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing and using same
WO2007115207A2 (en) * 2006-03-31 2007-10-11 Regents Of The University Of Minnesota Irf-5 haplotypes in systemic lupus erythematosus
US7914988B1 (en) 2006-03-31 2011-03-29 Illumina, Inc. Gene expression profiles to predict relapse of prostate cancer
US20070231805A1 (en) * 2006-03-31 2007-10-04 Baynes Brian M Nucleic acid assembly optimization using clamped mismatch binding proteins
US20070232556A1 (en) * 2006-03-31 2007-10-04 Montine Thomas J Methods and compositions for the treatment of neurological diseases and disorders
US20090222957A1 (en) * 2006-04-07 2009-09-03 Ceres Inc. Regulatory protein-regulatory region associations related to alkaloid biosynthesis
US7285388B1 (en) * 2006-04-07 2007-10-23 Merlogen, Llc Methods for identification of alport syndrome
US7830575B2 (en) 2006-04-10 2010-11-09 Illumina, Inc. Optical scanner with improved scan time
JP2009538123A (en) * 2006-04-19 2009-11-05 アプライド バイオシステムズ, エルエルシー Reagents, methods and libraries for gel-free bead-based sequencing
US7943651B2 (en) * 2006-04-20 2011-05-17 Glaxo Group Limited Compounds
CA2650520A1 (en) * 2006-04-24 2008-01-31 Gloucester Pharmaceuticals Treatment of ras-expressing tumors
EP2044213A2 (en) * 2006-04-24 2009-04-08 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
AU2007244683A1 (en) 2006-04-27 2007-11-08 Pikamab, Inc. Methods and compositions for antibody therapy
WO2007130434A2 (en) * 2006-05-02 2007-11-15 Applera Corporation Variable volume dispenser and method
WO2007131103A2 (en) * 2006-05-03 2007-11-15 Quadraspec, Inc. Direct printing of patterned hydrophobic wells
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
JP5497431B2 (en) * 2006-05-03 2014-05-21 プレジデント アンド フェローズ オブ ハーバード カレッジ Histone deacetylase and tubulin deacetylase inhibitors
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US20080003142A1 (en) 2006-05-11 2008-01-03 Link Darren R Microfluidic devices
WO2007133740A1 (en) * 2006-05-15 2007-11-22 Generation Biotech, Llc Method for identification of novel physical linkage of genomic sequences
JP2007304043A (en) * 2006-05-15 2007-11-22 Canon Inc Method for manufacturing probe-fixing carrier
US20100216657A1 (en) * 2006-05-16 2010-08-26 Arcxis Biotechnologies, Inc. Pcr-free sample preparation and detection systems for high speed biologic analysis and identification
CN101443009A (en) * 2006-05-18 2009-05-27 卫材R&D管理有限公司 Antitumor agent for thyroid cancer
JP2010527577A (en) 2006-05-22 2010-08-19 クリニカル ジェノミクス ピーティーワイ リミテッド Detection method
EP1862538A1 (en) * 2006-05-29 2007-12-05 IMBA-Institut für Molekulare Biotechnologie GmbH siRNA kinase and methods of use
US20100285973A1 (en) * 2006-05-30 2010-11-11 Synergenz Bioscience Limited of Sea Meadow House Methods and compositions for assessment of pulmonary function and disorders
EP2029777B1 (en) 2006-05-31 2017-03-08 Sequenom, Inc. Methods and compositions for the extraction of nucleic acid from a sample
WO2007140388A2 (en) * 2006-05-31 2007-12-06 The Johns Hopkins University Ablation based laser machining of biomolecule patterns on substrates
EP2035439A4 (en) 2006-06-05 2010-01-13 Cancer Care Ontario Assessment of risk for colorectal cancer
US9133504B2 (en) * 2006-06-05 2015-09-15 California Institute Of Technology Real time microarrays
US11001881B2 (en) 2006-08-24 2021-05-11 California Institute Of Technology Methods for detecting analytes
US8957027B2 (en) 2006-06-08 2015-02-17 Celgene Corporation Deacetylase inhibitor therapy
US7486865B2 (en) * 2006-06-12 2009-02-03 Pacific Biosciences Of California, Inc. Substrates for performing analytical reactions
EP2366801B1 (en) 2006-06-14 2016-10-19 Verinata Health, Inc Methods for the diagnosis of fetal abnormalities
AU2007260676A1 (en) 2006-06-14 2007-12-21 Artemis Health, Inc. Rare cell analysis using sample splitting and DNA tags
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
KR100954322B1 (en) 2006-06-14 2010-04-21 주식회사 엘지생명과학 Gene familyLBFL313 associated with pancreatic cancer
EP2029780A4 (en) * 2006-06-16 2010-03-31 Pacific Biosciences California Controlled initiation of primer extension
WO2007149696A1 (en) * 2006-06-23 2007-12-27 Applera Corporation Systems and methods for cooling in biological analysis instruments
US8009889B2 (en) 2006-06-27 2011-08-30 Affymetrix, Inc. Feature intensity reconstruction of biological probe array
US8178316B2 (en) * 2006-06-29 2012-05-15 President And Fellows Of Harvard College Evaluating proteins
US20080004410A1 (en) * 2006-06-30 2008-01-03 Yu-Chin Lai Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
US20100022403A1 (en) * 2006-06-30 2010-01-28 Nurith Kurn Methods for fragmentation and labeling of nucleic acids
EP2083264A1 (en) 2006-07-10 2009-07-29 Toto Ltd. Electrolyte-containing sheet for use in specific detection of analyte using photocurrent, and, employing the sheet, method of detection, sensor unit and measuring apparatus
WO2008008986A2 (en) 2006-07-13 2008-01-17 University Of Iowa Research Foundation Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
WO2008008284A2 (en) 2006-07-14 2008-01-17 The Regents Of The University Of California Cancer biomarkers and methods of use threof
US8213017B2 (en) * 2006-07-17 2012-07-03 Max Wiki Analytical system comprising an arrangement for temporally variable spatial light modulation and detection method executable therewith
US20080241951A1 (en) * 2006-07-20 2008-10-02 Visigen Biotechnologies, Inc. Method and apparatus for moving stage detection of single molecular events
WO2008009132A1 (en) * 2006-07-21 2008-01-24 The Governors Of The University Of Alberta Tissue rejection
KR100813262B1 (en) * 2006-07-25 2008-03-13 삼성전자주식회사 Method for producing a patterned spot microarray using photocatalyst and a microarray produced by the method
US20080026373A1 (en) * 2006-07-26 2008-01-31 Rodionova Natalia A Assays Based On Light Emission From Analyte Complexes Within A Cassette
WO2008013918A2 (en) * 2006-07-26 2008-01-31 Myelin Repair Foundation, Inc. Cell cycle regulation and differentiation
US7700756B2 (en) * 2006-07-27 2010-04-20 Southern Illinois University Metabolic primers for the detection of perchlorate-reducing bacteria and methods of use thereof
US11525156B2 (en) 2006-07-28 2022-12-13 California Institute Of Technology Multiplex Q-PCR arrays
WO2008014485A2 (en) 2006-07-28 2008-01-31 California Institute Of Technology Multiplex q-pcr arrays
JP4866462B2 (en) 2006-08-03 2012-02-01 ナショナル ユニバーシティ オブ シンガポール Microarray system and method for manufacturing microarray
CN103397043A (en) 2006-08-04 2013-11-20 维莱尼姆公司 Glucanases, nucleic acids encoding same and method for making and using same
NZ574659A (en) 2006-08-07 2012-08-31 Nsure Holding B V Quality control of agricultural products based on gene expression
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
TWI316873B (en) * 2006-08-08 2009-11-11 Ind Tech Res Inst Apparatus of manufacturing biochip and manufacture method of biochip tip array
JP5244103B2 (en) 2006-08-09 2013-07-24 ホームステッド クリニカル コーポレイション Organ-specific protein and method of use thereof
US7626185B2 (en) * 2006-08-11 2009-12-01 Battelle Memorial Institute Patterning compositions, masks, and methods
US7993832B2 (en) 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
KR100755672B1 (en) * 2006-08-24 2007-09-05 삼성전자주식회사 Oligomer probe array having probe cell active formed in substrate and fabrication method thereof
BRPI0716571A2 (en) 2006-08-24 2013-11-05 Surface Logix Inc PHARMACEUTICALLY OPTIMIZED COMPOUNDS
US11560588B2 (en) 2006-08-24 2023-01-24 California Institute Of Technology Multiplex Q-PCR arrays
WO2008026748A1 (en) * 2006-08-28 2008-03-06 Eisai R & D Management Co., Ltd. Antitumor agent for undifferentiated gastric cancer
US20080131893A1 (en) * 2006-08-31 2008-06-05 Mayo Foundation For Medical Education And Research Predicting Parkinson's Disease
US7687103B2 (en) * 2006-08-31 2010-03-30 Gamida For Life B.V. Compositions and methods for preserving permeation layers for use on active electronic matrix devices
US8053191B2 (en) 2006-08-31 2011-11-08 Westend Asset Clearinghouse Company, Llc Iterative nucleic acid assembly using activation of vector-encoded traits
EP3936857B1 (en) 2006-09-01 2023-06-21 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US7985542B2 (en) * 2006-09-07 2011-07-26 Institut Pasteur Genomic morse code
EP1900824A1 (en) * 2006-09-14 2008-03-19 Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts Gene expression signature for the prognosis, diagnosis and therapy of prostate cancer and uses thereof
US20100021885A1 (en) * 2006-09-18 2010-01-28 Mark Fielden Reagent sets and gene signatures for non-genotoxic hepatocarcinogenicity
US20090131348A1 (en) 2006-09-19 2009-05-21 Emmanuel Labourier Micrornas differentially expressed in pancreatic diseases and uses thereof
WO2008036776A2 (en) 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
GB0618514D0 (en) * 2006-09-20 2006-11-01 Univ Nottingham Trent Method of detecting interactions on a microarray using nuclear magnetic resonance
CA2663001A1 (en) 2006-09-21 2008-03-27 Verenium Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
DK2617814T3 (en) 2006-09-21 2016-02-22 Basf Enzymes Llc Phytases, nucleic acids encoding them, and methods of producing and using them
US8273539B2 (en) 2006-09-25 2012-09-25 Mayo Foundation For Medical Education And Research Extracellular and membrane-associated prostate cancer markers
KR100818275B1 (en) * 2006-09-26 2008-03-31 삼성전자주식회사 Primer set for amplifying target sequences of Norovirus probe set specifically hybridizable with the target sequences of Norovirus microarray having the immobilized probe set and method for detecting the presence of Norovirus using the probe set
EP2069377A4 (en) 2006-09-27 2009-11-11 Univ California Methods and compositions for the treatment of skin diseases and disorders
KR100868760B1 (en) * 2006-09-28 2008-11-17 삼성전자주식회사 Primer set, probe set, method and kit for discriminating gram negative and positive bacteria
FR2906537A1 (en) * 2006-09-28 2008-04-04 Biomerieux Sa METHOD FOR IN VITRO DIAGNOSIS OF BRONCHO-PULMONARY CANCER BY DETECTION OF ALTERNATIVE MAJORITY TRANSCRIPTS OF KLK8 GENE ENCODING KALLICREIN 8 AND USE THEREOF FOR THE PROGNOSIS OF SURVIVAL
US20100240544A1 (en) * 2006-09-29 2010-09-23 Liu David J Aptamer biochip for multiplexed detection of biomolecules
EP2762886A1 (en) 2006-09-29 2014-08-06 Translational Therapeutics, Inc. EIF4E Regulon-based diagnostics
US9096953B2 (en) * 2006-09-29 2015-08-04 Intel Corporation Method for high throughput, high volume manufacturing of biomolecule micro arrays
KR100868765B1 (en) * 2006-09-29 2008-11-17 삼성전자주식회사 A primer set for amplifying target sequences of bacterial species resistant to antibiotics, probe set specifically hybridizable with the target sequences of the bacterial species, a microarray having immobilized the probe set and a method for detecting the presence of one or more of the bacterial species
US20080079663A1 (en) * 2006-10-03 2008-04-03 Sharp Laboratories Of America, Inc. Micro-pixelated fluid-assay precursor structure
US8232108B2 (en) * 2006-10-06 2012-07-31 Sharp Laboratories Of America, Inc. Method of making micro-pixelated fluid-assay structure
JP5420414B2 (en) 2006-10-06 2014-02-19 シリゲン グループ リミテッド Fluorescence methods and materials for directional biomarker signal amplification
US8236571B2 (en) * 2006-10-06 2012-08-07 Sharp Laboratories Of America, Inc. Method of making micro-pixelated fluid-assay precursor structure
US8236245B2 (en) 2006-10-06 2012-08-07 Sharp Laboratories Of America, Inc. Micro-pixelated fluid-assay precursor structure
US8236244B2 (en) * 2006-10-06 2012-08-07 Sharp Laboratories Of America, Inc. Micro-pixelated fluid-assay structure with on-board addressable, pixel-specific functionalization
US8232109B2 (en) * 2006-10-06 2012-07-31 Sharp Laboratories Of America, Inc. Micro-pixelated active-matrix fluid-assay performance
US8231831B2 (en) * 2006-10-06 2012-07-31 Sharp Laboratories Of America, Inc. Micro-pixelated fluid-assay structure
JP5143841B2 (en) 2006-10-10 2013-02-13 ロス アラモス ナショナル セキュリティー,エルエルシー Advanced drug development and manufacturing
US20080167532A1 (en) * 2006-10-13 2008-07-10 Mayo Foundation For Medical Education And Research Assessing cancer treatment responsiveness
US20080090236A1 (en) * 2006-10-13 2008-04-17 Yakhini Zohar H Methods and systems for identifying tumor progression in comparative genomic hybridization data
CA2666584A1 (en) * 2006-10-17 2008-04-24 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
US9845494B2 (en) 2006-10-18 2017-12-19 Affymetrix, Inc. Enzymatic methods for genotyping on arrays
US20080108149A1 (en) * 2006-10-23 2008-05-08 Narayan Sundararajan Solid-phase mediated synthesis of molecular microarrays
WO2008070352A2 (en) 2006-10-27 2008-06-12 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US8618248B2 (en) 2006-10-31 2013-12-31 President And Fellows Of Harvard College Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides
DK2444807T3 (en) 2006-11-01 2014-08-11 Ventana Med Syst Inc MONO AND DINITROPYRAZOLHAPTEN CONJUGATES
DE102006035388A1 (en) * 2006-11-02 2008-05-15 Signature Diagnostics Ag Prognostic markers for the classification of colon carcinomas based on expression profiles of biological samples
DE102006035392A1 (en) 2006-11-02 2008-10-16 Signature Diagnostics Ag Prognostic markers for the prediction of five-year progression-free survival of patients with colon carcinoma based on expression profiles of biological samples
DE102006035393A1 (en) 2006-11-02 2008-05-15 Signature Diagnostics Ag Prognostic markers for the classification of the three-year progression-free survival of patients with colon carcinoma based on expression profiles of biological samples
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
CA2668235A1 (en) 2006-11-02 2008-06-05 Yale University Assessment of oocyte competence
WO2008100352A2 (en) 2006-11-03 2008-08-21 Baylor Research Institute Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
NZ551157A (en) * 2006-11-08 2008-06-30 Rebecca Lee Roberts Method of identifying individuals at risk of thiopurine drug resistance and intolerance - GMPS
US20080113915A1 (en) * 2006-11-09 2008-05-15 Duke University SAPAP3 knockout mouse and clinical modeling associated with the SAPAP3 gene
WO2008070375A2 (en) 2006-11-09 2008-06-12 Complete Genomics, Inc. Selection of dna adaptor orientation
US20090105961A1 (en) * 2006-11-09 2009-04-23 Complete Genomics, Inc. Methods of nucleic acid identification in large-scale sequencing
WO2008140484A2 (en) 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2008060871A1 (en) * 2006-11-10 2008-05-22 Mayo Foundation For Medical Education And Research Biomarkers for chronic vascular dysfunction
WO2008060448A2 (en) 2006-11-10 2008-05-22 Massachusetts Institute Of Technology Small molecule pak inhibitors
JP2010508859A (en) * 2006-11-15 2010-03-25 ザ ユニバーシティ オブ ブリティッシュ コロンビア Polymorphisms predicting platinum coordination complex-induced ototoxicity
EP2527501A1 (en) 2006-11-15 2012-11-28 The University Of British Columbia Polymorphisms predictive of anthracycline-induced cardiotoxicity
US20080242560A1 (en) * 2006-11-21 2008-10-02 Gunderson Kevin L Methods for generating amplified nucleic acid arrays
US7813013B2 (en) * 2006-11-21 2010-10-12 Illumina, Inc. Hexagonal site line scanning method and system
US7791013B2 (en) * 2006-11-21 2010-09-07 Illumina, Inc. Biological microarray line scanning method and system
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US9114398B2 (en) 2006-11-29 2015-08-25 Canon U.S. Life Sciences, Inc. Device and method for digital multiplex PCR assays
US8293684B2 (en) * 2006-11-29 2012-10-23 Exiqon Locked nucleic acid reagents for labelling nucleic acids
US7522282B2 (en) * 2006-11-30 2009-04-21 Purdue Research Foundation Molecular interferometric imaging process and apparatus
US20100291569A1 (en) * 2006-11-30 2010-11-18 Abbott Laboratories Assay for prediction of response to met antagonists
DK2099935T3 (en) * 2006-11-30 2014-04-07 Univ California ARRAY FOR DETECTION OF MICROBES
EP2099937A2 (en) * 2006-11-30 2009-09-16 Decode Genetics EHF Genetic susceptibility variants of type 2 diabetes mellitus
US7807359B2 (en) * 2006-12-01 2010-10-05 Quest Diagnostics Investments Incorporated Methods of detecting TPMT mutations
US7989396B2 (en) * 2006-12-05 2011-08-02 The Board Of Trustees Of The Leland Stanford Junior University Biomolecule immobilization on biosensors
US7902345B2 (en) 2006-12-05 2011-03-08 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
BRPI0720116B8 (en) * 2006-12-05 2021-07-27 Decode Genetics Ehf method for determining a susceptibility to cardiac arrhythmia or stroke in a human subject, use of an oligonucleotide probe, and apparatus for determining a genetic indicator for cardiac arrhythmia and/or stroke in a human subject
US20100143373A1 (en) 2006-12-06 2010-06-10 Medimmune, Llc Methods of treating systemic lupus erythematosus
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
JP5622392B2 (en) 2006-12-14 2014-11-12 ライフ テクノロジーズ コーポレーション Method and apparatus for analyte measurement using large-scale FET arrays
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US11339430B2 (en) 2007-07-10 2022-05-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US20080182328A1 (en) * 2006-12-19 2008-07-31 The Burnham Institute Mammalian extraembryonic endoderm cells and methods of isolation
US7622295B2 (en) * 2006-12-19 2009-11-24 Edelmira Cabezas Molecular microarrays and helical peptides
CA2673092A1 (en) * 2006-12-19 2008-06-26 Synergenz Bioscience Limited Methods and compositions for the assessment of cardiovascular function and disorders
KR100834745B1 (en) * 2006-12-20 2008-06-09 삼성전자주식회사 Oligomer probe array chip based on analysis-friendly layout, mask being used in fabrication thereof, and hybridization analysis method thereof
ATE528286T1 (en) 2006-12-20 2011-10-15 Bayer Healthcare Llc 4-Ä4-Ä(Ä3-TERT-BUTYL-1-Ä3-(HYDROXYMETHYL)PHENYL - 1H-PYRAZOLE-5-YLÜCARBAMOYL)-AMINOÜ-3- CHLOROPHENOXYÜ-N-METHYLPYRIDINE-2-CARBOXAMIDE AS AN INHIBITOR OF THE VEGFR KINASE FOR TREATMENT OF CANCER
US7932034B2 (en) * 2006-12-20 2011-04-26 The Board Of Trustees Of The Leland Stanford Junior University Heat and pH measurement for sequencing of DNA
US20080153135A1 (en) * 2006-12-20 2008-06-26 Liu Timothy Z Methods and apparatus for conducting amplification reactions on high density hydrophilic patterned microplates
EP2479267B1 (en) 2006-12-21 2016-12-21 BASF Enzymes LLC Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
WO2008080015A2 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
WO2008079909A1 (en) * 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
PE20121126A1 (en) * 2006-12-21 2012-08-24 Plexxikon Inc PIRROLO [2,3-B] PYRIDINES COMPOUNDS AS KINASE MODULATORS
US20080153134A1 (en) * 2006-12-22 2008-06-26 Willy Wiyatno Methods and apparatus for generating hydrophilic patterning of high density microplates using an amphiphilic polymer
US8614086B2 (en) * 2006-12-28 2013-12-24 Intel Corporation Quality control methods for the manufacture of polymer arrays
US7923237B2 (en) * 2006-12-28 2011-04-12 Intel Corporation Method and apparatus for combined electrochemical synthesis and detection of analytes
US20080161202A1 (en) * 2006-12-29 2008-07-03 Edelmira Cabezas Novel strategy for selective regulation of background surface property in microarray fabrication and method to eliminated self quenching in micro arrays
US20100248975A1 (en) * 2006-12-29 2010-09-30 Gunjan Tiwari Fluorogenic peptide substrate arrays for highly multiplexed, real-time monitoring of kinase activities
WO2008085857A2 (en) 2007-01-04 2008-07-17 Children's Hospital Medical Center Processing text with domain-specific spreading activation methods
WO2008086322A2 (en) * 2007-01-05 2008-07-17 Integrated Dna Technologies, Inc. Method for estimating melting temperature of a nucleic acid in buffers containing divalent ions
KR101443214B1 (en) * 2007-01-09 2014-09-24 삼성전자주식회사 A composition, kit and microarray for diagnosing the risk of lung cancer recurrence in a patient after lung cancer treatment or a lung cancer patient
JP5690068B2 (en) * 2007-01-11 2015-03-25 エラスムス ユニバーシティ メディカル センター Circular chromosome conformation capture (4C)
US20110136099A1 (en) 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US7855054B2 (en) * 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US20080175757A1 (en) * 2007-01-19 2008-07-24 Andrew Powell Microarray device with elastomeric well structure
WO2008089495A2 (en) 2007-01-19 2008-07-24 Purdue Research Foundation System with extended range of molecular sensing through integrated multi-modal data acquisition
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
EP2629094A1 (en) 2007-01-24 2013-08-21 Carnegie Mellon University Optical biosensors
US8821799B2 (en) 2007-01-26 2014-09-02 Palo Alto Research Center Incorporated Method and system implementing spatially modulated excitation or emission for particle characterization with enhanced sensitivity
US9164037B2 (en) * 2007-01-26 2015-10-20 Palo Alto Research Center Incorporated Method and system for evaluation of signals received from spatially modulated excitation and emission to accurately determine particle positions and distances
CA2676796C (en) * 2007-01-29 2016-02-23 Eisai R & D Management Co., Ltd. Composition for treatment of undifferentiated gastric cancer
AR065544A1 (en) 2007-01-30 2009-06-17 Verenium Corp ENZYMES FOR THE TREATMENT OF NUCLEIC ACID LIGNOCELLULOSICS THAT CODE AND METHODS TO PREPARE AND USE THEM
EP2993473A1 (en) 2007-01-30 2016-03-09 Pharmacyclics, Inc. Methods for determining cancer resistance to histone deacetylase inhibitors
US11035823B2 (en) 2009-03-17 2021-06-15 Qiagen Sciences, Llc Methods and devices for sequencing nucleic acids in smaller batches
US11940413B2 (en) 2007-02-05 2024-03-26 IsoPlexis Corporation Methods and devices for sequencing nucleic acids in smaller batches
US8612161B2 (en) 2008-03-19 2013-12-17 Intelligent Biosystems Inc. Methods and compositions for base calling nucleic acids
US8481259B2 (en) 2007-02-05 2013-07-09 Intelligent Bio-Systems, Inc. Methods and devices for sequencing nucleic acids in smaller batches
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
SG193026A1 (en) 2007-02-07 2013-09-30 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
KR100827449B1 (en) * 2007-02-07 2008-05-07 삼성전자주식회사 Photolabile compound, oligomer probe array and substrate for oligomer probe array with the same and the method of fabricating the same
WO2008098142A2 (en) 2007-02-08 2008-08-14 Sequenom, Inc. Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
AU2008218542B2 (en) * 2007-02-21 2014-06-26 Decode Genetics Ehf. Genetic susceptibility variants associated with cardiovascular disease
US9581595B2 (en) 2007-02-26 2017-02-28 Laboratory Corporation Of America Holdings Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
EP1961825A1 (en) 2007-02-26 2008-08-27 INSERM (Institut National de la Santé et de la Recherche Medicale) Method for predicting the occurrence of metastasis in breast cancer patients
AU2008222563A1 (en) 2007-03-05 2008-09-12 Cancer Care Ontario Assessment of risk for colorectal cancer
US20080220537A1 (en) * 2007-03-07 2008-09-11 Pacific Biosciences Of California, Inc. Substrates and methods for selective immobilization of active molecules
US20080220983A1 (en) * 2007-03-08 2008-09-11 Switchgear Genomics A California Corporation Functional arrays for high throughput characterization of regulatory elements in untranslated regions of genes
US7844609B2 (en) 2007-03-16 2010-11-30 Expanse Networks, Inc. Attribute combination discovery
US20080234143A1 (en) * 2007-03-23 2008-09-25 Pacific Biosciences Of California, Inc. Mechanical methods for producing substrates having selectively immobilized molecules
CN101874120B (en) * 2007-03-26 2015-01-14 解码遗传学私营有限责任公司 Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
US8652780B2 (en) 2007-03-26 2014-02-18 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
CA2681722A1 (en) * 2007-03-26 2008-10-02 Purdue Research Foundation Method and apparatus for conjugate quadrature interferometric detection of an immunoassay
US20080243865A1 (en) * 2007-03-28 2008-10-02 Oracle International Corporation Maintaining global state of distributed transaction managed by an external transaction manager for clustered database systems
US20080241831A1 (en) * 2007-03-28 2008-10-02 Jian-Bing Fan Methods for detecting small RNA species
US7572990B2 (en) * 2007-03-30 2009-08-11 Intermec Ip Corp. Keypad overlay membrane
CA2683804A1 (en) * 2007-04-13 2008-10-23 Dana Farber Cancer Institute, Inc. Receptor tyrosine kinase profiling
AU2008239594B2 (en) 2007-04-13 2013-10-24 Beth Israel Deaconess Medical Center Methods for treating cancer resistant to ErbB therapeutics
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20100190166A1 (en) * 2007-04-19 2010-07-29 The Governors Of The University Of Alberta Tissue rejection biomarkers
US20080268440A1 (en) * 2007-04-26 2008-10-30 Liu Timothy Z Biomolecule immobilization on surface via hydrophobic interactions
CA3017478A1 (en) 2007-04-27 2008-11-06 The Regents Of The University Of California Plant co2 sensors, nucleic acids encoding them, and methods for making and using them
EP2615172A1 (en) 2007-04-27 2013-07-17 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
EP2481805A3 (en) 2007-04-30 2012-10-24 The Ohio State University Research Foundation Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis
DK2155907T3 (en) 2007-04-30 2015-08-31 Decode Genetics Ehf Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction
US20080274458A1 (en) * 2007-05-01 2008-11-06 Latham Gary J Nucleic acid quantitation methods
CA2685382C (en) 2007-05-01 2023-02-21 The Regents Of The University Of California Methods for diagnosing ischemia
TWI445544B (en) 2007-05-01 2014-07-21 Biogen Idec Inc Compositions and methods for increasing vascularization
EP2162459B1 (en) * 2007-05-01 2017-10-04 University of Miami Transcriptomic biomarkers for individual risk assessment in new onset heart failure
WO2008137838A2 (en) 2007-05-03 2008-11-13 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
US20080286881A1 (en) * 2007-05-14 2008-11-20 Apel William A Compositions and methods for combining report antibodies
US8200440B2 (en) 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data
CA2687787A1 (en) * 2007-05-21 2008-12-18 Dana Farber Cancer Institute, Inc. Compositions and methods for cancer gene discovery
US20080293589A1 (en) * 2007-05-24 2008-11-27 Affymetrix, Inc. Multiplex locus specific amplification
EP2535425A1 (en) * 2007-05-25 2012-12-19 Decode Genetics EHF. Variantes génétiques sur les chr 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein
US20100203051A1 (en) 2007-05-31 2010-08-12 The University Of Queensland Diagnostic markers for ankylosing spondylitis and uses thereof
US8351674B2 (en) * 2007-05-31 2013-01-08 Battelle Energy Alliance, Llc Image portion identification methods, image parsing methods, image parsing systems, and articles of manufacture
WO2008151146A2 (en) * 2007-06-01 2008-12-11 Digitab, Inc. Peptide arrays and methods of use
PE20090321A1 (en) 2007-06-04 2009-04-20 Genentech Inc ANTI-NOTCH1 NRR ANTIBODIES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION
CA2688433A1 (en) 2007-06-06 2008-12-11 Domantis Limited Methods for selecting protease resistant polypeptides
AU2008261869B2 (en) 2007-06-08 2014-12-18 Biogen Ma Inc. Biomarkers for predicting anti-TNF responsiveness or non-responsiveness
US8097422B2 (en) 2007-06-20 2012-01-17 Salk Institute For Biological Studies Kir channel modulators
GB0713183D0 (en) * 2007-07-06 2007-08-15 King S College London Method
DE102007031526B4 (en) 2007-07-06 2010-07-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Use of an anode in a fuel cell for the oxidation of ethanol and / or at least one C3 to C10-containing alcohol
WO2009009662A1 (en) * 2007-07-10 2009-01-15 University Of South Florida Method of predicting non-response to first line chemotherapy
EP2666873B1 (en) 2007-07-12 2016-03-09 The Brigham and Women's Hospital, Inc. Compositions and methods for diagnosing and assessing inflammatory myopathies
WO2009012357A2 (en) 2007-07-17 2009-01-22 The General Hospital Corporation Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
AU2008276063B2 (en) 2007-07-17 2013-11-28 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
KR20090012582A (en) * 2007-07-30 2009-02-04 삼성전자주식회사 Apparatus for synthesizing polymer on a substrate and method of synthesizing polymer
US7507539B2 (en) * 2007-07-30 2009-03-24 Quest Diagnostics Investments Incorporated Substractive single label comparative hybridization
US8461303B2 (en) 2007-08-02 2013-06-11 Gilead Biologics, Inc. LOX and LOXL2 inhibitors and uses thereof
US20110135648A1 (en) * 2007-08-08 2011-06-09 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof
WO2009023676A1 (en) * 2007-08-12 2009-02-19 Integrated Dna Technologies, Inc. Microarray system with improved sequence specificity
WO2009023733A1 (en) * 2007-08-13 2009-02-19 Trustees Of Tufts College Methods and microarrays for detecting enteric viruses
JP2010535529A (en) * 2007-08-13 2010-11-25 アルマック ダイアグノスティックス リミテッド 3'-based sequencing method for microarray manufacturing
CA2695064A1 (en) 2007-08-14 2009-02-19 F. Hoffmann-La Roche Ag Predictive markers for egfr inhibitors treatment
JP5368445B2 (en) 2007-08-14 2013-12-18 エフ.ホフマン−ラ ロシュ アーゲー Predictive marker for EGFR inhibitor treatment
MX2010001571A (en) 2007-08-14 2010-03-15 Hoffmann La Roche Predictive markers for egfr inhibitor treatment.
SI2179056T1 (en) 2007-08-14 2012-12-31 F. Hoffmann-La Roche Ag Egfr inhibitor treatment marker
US8071561B2 (en) * 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US20110166028A1 (en) * 2007-08-28 2011-07-07 Donald Bergstrom Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancers
US20090060786A1 (en) * 2007-08-29 2009-03-05 Gibum Kim Microfluidic apparatus for wide area microarrays
WO2009032781A2 (en) 2007-08-29 2009-03-12 Sequenom, Inc. Methods and compositions for universal size-specific polymerase chain reaction
EP2201374B1 (en) * 2007-08-30 2015-10-07 Trustees Of Tufts College Methods for determining the concentration of an analyte in solution.
US9388457B2 (en) 2007-09-14 2016-07-12 Affymetrix, Inc. Locus specific amplification using array probes
US20090180931A1 (en) 2007-09-17 2009-07-16 Sequenom, Inc. Integrated robotic sample transfer device
JP5723154B2 (en) 2007-09-19 2015-05-27 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー SiRNA sequence-independent modification format for reducing the influence of off-target phenotype in RNAi and its stabilized form
EP2212434A1 (en) * 2007-10-01 2010-08-04 Applied Biosystems Inc. Chase ligation sequencing
MX2010003600A (en) 2007-10-03 2010-12-14 Verenium Corp Xylanases, nucleic acids encoding them and methods for making and using them.
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods
AU2008310530A1 (en) * 2007-10-12 2009-04-16 Decode Genetics Ehf Sequence variants for inferring human pigmentation patterns
EP2209810A1 (en) * 2007-10-15 2010-07-28 King's College London Viral therapeutic
US8951731B2 (en) * 2007-10-15 2015-02-10 Complete Genomics, Inc. Sequence analysis using decorated nucleic acids
WO2009052573A1 (en) 2007-10-23 2009-04-30 Clinical Genomics Pty. Ltd. A method of diagnosing neoplasms
CN102099485A (en) 2007-10-23 2011-06-15 临床基因组学有限公司 A method of diagnosing neoplasms - II
EP2053132A1 (en) 2007-10-23 2009-04-29 Roche Diagnostics GmbH Enrichment and sequence analysis of geomic regions
US20090263872A1 (en) * 2008-01-23 2009-10-22 Complete Genomics Inc. Methods and compositions for preventing bias in amplification and sequencing reactions
US7897344B2 (en) * 2007-11-06 2011-03-01 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors into library constructs
US8298768B2 (en) * 2007-11-29 2012-10-30 Complete Genomics, Inc. Efficient shotgun sequencing methods
US8415099B2 (en) * 2007-11-05 2013-04-09 Complete Genomics, Inc. Efficient base determination in sequencing reactions
JP2011502162A (en) * 2007-10-29 2011-01-20 ザ ユニバーシティー オブ カリフォルニア Osteoarthritis gene therapy
US8518640B2 (en) * 2007-10-29 2013-08-27 Complete Genomics, Inc. Nucleic acid sequencing and process
EP2215209B1 (en) 2007-10-30 2018-05-23 Complete Genomics, Inc. Apparatus for high throughput sequencing of nucleic acids
JP4400668B2 (en) 2007-11-01 2010-01-20 株式会社豊田中央研究所 Method for producing solid-phase body on which minute object is immobilized and use thereof
WO2009061840A1 (en) * 2007-11-05 2009-05-14 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors employing selective methylation
US8906700B2 (en) 2007-11-06 2014-12-09 Ambergen, Inc. Methods and compositions for phototransfer
AU2008323701B2 (en) 2007-11-07 2015-03-26 Genentech, Inc Methods and compositions for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
JP5638244B2 (en) * 2007-11-09 2014-12-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 Combination of angiogenesis inhibitors and antitumor platinum complexes
WO2009067657A2 (en) * 2007-11-21 2009-05-28 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Methods of identifying molecular function
US20090142759A1 (en) * 2007-11-29 2009-06-04 Erik Larsson qPCR array with IN SITU primer synthesis
US8093063B2 (en) * 2007-11-29 2012-01-10 Quest Diagnostics Investments Incorporated Assay for detecting genetic abnormalities in genomic nucleic acids
US8697360B2 (en) 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
US8003325B2 (en) * 2007-11-30 2011-08-23 Mayo Foundation For Medical Education And Research Polymorphisms of the BLyS gene and use in diagnostic methods
US8592150B2 (en) 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
EP2610351B1 (en) 2007-12-05 2015-07-08 Complete Genomics, Inc. Efficient base determination in sequencing reactions
WO2009075773A2 (en) * 2007-12-07 2009-06-18 Goldstein Steven A Identification of toxin ligands
US8004669B1 (en) 2007-12-18 2011-08-23 Plexera Llc SPR apparatus with a high performance fluid delivery system
WO2009117033A2 (en) 2007-12-19 2009-09-24 Singulex, Inc. Scanning analyzer for single molecule detection and methods of use
US20110003708A1 (en) * 2007-12-27 2011-01-06 Compugen Ltd. Biomarkers for the prediction of renal injury
EP2570493B1 (en) 2008-01-02 2016-08-10 Suregene LLC Genetic markers of mental illness
US8709772B2 (en) 2008-01-03 2014-04-29 Verenium Corporation Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
EP2581455A3 (en) 2008-01-17 2013-07-10 Suregene LLC Genetic markers of mental illness
WO2009094318A2 (en) * 2008-01-22 2009-07-30 Veridex, Llc Molecular staging of stage ii and iii colon cancer and prognosis
JP5592802B2 (en) 2008-01-25 2014-09-17 セラノスティクス ラボラトリー Methods and compositions for assessing drug response
WO2009097368A2 (en) 2008-01-28 2009-08-06 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US8658379B2 (en) 2008-01-29 2014-02-25 University of Pittsburgh—of the Commonwealth System of Higher Education Follistatin-like protein-1 as a biomarker for sepsis
US8211652B2 (en) * 2008-01-29 2012-07-03 University of Pittsburgh—of the Commonwealth System of Higher Education FSTL-1 as a biomaker of inflammation
US7763856B2 (en) * 2008-01-31 2010-07-27 Palo Alto Research Center Incorporated Producing time variation in emanating light
US7701580B2 (en) * 2008-02-01 2010-04-20 Palo Alto Research Center Incorporated Transmitting/reflecting emanating light with time variation
US8153950B2 (en) * 2008-12-18 2012-04-10 Palo Alto Research Center Incorporated Obtaining sensing results and/or data in response to object detection
US8263955B2 (en) * 2008-12-18 2012-09-11 Palo Alto Research Center Incorporated Causing relative motion
US7894068B2 (en) * 2008-02-04 2011-02-22 Palo Alto Research Center Incorporated Producing filters with combined transmission and/or reflection functions
AU2009208607B2 (en) * 2008-01-31 2013-08-01 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US8373860B2 (en) * 2008-02-01 2013-02-12 Palo Alto Research Center Incorporated Transmitting/reflecting emanating light with time variation
US8629981B2 (en) 2008-02-01 2014-01-14 Palo Alto Research Center Incorporated Analyzers with time variation based on color-coded spatial modulation
EP2245197B1 (en) * 2008-02-07 2016-10-12 Whitespace Enterprise Corporation Improvements in and relating to analysis
CA2618163A1 (en) 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers
US8034568B2 (en) * 2008-02-12 2011-10-11 Nugen Technologies, Inc. Isothermal nucleic acid amplification methods and compositions
US8105777B1 (en) 2008-02-13 2012-01-31 Nederlands Kanker Instituut Methods for diagnosis and/or prognosis of colon cancer
AU2009213689B2 (en) 2008-02-14 2014-11-20 Decode Genetics Ehf. Susceptibility variants for lung cancer
US20090233809A1 (en) * 2008-03-04 2009-09-17 Affymetrix, Inc. Resequencing methods for identification of sequence variants
AU2009223671B2 (en) 2008-03-11 2014-11-27 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
US9074244B2 (en) 2008-03-11 2015-07-07 Affymetrix, Inc. Array-based translocation and rearrangement assays
EP2253713B1 (en) 2008-03-11 2015-02-25 National Cancer Center Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using snp array
EP3369827B1 (en) 2008-03-12 2020-12-23 The Rockefeller University Methods and compositions for translational profiling and molecular phenotyping
US7932036B1 (en) 2008-03-12 2011-04-26 Veridex, Llc Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase
US10745740B2 (en) 2008-03-19 2020-08-18 Qiagen Sciences, Llc Sample preparation
US9017973B2 (en) 2008-03-19 2015-04-28 Intelligent Biosystems, Inc. Methods and compositions for incorporating nucleotides
US7846666B2 (en) 2008-03-21 2010-12-07 Nugen Technologies, Inc. Methods of RNA amplification in the presence of DNA
CA2718137A1 (en) 2008-03-26 2009-10-01 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
US8796184B2 (en) 2008-03-28 2014-08-05 Sentilus, Inc. Detection assay devices and methods of making and using the same
EP2107125A1 (en) 2008-03-31 2009-10-07 Eppendorf Array Technologies SA (EAT) Real-time PCR of targets on a micro-array
NZ588905A (en) 2008-04-01 2012-08-31 Decode Genetics Ehf Genetic testing method for determining susceptibility to abdominal aortic aneurysm by assay for selected polymorphisms associated with the disease
US20090246788A1 (en) 2008-04-01 2009-10-01 Roche Nimblegen, Inc. Methods and Assays for Capture of Nucleic Acids
WO2009132028A1 (en) * 2008-04-21 2009-10-29 Complete Genomics, Inc. Array structures for nucleic acid detection
WO2009130588A2 (en) 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
US20090269746A1 (en) * 2008-04-25 2009-10-29 Gil Atzmon Microsequencer-whole genome sequencer
US20110118125A1 (en) * 2008-05-03 2011-05-19 Tufts Medical Center, Inc. Neonatal salivary genomics
US8039817B2 (en) 2008-05-05 2011-10-18 Illumina, Inc. Compensator for multiple surface imaging
JP2009268665A (en) * 2008-05-07 2009-11-19 Canon Inc Inhalation device
US20110105356A1 (en) * 2008-05-07 2011-05-05 Derosier Chad F Compositions and methods for providing substances to and from an array
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
JP2010043063A (en) 2008-05-09 2010-02-25 Agency For Science Technology & Research Diagnosis and treatment of kawasaki disease
US20110111417A1 (en) 2008-05-14 2011-05-12 Millennium Pharmaceuticals, Inc. Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
KR100956447B1 (en) * 2008-05-16 2010-05-06 한국전자통신연구원 A method for fabricating patterned biosensor substrate and a biosensor using the same
WO2009143603A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
JP2011521630A (en) 2008-05-30 2011-07-28 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア Methods for diagnosing renal allograft rejection using genomics or proteomic expression profiling
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US20090298082A1 (en) * 2008-05-30 2009-12-03 Klee George G Biomarker panels for predicting prostate cancer outcomes
EP2297349A1 (en) * 2008-06-04 2011-03-23 The Arizona Board Of Regents On Behalf Of The University Of Arizona Diffuse large b-cell lymphoma markers and uses therefor
WO2009149359A2 (en) 2008-06-06 2009-12-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Survival predictor for diffuse large b cell lymphoma
WO2009152102A2 (en) * 2008-06-10 2009-12-17 The Regents Of The University Of California Pro-fluorescent probes
WO2010008480A2 (en) 2008-06-25 2010-01-21 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes using large scale fet arrays
CA2729856A1 (en) * 2008-07-04 2010-01-07 Decode Genetics Ehf. Copy number variations predictive of risk of schizophrenia
EP2313525A2 (en) 2008-07-07 2011-04-27 Decode Genetics EHF Genetic variants for breast cancer risk assessment
US8962248B2 (en) 2008-07-09 2015-02-24 Panasonic Corporation Sequencer
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
CA2731730C (en) * 2008-07-23 2017-06-13 President And Fellows Of Harvard College Deacetylase inhibitors and uses thereof
US9182406B2 (en) * 2008-08-04 2015-11-10 Biodesy, Inc. Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
CN102177252B (en) * 2008-08-12 2014-12-24 解码遗传学私营有限责任公司 Genetic variants useful for risk assessment of thyroid cancer
US8530716B2 (en) * 2008-08-14 2013-09-10 Bp Corporation North America Inc. Melt-crystallization separation and purification process
US20110212855A1 (en) * 2008-08-15 2011-09-01 Decode Genetics Ehf. Genetic Variants Predictive of Cancer Risk
EP2324129A4 (en) 2008-08-18 2012-06-20 Univ Leland Stanford Junior Methods and compositions for determining a graft tolerant phenotype in a subject
WO2010025310A2 (en) 2008-08-27 2010-03-04 Westend Asset Clearinghouse Company, Llc Methods and devices for high fidelity polynucleotide synthesis
KR20100025328A (en) * 2008-08-27 2010-03-09 삼성전자주식회사 Method of producing microarray having immoblized double strand nucleic acids comprising double strand region and terminal single strand region
US8357503B2 (en) 2008-08-29 2013-01-22 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
CA2734519C (en) 2008-08-29 2018-11-13 Centocor Ortho Biotech Inc. Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel
US8198062B2 (en) 2008-08-29 2012-06-12 Dsm Ip Assets B.V. Hydrolases, nucleic acids encoding them and methods for making and using them
US8153391B2 (en) 2008-08-29 2012-04-10 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
AU2009292629B2 (en) 2008-09-16 2014-03-20 Pacific Biosciences Of California, Inc. Substrates and optical systems and methods of use thereof
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US8476013B2 (en) * 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US20100075439A1 (en) * 2008-09-23 2010-03-25 Quanterix Corporation Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantification
US8222047B2 (en) * 2008-09-23 2012-07-17 Quanterix Corporation Ultra-sensitive detection of molecules on single molecule arrays
US20100075862A1 (en) * 2008-09-23 2010-03-25 Quanterix Corporation High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample
WO2010036943A2 (en) 2008-09-25 2010-04-01 Suregene Llc Genetic markers for assessing risk of developing bipolar disorder
US20100087325A1 (en) * 2008-10-07 2010-04-08 Illumina, Inc. Biological sample temperature control system and method
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
EP2340314B8 (en) 2008-10-22 2015-02-18 Illumina, Inc. Preservation of information related to genomic dna methylation
US20100301398A1 (en) 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
CA2742324A1 (en) 2008-10-30 2010-06-03 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods for assessing rna patterns
JP5502413B2 (en) * 2008-10-31 2014-05-28 シスメックス株式会社 Test chip, test substance detection device, and test substance specific detection method
JP5391279B2 (en) * 2008-10-31 2014-01-15 アッヴィ・インコーポレイテッド Method for constructing a panel of cancer cell lines for use in testing the efficacy of one or more pharmaceutical compositions
EP2362958A2 (en) * 2008-10-31 2011-09-07 Abbott Laboratories Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations
US8498821B2 (en) * 2008-10-31 2013-07-30 Abbvie Inc. Genomic classification of malignant melanoma based on patterns of gene copy number alterations
MX2011004606A (en) * 2008-10-31 2011-05-25 Abbott Lab Genomic classification of colorectal cancer based on patterns of gene copy number alterations.
WO2010054195A2 (en) 2008-11-07 2010-05-14 Centocor Ortho Biotech Inc. Markers and methods for assessing and treating lupus patients susceptible to photoprovocation
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
CA2743211A1 (en) 2008-11-12 2010-05-20 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems of using exosomes for determining phenotypes
GB0820822D0 (en) 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
CA2743464A1 (en) 2008-11-14 2010-05-20 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
JP5840498B2 (en) 2008-12-05 2016-01-06 グラクソ グループ リミテッドGlaxo Group Limited Methods for selecting protease resistant polypeptides
EP2373817A4 (en) * 2008-12-10 2013-01-02 Illumina Inc Methods and compositions for hybridizing nucleic acids
US8039794B2 (en) 2008-12-16 2011-10-18 Quest Diagnostics Investments Incorporated Mass spectrometry assay for thiopurine-S-methyl transferase activity and products generated thereby
US8374818B2 (en) * 2008-12-19 2013-02-12 Affymetrix, Inc. System, method and apparatus for calibrating inspection tools
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
US20100161607A1 (en) * 2008-12-22 2010-06-24 Jasjit Singh System and method for analyzing genome data
EP2382472B1 (en) 2008-12-23 2015-05-06 F.Hoffmann-La Roche Ag Methods and compositions for diagnostic use in cancer patients
US8108406B2 (en) 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
EP3276526A1 (en) 2008-12-31 2018-01-31 23Andme, Inc. Finding relatives in a database
US8715732B2 (en) * 2009-01-05 2014-05-06 Cornell University Nucleic acid hydrogel via rolling circle amplification
KR20110106436A (en) * 2009-01-09 2011-09-28 신텔렉트 인코포레이티드 Genetic analysis of cells
JP2012514981A (en) 2009-01-12 2012-07-05 イントレクソン コーポレイション Cell-mediated sectioning and migration of cell colonies
EP2387627B1 (en) 2009-01-15 2016-03-30 Adaptive Biotechnologies Corporation Adaptive immunity profiling and methods for generation of monoclonal antibodies
EP2387563B2 (en) 2009-01-16 2022-04-27 Exelixis, Inc. Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quinolin-4-yl]oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
SG173078A1 (en) 2009-01-22 2011-08-29 Momenta Pharmaceuticals Inc Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from cho cells
KR20100086827A (en) * 2009-01-23 2010-08-02 삼성전자주식회사 Method of analyzing probe nucleic acid, microarray and kit for same and method of determining yield for probe synthesis
US8940501B2 (en) 2009-01-30 2015-01-27 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
EP2393596B1 (en) * 2009-02-09 2016-09-28 Whitespace Enterprise Corporation Microfluidic devices and methods of providing a storable sample
JP2012517238A (en) 2009-02-11 2012-08-02 カリス エムピーアイ インコーポレイテッド Molecular profiling of tumors
US20100331204A1 (en) * 2009-02-13 2010-12-30 Jeff Jeddeloh Methods and systems for enrichment of target genomic sequences
US20110306069A1 (en) 2009-02-19 2011-12-15 Qingyu Wu Corin As A Marker For Heart Failure
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
DK2406399T3 (en) * 2009-03-09 2018-03-12 Bioatla Llc MIRAC PROTEINS
JP5342421B2 (en) * 2009-03-11 2013-11-13 信越化学工業株式会社 Method for producing molecular immobilization substrate
ES2742251T3 (en) 2009-03-16 2020-02-13 Pangu Biopharma Ltd Compositions and methods comprising variants of histidyl tarn synthetase splicing that have non-canonical biological activities
EP2408936A4 (en) * 2009-03-18 2013-01-30 Sequenom Inc Use of thermostable endonucleases for generating reporter molecules
WO2010107088A1 (en) 2009-03-18 2010-09-23 Toto株式会社 Measurement device used for specifically detecting substance to be examined using photocurrent, sensor unit used for same, and method for specifically detecting substance to be examined using photocurrent
EP3415235A1 (en) 2009-03-23 2018-12-19 Raindance Technologies Inc. Manipulation of microfluidic droplets
WO2010111686A2 (en) 2009-03-27 2010-09-30 Life Technologies Corp Labeled enzyme compositions, methods & systems
WO2010113088A1 (en) * 2009-03-31 2010-10-07 Centre Hospitalier Universitaire Vaudois Methylation ligation-dependent macroarray (mlm)
CA2757289A1 (en) 2009-03-31 2010-10-21 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
CN102449165B (en) 2009-04-03 2014-07-09 解码遗传学私营有限责任公司 Genetic markers for risk management of atrial fibrillation and stroke
EP3211095B1 (en) 2009-04-03 2019-01-02 Sequenom, Inc. Nucleic acid preparation compositions and methods
AR078033A1 (en) 2009-04-03 2011-10-12 Plexxikon Inc A SOLID DISPERSION, CONTAINING THE COMPOUND {3- [5- (4- (CHLORINE-PHENYL) -1H-PIRROLO [2,3-B] PIRIDINA-3-CARBONIL] -2,4-DIFLUOR-PHENIL} -AMIDA OF PROPANE-1-SULPHONIC ACID, COMPOSITIONS AND FORMULATIONS THAT INCLUDE SUCH SOLID DISPERSION; METHODS FOR MANUFACTURING SUCH SOLID DISPERSION, FORMS 1 AND 2
US20100297127A1 (en) 2009-04-08 2010-11-25 Ghilardi Nico P Use of il-27 antagonists to treat lupus
CN102448977A (en) * 2009-04-09 2012-05-09 加州理工学院 Multiplexed sites for polymer synthesis
BRPI1011394A8 (en) 2009-04-18 2018-06-26 Genentech Inc method for assessing B cell linforma responsiveness to anti-cd40 antibody treatment
US20100330569A1 (en) 2009-04-23 2010-12-30 Intelligent Bio-Systems, Inc. Hydroxymethyl Linkers For Labeling Nucleotides
US8741581B2 (en) 2009-04-27 2014-06-03 Technion Research And Development Foundation Ltd. Markers for cancer detection
US9206482B2 (en) 2009-04-29 2015-12-08 Genomedx Biosciences Inc. Systems and methods for expression-based classification of thyroid tissue
EP2427575B1 (en) 2009-05-07 2018-01-24 Veracyte, Inc. Methods for diagnosis of thyroid conditions
EP2451975A4 (en) * 2009-05-08 2013-08-14 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
WO2010129937A2 (en) * 2009-05-08 2010-11-11 Life Technologies Corporation Methods for detecting genetic variations in dna samples
EP2253715A1 (en) 2009-05-14 2010-11-24 RWTH Aachen New targets for cancer therapy and/or diagnosis
NZ596459A (en) 2009-05-21 2013-11-29 Verenium Corp Phytases, nucleic acids encoding them and methods for making and using them
US20100298171A1 (en) * 2009-05-22 2010-11-25 Affymetrix, Inc. Apparatus for polymer synthesis
US9767342B2 (en) 2009-05-22 2017-09-19 Affymetrix, Inc. Methods and devices for reading microarrays
US8776573B2 (en) 2009-05-29 2014-07-15 Life Technologies Corporation Methods and apparatus for measuring analytes
US20120261274A1 (en) 2009-05-29 2012-10-18 Life Technologies Corporation Methods and apparatus for measuring analytes
WO2010138456A2 (en) 2009-05-29 2010-12-02 The Regents Of The University Of California B cell signature associated with tolerance in transplant recipients
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
CN102575252B (en) 2009-06-01 2016-04-20 光环生物干扰疗法公司 For polynucleotide, the compoistion and method of use of multivalence RNA interference
WO2010141546A1 (en) 2009-06-02 2010-12-09 University Of Miami Diagnostic transcriptomic biomakers in inflammatory cardiomyopathies
US8632975B2 (en) 2009-06-05 2014-01-21 Life Technologies Corporation Nucleotide transient binding for sequencing methods
EP2977455B1 (en) 2009-06-15 2020-04-15 Complete Genomics, Inc. Method for long fragment read sequencing
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
EP2443459B1 (en) 2009-06-19 2018-12-26 The Arizona Board of Regents, A Body Corporate Of the State of Arizona acting for and on behalf Of Arizona State University Compound arrays for sample profiling
JP5359600B2 (en) * 2009-06-24 2013-12-04 Jsr株式会社 Acid transfer resin composition and biochip manufacturing method
SG177355A1 (en) 2009-06-26 2012-02-28 Sirigen Inc Signal amplified biological detection with conjugated polymers
WO2011006169A1 (en) 2009-07-10 2011-01-13 Portola Pharmaceuticals, Inc. Methods for diagnosis and treatment of thrombotic disorders mediated by cyp2c19*2
AU2010269841A1 (en) 2009-07-10 2012-02-23 Decode Genetics Ehf Genetic markers associated with risk of diabetes mellitus
AU2010273585B2 (en) 2009-07-13 2015-04-23 Genentech, Inc. Diagnostic methods and compositions for treatment of cancer
US8501406B1 (en) 2009-07-14 2013-08-06 Pacific Biosciences Of California, Inc. Selectively functionalized arrays
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
UA108618C2 (en) 2009-08-07 2015-05-25 APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
MX2012001716A (en) 2009-08-14 2012-04-02 Genentech Inc Biological markers for monitoring patient response to vegf antagonists.
SG10201407329RA (en) * 2009-08-14 2015-01-29 Phasebio Pharmaceuticals Inc Modified vasoactive intestinal peptides
US9771618B2 (en) * 2009-08-19 2017-09-26 Bioarray Genetics, Inc. Methods for treating breast cancer
EP3805762B1 (en) 2009-08-22 2024-02-07 Ares Trading S.A. Imaging and evaluating embryos, oocytes, and stem cells
US20110059453A1 (en) * 2009-08-23 2011-03-10 Affymetrix, Inc. Poly(A) Tail Length Measurement by PCR
US20110052446A1 (en) 2009-08-31 2011-03-03 Life Technologies Corporation Flow cells and methods of filling and using same
US10174368B2 (en) 2009-09-10 2019-01-08 Centrillion Technology Holdings Corporation Methods and systems for sequencing long nucleic acids
WO2011032040A1 (en) 2009-09-10 2011-03-17 Centrillion Technology Holding Corporation Methods of targeted sequencing
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
US8969009B2 (en) * 2009-09-17 2015-03-03 Vicki S. Thompson Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
ES2530732T3 (en) 2009-09-17 2015-03-05 Hoffmann La Roche Diagnostic procedures for lung cancer
US9410965B2 (en) * 2009-09-17 2016-08-09 Battelle Energy Alliance, Llc Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
AU2010298000A1 (en) 2009-09-25 2012-04-05 Signature Genomics Laboratories Llc Multiplex (+/-) stranded arrays and assays for detecting chromosomal abnormalities associated with cancer and other diseases
TWI384554B (en) * 2009-10-02 2013-02-01 Univ Southern Taiwan Tech Cell particle control biochip with three layers of electrodes and microcavity arrays and manufacture method for the same
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
UA109884C2 (en) 2009-10-16 2015-10-26 A POLYPEPTIDE THAT HAS THE ACTIVITY OF THE PHOSPHATIDYLINOSYTOL-SPECIFIC PHOSPHOLIPASE C, NUCLEIC ACID, AND METHOD OF METHOD
UA111708C2 (en) 2009-10-16 2016-06-10 Бандж Ойлз, Інк. METHOD OF OIL REFINING
PL2488873T3 (en) 2009-10-16 2016-01-29 Novartis Ag Biomarkers of tumor pharmacodynamic response
EP2491140A1 (en) 2009-10-19 2012-08-29 Stichting Het Nederlands Kanker Instituut Predicting response to anti-cancer therapy via array comparative genomic hybridization
US20120316080A1 (en) 2009-10-19 2012-12-13 Stichting Het Nederlands Kanker Instiuut Differentiation between brca2-associated tumours and sporadic tumours via array comparative genomic hybridization
US20120322677A1 (en) 2009-10-19 2012-12-20 Stichting Het Nederlands Kanker Instituut Predicting benefit of anti-cancer therapy via array comparative genomic hybridization
EP2314714A1 (en) 2009-10-22 2011-04-27 Universiteit Leiden Disease susceptibility
EP2491137B1 (en) 2009-10-22 2018-07-25 Universiteit Leiden Biomarkers associated with depression
EP3272884A3 (en) 2009-10-26 2018-02-14 Abbott Molecular Inc. Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer
WO2011056688A2 (en) 2009-10-27 2011-05-12 Caris Life Sciences, Inc. Molecular profiling for personalized medicine
EP2494069B1 (en) 2009-10-30 2013-10-02 Roche Diagniostics GmbH Method for detecting balanced chromosomal aberrations in a genome
US10207240B2 (en) 2009-11-03 2019-02-19 Gen9, Inc. Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly
US7972793B2 (en) 2009-11-04 2011-07-05 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
US20120282276A1 (en) 2009-11-05 2012-11-08 The Regents Of The University Of Michigan Biomarkers predictive of progression of fibrosis
NZ599866A (en) 2009-11-06 2014-09-26 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
WO2011060069A2 (en) 2009-11-11 2011-05-19 Momenta Pharmaceuticals, Inc. Glycosyl transferase from chinese hamster and related methods
CA2812929C (en) * 2009-11-12 2015-02-03 Texas Tech University Compositions and methods for treating hyperproliferative disorders
WO2011062962A2 (en) 2009-11-17 2011-05-26 The Trustees Of The University Of Pennsylvania Smndelta7 degron: novel compositions and methods of use
CN102713629B (en) 2009-11-20 2016-02-24 俄勒冈健康科学大学 For detecting the method for m tuberculosis infection
JP6220126B2 (en) * 2009-11-23 2017-10-25 セルリアン・ファーマ・インコーポレイテッド Polymers based on cyclodextrins for therapeutic delivery
WO2011066185A1 (en) 2009-11-25 2011-06-03 Gen9, Inc. Microfluidic devices and methods for gene synthesis
ES2574055T3 (en) 2009-11-25 2016-06-14 Gen9, Inc. Methods and apparatus for error reduction in chip-based DNA
WO2011066589A1 (en) 2009-11-30 2011-06-03 Caris Life Sciences Luxembourg Holdings Methods and systems for isolating, storing, and analyzing vesicles
US9290813B2 (en) 2009-12-02 2016-03-22 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
US8501122B2 (en) 2009-12-08 2013-08-06 Affymetrix, Inc. Manufacturing and processing polymer arrays
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US20110143966A1 (en) * 2009-12-15 2011-06-16 Affymetrix, Inc. Surface Modifications and Methods for their Synthesis and Use
US9315857B2 (en) 2009-12-15 2016-04-19 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse label-tags
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
GB0922085D0 (en) 2009-12-17 2010-02-03 Cambridge Entpr Ltd Cancer diagnosis and treatment
DE102009059112A1 (en) 2009-12-18 2011-06-22 Biotype Diagnostic GmbH, 01109 A device for determining molecular interactions, and a film for producing such
FR2954349A1 (en) 2009-12-22 2011-06-24 Agronomique Inst Nat Rech SULFATASE SELECTIVELY MODIFYING GLYCOSAMINOGLYCANS
ES2577017T3 (en) 2009-12-22 2016-07-12 Sequenom, Inc. Procedures and kits to identify aneuploidy
GB0922377D0 (en) 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
EP2517020B1 (en) 2009-12-23 2015-10-21 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
PL2516465T3 (en) 2009-12-23 2016-11-30 Anti-bv8 antibodies and uses thereof
JP2013515500A (en) 2009-12-29 2013-05-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド A composition comprising ginger for the improvement or prevention of inflammatory diseases
SG182303A1 (en) 2009-12-31 2012-08-30 Ventana Med Syst Inc Methods for producing uniquely specific nucleic acid probes
US9217144B2 (en) 2010-01-07 2015-12-22 Gen9, Inc. Assembly of high fidelity polynucleotides
CA2787027A1 (en) 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Detection of gastrointestinal disorders
WO2011091086A1 (en) 2010-01-19 2011-07-28 Sirigen Inc. Novel reagents for directed biomarker signal amplification
WO2011090793A2 (en) 2010-01-20 2011-07-28 Customarray, Inc. Multiplex microarray of serially deposited biomolecules on a microarray
CA3101636A1 (en) 2010-01-26 2011-08-04 National Jewish Health Diagnosis and prognosis of idiopathic interstitial pneumonia by rs35705950 snp in muc5b gene promoter
CN102781517B (en) 2010-02-01 2015-11-25 小利兰·斯坦福大学托管委员会 The method of Diagnosis and Treat noninsulindependent diabetes
EP3151052A1 (en) 2010-02-01 2017-04-05 Illumina, Inc. Focusing methods and optical systems and assemblies using the same
EA201201113A1 (en) 2010-02-10 2013-03-29 Новартис Аг METHODS AND CONNECTIONS FOR GROWTH OF MUSCLE
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
WO2011100604A2 (en) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Digital analyte analysis
US8415171B2 (en) 2010-03-01 2013-04-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
ES2544635T3 (en) 2010-03-01 2015-09-02 Quanterix Corporation Methods to extend the dynamic range in assays for the detection of molecules or particles
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
US9678068B2 (en) 2010-03-01 2017-06-13 Quanterix Corporation Ultra-sensitive detection of molecules using dual detection methods
US8716467B2 (en) 2010-03-03 2014-05-06 Gen9, Inc. Methods and devices for nucleic acid synthesis
WO2011108930A1 (en) 2010-03-04 2011-09-09 Interna Technologies Bv A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT
CN202281746U (en) 2010-03-06 2012-06-20 伊鲁米那股份有限公司 Measuring equipment for detecting optical signal from sample as well as optical module and optical system for measuring equipment
EP2369325A1 (en) 2010-03-12 2011-09-28 Eppendorf Ag Array analysis for online detection
CA2794255C (en) 2010-03-25 2020-01-14 Minnie M. Sarwal Protein and gene biomarkers for rejection of organ transplants
JP2013526852A (en) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス Circulating biomarkers for disease
EP2765227A3 (en) 2010-04-06 2014-12-10 The George Washington University Compositions and methods for identifying autism spectrum disorders
ES2644258T5 (en) 2010-04-16 2021-02-02 Momentum Bioscience Ltd Useful Enzyme Activity Measurement Methods for Determining Cell Viability in Non-Purified Samples
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
CN103079567A (en) 2010-04-17 2013-05-01 拜尔健康护理有限责任公司 Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions
KR20120137407A (en) 2010-04-19 2012-12-20 더 프록터 앤드 갬블 캄파니 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto
JP2013524946A (en) 2010-04-19 2013-06-20 ザ プロクター アンド ギャンブル カンパニー Combination of energy and topical composition for regulating mammalian skin condition
WO2011139714A2 (en) 2010-04-26 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
CN103096911B (en) 2010-04-27 2018-05-29 Atyr 医药公司 Treatment relevant with the protein fragments of Isoleucyl-tRNA synthetase, diagnosis and the innovation of antibody compositions are found
US20120003639A1 (en) 2010-04-27 2012-01-05 Prelude, Inc. Cancer biomarkers and methods of use thereof
WO2011139853A2 (en) 2010-04-28 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
WO2011150279A2 (en) 2010-05-27 2011-12-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
CA2800557A1 (en) 2010-04-29 2011-11-03 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy
CN103097523B (en) 2010-04-29 2016-09-28 Atyr医药公司 The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds
AU2011248457B2 (en) 2010-04-29 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
US8961961B2 (en) 2010-05-03 2015-02-24 a Tyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
US8981045B2 (en) 2010-05-03 2015-03-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases
CN105820252B (en) 2010-05-03 2020-07-21 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl- α -tRNA synthetases
CA2798139C (en) 2010-05-04 2019-09-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
US20120065085A1 (en) 2010-05-10 2012-03-15 Abbott Laboratories Detection of chromosomal abnormalities associated with endometrial cancer
US10240194B2 (en) 2010-05-13 2019-03-26 Gen9, Inc. Methods for nucleotide sequencing and high fidelity polynucleotide synthesis
CN103200953B (en) 2010-05-14 2017-02-15 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
CN106691462B (en) 2010-05-17 2020-11-10 申提留斯控股有限公司 Detection device and related method of use
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
WO2011146725A1 (en) 2010-05-19 2011-11-24 Bayer Healthcare Llc Biomarkers for a multikinase inhibitor
EP2388336A1 (en) 2010-05-19 2011-11-23 Signature Diagnostics AG Method and kits for diagnosing colorectal cancer
WO2011150168A1 (en) 2010-05-28 2011-12-01 Gen9, Inc. Methods and devices for in situ nucleic acid synthesis
EP2575857B1 (en) 2010-06-01 2018-01-24 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
WO2011153224A2 (en) 2010-06-02 2011-12-08 Genentech, Inc. Diagnostic methods and compositions for treatment of cancer
CA2800913C (en) 2010-06-03 2019-07-23 Pharmacyclics, Inc. The use of inhibitors of bruton's tyrosine kinase (btk)
US9228240B2 (en) 2010-06-03 2016-01-05 California Institute Of Technology Methods for detecting and quantifying viable bacterial endo-spores
WO2011150976A1 (en) 2010-06-04 2011-12-08 bioMérieux Method and kit for the prognosis of colorectal cancer
EP2576837B1 (en) 2010-06-04 2017-09-06 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
WO2011154139A2 (en) 2010-06-07 2011-12-15 Roche Diagnostics Gmbh Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
CN103153346A (en) 2010-06-16 2013-06-12 戴纳瓦克斯技术公司 Methods of treatment using tlr7 and/or tlr9 inhibitors
US9353412B2 (en) 2010-06-18 2016-05-31 Illumina, Inc. Conformational probes and methods for sequencing nucleic acids
BR112012032462A2 (en) 2010-06-25 2016-11-08 Eisai R&D Man Co Ltd antitumor agent employing compounds which, in combination, have kinase inhibiting effect.
US9164070B2 (en) 2010-06-30 2015-10-20 Life Technologies Corporation Column adc
US20120001646A1 (en) 2010-06-30 2012-01-05 Life Technologies Corporation Methods and apparatus for testing isfet arrays
JP2013533482A (en) 2010-06-30 2013-08-22 ライフ テクノロジーズ コーポレーション Ion-sensitive charge storage circuit and method
US11307166B2 (en) 2010-07-01 2022-04-19 Life Technologies Corporation Column ADC
JP5876044B2 (en) 2010-07-03 2016-03-02 ライフ テクノロジーズ コーポレーション Chemically sensitive sensor with lightly doped drain
CA2804599C (en) 2010-07-06 2023-01-31 Interna Technologies Bv Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
SG10201505475XA (en) 2010-07-12 2015-09-29 Celgene Corp Romidepsin solid forms and uses thereof
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
CA2803011C (en) 2010-07-16 2019-12-03 Tocagen Inc. Retrovirus detection
CN103392182B (en) 2010-08-02 2017-07-04 众有生物有限公司 System and method for finding pathogenic mutation in genetic disease
WO2012019099A2 (en) 2010-08-05 2012-02-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Follistatin-like-protein-1 as a biomarker for inflammatory disorders
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
US11203786B2 (en) 2010-08-06 2021-12-21 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
US11031095B2 (en) 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US10533223B2 (en) 2010-08-06 2020-01-14 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US8834847B2 (en) 2010-08-12 2014-09-16 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
WO2012021969A1 (en) 2010-08-16 2012-02-23 Mount Sinai Hospital Markers of the male urogenital tract
NZ606725A (en) 2010-08-24 2014-06-27 Dana Farber Cancer Inst Inc Methods for predicting anti-cancer response
CN103108650A (en) 2010-08-25 2013-05-15 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
US8859502B2 (en) 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
CA3154149A1 (en) 2010-09-13 2012-03-22 Clinical Genomics Pty. Ltd. Epigenetic markers of colorectal cancers and diagnostic methods using the same
KR20130115250A (en) 2010-09-15 2013-10-21 알막 다이아그노스틱스 리미티드 Molecular diagnostic test for cancer
EP2617061B1 (en) 2010-09-15 2021-06-30 Life Technologies Corporation Methods and apparatus for measuring analytes
EP2616554A1 (en) 2010-09-17 2013-07-24 President and Fellows of Harvard College Functional genomics assay for characterizing pluripotent stem cell utility and safety
WO2012038837A2 (en) 2010-09-20 2012-03-29 Stichting Het Nederlands Kanker Instituut Methods for predicting response to anti-cancer therapy in cancer patients
DK2623613T3 (en) 2010-09-21 2016-10-03 Population Genetics Tech Ltd Increasing the reliability of the allele-indications by molecular counting
CN105911126B (en) 2010-09-24 2018-12-18 生命科技公司 Matched transistor pair circuit
US9110079B2 (en) 2010-09-29 2015-08-18 Biomerieux Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
US8759038B2 (en) 2010-09-29 2014-06-24 Illumina Cambridge Limited Compositions and methods for sequencing nucleic acids
EP3447155A1 (en) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwich assays in droplets
CA2811789A1 (en) 2010-10-06 2012-04-12 Bp Corporation North America Inc. Variant cbh i polypeptides with reduced product inhibition
US9279770B2 (en) 2010-10-15 2016-03-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mid-infrared imaging of microarrays
US20120095029A1 (en) 2010-10-15 2012-04-19 Hoffmann-La Roche Inc. Ipp complex as marker for erlotinib treatment
EP2633069B1 (en) 2010-10-26 2015-07-01 Illumina, Inc. Sequencing methods
US20130315934A1 (en) 2010-10-28 2013-11-28 Yale University Methods and Compositions for Assessing and Treating Cancer
GB201018312D0 (en) 2010-10-29 2010-12-15 Vib Vzw Metagene expression signature for prognosis of breast cancer patients
US10457935B2 (en) 2010-11-12 2019-10-29 Gen9, Inc. Protein arrays and methods of using and making the same
EP3360963B1 (en) 2010-11-12 2019-11-06 Gen9, Inc. Methods and devices for nucleic acids synthesis
JP6163104B2 (en) 2010-11-15 2017-07-12 アクセラレイテッド・バイオサイエンシズ・コーポレーション Generation of neural stem cells from human trophoblast stem cells
WO2012068400A2 (en) 2010-11-17 2012-05-24 Asuragen, Inc. Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
JP2014506117A (en) 2010-11-24 2014-03-13 エフ.ホフマン−ラ ロシュ アーゲー Method for detecting mild inflammation
WO2012071525A2 (en) 2010-11-24 2012-05-31 Yale University Compositions and methods for diagnosing and treating diseases and disorders associated with d-dt
JP5754685B2 (en) * 2010-12-02 2015-07-29 国立研究開発法人農業・食品産業技術総合研究機構 How to synthesize a build-up combinatorial library on a substrate
EP2651961A1 (en) 2010-12-13 2013-10-23 De Staat Der Nederlanden, Vert. Door De Minister Van VWS Protein affinity tag and uses thereof
KR20120066924A (en) 2010-12-15 2012-06-25 제일모직주식회사 Ortho-nitrobenzyl ester compound and positive type photosensitive resin composition including the same
WO2012083240A2 (en) 2010-12-16 2012-06-21 Dana-Farber Cancer Institute, Inc. Oligonucleotide array for tissue typing
JP2012131718A (en) 2010-12-20 2012-07-12 Samsung Electronics Co Ltd Method for synthesizing compound, microarray, composition for acid transfer, and composition for fabricating biochip
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
US8951781B2 (en) 2011-01-10 2015-02-10 Illumina, Inc. Systems, methods, and apparatuses to image a sample for biological or chemical analysis
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
EP2663656B1 (en) 2011-01-13 2016-08-24 Decode Genetics EHF Genetic variants as markers for use in urinary bladder cancer risk assessment
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US8756020B2 (en) 2011-01-25 2014-06-17 Ariosa Diagnostics, Inc. Enhanced risk probabilities using biomolecule estimations
US11270781B2 (en) 2011-01-25 2022-03-08 Ariosa Diagnostics, Inc. Statistical analysis for non-invasive sex chromosome aneuploidy determination
WO2012103031A2 (en) 2011-01-25 2012-08-02 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
PE20141360A1 (en) 2011-02-07 2014-10-13 Plexxikon Inc COMPOUNDS AND METHODS FOR THE MODULATION OF KINASES AND INDICATIONS FOR THEM.
EP2673381A4 (en) 2011-02-07 2014-10-15 Univ Toronto Bioprobes and methods of use thereof
US20130345085A1 (en) 2011-02-10 2013-12-26 Mitsubishi Rayon Co., Ltd. Method for detecting nucleic acid
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
TWI558702B (en) 2011-02-21 2016-11-21 普雷辛肯公司 Solid forms of a pharmaceutically active substance
CN103460038A (en) 2011-02-23 2013-12-18 里兰斯坦福初级大学理事会 Methods of detecting aneuploidy in human embryos
EP3062108B1 (en) 2011-02-24 2019-06-19 Hill's Pet Nutrition, Inc. Methods for diagnosing kidney disorders in a feline
US20140057295A1 (en) 2011-02-28 2014-02-27 Barbara J. Stegmann Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
US20120219950A1 (en) 2011-02-28 2012-08-30 Arnold Oliphant Assay systems for detection of aneuploidy and sex determination
SG10201601224WA (en) 2011-03-02 2016-03-30 Berg Llc Interrogatory cell-based assays and uses thereof
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
ES2551922T3 (en) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Rapid cell purification systems
JP2014509515A (en) 2011-03-18 2014-04-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 Methods and compositions for predicting response to eribulin
WO2012129347A1 (en) 2011-03-21 2012-09-27 Biodesy, Llc Classification of kinase inhibitors using nonlinear optical techniques
EP2689028B1 (en) 2011-03-23 2017-08-30 Pacific Biosciences Of California, Inc. Isolation of polymerase-nucleic acid complexes and loading onto substrates
WO2012129758A1 (en) 2011-03-25 2012-10-04 Biomerieux Method and kit for determining in vitro probability for individual to suffer from colorectal cancer
EP2691538A1 (en) 2011-03-28 2014-02-05 Novartis AG Markers associated with cyclin-dependent kinase inhibitors
WO2012134813A1 (en) 2011-03-31 2012-10-04 St. Jude Children's Research Hospital Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
US20120252682A1 (en) 2011-04-01 2012-10-04 Maples Corporate Services Limited Methods and systems for sequencing nucleic acids
US20140287931A1 (en) 2011-04-04 2014-09-25 Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis Methods and compositions for predicting resistance to anticancer treatment
WO2012138783A2 (en) 2011-04-04 2012-10-11 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment
EP2694554A1 (en) 2011-04-08 2014-02-12 Gilead Biologics, Inc. Methods and compositions for normalization of tumor vasculature by inhibition of loxl2
US20120258871A1 (en) 2011-04-08 2012-10-11 Prognosys Biosciences, Inc. Peptide constructs and assay systems
WO2012142301A2 (en) 2011-04-12 2012-10-18 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
WO2012142656A1 (en) 2011-04-18 2012-10-26 Garvan Institute Of Medical Research Method of diagnosing cancer
EP2700403B1 (en) 2011-04-18 2015-11-25 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
AU2012249531B2 (en) 2011-04-29 2017-06-29 Sequenom, Inc. Quantification of a minority nucleic acid species
EP2520661A1 (en) 2011-05-02 2012-11-07 Rheinische Friedrich-Wilhelms-Universität Bonn Blood-based gene expression signatures in lung cancer
EP2527459A1 (en) 2011-05-02 2012-11-28 Rheinische Friedrich-Wilhelms-Universität Bonn Blood-based gene detection of non-small cell lung cancer
CA2834976C (en) 2011-05-04 2016-03-15 Htg Molecular Diagnostics, Inc. Quantitative nuclease protection assay (qnpa) and sequencing (qnps) improvements
RU2631487C2 (en) 2011-05-17 2017-09-22 Плексксикон Инк. Kinases modulation and indications for its use
EP2710147A1 (en) 2011-05-18 2014-03-26 Rheinische Friedrich-Wilhelms-Universität Bonn Molecular analysis of acute myeloid leukemia
WO2012159089A1 (en) 2011-05-19 2012-11-22 Sequenom, Inc. Products and processes for multiplex nucleic acid identification
EP2524967A1 (en) 2011-05-19 2012-11-21 Signature Diagnostics AG Methods and kits for diagnosing colorectal cancer
EP2524968A1 (en) 2011-05-19 2012-11-21 Signature Diagnostics AG Methods and kits for diagnosing colorectal cancer
US20140106986A1 (en) 2011-06-01 2014-04-17 Medical Prognosis Institute A/S Methods and devices for prognosis of cancer relapse
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US20140094461A1 (en) 2011-06-02 2014-04-03 Novartis Ag Biomarkers for hedgehog inhibitor therapy
WO2012167142A2 (en) 2011-06-02 2012-12-06 Raindance Technolgies, Inc. Enzyme quantification
BR112013031019A2 (en) 2011-06-02 2017-03-21 Almac Diagnostics Ltd molecular diagnostic test for cancer
EP2714937B1 (en) 2011-06-03 2018-11-14 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
CA2873553C (en) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
EP2718465B1 (en) * 2011-06-09 2022-04-13 Illumina, Inc. Method of making an analyte array
US9752176B2 (en) 2011-06-15 2017-09-05 Ginkgo Bioworks, Inc. Methods for preparative in vitro cloning
EP3517611A3 (en) 2011-06-15 2019-09-04 Gen9, Inc. Methods for preparative in vitro cloning
US10144969B2 (en) 2011-06-15 2018-12-04 Colgate-Palmolive Company Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline
US10711308B2 (en) 2011-06-17 2020-07-14 Brigham And Women's Hospital, Inc. Mutation signatures for predicting the survivability of myelodysplastic syndrome subjects
WO2012174378A2 (en) 2011-06-17 2012-12-20 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
WO2012178007A1 (en) 2011-06-22 2012-12-27 Yale University COMPOSITIONS AND METHODS OF DIAGNOSING DISEASES AND DISORDERS ASSOCIATED WITH β CELL DEATH
US20140235474A1 (en) 2011-06-24 2014-08-21 Sequenom, Inc. Methods and processes for non invasive assessment of a genetic variation
WO2013009705A2 (en) 2011-07-09 2013-01-17 The Trustees Of Columbia University In The City Of New York Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
KR101545826B1 (en) 2011-07-25 2015-08-19 씨에스아이알 Array printing
US8723140B2 (en) 2011-08-09 2014-05-13 Palo Alto Research Center Incorporated Particle analyzer with spatial modulation and long lifetime bioprobes
US9029800B2 (en) 2011-08-09 2015-05-12 Palo Alto Research Center Incorporated Compact analyzer with spatial modulation and multiple intensity modulated excitation sources
AU2012300401B2 (en) 2011-08-26 2018-02-08 Gen9, Inc. Compositions and methods for high fidelity assembly of nucleic acids
US9435812B2 (en) 2011-08-31 2016-09-06 Ventana Medical Systems, Inc. Expression of ETS related gene (ERG) and phosphatase and tensin homolog (PTEN) correlates with prostate cancer capsular penetration
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
WO2013036290A1 (en) 2011-09-09 2013-03-14 Yale University Compositions and methods for assessing and treating inflammatory diseases and disorders
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
CN104040337B (en) 2011-09-22 2017-07-14 迈德维特科学有限公司 Screening technique
EP2762873A4 (en) 2011-09-26 2015-05-20 Toto Ltd Method for specifically detecting test substance
JP2015527870A (en) 2011-10-03 2015-09-24 セルマティックス, インコーポレイテッド Method and device for assessing the risk of presumed births developing a condition
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
WO2013052907A2 (en) 2011-10-06 2013-04-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9566560B2 (en) 2011-10-06 2017-02-14 Illumina, Inc. Array domains having rotated patterns
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20130090329A1 (en) 2011-10-07 2013-04-11 Suregene, Llc Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature
US10221454B2 (en) 2011-10-10 2019-03-05 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
WO2013056241A2 (en) 2011-10-14 2013-04-18 Pacific Biosciences Of California, Inc. Real-time redox sequencing
US10501791B2 (en) 2011-10-14 2019-12-10 President And Fellows Of Harvard College Sequencing by structure assembly
WO2013059746A1 (en) 2011-10-19 2013-04-25 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
PL2768985T3 (en) 2011-10-21 2019-10-31 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
WO2013063519A1 (en) 2011-10-26 2013-05-02 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
WO2013063544A1 (en) 2011-10-27 2013-05-02 Asuragen, Inc. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
EP2771103B1 (en) 2011-10-28 2017-08-16 Illumina, Inc. Microarray fabrication system and method
US9827246B2 (en) 2011-10-28 2017-11-28 Millennium Pharmaceuticals, Inc. Biomarkers of response to NAE inhibitors
US10837879B2 (en) 2011-11-02 2020-11-17 Complete Genomics, Inc. Treatment for stabilizing nucleic acid arrays
US10100092B2 (en) 2011-11-03 2018-10-16 Vca, Inc. Compositions and methods to detect various infectious organisms
DK2773779T3 (en) 2011-11-04 2020-11-23 Population Bio Inc METHODS AND COMPOSITIONS FOR DIAGNOSIS, FORECAST AND PREVENTION OF NEUROLOGICAL CONDITIONS
US9212381B2 (en) 2011-11-10 2015-12-15 President And Fellows Of Harvard College Methods and compositions for labeling polypeptides
EP2776043B1 (en) 2011-11-11 2018-02-21 Millennium Pharmaceuticals, Inc. Biomarkers of response to proteasome inhibitors
CN104126017A (en) 2011-11-11 2014-10-29 米伦纽姆医药公司 Biomarkers of response to proteasome inhibitors
KR102385013B1 (en) 2011-11-18 2022-04-12 알닐람 파마슈티칼스 인코포레이티드 RNAi AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES
CA2856107C (en) 2011-11-18 2022-10-18 Memorial Sloan-Kettering Cancer Center 2-hydroxyglutarate as a biomarker for chronic hypoxia
US10437858B2 (en) 2011-11-23 2019-10-08 23Andme, Inc. Database and data processing system for use with a network-based personal genetics services platform
CA2857597A1 (en) 2011-11-30 2013-06-06 AbbVie Deutschland GmbH & Co. KG Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
EP3483288B1 (en) 2011-11-30 2022-03-16 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification
KR102047569B1 (en) * 2011-11-30 2019-11-21 소니 주식회사 Chemical sensor, chemical sensor module, chemical substance detector and method for detecting chemical substance
US9970984B2 (en) 2011-12-01 2018-05-15 Life Technologies Corporation Method and apparatus for identifying defects in a chemical sensor array
US8748097B1 (en) 2011-12-02 2014-06-10 President And Fellows Of Harvard College Identification of agents for treating calcium disorders and uses thereof
AU2012352153B2 (en) 2011-12-13 2018-07-26 Veracyte, Inc. Cancer diagnostics using non-coding transcripts
WO2013087789A1 (en) 2011-12-13 2013-06-20 Glykos Finland Ltd. Antibody isoform arrays and methods thereof
CA2859149A1 (en) 2011-12-19 2013-06-27 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
EP2795500B1 (en) 2011-12-20 2020-04-15 Siemens Healthcare Diagnostics Inc. Coated substrates for high energy capture phase binding and methods of production and use thereof
EP2794907B2 (en) 2011-12-21 2022-11-23 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
WO2013096819A2 (en) 2011-12-22 2013-06-27 Ibis Biosciences, Inc. Macromolecule positioning by electrical potential
US9823246B2 (en) 2011-12-28 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon
WO2013102081A2 (en) 2011-12-29 2013-07-04 Ibis Biosciences, Inc. Macromolecule delivery to nanowells
WO2013101771A2 (en) 2011-12-30 2013-07-04 Genentech, Inc. Compositions and method for treating autoimmune diseases
WO2013102101A1 (en) 2011-12-30 2013-07-04 Somalogic, Inc. Aptamers and diagnostic methods for detecting the egf receptor
AU2013207778B2 (en) 2012-01-13 2017-10-12 Genentech, Inc. Biological markers for identifying patients for treatment with VEGF antagonists
US8821798B2 (en) 2012-01-19 2014-09-02 Life Technologies Corporation Titanium nitride as sensing layer for microwell structure
US8747748B2 (en) 2012-01-19 2014-06-10 Life Technologies Corporation Chemical sensor with conductive cup-shaped sensor surface
CA2861856C (en) 2012-01-20 2020-06-02 Sequenom, Inc. Diagnostic processes that factor experimental conditions
EP3418397B1 (en) 2012-01-24 2020-10-07 CD Diagnostics, Inc. System for detecting infection in synovial fluid
CN105861487B (en) 2012-01-26 2020-05-05 纽亘技术公司 Compositions and methods for targeted nucleic acid sequence enrichment and efficient library generation
US9135497B2 (en) 2012-01-27 2015-09-15 National Instruments Corporation Identifying randomly distributed microparticles in images to sequence a polynucleotide
JP6012767B2 (en) 2012-02-07 2016-10-25 ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー Substrates, peptide arrays, and methods
US10407724B2 (en) 2012-02-09 2019-09-10 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
EP3311847A1 (en) 2012-02-16 2018-04-25 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
WO2013123125A1 (en) 2012-02-17 2013-08-22 President And Fellows Of Harvard College Assembly of nucleic acid sequences in emulsions
EP2827882B1 (en) 2012-02-21 2020-04-08 Cytonics Corporation Systems, compositions, and methods for transplantation
EP2817318A4 (en) 2012-02-22 2016-04-27 Univ Pennsylvania Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer
WO2013124740A2 (en) 2012-02-23 2013-08-29 Stichting Vu-Vumc BRCA DEFICIENCY PROTEIN AND mRNA SIGNATURES USEFUL IN IDENTIFICATION OF PATIENTS WITH BRCA-DEFICIENT TUMORS AND PREDICTING BENEFIT OF ANTI-CANCER THERAPY IN CANCER PATIENTS
EP3415915A1 (en) 2012-02-23 2018-12-19 Children's Medical Center Corporation Methods for predicting anti-cancer response
US11177020B2 (en) 2012-02-27 2021-11-16 The University Of North Carolina At Chapel Hill Methods and uses for molecular tags
CA2865575C (en) 2012-02-27 2024-01-16 Cellular Research, Inc. Compositions and kits for molecular counting
EP3287531B1 (en) 2012-02-28 2019-06-19 Agilent Technologies, Inc. Method for attaching a counter sequence to a nucleic acid sample
EP2820129A1 (en) 2012-03-02 2015-01-07 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3372694A1 (en) 2012-03-05 2018-09-12 Adaptive Biotechnologies Corporation Determining paired immune receptor chains from frequency matched subunits
US9150853B2 (en) 2012-03-21 2015-10-06 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
WO2013144202A1 (en) 2012-03-29 2013-10-03 Roche Diagnostics Gmbh Biomarkers for discriminating healthy and/or non-malignant neoplastic colorectal cells from colorectal cancer cells
CA2867588A1 (en) 2012-03-30 2013-10-03 Genentech, Inc. Diagnostic methods and compositions for treatment of cancer
SG11201406201YA (en) 2012-04-02 2014-10-30 Berg Llc Interrogatory cell-based assays and uses thereof
AU2013243300B2 (en) 2012-04-05 2018-12-06 Oregon Health & Science University Gene expression panel for breast cancer prognosis
WO2013163263A2 (en) 2012-04-24 2013-10-31 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
JP6513019B2 (en) 2012-05-04 2019-05-15 ノバルティス アーゲー Biomarkers for IAP inhibitor treatment
CN107586832B (en) 2012-05-08 2021-03-30 适应生物技术公司 Compositions and methods for measuring and calibrating amplification bias in multiplex PCR reactions
WO2013167387A1 (en) 2012-05-10 2013-11-14 Ventana Medical Systems, Inc. Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
CA2872867C (en) 2012-05-11 2020-09-15 Clinical Genomics Pty Ltd Diagnostic gene marker panel for colorectal cancer
AU2013262435B2 (en) 2012-05-18 2019-03-07 Clinical Genomics Pty. Ltd. A method of screening for colorectal cancer
WO2013173844A1 (en) 2012-05-18 2013-11-21 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
PT2852671T (en) 2012-05-21 2018-11-29 Univ California Generation of human ips cells by a synthetic self- replicative rna
US8786331B2 (en) 2012-05-29 2014-07-22 Life Technologies Corporation System for reducing noise in a chemical sensor array
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
WO2013184754A2 (en) 2012-06-05 2013-12-12 President And Fellows Of Harvard College Spatial sequencing of nucleic acids using dna origami probes
WO2013182645A1 (en) 2012-06-07 2013-12-12 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
EP3339861B8 (en) 2012-06-15 2023-11-01 Genesis Theranostix Korlatolt Felelossegu Tarsasag Biomarker test for prediction or early detection of preeclampsia
EP3182126A3 (en) 2012-06-15 2017-08-02 Wayne State University Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome
GB2518078B (en) 2012-06-18 2015-04-29 Nugen Technologies Inc Compositions and methods for negative selection of non-desired nucleic acid sequences
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN104685116A (en) 2012-06-25 2015-06-03 Gen9股份有限公司 Methods for nucleic acid assembly and high throughput sequencing
EP2870263A1 (en) 2012-07-03 2015-05-13 InteRNA Technologies B.V. Diagnostic portfolio and its uses
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
WO2014009245A2 (en) 2012-07-09 2014-01-16 Qithera Gmbh Novel drug target indentification methods
ES2661883T3 (en) 2012-07-09 2018-04-04 Novartis Ag Biomarkers associated with CDK inhibitors
CA2878979C (en) 2012-07-13 2021-09-14 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
WO2014015217A1 (en) 2012-07-19 2014-01-23 Vertex Pharmaceuticals Incorporated Biomarkers for hcv infected patients
EP2875156A4 (en) 2012-07-19 2016-02-24 Ariosa Diagnostics Inc Multiplexed sequential ligation-based detection of genetic variants
CN108875312A (en) 2012-07-19 2018-11-23 哈佛大学校长及研究员协会 Utilize the method for nucleic acid storage information
US10441636B2 (en) 2012-07-20 2019-10-15 La Trobe University Method of diagnosis and treatment
EP2877494B1 (en) 2012-07-23 2020-07-15 La Jolla Institute for Allergy and Immunology Ptprs and proteoglycans in autoimmune disease
BR112015001690A2 (en) 2012-07-24 2017-11-07 Pharmacyclics Inc mutations associated with resistance to bruton tyrosine kinase inhibitors (btk)
EP2877596A1 (en) 2012-07-27 2015-06-03 Novartis AG Prediction of treatment response to jak/stat inhibitor
EP2880447B1 (en) 2012-07-31 2019-05-15 Novartis AG Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
DK3435084T3 (en) 2012-08-16 2023-05-30 Mayo Found Medical Education & Res PROSTATE CANCER PROGNOSIS USING BIOMARKERS
US10895534B2 (en) 2012-08-20 2021-01-19 Illumina, Inc. Method and system for fluorescence lifetime based sequencing
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
PT2893040T (en) 2012-09-04 2019-04-01 Guardant Health Inc Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
AU2013202506B2 (en) 2012-09-07 2015-06-18 Celgene Corporation Resistance biomarkers for hdac inhibitors
DK2895621T3 (en) 2012-09-14 2020-11-30 Population Bio Inc METHODS AND COMPOSITION FOR DIAGNOSIS, FORECAST AND TREATMENT OF NEUROLOGICAL CONDITIONS
WO2014048942A1 (en) 2012-09-25 2014-04-03 Ventana Medical Systems, Inc. Probes for pten, pik3ca, met, and top2a, and method for using the probes
US10233495B2 (en) 2012-09-27 2019-03-19 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
EP3974564A1 (en) 2012-09-28 2022-03-30 Vibrant Holdings, LLC Methods, systems, and arrays for biomolecular analysis
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
CA2886783A1 (en) 2012-10-01 2014-04-10 Millennium Pharmaceuticals, Inc. Biomarkers and methods to predict response to inhibitors and uses thereof
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
US20140100124A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10162800B2 (en) 2012-10-17 2018-12-25 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9476089B2 (en) 2012-10-18 2016-10-25 President And Fellows Of Harvard College Methods of making oligonucleotide probes
WO2014062635A1 (en) 2012-10-19 2014-04-24 Novartis Ag Markers for acute lymphoblastic leukemia
EP2722105A1 (en) 2012-10-22 2014-04-23 Universität Wien Method of in situ synthesizing microarrays
CN104769410B (en) 2012-11-06 2018-07-27 拜奥-多特公司 The controlled printing of cell sample for karyotyping
WO2014074942A1 (en) 2012-11-08 2014-05-15 Illumina, Inc. Risk variants of alzheimer's disease
AU2013202507B9 (en) 2012-11-14 2015-08-13 Celgene Corporation Inhibition of drug resistant cancer cells
CA2891651C (en) 2012-11-14 2019-01-22 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
WO2014078652A1 (en) 2012-11-16 2014-05-22 Zs Genetics, Inc. Heavy atom labeled nucleosides, nucleotides, and nucleic acid polymers, and uses thereof
GB201220924D0 (en) 2012-11-21 2013-01-02 Cancer Res Inst Royal Materials and methods for determining susceptibility or predisposition to cancer
MX367366B (en) 2012-11-27 2019-08-16 Univ Pontificia Catolica Chile Compositions and methods for diagnosing thyroid tumors.
RU2660349C2 (en) 2012-11-28 2018-07-05 Мерк Шарп И Доум Корп. Compositions and methods for treatment of malignant tumour
AU2013352307B2 (en) 2012-11-30 2018-11-15 Accelerated Biosciences Corp. Methods of differentiating stem cells by modulating miR-124
US11091809B2 (en) 2012-12-03 2021-08-17 Almac Diagnostic Services Limited Molecular diagnostic test for cancer
EP3336187A1 (en) 2012-12-05 2018-06-20 Alnylam Pharmaceuticals, Inc. Pcsk9 irna compositions and methods of use thereof
ES2701749T3 (en) 2012-12-12 2019-02-25 Broad Inst Inc Methods, models, systems and apparatus to identify target sequences for Cas enzymes or CRISPR-Cas systems for target sequences and transmit results thereof
AU2013359199C1 (en) 2012-12-12 2021-06-17 Massachusetts Institute Of Technology Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
US20140186843A1 (en) 2012-12-12 2014-07-03 Massachusetts Institute Of Technology Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
SG11201504519TA (en) 2012-12-12 2015-07-30 Broad Inst Inc Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
ES2576128T3 (en) 2012-12-12 2016-07-05 The Broad Institute, Inc. Modification by genetic technology and optimization of systems, methods and compositions for the manipulation of sequences with functional domains
WO2014093701A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
US9836577B2 (en) 2012-12-14 2017-12-05 Celmatix, Inc. Methods and devices for assessing risk of female infertility
WO2014100626A1 (en) 2012-12-21 2014-06-26 Hutman Diagnostics AG Microarrays
BR112015009004A8 (en) 2012-12-21 2021-07-20 Eisai R&D Man Co Ltd amorphous form of quinoline derivative and method of production thereof
US9080968B2 (en) 2013-01-04 2015-07-14 Life Technologies Corporation Methods and systems for point of use removal of sacrificial material
US9841398B2 (en) 2013-01-08 2017-12-12 Life Technologies Corporation Methods for manufacturing well structures for low-noise chemical sensors
US9932626B2 (en) 2013-01-15 2018-04-03 Quanterix Corporation Detection of DNA or RNA using single molecule arrays and other techniques
EP2946345B1 (en) 2013-01-17 2024-04-03 Personalis, Inc. Methods and systems for genetic analysis
US20140206841A1 (en) * 2013-01-18 2014-07-24 Protein Technologies, Inc. Peptide Synthesis Apparatus and Methods Using Infrared Energy
WO2014113804A1 (en) 2013-01-21 2014-07-24 Abbvie Inc. Anti-tnf and anti-il17 combination therapy biomarkers for inflammatory disease
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US8962366B2 (en) 2013-01-28 2015-02-24 Life Technologies Corporation Self-aligned well structures for low-noise chemical sensors
US9896728B2 (en) 2013-01-29 2018-02-20 Arcticrx Ltd. Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
US9411930B2 (en) 2013-02-01 2016-08-09 The Regents Of The University Of California Methods for genome assembly and haplotype phasing
AU2014212152B2 (en) 2013-02-01 2020-02-06 The Regents Of The University Of California Methods for genome assembly and haplotype phasing
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
JP2016514091A (en) 2013-02-08 2016-05-19 ミスフォールディング ダイアグノスティクス, インコーポレイテッド Transthyretin antibodies and uses thereof
KR102544414B1 (en) 2013-02-14 2023-06-15 더 리전츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코퍼레이트 Methods for predicting risk of interstitial pneumonia
CA2901029C (en) 2013-02-15 2020-06-16 John J. Rajasekaran Methods and compositions for amplified electrochemiluminescence detection
AR094873A1 (en) 2013-02-25 2015-09-02 Genentech Inc METHODS AND COMPOSITIONS TO DETECT AND TREAT MUTANTS OF AKT RESISTANT TO DRUGS
US9512422B2 (en) 2013-02-26 2016-12-06 Illumina, Inc. Gel patterned surfaces
US9267171B2 (en) 2013-02-28 2016-02-23 New York University DNA photolithography with cinnamate crosslinkers
WO2014133855A1 (en) 2013-02-28 2014-09-04 Caprion Proteomics Inc. Tuberculosis biomarkers and uses thereof
EP2972353B1 (en) 2013-03-11 2023-02-22 Meso Scale Technologies, LLC Improved methods for conducting multiplexed assays
TWI582239B (en) 2013-03-11 2017-05-11 諾華公司 Markers associated with wnt inhibitors
US8963216B2 (en) 2013-03-13 2015-02-24 Life Technologies Corporation Chemical sensor with sidewall spacer sensor surface
US8841217B1 (en) 2013-03-13 2014-09-23 Life Technologies Corporation Chemical sensor with protruded sensor surface
US11060145B2 (en) 2013-03-13 2021-07-13 Sequenom, Inc. Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
EP3611189A1 (en) 2013-03-14 2020-02-19 Novartis AG Antibodies against notch 3
US9146248B2 (en) 2013-03-14 2015-09-29 Intelligent Bio-Systems, Inc. Apparatus and methods for purging flow cells in nucleic acid sequencing instruments
WO2014160080A1 (en) 2013-03-14 2014-10-02 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
HUE034987T2 (en) 2013-03-14 2018-05-02 Alnylam Pharmaceuticals Inc Complement component c5 irna compositions and methods of use thereof
WO2014159242A1 (en) 2013-03-14 2014-10-02 Novartis Ag Notch 3 mutants and uses thereof
US20140274749A1 (en) 2013-03-15 2014-09-18 Affymetrix, Inc. Systems and Methods for SNP Characterization and Identifying off Target Variants
US10006919B2 (en) 2013-03-15 2018-06-26 Arizona Board Of Regents On Behalf Of Arizona State University Peptide array quality control
US9116117B2 (en) 2013-03-15 2015-08-25 Life Technologies Corporation Chemical sensor with sidewall sensor surface
US9591268B2 (en) 2013-03-15 2017-03-07 Qiagen Waltham, Inc. Flow cell alignment methods and systems
WO2014144383A1 (en) 2013-03-15 2014-09-18 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Non-covalent patterned chemical features and use thereof in maldi-based quality control
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
EP4163387A1 (en) 2013-03-15 2023-04-12 The University of Chicago Methods and compositions related to t-cell activity
CN105051525B (en) 2013-03-15 2019-07-26 生命科技公司 Chemical device with thin conducting element
US10535420B2 (en) 2013-03-15 2020-01-14 Affymetrix, Inc. Systems and methods for probe design to detect the presence of simple and complex indels
WO2014149778A1 (en) 2013-03-15 2014-09-25 Life Technologies Corporation Chemical sensors with consistent sensor surface areas
US10119134B2 (en) 2013-03-15 2018-11-06 Abvitro Llc Single cell bar-coding for antibody discovery
EP2971130A4 (en) 2013-03-15 2016-10-05 Nugen Technologies Inc Sequential sequencing
US9835585B2 (en) 2013-03-15 2017-12-05 Life Technologies Corporation Chemical sensor with protruded sensor surface
US9868992B2 (en) 2013-03-15 2018-01-16 Baylor Research Institute Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
WO2014149780A1 (en) 2013-03-15 2014-09-25 Life Technologies Corporation Chemical sensor with consistent sensor surface areas
EP2971149B1 (en) 2013-03-15 2018-05-09 Baylor Research Institute Ulcerative colitis (uc)-associated colorectal neoplasia markers
WO2014155105A2 (en) 2013-03-27 2014-10-02 Bluegnome Ltd Assessment of risk of aneuploidy
US10930368B2 (en) 2013-04-03 2021-02-23 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2014169928A1 (en) * 2013-04-17 2014-10-23 Karlsruher Institut für Technologie Method for combinatorial particle manipulation for producing high-density molecular arrays, particularly peptide arrays, and molecular arrays which can be obtained therefrom
US20160091485A1 (en) 2013-04-25 2016-03-31 The Broad Institute, Inc. Markers for ezh2 inhibitors
CA2908391A1 (en) 2013-05-01 2014-11-06 Five Prime Therapeutics, Inc. Methods of treating cancer
CN105378113B (en) 2013-05-06 2020-02-21 加利福尼亚太平洋生物科学股份有限公司 Real-time electronic sequencing
US20140336063A1 (en) 2013-05-09 2014-11-13 Life Technologies Corporation Windowed Sequencing
ES2687968T3 (en) 2013-05-14 2018-10-30 Eisai R&D Management Co., Ltd. Biomarkers to predict and evaluate the reactivity of subjects with endometrial cancer to compounds with lenvatinib
WO2014187308A2 (en) 2013-05-21 2014-11-27 生物梅里埃股份公司 Colorectal cancer prognosis agent kit
PT2999785T (en) 2013-05-22 2018-07-09 Alnylam Pharmaceuticals Inc Serpina1 irna compositions and methods of use thereof
BR112015029276B1 (en) 2013-05-22 2022-07-12 Alnylam Pharmaceuticals, Inc DUAL STRIP IRNA AGENT CAPABLE OF INHIBITING THE EXPRESSION OF TMPRSS6, PHARMACEUTICAL COMPOSITION AND USE THEREOF
MX2015015426A (en) 2013-05-23 2016-06-10 Five Prime Therapeutics Inc Methods of treating cancer.
CA2910205C (en) 2013-05-24 2023-04-04 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2014195032A1 (en) 2013-06-07 2014-12-11 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
US10458942B2 (en) 2013-06-10 2019-10-29 Life Technologies Corporation Chemical sensor array having multiple sensors per well
EP3008229B1 (en) 2013-06-10 2020-05-27 President and Fellows of Harvard College Early developmental genomic assay for characterizing pluripotent stem cell utility and safety
ES2775213T3 (en) 2013-06-13 2020-07-24 Ariosa Diagnostics Inc Statistical analysis for the non-invasive determination of aneuploidies of the sex chromosomes
US10544449B2 (en) 2013-06-14 2020-01-28 Pacific Biosciences Of California, Inc. Bis-biotinylation tags
CN105308073B (en) 2013-06-14 2019-08-13 加利福尼亚太平洋生物科学股份有限公司 Double biotinylation tags
KR20160034901A (en) 2013-06-17 2016-03-30 더 브로드 인스티튜트, 인코퍼레이티드 Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
BR122021009076B1 (en) 2013-06-17 2024-02-15 The Broad Institute Inc. VIRAL VECTOR CONTAINING HETEROLOGOUS NUCLEIC ACID MOLECULE(S), COMPOSITION, USE AND METHODS THEREOF
WO2014204728A1 (en) 2013-06-17 2014-12-24 The Broad Institute Inc. Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells
KR20160044457A (en) 2013-06-17 2016-04-25 더 브로드 인스티튜트, 인코퍼레이티드 Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
RU2716420C2 (en) 2013-06-17 2020-03-11 Те Брод Инститьют Инк. Delivery and use of systems of crispr-cas, vectors and compositions for targeted action and therapy in liver
IL303830A (en) 2013-06-21 2023-08-01 Sequenom Inc Methods and processes for non-invasive assessment of genetic variations
US9069358B2 (en) 2013-06-24 2015-06-30 Biolytic Lab Performance, Inc. System for controlling and optimizing reactions in solid phase synthesis of small molecules
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
US9404922B2 (en) 2013-07-15 2016-08-02 The Rockefeller University Recombinant phages and proteins
US9409139B2 (en) 2013-08-05 2016-08-09 Twist Bioscience Corporation De novo synthesized gene libraries
EA201690213A1 (en) 2013-08-12 2016-07-29 Дженентек, Инк. COMPOSITIONS AND METHOD FOR TREATMENT OF CONNECTED STATES
GB201314721D0 (en) * 2013-08-16 2013-10-02 Almagen Ltd A method of selectively masking one or more sites on a surface and a method of synthesising an array of molecules
US9683937B2 (en) * 2013-08-23 2017-06-20 Semiconductor Components Industries, Llc Imaging devices for molecule detection
DK3039424T3 (en) 2013-08-28 2020-08-31 Crown Bioscience Inc Taicang Gene expression signatures predictive of an individual's response to a multikinase inhibitor and methods of using them
CA2922806A1 (en) 2013-08-28 2015-03-05 Cytonics Corporation Systems, compositions, and methods for transplantation and treating conditions utilizing a composition comprising a wild-type or a variant a2m polypeptide or portion thereof
AU2014312208B2 (en) 2013-08-28 2019-07-25 Becton, Dickinson And Company Massively parallel single cell analysis
US10456470B2 (en) 2013-08-30 2019-10-29 Genentech, Inc. Diagnostic methods and compositions for treatment of glioblastoma
GB2534067B (en) 2013-08-30 2021-07-21 Personalis Inc Methods and systems for genomic analysis
SG10201802231RA (en) 2013-09-19 2018-05-30 Univ Leland Stanford Junior Methods and compositions for producing hepatocyte-like cells
EP3543353A1 (en) 2013-09-23 2019-09-25 The University of Chicago Methods and compositions relating to cancer therapy with dna damaging agents
AR097738A1 (en) 2013-09-23 2016-04-13 Alnylam Pharmaceuticals Inc METHODS TO TREAT OR PREVENT DISEASES ASSOCIATED WITH TRANSTIRETINE (TTR)
US9352315B2 (en) 2013-09-27 2016-05-31 Taiwan Semiconductor Manufacturing Company, Ltd. Method to produce chemical pattern in micro-fluidic structure
GB2534315B (en) 2013-10-02 2020-08-05 Univ Leland Stanford Junior WNT compositions and methods for purification
AU2014329535B2 (en) 2013-10-03 2017-09-07 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
GB2535066A (en) 2013-10-03 2016-08-10 Personalis Inc Methods for analyzing genotypes
DK3053071T3 (en) 2013-10-04 2024-01-22 Sequenom Inc METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
WO2015054292A1 (en) 2013-10-07 2015-04-16 Cellular Research, Inc. Methods and systems for digitally counting features on arrays
JP6680680B2 (en) 2013-10-07 2020-04-15 セクエノム, インコーポレイテッド Methods and processes for non-invasive assessment of chromosomal alterations
EP3058091B1 (en) 2013-10-18 2020-03-25 The Broad Institute, Inc. Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing
MX2016005159A (en) 2013-10-23 2016-07-05 Genentech Inc Methods of diagnosing and treating eosinophilic disorders.
EP3066218B1 (en) 2013-11-05 2018-12-26 HTG Molecular Diagnostics, Inc. Methods for detecting nucleic acids
CA2929826C (en) 2013-11-06 2022-08-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for selecting and treating lymphoma types
DK3511422T3 (en) 2013-11-12 2023-02-06 Population Bio Inc METHODS AND COMPOSITIONS FOR DIAGNOSING, PROGNOSIS AND TREATMENT OF ENDOMETRIOSIS
JP6525473B2 (en) 2013-11-13 2019-06-05 ニューゲン テクノロジーズ, インコーポレイテッド Compositions and methods for identifying replicate sequencing leads
EP3080292B1 (en) 2013-12-09 2022-02-02 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
AU2014361826A1 (en) 2013-12-12 2016-06-23 Massachusetts Institute Of Technology Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for targeting disorders and diseases using particle delivery components
IL282401B (en) 2013-12-12 2022-08-01 Alnylam Pharmaceuticals Inc Complement component irna compositions and methods of use thereof
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US20160304969A1 (en) 2013-12-17 2016-10-20 Merck Sharp & Dohme Corp. Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonists
DK3083997T3 (en) 2013-12-20 2020-10-19 Univ Lausanne DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES OF LONG NON-CODING RNAES FOR HEART DISEASES AND REGENERATIVE MEDICINES
NZ630311A (en) 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof
AU2014369841B2 (en) 2013-12-28 2019-01-24 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
EP3090061A2 (en) 2013-12-31 2016-11-09 F. Hoffmann-La Roche AG Methods of assessing epigenetic regulation of genome function via dna methylation status and systems and kits therefor
CN112322735A (en) 2014-01-16 2021-02-05 启迪公司 Gene expression panels for prognosis of prostate cancer recurrence
WO2015116627A1 (en) 2014-01-29 2015-08-06 Arizona Board Of Regents On Behalf Of Arizona State University Microreactor array platform
GB201409479D0 (en) 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer
WO2015120130A1 (en) 2014-02-07 2015-08-13 Novartis Ag Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
ES2873248T3 (en) 2014-02-08 2021-11-03 Hoffmann La Roche Methods to treat Alzheimer's disease
EP3107926B1 (en) 2014-02-21 2020-09-09 Vibrant Holdings, LLC Selective photo activation of amino acids for single step peptide coupling
CN106232827A (en) 2014-02-21 2016-12-14 哈佛学院董事及会员团体 From the beginning the design of allosteric protein
KR20160123385A (en) 2014-02-24 2016-10-25 칠드런즈 호스피탈 메디칼 센터 Methods and compositions for personalized pain management
WO2015131107A1 (en) 2014-02-28 2015-09-03 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
US20170292149A1 (en) 2014-03-05 2017-10-12 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
EP3117011B1 (en) 2014-03-13 2020-05-06 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9885086B2 (en) 2014-03-20 2018-02-06 Pharmacyclics Llc Phospholipase C gamma 2 and resistance associated mutations
EP3800267A1 (en) 2014-03-27 2021-04-07 Yale University Circulating micrornas as biomarkers for endometriosis
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2777529T3 (en) 2014-04-17 2020-08-05 Adaptive Biotechnologies Corp Quantification of adaptive immune cell genomes in a complex mixture of cells
WO2015172046A1 (en) 2014-05-08 2015-11-12 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating cystic fibrosis
WO2015175375A1 (en) 2014-05-13 2015-11-19 Short Jay M Conditionally active biological proteins
JP2017516501A (en) 2014-05-30 2017-06-22 ジーンセントリック ダイアグノスティクス, インコーポレイテッド Lung cancer typing method
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
AU2015273443B2 (en) 2014-06-13 2021-03-04 Q-Linea Ab Method for detecting and characterising a microorganism
WO2016011052A1 (en) 2014-07-14 2016-01-21 Genentech, Inc. Diagnostic methods and compositions for treatment of glioblastoma
US11214836B2 (en) 2014-07-15 2022-01-04 Ontario Institute For Cancer Research Methods and devices for predicting anthracycline treatment efficacy
EP3169811A4 (en) 2014-07-17 2017-12-27 Celmatix Inc. Methods and systems for assessing infertility and related pathologies
EP3175000B1 (en) 2014-07-30 2020-07-29 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2956925C (en) 2014-08-01 2024-02-13 Dovetail Genomics, Llc Tagging nucleic acids for sequence assembly
WO2016023026A1 (en) 2014-08-08 2016-02-11 Children's Hospital Medical Center Diagnostic method for distinguishing forms of esophageal eosinophilia
US10093967B2 (en) 2014-08-12 2018-10-09 The Regents Of The University Of Michigan Detection of nucleic acids
US20180363070A9 (en) 2014-08-12 2018-12-20 Univ Wayne State Systems and methods to detect stem cell stress and uses thereof
DK3686288T3 (en) 2014-08-15 2023-05-22 Myriad Genetics Inc METHODS AND MATERIALS FOR THE ANALYSIS OF HOMOLOGOUS RECOMBINATION DEFICIENCY
ES2780904T3 (en) 2014-08-17 2020-08-27 Broad Inst Inc Genomic editing using Cas9 nickases
US11111288B2 (en) 2014-08-28 2021-09-07 Bioatla, Inc. Conditionally active chimeric antigen receptors for modified t-cells
RU2764074C2 (en) 2014-08-28 2022-01-13 Байоатла, Ллк Conditionally active chimeric antigen receptors for modified t-cells
EP3453396A1 (en) 2014-08-28 2019-03-13 Yale University Compositions and methods for treating an inflammatory disease or disorder
HRP20221047T1 (en) 2014-08-28 2022-11-11 Eisai R&D Management Co., Ltd. High-purity quinoline derivative and method for manufacturing same
US10513699B2 (en) 2014-09-03 2019-12-24 Bioatla, Llc Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts
WO2016036403A1 (en) 2014-09-05 2016-03-10 Population Diagnostics Inc. Methods and compositions for inhibiting and treating neurological conditions
WO2016038550A1 (en) 2014-09-11 2016-03-17 Novartis Ag Inhibition of prmt5 to treat mtap-deficiency-related diseases
WO2016040589A1 (en) 2014-09-12 2016-03-17 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting complement component c5 and methods of use thereof
EP3194624B1 (en) 2014-09-15 2022-02-16 Garvan Institute of Medical Research Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
ES2727656T3 (en) 2014-09-15 2019-10-17 Abvitro Llc High performance sequencing of nucleotide banks
DK3198035T3 (en) 2014-09-26 2023-01-30 Allarity Therapeutics Europe ApS Methods for predicting drug response
PL3200786T3 (en) 2014-10-03 2020-03-31 Novartis Ag Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
JOP20200115A1 (en) 2014-10-10 2017-06-16 Alnylam Pharmaceuticals Inc Compositions And Methods For Inhibition Of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
WO2016061487A1 (en) 2014-10-17 2016-04-21 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting aminolevulinic acid synthase-1 (alas1) and uses thereof
EP3212790B1 (en) 2014-10-29 2020-03-25 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10125399B2 (en) 2014-10-30 2018-11-13 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
EP3904519A1 (en) 2014-10-30 2021-11-03 Genzyme Corporation Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof
CN111024936A (en) 2014-11-05 2020-04-17 纳迈达斯生物科技中心 Metal composites for enhanced imaging
CN107206043A (en) 2014-11-05 2017-09-26 维拉赛特股份有限公司 The system and method for diagnosing idiopathic pulmonary fibrosis on transbronchial biopsy using machine learning and higher-dimension transcript data
US11708608B2 (en) 2014-11-10 2023-07-25 Genentech, Inc. Therapeutic and diagnostic methods for IL-33-mediated disorders
EP3218482A4 (en) 2014-11-11 2018-05-09 Abbott Molecular Inc. Hybridization probes and methods
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
CA3148687A1 (en) 2014-11-26 2016-06-02 Accelerated Biosciences Corp. Induced hepatocytes and uses thereof
US10479997B2 (en) 2014-12-01 2019-11-19 Novartis Ag Compositions and methods for diagnosis and treatment of prostate cancer
AU2015358384B2 (en) 2014-12-03 2021-03-04 Auckland Uniservices, Ltd. Kinase inhibitor prodrug for the treatment of cancer
WO2016090323A1 (en) 2014-12-05 2016-06-09 Prelude, Inc. Dcis recurrence and invasive breast cancer
SG10202012249YA (en) 2014-12-08 2021-01-28 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
EP3230498B1 (en) 2014-12-09 2023-01-18 Merck Sharp & Dohme LLC System and methods for deriving gene signature biomarkers of response to pd-1 antagonists
WO2016094874A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Escorted and functionalized guides for crispr-cas systems
WO2016094872A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Dead guides for crispr transcription factors
EP3230451B1 (en) 2014-12-12 2021-04-07 The Broad Institute, Inc. Protected guide rnas (pgrnas)
KR102593647B1 (en) 2014-12-18 2023-10-26 라이프 테크놀로지스 코포레이션 High data rate integrated circuit with transmitter configuration
EP3234575B1 (en) 2014-12-18 2023-01-25 Life Technologies Corporation Apparatus for measuring analytes using large scale fet arrays
US10077472B2 (en) 2014-12-18 2018-09-18 Life Technologies Corporation High data rate integrated circuit with power management
EP3237906B8 (en) 2014-12-23 2020-10-28 Bluelight Therapeutics, Inc. Attachment of proteins to interfaces for use in nonlinear optical detection
CA2970370A1 (en) 2014-12-24 2016-06-30 Massachusetts Institute Of Technology Crispr having or associated with destabilization domains
CN107223163A (en) 2014-12-24 2017-09-29 豪夫迈·罗氏有限公司 For the treatment of bladder cancer, diagnosis and method of prognosis
US10302972B2 (en) 2015-01-23 2019-05-28 Pacific Biosciences Of California, Inc. Waveguide transmission
WO2016123125A1 (en) 2015-01-27 2016-08-04 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
CN107428818A (en) 2015-01-29 2017-12-01 密西根州立大学校董会 Hide polypeptide and application thereof
WO2016126987A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly
CA2975852A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
EP3256151B1 (en) 2015-02-09 2020-08-05 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating muscle disease and disorders
US10801065B2 (en) 2015-02-10 2020-10-13 Dana-Farber Cancer Institute, Inc. Methods of determining levels of exposure to radiation and uses thereof
US11434264B2 (en) 2015-02-13 2022-09-06 Quanterix Corporation Immunoassays for differential detection of clostridium difficile
CA2976445A1 (en) 2015-02-13 2016-08-18 Alnylam Pharmaceuticals, Inc. Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
CA2976902A1 (en) 2015-02-17 2016-08-25 Dovetail Genomics Llc Nucleic acid sequence assembly
US10697010B2 (en) 2015-02-19 2020-06-30 Becton, Dickinson And Company High-throughput single-cell analysis combining proteomic and genomic information
AU2016222788B2 (en) 2015-02-24 2022-03-31 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
AU2016222830B2 (en) 2015-02-24 2021-02-25 Bioatla Llc Conditionally active biological proteins
NZ734644A (en) 2015-02-24 2023-02-24 Hope City Chemically encoded spatially addressed library screening platforms
PT3263106T (en) 2015-02-25 2024-01-12 Eisai R&D Man Co Ltd Method for suppressing bitterness of quinoline derivative
CN107208158B (en) 2015-02-27 2022-01-28 贝克顿迪金森公司 Spatially addressable molecular barcode
WO2016140717A1 (en) 2015-03-04 2016-09-09 Merck Sharp & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
AU2016228516A1 (en) 2015-03-12 2017-09-21 Vibrant Holdings, Llc Polypeptide arrays and methods of attaching polypeptides to an array
US9708647B2 (en) 2015-03-23 2017-07-18 Insilixa, Inc. Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays
CA3225867A1 (en) 2015-03-24 2016-09-29 Illumina, Inc. Methods, carrier assemblies, and systems for imaging samples for biological or chemical analysis
GB2554572B (en) 2015-03-26 2021-06-23 Dovetail Genomics Llc Physical linkage preservation in DNA storage
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
WO2016161022A2 (en) 2015-03-30 2016-10-06 Accerlate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
EP3835431B1 (en) 2015-03-30 2022-11-02 Becton, Dickinson and Company Methods for combinatorial barcoding
EP3277294A4 (en) 2015-04-01 2018-11-14 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
WO2016164641A1 (en) 2015-04-08 2016-10-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP3283882B1 (en) 2015-04-17 2020-12-16 Merck Sharp & Dohme Corp. Blood-based biomarkers of tumor sensitivity to pd-1 antagonists
EP3286569B1 (en) 2015-04-20 2020-07-22 H. Hoffnabb-La Roche Ag Specific peptide binders to proteins identified via systemic discovery, maturation and extension process
US9981239B2 (en) 2015-04-21 2018-05-29 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
EP3286326A1 (en) 2015-04-23 2018-02-28 Cellular Research, Inc. Methods and compositions for whole transcriptome amplification
AU2016250849A1 (en) 2015-04-24 2017-11-02 Agena Bioscience, Inc. Multiplex methods for detection and quantification of minor variants
GB201507026D0 (en) 2015-04-24 2015-06-10 Linea Ab Q Medical sample transportation container
US10233489B2 (en) 2015-04-24 2019-03-19 Agena Bioscience, Inc. Multiplexed method for the identification and quantitation of minor alleles and polymorphisms
US10989716B2 (en) 2015-05-01 2021-04-27 The University Of British Columbia Biomarkers for the detection of acute rejection in heart transplantation
WO2016176726A1 (en) 2015-05-01 2016-11-10 Griffith University Diagnostic methods
US10900975B2 (en) 2015-05-12 2021-01-26 Arizona Board Of Regents On Behalf Of Arizona State University Systems and methods of epitope binning and antibody profiling
AU2016271049B9 (en) 2015-05-29 2019-07-18 Illumina, Inc. Sample carrier and assay system for conducting designated reactions
WO2016196065A1 (en) 2015-05-29 2016-12-08 Genentech, Inc. Methods and compositions for assessing responsiveness of cancers to bet inhibitors
US11124823B2 (en) 2015-06-01 2021-09-21 Becton, Dickinson And Company Methods for RNA quantification
WO2016201301A1 (en) 2015-06-12 2016-12-15 Alnylam Pharmaceuticals, Inc. Complement component c5 irna compositions and methods of use thereof
RU2729936C2 (en) 2015-06-16 2020-08-13 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Anticancer agent
WO2016205749A1 (en) 2015-06-18 2016-12-22 The Broad Institute Inc. Novel crispr enzymes and systems
AU2016279077A1 (en) 2015-06-18 2019-03-28 Omar O. Abudayyeh Novel CRISPR enzymes and systems
WO2016205323A1 (en) 2015-06-18 2016-12-22 Alnylam Pharmaceuticals, Inc. Polynucleotde agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
US10494632B2 (en) 2015-07-10 2019-12-03 Alnylam Pharmaceuticals, Inc. Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof
JP6962914B2 (en) 2015-07-20 2021-11-05 センティルス ホールディングカンパニー エルエルシーSentilus Holdco, Llc Chips, detectors, and how they are manufactured and used
GB201512869D0 (en) 2015-07-21 2015-09-02 Almac Diagnostics Ltd Gene signature for minute therapies
KR101844048B1 (en) 2015-07-22 2018-03-30 주식회사 스몰머신즈 Molecule immobilization patterns and method for forming the same
US10829484B2 (en) 2015-07-28 2020-11-10 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP3328440A4 (en) 2015-07-28 2019-01-16 Otonomy, Inc. Treatment using truncated trk b and trk c antagonists
EP3124619B1 (en) 2015-07-31 2019-03-06 Menicon Co., Ltd Reagents, method and kit for across and within dog breed glaucoma diagnosis
CN108136051A (en) 2015-08-04 2018-06-08 Cd诊断股份有限公司 The method for detecting bad local organization reaction (ALTR) necrosis
WO2017024049A1 (en) 2015-08-06 2017-02-09 Pacific Biosciences Of California, Inc. Single-molecule nanofet sequencing systems and methods
EP3130681B1 (en) 2015-08-13 2019-11-13 Centrillion Technology Holdings Corporation Methods for synchronizing nucleic acid molecules
EP3130682B1 (en) * 2015-08-13 2020-03-18 Centrillion Technology Holdings Corporation Methods for generating polymer arrays
AU2016312530A1 (en) 2015-08-24 2018-03-01 Halo-Bio Rnai Therapeutics, Inc. Polynucleotide nanoparticles for the modulation of gene expression and uses thereof
CN116338219A (en) 2015-08-24 2023-06-27 亿明达股份有限公司 In-line accumulator and flow control system for biological and chemical assays
CN114525280A (en) 2015-09-02 2022-05-24 阿尔尼拉姆医药品有限公司 iRNA compositions of programmed cell death 1 ligand 1(PD-L1) and methods of use thereof
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US9499861B1 (en) 2015-09-10 2016-11-22 Insilixa, Inc. Methods and systems for multiplex quantitative nucleic acid amplification
JP6940484B2 (en) 2015-09-11 2021-09-29 セルラー リサーチ, インコーポレイテッド Methods and compositions for library normalization
EP3141613A1 (en) 2015-09-11 2017-03-15 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Detection of quality of surface water
US10758886B2 (en) 2015-09-14 2020-09-01 Arizona Board Of Regents On Behalf Of Arizona State University Conditioned surfaces for in situ molecular array synthesis
AU2016324296A1 (en) 2015-09-18 2018-04-12 Twist Bioscience Corporation Oligonucleic acid variant libraries and synthesis thereof
US11512347B2 (en) 2015-09-22 2022-11-29 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
KR20180085717A (en) 2015-09-24 2018-07-27 에이비비트로, 엘엘씨 Affinity-oligonucleotide conjugates and their use
WO2018057051A1 (en) 2016-09-24 2018-03-29 Abvitro Llc Affinity-oligonucleotide conjugates and uses thereof
CN113774495A (en) 2015-09-25 2021-12-10 阿布维特罗有限责任公司 High throughput method for T cell receptor targeted identification of naturally paired T cell receptor sequences
WO2017050874A1 (en) 2015-09-25 2017-03-30 F. Hoffmann-La Roche Ag Process for producing thioesters employing a sortase a
WO2017050866A1 (en) 2015-09-25 2017-03-30 F. Hoffmann-La Roche Ag Novel soluble sortase a
CN108026560A (en) 2015-09-25 2018-05-11 豪夫迈·罗氏有限公司 Reacted in eutectic solvent using the acid amides that turns of sorting enzyme
CA3000405A1 (en) 2015-09-29 2017-04-06 Htg Molecular Diagnostics, Inc. Methods for subtyping diffuse large b-cell lymphoma (dlbcl)
AU2016331663B2 (en) 2015-09-30 2022-04-07 Immunexpress Pty Ltd Pathogen biomarkers and uses therefor
EP3362102A1 (en) 2015-10-14 2018-08-22 Life Technologies Corporation Ribonucleoprotein transfection agents
US20180305748A1 (en) 2015-10-18 2018-10-25 Affymetrix, Inc. Multiallelic Genotyping of Single Nucleotide Polymorphisms and Indels
AU2016341198B2 (en) 2015-10-19 2023-03-09 Dovetail Genomics, Llc Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection
EP3365441A1 (en) 2015-10-22 2018-08-29 The Broad Institute Inc. Type vi-b crispr enzymes and systems
TW201723190A (en) 2015-10-22 2017-07-01 永斯醫療股份有限公司 Gene signatures for determining ICOS expression
WO2017075294A1 (en) 2015-10-28 2017-05-04 The Board Institute Inc. Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction
US10427126B2 (en) 2015-10-28 2019-10-01 Roche Sequencing Solutions, Inc. System and method for longitudinal analysis of peptide synthesis
CA3005430A1 (en) 2015-11-16 2017-05-26 Revere Biosensors, Llc Systems and methods for identifying and distinguishing genetic samples
WO2017087696A1 (en) 2015-11-18 2017-05-26 Pacific Biosciences Of California, Inc. Methods and compositions for loading of polymerase complexes
EP3384041B1 (en) 2015-11-30 2021-01-20 H. Hoffnabb-La Roche Ag Method for identification of protease substrates
CN115920796A (en) 2015-12-01 2023-04-07 特韦斯特生物科学公司 Functionalized surfaces and preparation thereof
CA3007462C (en) 2015-12-07 2023-10-24 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP3978619A1 (en) 2015-12-09 2022-04-06 Intuitive Biosciences, Inc. Automated silver enhancement system
EP3390668A4 (en) 2015-12-17 2020-04-01 Guardant Health, Inc. Methods to determine tumor gene copy number by analysis of cell-free dna
US20190233814A1 (en) 2015-12-18 2019-08-01 The Broad Institute, Inc. Novel crispr enzymes and systems
WO2017106918A1 (en) 2015-12-24 2017-06-29 Immunexpress Pty Ltd Triage biomarkers and uses therefor
EP3402572B1 (en) 2016-01-13 2022-03-16 Children's Hospital Medical Center Compositions and methods for treating allergic inflammatory conditions
US10519442B2 (en) 2016-02-11 2019-12-31 City Of Hope Twist signaling inhibitor compositions and methods of using the same
US10184939B2 (en) 2016-02-12 2019-01-22 Roche Sequencing Solutions, Inc. Detection of neoantigens using peptide arrays
KR20180116377A (en) 2016-02-23 2018-10-24 더브테일 제노믹스 엘엘씨 Generation and Hexagonal Paging of a Paged Read Set for Genome Assemblies
WO2017155858A1 (en) 2016-03-07 2017-09-14 Insilixa, Inc. Nucleic acid sequence identification using solid-phase cyclic single base extension
CN109641935A (en) 2016-03-25 2019-04-16 莫拉利达尔·瑞迪·穆拉 Combinatorial compound and biomarker exploitation
EP3436578B1 (en) 2016-03-30 2022-01-19 F. Hoffmann-La Roche AG Improved sortase
US11845938B2 (en) 2016-03-31 2023-12-19 City Of Hope Aptamer compositions and the use thereof
AU2017240164A1 (en) * 2016-04-01 2018-11-15 HealthTell, Inc. Array-based peptide libraries for therapeutic antibody characterization
WO2017176652A2 (en) 2016-04-04 2017-10-12 Sinopia Biosciences, Inc. Treating extrapyramidal syndrome using trapidil
AU2017253107B2 (en) 2016-04-19 2023-07-20 Massachusetts Institute Of Technology CPF1 complexes with reduced indel activity
MA45295A (en) 2016-04-19 2019-02-27 Alnylam Pharmaceuticals Inc HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP / VIGILINE) RNA COMPOSITION AND METHODS FOR USING THEM
AU2017257274B2 (en) 2016-04-19 2023-07-13 Massachusetts Institute Of Technology Novel CRISPR enzymes and systems
CN110382692A (en) 2016-04-19 2019-10-25 博德研究所 Novel C RISPR enzyme and system
US20190128895A1 (en) 2016-04-20 2019-05-02 Ldx Prognostics Limited Co. Methods and compositions for prognosing preterm birth
CA3021569A1 (en) 2016-04-20 2017-10-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Evaluation of mantle cell lymphoma and methods related thereto
GB2554767A (en) 2016-04-21 2018-04-11 Q Linea Ab Detecting and characterising a microorganism
AU2017261189B2 (en) 2016-05-02 2023-02-09 Becton, Dickinson And Company Accurate molecular barcoding
RS63698B1 (en) 2016-05-13 2022-11-30 Bioatla Inc Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof
EP3954771A1 (en) 2016-05-13 2022-02-16 Dovetail Genomics, LLC Recovering long-range linkage information from preserved samples
CN109863251B (en) 2016-05-17 2022-11-18 基因中心治疗公司 Method for subtyping lung squamous cell carcinoma
CA3024747A1 (en) 2016-05-17 2017-11-23 Genecentric Therapeutics, Inc. Methods for subtyping of lung adenocarcinoma
JP6691617B2 (en) 2016-05-17 2020-04-28 エルディエックス・プログノスティクス・リミテッド・カンパニーLdx Prognostics Limited Co. Methods and compositions for providing an assessment of preeclampsia
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
WO2017205691A1 (en) 2016-05-26 2017-11-30 Cellular Research, Inc. Molecular label counting adjustment methods
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
GB2600627B (en) 2016-05-27 2022-12-07 Personalis Inc Personalized genetic testing
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
US20200185063A1 (en) 2016-06-05 2020-06-11 Berg Llc Systems and methods for patient stratification and identification of potential biomarkers
JP2019518028A (en) 2016-06-10 2019-06-27 アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. Complement component C5i RNA composition and its use for treating paroxysmal nocturnal hemoglobinuria (PNH)
WO2017222834A1 (en) 2016-06-10 2017-12-28 City Of Hope Compositions and methods for mitochondrial genome editing
JP7267013B2 (en) 2016-06-17 2023-05-01 ザ・ブロード・インスティテュート・インコーポレイテッド Type VI CRISPR orthologs and systems
EP3472354A4 (en) 2016-06-17 2020-01-01 California Institute of Technology Nucleic acid reactions and related methods and compositions
KR20190019190A (en) 2016-06-20 2019-02-26 헬스텔 인크. Diagnosis and treatment of autoimmune diseases
KR20190020106A (en) 2016-06-20 2019-02-27 헬스텔 인크. Differential diagnosis method of autoimmune disease
WO2018003195A1 (en) 2016-06-29 2018-01-04 三菱ケミカル株式会社 Composition for preventing drying of gel, gel composite and dna chip containing said composite, and method for producing said composition, composite, and chip
US20210222164A1 (en) 2016-06-29 2021-07-22 The Broad Institute, Inc. Crispr-cas systems having destabilization domain
EP3875603A1 (en) 2016-07-12 2021-09-08 Life Technologies Corporation Compositions and methods for detecting nucleic acid regions
WO2018013883A1 (en) 2016-07-14 2018-01-18 Caprion Proteomics Inc. Biomarkers of latent tuberculosis infection
US11200963B2 (en) 2016-07-27 2021-12-14 Sequenom, Inc. Genetic copy number alteration classifications
CN109790585A (en) 2016-08-04 2019-05-21 贝勒研究院 Method for diagnosing and treating cancer of the esophagus
EP3497446B1 (en) 2016-08-15 2021-04-28 F. Hoffmann-La Roche AG Method and composition for detection of peptide cyclization using protein tags
CA3034769A1 (en) 2016-08-22 2018-03-01 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
CN110506127B (en) 2016-08-24 2024-01-12 维拉科特Sd公司 Use of genomic tags to predict responsiveness of prostate cancer patients to post-operative radiation therapy
WO2018053228A1 (en) 2016-09-15 2018-03-22 The Regents Of The University Of California Biomarkers for bipolar disorder and schizophrenia
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
WO2018057526A2 (en) 2016-09-21 2018-03-29 Twist Bioscience Corporation Nucleic acid based data storage
TW201815766A (en) 2016-09-22 2018-05-01 美商普雷辛肯公司 Compounds and methods for IDO and TDO modulation, and indications therefor
CN109791157B (en) 2016-09-26 2022-06-07 贝克顿迪金森公司 Measuring protein expression using reagents with barcoded oligonucleotide sequences
WO2018064116A1 (en) 2016-09-28 2018-04-05 Illumina, Inc. Methods and systems for data compression
JP2020510608A (en) 2016-11-02 2020-04-09 デビオファーム インターナショナル, エス. アー. Method for improving anti-CD37 immunoconjugate therapy
JP7228510B2 (en) 2016-11-08 2023-02-24 ベクトン・ディキンソン・アンド・カンパニー Cell labeling method
CN109952612B (en) 2016-11-08 2023-12-01 贝克顿迪金森公司 Method for classifying expression profiles
KR20190082275A (en) 2016-11-09 2019-07-09 헬스텔 인크. Coatings with adjustable amine density
CN110168370A (en) 2016-11-11 2019-08-23 健康之语公司 Method for identifying candidate biomarker
US10646540B2 (en) 2016-11-18 2020-05-12 City Of Hope Peptide inhibitors of twist
WO2018098241A1 (en) 2016-11-22 2018-05-31 University Of Rochester Methods of assessing risk of recurrent prostate cancer
TW202313978A (en) 2016-11-23 2023-04-01 美商阿尼拉製藥公司 Serpina1 irna compositions and methods of use thereof
JP2020514746A (en) 2016-12-01 2020-05-21 ノーティラス バイオテクノロジー インコーポレイテッド How to assay proteins
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
US10907274B2 (en) 2016-12-16 2021-02-02 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
KR20230166146A (en) 2016-12-16 2023-12-06 알닐람 파마슈티칼스 인코포레이티드 Methods for treating or preventing ttr-associated diseases using transthyretin(ttr) irna compositions
DK3554681T3 (en) 2016-12-16 2022-03-21 Brigham & Womens Hospital Inc PROCEDURE FOR PROTEINCORONA SENSOR RAY FOR EARLY DETECTION OF DISEASES
CA3047580A1 (en) 2016-12-23 2018-07-26 Plexxikon Inc. Compounds and methods for cdk8 modulation and indications therefor
EP3568234B1 (en) 2017-01-13 2023-09-06 Cellular Research, Inc. Hydrophilic coating of fluidic channels
US11208697B2 (en) 2017-01-20 2021-12-28 Decipher Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
EP3571309A4 (en) 2017-01-20 2020-11-25 Children's Hospital Medical Center Methods and compositions relating to oprm1 dna methylation for personalized pain management
US11694768B2 (en) 2017-01-24 2023-07-04 Sequenom, Inc. Methods and processes for assessment of genetic variations
US11267885B2 (en) 2017-01-26 2022-03-08 Zlip Holding Limited CD47 antigen binding unit and uses thereof
AU2018213315A1 (en) 2017-01-26 2019-07-25 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
EP3577232A1 (en) 2017-02-01 2019-12-11 Cellular Research, Inc. Selective amplification using blocking oligonucleotides
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
CN110892485B (en) 2017-02-22 2024-03-22 特韦斯特生物科学公司 Nucleic acid-based data storage
US11179413B2 (en) 2017-03-06 2021-11-23 Novartis Ag Methods of treatment of cancer with reduced UBB expression
EP3593140A4 (en) 2017-03-09 2021-01-06 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
US11746381B2 (en) 2017-03-10 2023-09-05 Cancer Diagnostics Research Innvovations, LLC Methods for diagnosing and treating gastric cancer using miRNA expression
EP3595674A4 (en) 2017-03-15 2020-12-16 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
CN110520543A (en) 2017-03-29 2019-11-29 中美冠科生物技术(太仓)有限公司 Determine gastric cancer to the system and method for Cetuximab sensibility
WO2018187191A1 (en) 2017-04-03 2018-10-11 Jounce Therapeutics, Inc Compositions and methods for the treatment of cancer
KR20200015895A (en) 2017-04-18 2020-02-13 알닐람 파마슈티칼스 인코포레이티드 How to treat a subject infected with hepatitis B virus (HBV)
CA3057157A1 (en) 2017-04-28 2018-11-01 Merck Sharp & Dohme Corp. Biomarkers for cancer therapeutics
JP7430301B2 (en) 2017-05-09 2024-02-13 リヴィア バイオセンサーズ,エルエルシー Systems and methods for identifying and differentiating genetic samples
CA3062716A1 (en) 2017-05-12 2018-11-15 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
WO2018209398A1 (en) 2017-05-17 2018-11-22 Microbio Pty Ltd Biomarkers and uses thereof
US11484543B2 (en) 2017-05-18 2022-11-01 The Rockefeller University Compositions and methods for diagnosing and treating diseases and disorders associated with mutant KCNJ5
WO2018213803A1 (en) 2017-05-19 2018-11-22 Neon Therapeutics, Inc. Immunogenic neoantigen identification
CA3063904A1 (en) 2017-05-22 2018-11-29 Edith Cowan University A method for the determination of early stage melanoma using autoantibody biomarkers
US10538808B2 (en) 2017-05-26 2020-01-21 Vibrant Holdings, Llc Photoactive compounds and methods for biomolecule detection and sequencing
CN110914448A (en) 2017-06-02 2020-03-24 昂飞股份有限公司 Array-based method for analyzing mixed samples using differentially labeled allele-specific probes
WO2018223057A1 (en) 2017-06-02 2018-12-06 Affymetrix, Inc. Array-based methods for analysing mixed samples using different allele-specific labels, in particular for detection of fetal aneuploidies
US11441174B2 (en) 2017-06-02 2022-09-13 Affymetrix, Inc. Array-based methods for analysing mixed samples using differently labelled allele-specific probes
CA3059559A1 (en) 2017-06-05 2018-12-13 Becton, Dickinson And Company Sample indexing for single cells
US10428067B2 (en) 2017-06-07 2019-10-01 Plexxikon Inc. Compounds and methods for kinase modulation
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
US10696965B2 (en) 2017-06-12 2020-06-30 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
EP3638814B8 (en) 2017-06-14 2023-06-21 The United States of America, as Represented by The Secretary, Department of Health and Human Services Method for determining lymphoma type
CA3070991C (en) 2017-06-19 2023-10-17 Massachusetts Institute Of Technology Automated methods for scalable, parallelized enzymatic biopolymer synthesis and modification using microfluidic devices
EP3655418A4 (en) 2017-06-22 2021-05-19 Triact Therapeutics, Inc. Methods of treating glioblastoma
WO2018236548A1 (en) 2017-06-23 2018-12-27 Inscripta, Inc. Nucleic acid-guided nucleases
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
US11420941B2 (en) * 2017-06-29 2022-08-23 Cowper Sciences Inc. Methods and systems for mask alignment in manufacturing process of arrays
US11739386B2 (en) 2017-07-21 2023-08-29 Genecentric Therapeutics, Inc. Methods for determining response to PARP inhibitors
EP4085919A3 (en) 2017-07-21 2023-02-08 Novartis AG Compositions and methods to treat cancer
JP7382919B2 (en) 2017-08-11 2023-11-17 シティ・オブ・ホープ RNA aptamer for transferrin receptor (TfR)
EP3676404A1 (en) 2017-08-31 2020-07-08 Novartis AG Methods of selecting a treatment for cancer patients
CN111094938A (en) * 2017-09-01 2020-05-01 生物辐射实验室股份有限公司 High power laser for western blotting
EP3679143A1 (en) 2017-09-08 2020-07-15 Life Technologies Corporation Methods for improved homologous recombination and compositions thereof
WO2019051316A1 (en) 2017-09-08 2019-03-14 Life Technologies Corporation Methods for improved homologous recombination and compositions thereof
EP3681906A4 (en) 2017-09-11 2021-06-09 Twist Bioscience Corporation Gpcr binding proteins and synthesis thereof
WO2019060607A1 (en) 2017-09-20 2019-03-28 Quanterix Corporation Methods and systems for the detection of analyte molecules
WO2019067991A1 (en) 2017-09-29 2019-04-04 Triact Therapeutics, Inc. Iniparib formulations and uses thereof
EP3696275A4 (en) 2017-10-11 2021-05-26 MGI Tech Co., Ltd. Method for improving loading and stability of nucleic acid on solid support
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
GB2583590A (en) 2017-10-20 2020-11-04 Twist Bioscience Corp Heated nanowells for polynucleotide synthesis
US11721412B2 (en) 2017-10-23 2023-08-08 Nautilus Subsidiary, Inc. Methods for identifying a protein in a sample of unknown proteins
SG11202002753QA (en) 2017-10-26 2020-05-28 Nat Univ Singapore A new approach for universal monitoring of minimal residual disease in acute myeloid leukemia
CN111226118A (en) 2017-10-27 2020-06-02 加利福尼亚大学董事会 Salivary extracellular RNA biomarkers for gingivitis
WO2019089922A1 (en) 2017-11-01 2019-05-09 Alnylam Pharmaceuticals, Inc. Complement component c3 irna compositions and methods of use thereof
CA3079524A1 (en) 2017-11-03 2019-05-09 Interna Technologies B.V. Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
US20200385719A1 (en) 2017-11-16 2020-12-10 Alnylam Pharmaceuticals, Inc. Kisspeptin 1 (kiss1) irna compositions and methods of use thereof
WO2019100039A1 (en) 2017-11-20 2019-05-23 Alnylam Pharmaceuticals, Inc. Serum amyloid p component (apcs) irna compositions and methods of use thereof
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
US20200377958A1 (en) 2017-12-01 2020-12-03 Millennium Pharmaceuticals, Inc. Biomarkers and methods for treatment with nae inhibitors
US11332736B2 (en) 2017-12-07 2022-05-17 The Broad Institute, Inc. Methods and compositions for multiplexing single cell and single nuclei sequencing
AR113490A1 (en) 2017-12-12 2020-05-06 Amgen Inc RNAi CONSTRUCTIONS TO INHIBIT THE EXPRESSION OF PNPLA3 AND METHODS OF USE OF THE SAME
JP2021508491A (en) 2017-12-18 2021-03-11 アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. High Mobility Group Box-1 (HMGB1) iRNA Composition and How to Use It
US11939575B2 (en) 2017-12-19 2024-03-26 City Of Hope Modified tracrRNAs gRNAs, and uses thereof
EP3728636A1 (en) 2017-12-19 2020-10-28 Becton, Dickinson and Company Particles associated with oligonucleotides
WO2019126472A1 (en) 2017-12-22 2019-06-27 Genentech, Inc. Use of pilra binding agents for treatment of a disease
CA3086915A1 (en) 2017-12-29 2019-07-04 Sujal M. Patel Decoding approaches for protein identification
KR20200106067A (en) 2018-01-04 2020-09-10 트위스트 바이오사이언스 코포레이션 DNA-based digital information storage
MA51678A (en) 2018-01-25 2020-12-02 Biogen Ma Inc MUSCLE AMYOTROPHY TREATMENT METHODS
JP7418337B2 (en) 2018-02-09 2024-01-19 ジェネンテック, インコーポレイテッド Treatment and diagnosis of mast cell-mediated inflammatory diseases
US11859250B1 (en) 2018-02-23 2024-01-02 Children's Hospital Medical Center Methods for treating eosinophilic esophagitis
WO2019195633A1 (en) 2018-04-04 2019-10-10 Ignite Biosciences, Inc. Methods of generating nanoarrays and microarrays
IT201800004253A1 (en) 2018-04-05 2019-10-05 Compositions and methods for the treatment of hereditary dominant catecholaminergic polymorphic ventricular tachycardia.
US11957695B2 (en) 2018-04-26 2024-04-16 The Broad Institute, Inc. Methods and compositions targeting glucocorticoid signaling for modulating immune responses
WO2019213276A1 (en) 2018-05-02 2019-11-07 Novartis Ag Regulators of human pluripotent stem cells and uses thereof
EP3788171B1 (en) 2018-05-03 2023-04-05 Becton, Dickinson and Company High throughput multiomics sample analysis
EP3788170A1 (en) 2018-05-03 2021-03-10 Becton, Dickinson and Company Molecular barcoding on opposite transcript ends
US20210386829A1 (en) 2018-05-04 2021-12-16 The Broad Institute, Inc. Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses
WO2019217704A1 (en) 2018-05-09 2019-11-14 Vibrant Holdings, Llc Methods of synthesizing a polynucleotide array using photactivated agents
TW202016304A (en) 2018-05-14 2020-05-01 美商阿尼拉製藥公司 Angiotensinogen (agt) irna compositions and methods of use thereof
SG11202011467RA (en) 2018-05-18 2020-12-30 Twist Bioscience Corp Polynucleotides, reagents, and methods for nucleic acid hybridization
EP3802847A4 (en) * 2018-05-29 2022-03-09 Centrillion Technologies, Inc. Increasing efficiency of photochemical reactions on substrates
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
EP3827094A1 (en) 2018-07-24 2021-06-02 Affymetrix, Inc. Array based method and kit for determining copy number and genotype in pseudogenes
FI3625368T3 (en) 2018-08-08 2023-01-13 Methods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing
SG11202100715WA (en) 2018-08-13 2021-02-25 Alnylam Pharmaceuticals Inc HEPATITIS B VIRUS (HBV) dsRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
WO2020036926A1 (en) 2018-08-17 2020-02-20 Cellecta, Inc. Multiplex preparation of barcoded gene specific dna fragments
US20210317429A1 (en) 2018-08-20 2021-10-14 The Broad Institute, Inc. Methods and compositions for optochemical control of crispr-cas9
CA3112792A1 (en) 2018-09-14 2020-03-19 Prelude Corporation Method of selection for treatment of subjects at risk of invasive breast cancer
JP2022500003A (en) 2018-09-18 2022-01-04 アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. Ketohexokinase (KHK) iRNA composition and its usage
JP2022501388A (en) 2018-09-19 2022-01-06 ラホヤ インスティチュート フォー イミュノロジー PTPRS and proteoglycans in rheumatoid arthritis
WO2020069055A1 (en) 2018-09-28 2020-04-02 Alnylam Pharmaceuticals, Inc. Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated ocular diseases
EP3861134A1 (en) 2018-10-01 2021-08-11 Becton, Dickinson and Company Determining 5' transcript sequences
EP3861347B1 (en) 2018-10-05 2022-12-21 Eisai R&D Management Co., Ltd. Biomarkers for a combination therapy comprising lenvatinib and everolimus
US20210333281A1 (en) 2018-10-05 2021-10-28 Eisai R&D Management Co., Ltd. Biomarkers for a therapy comprising a sorafenib compound
CA3115922A1 (en) 2018-10-09 2020-04-16 Genecentric Therapeutics, Inc. Detecting cancer cell of origin
WO2020077135A1 (en) 2018-10-10 2020-04-16 Dana-Farber Cancer Institute, Inc. Modulating resistance to bcl-2 inhibitors
AU2019360758A1 (en) 2018-10-18 2021-05-20 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune index that characterizes disease activity
BR112021008999A2 (en) 2018-11-07 2021-08-10 Seer, Inc. compositions, methods and systems for the analysis of corona protein and its uses.
JP2022506546A (en) 2018-11-08 2022-01-17 ベクトン・ディキンソン・アンド・カンパニー Single-cell whole transcriptome analysis using random priming
US11884980B2 (en) 2018-11-28 2024-01-30 Bioscreening & Diagnostics Llc Method for detection of traumatic brain injury
MX2021006234A (en) 2018-11-30 2021-09-10 Caris Mpi Inc Next-generation molecular profiling.
KR20210108970A (en) 2018-12-07 2021-09-03 엘리먼트 바이오사이언스, 인크. Flow cell devices and uses thereof
KR20210102932A (en) 2018-12-10 2021-08-20 암젠 인크 RNAI constructs for inhibiting PNPLA3 expression and methods of use thereof
EP3894552A1 (en) 2018-12-13 2021-10-20 Becton, Dickinson and Company Selective extension in single cell whole transcriptome analysis
EP3898958A1 (en) 2018-12-17 2021-10-27 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof
AU2019406186A1 (en) 2018-12-20 2021-07-15 Praxis Precision Medicines, Inc. Compositions and methods for the treatment of KCNT1 related disorders
EP3677693A1 (en) 2019-01-03 2020-07-08 Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO Transpochimeric gene trancripts (tcgts) as cancer biomarkers
WO2020150356A1 (en) 2019-01-16 2020-07-23 Becton, Dickinson And Company Polymerase chain reaction normalization through primer titration
ES2945227T3 (en) 2019-01-23 2023-06-29 Becton Dickinson Co Antibody Associated Oligonucleotides
CN116063520A (en) 2019-01-30 2023-05-05 真和制药有限公司 anti-GAL 3 antibodies and uses thereof
EP3917571A4 (en) 2019-01-31 2022-10-12 Agency For Science, Technology And Research Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
WO2020160450A1 (en) 2019-02-01 2020-08-06 Health Research, Inc. Methods and compositions for treating resistant and recurrent forms of cancer
EP3924739A1 (en) 2019-02-12 2021-12-22 Biogen MA Inc. Biomarkers of progressive multifocal leukoencephalopathy
WO2020176680A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for antibody optimization
KR20210143766A (en) 2019-02-26 2021-11-29 트위스트 바이오사이언스 코포레이션 Variant Nucleic Acid Libraries for the GLP1 Receptor
CN113795251A (en) 2019-02-27 2021-12-14 马德拉治疗公司 Use of casein hydrolyzing protease P function as a biomarker of drug response to IMIPRIDONE-like agents
WO2020186101A1 (en) 2019-03-12 2020-09-17 The Broad Institute, Inc. Detection means, compositions and methods for modulating synovial sarcoma cells
WO2020186235A1 (en) 2019-03-14 2020-09-17 The Broad Institute, Inc. Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells
JP2022525322A (en) 2019-03-14 2022-05-12 インシリクサ, インコーポレイテッド Methods and systems for time-gate fluorescence-based detection
WO2020191102A1 (en) 2019-03-18 2020-09-24 The Broad Institute, Inc. Type vii crispr proteins and systems
WO2020191069A1 (en) 2019-03-18 2020-09-24 The Broad Institute, Inc. Modulation of type 2 immunity by targeting clec-2 signaling
EP3942023A1 (en) 2019-03-18 2022-01-26 The Broad Institute, Inc. Compositions and methods for modulating metabolic regulators of t cell pathogenicity
WO2020201267A1 (en) 2019-04-01 2020-10-08 Københavns Universitet Identification of pan-gamma secretase inhibitor (pan-gsi) theranostic response signatures for cancers
WO2020206046A1 (en) 2019-04-01 2020-10-08 The Broad Institute, Inc. Methods and compositions for cell therapy
JP2022526844A (en) 2019-04-12 2022-05-26 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Compositions and Methods for Increasing Muscle Mass and Oxidative Metabolism
JP2022529294A (en) 2019-04-17 2022-06-20 アイジェノミクス、ソシエダッド、リミターダ Improved methods for early diagnosis of uterine leiomyoma and leiomyoma
WO2020214642A1 (en) 2019-04-19 2020-10-22 Becton, Dickinson And Company Methods of associating phenotypical data and single cell sequencing data
KR20220015394A (en) 2019-04-30 2022-02-08 라리마 테라퓨틱스, 인코포레이티드 Frataxin sensitivity markers for determining the efficacy of prataxin replacement therapy
EP3965932A1 (en) 2019-05-08 2022-03-16 Scienion GmbH Assay plate with nano-vessels and sample recovery assembly
US20220243208A1 (en) 2019-05-15 2022-08-04 SQUADRA Lifesciences, Inc.. Aptamers against glioblastoma
US20220235340A1 (en) 2019-05-20 2022-07-28 The Broad Institute, Inc. Novel crispr-cas systems and uses thereof
CA3141902A1 (en) 2019-05-30 2020-12-03 Amgen Inc. Rnai constructs for inhibiting scap expression and methods of use thereof
EP3980541A1 (en) 2019-06-04 2022-04-13 Apterna Limited Aptamers against transferrin receptor (tfr)
SG11202113253SA (en) 2019-06-07 2021-12-30 Scribe Therapeutics Inc Engineered casx systems
CA3144644A1 (en) 2019-06-21 2020-12-24 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
JP2022538433A (en) 2019-06-27 2022-09-02 ロシュ シークエンシング ソリューションズ,インコーポレイティド Peptide library with enhanced subsequence diversity and method of using same
US11939622B2 (en) 2019-07-22 2024-03-26 Becton, Dickinson And Company Single cell chromatin immunoprecipitation sequencing assay
EP4007812A1 (en) 2019-08-01 2022-06-08 Alnylam Pharmaceuticals, Inc. Serpin family f member 2 (serpinf2) irna compositions and methods of use thereof
WO2021022108A2 (en) 2019-08-01 2021-02-04 Alnylam Pharmaceuticals, Inc. CARBOXYPEPTIDASE B2 (CPB2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
AU2020326698A1 (en) 2019-08-05 2022-02-24 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis
WO2021030522A1 (en) 2019-08-13 2021-02-18 Alnylam Pharmaceuticals, Inc. SMALL RIBOSOMAL PROTEIN SUBUNIT 25 (RPS25) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
US20220340911A1 (en) 2019-08-13 2022-10-27 Amgen Inc. Rnai constructs for inhibiting slc30a8 expression and methods of use thereof
US20220282333A1 (en) 2019-08-13 2022-09-08 The General Hospital Corporation Methods for predicting outcomes of checkpoint inhibition and treatment thereof
WO2021041922A1 (en) 2019-08-30 2021-03-04 The Broad Institute, Inc. Crispr-associated mu transposase systems
EP4028523A1 (en) 2019-09-09 2022-07-20 Scribe Therapeutics Inc. Compositions and methods for use in immunotherapy
WO2021050593A1 (en) 2019-09-09 2021-03-18 Scribe Therapeutics Inc. Compositions and methods for the targeting of sod1
PE20221416A1 (en) 2019-09-18 2022-09-20 Novartis Ag NKG2D FUSION PROTEINS AND THEIR USES
US11793787B2 (en) 2019-10-07 2023-10-24 The Broad Institute, Inc. Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
EP4045652A1 (en) 2019-10-18 2022-08-24 Alnylam Pharmaceuticals, Inc. Solute carrier family member irna compositions and methods of use thereof
TW202134435A (en) 2019-10-22 2021-09-16 美商阿尼拉製藥公司 Complement component c3 irna compositions and methods of use thereof
WO2021086982A2 (en) 2019-10-28 2021-05-06 Beckman Coulter, Inc. Compounds for the identification of microbial classes and uses thereof
US11844800B2 (en) 2019-10-30 2023-12-19 Massachusetts Institute Of Technology Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
TW202132567A (en) 2019-11-01 2021-09-01 美商阿尼拉製藥公司 Huntingtin (htt) irna agent compositions and methods of use thereof
WO2021092145A1 (en) 2019-11-06 2021-05-14 Alnylam Pharmaceuticals, Inc. Transthyretin (ttr) irna composition and methods of use thereof for treating or preventing ttr-associated ocular diseases
US11773436B2 (en) 2019-11-08 2023-10-03 Becton, Dickinson And Company Using random priming to obtain full-length V(D)J information for immune repertoire sequencing
EP4061945A1 (en) 2019-11-22 2022-09-28 Alnylam Pharmaceuticals, Inc. Ataxin3 (atxn3) rnai agent compositions and methods of use thereof
IL293489A (en) 2019-12-02 2022-08-01 Caris Mpi Inc Pan-cancer platinum response predictor
US20230033866A1 (en) 2019-12-06 2023-02-02 Scribe Therapeutics Inc. Compositions and methods for the targeting of rhodopsin
WO2021113769A1 (en) 2019-12-07 2021-06-10 Scribe Therapeutics Inc. Compositions and methods for the targeting of htt
KR20220115995A (en) 2019-12-13 2022-08-19 알닐람 파마슈티칼스 인코포레이티드 Human chromosome 9 open reading frame 72 (C9orf72) iRNA preparation compositions and methods of using the same
WO2021126734A1 (en) 2019-12-16 2021-06-24 Alnylam Pharmaceuticals, Inc. Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
US20230044602A1 (en) 2019-12-20 2023-02-09 EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE Cancer signatures, methods of generating cancer signatures, and uses thereof
US20230167424A1 (en) 2020-01-10 2023-06-01 Scribe Therapeutics Inc. Compositions and methods for the targeting of pcsk9
EP4090771A1 (en) 2020-01-13 2022-11-23 Jounce Therapeutics, Inc. Methods for the treatment of cancer
CN115244184A (en) 2020-01-13 2022-10-25 贝克顿迪金森公司 Methods and compositions for quantifying protein and RNA
WO2021154941A1 (en) 2020-01-31 2021-08-05 Alnylam Pharmaceuticals, Inc. Complement component c5 irna compositions for use in the treatment of amyotrophic lateral sclerosis (als)
AU2021218895A1 (en) 2020-02-10 2022-09-15 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
MX2022010052A (en) 2020-02-18 2022-09-05 Alnylam Pharmaceuticals Inc Apolipoprotein c3 (apoc3) irna compositions and methods of use thereof.
EP4114947A1 (en) 2020-03-05 2023-01-11 Alnylam Pharmaceuticals, Inc. Complement component c3 irna compositions and methods of use thereof for treating or preventing complement component c3-associated diseases
WO2021178736A1 (en) 2020-03-06 2021-09-10 Alnylam Pharmaceuticals, Inc. KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
AU2021237633A1 (en) 2020-03-18 2022-10-06 Scribe Therapeutics Inc. Compositions and methods for the targeting of C9orf72
EP4121534A1 (en) 2020-03-18 2023-01-25 Alnylam Pharmaceuticals, Inc. Compositions and methods for treating subjects having a heterozygous alanine-glyoxylate aminotransferase gene (agxt) variant
WO2021195307A1 (en) 2020-03-26 2021-09-30 Alnylam Pharmaceuticals, Inc. Coronavirus irna compositions and methods of use thereof
WO2021206917A1 (en) 2020-04-07 2021-10-14 Alnylam Pharmaceuticals, Inc. ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2021206922A1 (en) 2020-04-07 2021-10-14 Alnylam Pharmaceuticals, Inc. Transmembrane serine protease 2 (tmprss2) irna compositions and methods of use thereof
CA3172579A1 (en) 2020-04-15 2021-10-21 David C. Duffy Methods and systems related to highly sensitive assays and by deliveringcapture objects
CA3181400A1 (en) 2020-04-27 2021-11-04 Alnylam Pharmaceuticals, Inc. Apolipoprotein e (apoe) irna agent compositions and methods of use thereof
WO2021222549A1 (en) 2020-04-30 2021-11-04 Alnylam Pharmaceuticals, Inc. Complement factor b (cfb) irna compositions and methods of use thereof
WO2021224633A1 (en) 2020-05-06 2021-11-11 Orchard Therapeutics (Europe) Limited Treatment for neurodegenerative diseases
US20230173493A1 (en) 2020-05-08 2023-06-08 Scienion Gmbh Assay plate with nano-vessels and sample recovery assembly
WO2021231779A1 (en) 2020-05-14 2021-11-18 Becton, Dickinson And Company Primers for immune repertoire profiling
WO2021231673A1 (en) 2020-05-15 2021-11-18 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of leucine rich repeat kinase 2 (lrrk2)
WO2021231680A1 (en) 2020-05-15 2021-11-18 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of methyl-cpg binding protein 2 (mecp2)
WO2021231675A1 (en) 2020-05-15 2021-11-18 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of argininosuccinate synthetase (ass1)
EP4150077A1 (en) 2020-05-15 2023-03-22 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of transmembrane channel-like protein 1 (tmc1)
EP4150089A1 (en) 2020-05-15 2023-03-22 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of retinoschisin 1 (rs1)
EP4150078A1 (en) 2020-05-15 2023-03-22 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of argininosuccinate lyase (asl)
WO2021231692A1 (en) 2020-05-15 2021-11-18 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of otoferlin (otof)
EP4150087A1 (en) 2020-05-15 2023-03-22 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of gap junction protein beta 2 (gjb2)
WO2021247885A2 (en) 2020-06-01 2021-12-09 Amgen Inc. Rnai constructs for inhibiting hsd17b13 expression and methods of use thereof
AR122534A1 (en) 2020-06-03 2022-09-21 Triplet Therapeutics Inc METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY
WO2021252557A1 (en) 2020-06-09 2021-12-16 Alnylam Pharmaceuticals, Inc. Rnai compositions and methods of use thereof for delivery by inhalation
BR112022024420A2 (en) 2020-06-18 2023-01-17 Alnylam Pharmaceuticals Inc XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
IL299771A (en) 2020-07-10 2023-03-01 Inst Nat Sante Rech Med Methods and compositions for treating epilepsy
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
WO2022047359A1 (en) 2020-08-31 2022-03-03 Berg Llc Protein biomarkers for pancreatic cancer
CA3192695A1 (en) 2020-09-16 2022-03-24 Novigenix Sa Biomarkers for immune checkpoint inhibitors treatment
WO2022066847A1 (en) 2020-09-24 2022-03-31 Alnylam Pharmaceuticals, Inc. Dipeptidyl peptidase 4 (dpp4) irna compositions and methods of use thereof
EP4225917A1 (en) 2020-10-05 2023-08-16 Alnylam Pharmaceuticals, Inc. G protein-coupled receptor 75 (gpr75) irna compositions and methods of use thereof
WO2022087329A1 (en) 2020-10-23 2022-04-28 Alnylam Pharmaceuticals, Inc. Mucin 5b (muc5b) irna compositions and methods of use thereof
AU2021378290A1 (en) 2020-11-11 2023-06-29 Nautilus Subsidiary, Inc. Affinity reagents having enhanced binding and detection characteristics
IL302709A (en) 2020-11-13 2023-07-01 Alnylam Pharmaceuticals Inc COAGULATION FACTOR V (F5) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
AU2021383537A1 (en) 2020-11-18 2023-06-29 Astrazeneca Ab Steroid sparing
EP4247967A1 (en) 2020-11-20 2023-09-27 Becton, Dickinson and Company Profiling of highly expressed and lowly expressed proteins
EP4256053A1 (en) 2020-12-01 2023-10-11 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
US20240100185A1 (en) 2020-12-03 2024-03-28 Scribe Therapeutics Inc. Compositions and methods for the targeting of ptbp1
PE20231178A1 (en) 2020-12-03 2023-08-01 Scribe Therapeutics Inc ENGINEERING DESIGNED CLASS 2 TYPE V CRISPR SYSTEMS
WO2022125490A1 (en) 2020-12-08 2022-06-16 Alnylam Pharmaceuticals, Inc. Coagulation factor x (f10) irna compositions and methods of use thereof
WO2022123465A1 (en) 2020-12-09 2022-06-16 Cambridge Enterprise Limited Treatment of diseases associated with variant novel open reading frames
US20240060070A1 (en) 2020-12-16 2024-02-22 Cambridge Enterprise Limited Treatment of cancer associated with variant novel open reading frames
WO2022130259A2 (en) 2020-12-16 2022-06-23 Cambridge Enterprise Limited Treatment of cancer associated with dysregulated novel open reading frame products
EP4274896A1 (en) 2021-01-05 2023-11-15 Alnylam Pharmaceuticals, Inc. Complement component 9 (c9) irna compositions and methods of use thereof
WO2022162588A1 (en) 2021-01-28 2022-08-04 Cambridge Enterprise Limited Method of treatment of malaria by targetting open reading frames
JP2024508714A (en) 2021-02-12 2024-02-28 アルナイラム ファーマシューティカルズ, インコーポレイテッド Superoxide dismutase 1 (SOD1) iRNA composition and method for using the same for treating or preventing superoxide dismutase 1- (SOD1-) related neurodegenerative diseases
EP4294445A1 (en) 2021-02-19 2023-12-27 Pfizer Inc. Methods of protecting rna
JP2024509783A (en) 2021-02-25 2024-03-05 アルナイラム ファーマシューティカルズ, インコーポレイテッド Prion protein (PRNP) IRNA compositions and methods of use thereof
KR20230150844A (en) 2021-02-26 2023-10-31 알닐람 파마슈티칼스 인코포레이티드 Ketohexokinase (KHK) iRNA compositions and methods of using the same
CA3212128A1 (en) 2021-03-04 2022-09-09 Alnylam Pharmaceuticals, Inc. Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof
WO2022192419A2 (en) 2021-03-09 2022-09-15 Massachusetts Institute Of Technology Methods of treating inflammatory bowel disease (ibd) with anti- tnf-blockade
WO2022192519A1 (en) 2021-03-12 2022-09-15 Alnylam Pharmaceuticals, Inc. Glycogen synthase kinase 3 alpha (gsk3a) irna compositions and methods of use thereof
WO2022212231A2 (en) 2021-03-29 2022-10-06 Alnylam Pharmaceuticals, Inc. Huntingtin (htt) irna agent compositions and methods of use thereof
WO2022212153A1 (en) 2021-04-01 2022-10-06 Alnylam Pharmaceuticals, Inc. Proline dehydrogenase 2 (prodh2) irna compositions and methods of use thereof
US20230059578A1 (en) 2021-04-06 2023-02-23 Berg Llc Protein markers for estrogen receptor (er)-positive-like and estrogen receptor (er)-negative-like breast cancer
CA3214833A1 (en) 2021-04-06 2022-10-13 Bpgbio, Inc. Protein markers for the prognosis of breast cancer progression
EP4320440A1 (en) 2021-04-06 2024-02-14 BPGbio, Inc. Protein markers for estrogen receptor (er)-positive luminal a(la)-like and luminal b1 (lb1)-like breast cancer
IL307926A (en) 2021-04-26 2023-12-01 Alnylam Pharmaceuticals Inc Transmembrane protease, serine 6 (tmprss6) irna compositions and methods of use thereof
EP4330396A1 (en) 2021-04-29 2024-03-06 Alnylam Pharmaceuticals, Inc. Signal transducer and activator of transcription factor 6 (stat6) irna compositions and methods of use thereof
WO2022237974A1 (en) 2021-05-12 2022-11-17 Ecole Polytechnique Federale De Lausanne (Epfl) Krab-containing zinc finger protein and cancer
WO2022245583A1 (en) 2021-05-18 2022-11-24 Alnylam Pharmaceuticals, Inc. Sodium-glucose cotransporter-2 (sglt2) irna compositions and methods of use thereof
EP4341405A1 (en) 2021-05-20 2024-03-27 Korro Bio, Inc. Methods and compositions for adar-mediated editing
EP4347889A1 (en) 2021-05-28 2024-04-10 Centre Hospitalier Universitaire Vaudois (CHUV) Novel incrna controlling cardiac fibrosis
WO2022256283A2 (en) 2021-06-01 2022-12-08 Korro Bio, Inc. Methods for restoring protein function using adar
EP4347823A1 (en) 2021-06-02 2024-04-10 Alnylam Pharmaceuticals, Inc. Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
CN117561334A (en) 2021-06-04 2024-02-13 阿尔尼拉姆医药品有限公司 Human chromosome 9 open reading frame 72 (C9 ORF 72) iRNA pharmaceutical compositions and methods of use thereof
WO2022260939A2 (en) 2021-06-08 2022-12-15 Alnylam Pharmaceuticals, Inc. Compositions and methods for treating or preventing stargardt's disease and/or retinal binding protein 4 (rbp4)-associated disorders
US11756285B2 (en) 2021-06-10 2023-09-12 Bank Of America Corporation Image processing system and method for image noise removal
US20230194709A9 (en) 2021-06-29 2023-06-22 Seagate Technology Llc Range information detection using coherent pulse sets with selected waveform characteristics
WO2023278410A1 (en) 2021-06-29 2023-01-05 Korro Bio, Inc. Methods and compositions for adar-mediated editing
WO2023285616A1 (en) 2021-07-14 2023-01-19 Cambridge Enterprise Limited Treatment of schizophrenia and bipolar disorder
AU2022314619A1 (en) 2021-07-21 2024-01-04 Alnylam Pharmaceuticals, Inc. Metabolic disorder-associated target gene irna compositions and methods of use thereof
WO2023003995A1 (en) 2021-07-23 2023-01-26 Alnylam Pharmaceuticals, Inc. Beta-catenin (ctnnb1) irna compositions and methods of use thereof
WO2023009687A1 (en) 2021-07-29 2023-02-02 Alnylam Pharmaceuticals, Inc. 3-hydroxy-3-methylglutaryl-coa reductase (hmgcr) irna compositions and methods of use thereof
WO2023014677A1 (en) 2021-08-03 2023-02-09 Alnylam Pharmaceuticals, Inc. Transthyretin (ttr) irna compositions and methods of use thereof
KR20240042016A (en) 2021-08-04 2024-04-01 알닐람 파마슈티칼스 인코포레이티드 iRNA compositions and methods for silencing angiotensinogen (AGT)
IL310407A (en) 2021-08-13 2024-03-01 Alnylam Pharmaceuticals Inc Factor xii (f12) irna compositions and methods of use thereof
WO2023044370A2 (en) 2021-09-17 2023-03-23 Alnylam Pharmaceuticals, Inc. Irna compositions and methods for silencing complement component 3 (c3)
CA3232420A1 (en) 2021-09-20 2023-03-23 Alnylam Pharmaceuticals, Inc. Inhibin subunit beta e (inhbe) modulator compositions and methods of use thereof
WO2023064530A1 (en) 2021-10-15 2023-04-20 Alnylam Pharmaceuticals, Inc. Extra-hepatic delivery irna compositions and methods of use thereof
CA3234835A1 (en) 2021-10-22 2023-04-27 Korro Bio, Inc. Methods and compositions for disrupting nrf2-keap1 protein interaction by adar mediated rna editing
AU2022370883A1 (en) 2021-10-22 2024-04-18 Amgen Inc. Rnai constructs for inhibiting gpam expression and methods of use thereof
TW202334418A (en) 2021-10-29 2023-09-01 美商艾拉倫製藥股份有限公司 Huntingtin (htt) irna agent compositions and methods of use thereof
CA3234636A1 (en) 2021-10-29 2023-05-04 Alnylam Pharmaceuticals, Inc. Complement factor b (cfb) irna compositions and methods of use thereof
WO2023122762A1 (en) 2021-12-22 2023-06-29 Camp4 Therapeutics Corporation Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnas
WO2023122363A1 (en) 2021-12-23 2023-06-29 Illumina Software, Inc. Dynamic graphical status summaries for nucelotide sequencing
US20230215515A1 (en) 2021-12-23 2023-07-06 Illumina Software, Inc. Facilitating secure execution of external workflows for genomic sequencing diagnostics
WO2023129764A1 (en) 2021-12-29 2023-07-06 Illumina Software, Inc. Automatically switching variant analysis model versions for genomic analysis applications
WO2023141314A2 (en) 2022-01-24 2023-07-27 Alnylam Pharmaceuticals, Inc. Heparin sulfate biosynthesis pathway enzyme irna agent compositions and methods of use thereof
US20230357851A1 (en) 2022-04-06 2023-11-09 Larimar Therapeutics, Inc. Frataxin-sensitive markers for monitoring frataxin-replacement therapy
KR20230147016A (en) * 2022-04-13 2023-10-20 고려대학교 산학협력단 System and method for highly precision dna photosynthesis
WO2023235818A2 (en) 2022-06-02 2023-12-07 Scribe Therapeutics Inc. Engineered class 2 type v crispr systems
WO2023240074A1 (en) 2022-06-07 2023-12-14 Scribe Therapeutics Inc. Compositions and methods for the targeting of pcsk9
EP4314267A1 (en) 2022-06-07 2024-02-07 Scribe Therapeutics Inc. Compositions and methods for the targeting of pcsk9
WO2023240201A1 (en) 2022-06-08 2023-12-14 Larimar Therapeutics, Inc. Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome
WO2023240277A2 (en) 2022-06-10 2023-12-14 Camp4 Therapeutics Corporation Methods of modulating progranulin expression using antisense oligonucleotides targeting regulatory rnas
WO2024020572A1 (en) 2022-07-22 2024-01-25 New York Stem Cell Foundation, Inc. Methods and compositions for the treatment of ptsd
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders
WO2024039776A2 (en) 2022-08-18 2024-02-22 Alnylam Pharmaceuticals, Inc. Universal non-targeting sirna compositions and methods of use thereof
WO2024056902A2 (en) 2022-09-16 2024-03-21 Christopher Shaw Compositions and methods for treating neurological diseases

Family Cites Families (306)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR333561A (en) 1903-07-03 1903-11-28 Georges Rollet Method and apparatus for cleaning clothes
US3862056A (en) * 1967-12-15 1975-01-21 Allied Chem Semiconductor polymer compositions comprising a grafted block copolymer of synthetic rubber and polyolefin and carbon black
IL33640A (en) * 1969-01-16 1973-05-31 Kabi Ab Test strip packaged-unit
US3730844A (en) 1971-08-27 1973-05-01 Purdue Research Foundation Polynucleotide analysis
DE2150691C2 (en) * 1971-10-12 1982-09-09 Basf Ag, 6700 Ludwigshafen Photosensitive mixture and use of a photosensitive mixture for the production of a planographic printing plate
DE2242394A1 (en) * 1972-08-29 1974-03-14 Basf Ag MIXTURES OF SUBSTANCE HARDLED UNDER THE EFFECT OF LIGHT
JPS5183B2 (en) * 1973-03-07 1976-01-05
US3939350A (en) * 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
JPS6112373B2 (en) * 1974-09-04 1986-04-08 Hitachi Ltd
SE407115B (en) * 1975-10-06 1979-03-12 Kabi Ab PROCEDURES AND METAL ELECTRODES FOR THE STUDY OF ENZYMATIC AND OTHER BIOCHEMICAL REACTIONS
US4238757A (en) * 1976-03-19 1980-12-09 General Electric Company Field effect transistor for detection of biological reactions
DE2612359C3 (en) 1976-03-24 1978-10-26 Konishiroku Photo Ind. Co., Ltd., Tokio Electrophotographic recording material
US4259223A (en) * 1976-03-29 1981-03-31 California Institute Of Technology Cross-linked polyvinyl pyridine coated glass particle catalyst support and aqueous composition or polyvinyl pyridine adducted microspheres
US4145406A (en) * 1977-04-11 1979-03-20 Miles Laboratories, Inc. Specific binding - adsorbent assay method and test means
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
US4121222A (en) 1977-09-06 1978-10-17 A. B. Dick Company Drop counter ink replenishing system
US4180739A (en) 1977-12-23 1979-12-25 Varian Associates, Inc. Thermostatable flow cell for fluorescence measurements
US4448534A (en) * 1978-03-30 1984-05-15 American Hospital Corporation Antibiotic susceptibility testing
US4269933A (en) 1978-06-08 1981-05-26 E. I. Du Pont De Nemours And Company Methods of developing photopolymerizable compositions containing an 0-nitroaromatic compound as photoinhibitor
US4216245A (en) 1978-07-25 1980-08-05 Miles Laboratories, Inc. Method of making printed reagent test devices
US4258001A (en) * 1978-12-27 1981-03-24 Eastman Kodak Company Element, structure and method for the analysis or transport of liquids
US4427415A (en) * 1979-01-05 1984-01-24 Cleveland Patrick H Manifold vacuum biochemical test method and device
US4314821A (en) * 1979-04-09 1982-02-09 Minnesota Mining And Manufacturing Company Sandwich immunoassay using piezoelectric oscillator
US4342905A (en) 1979-08-31 1982-08-03 Nippon Kogaku K.K. Automatic focusing device of a microscope
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4327073A (en) 1980-04-07 1982-04-27 Huang Henry V Automated method for quantitative analysis of biological fluids
US4478967A (en) 1980-08-11 1984-10-23 Minnesota Mining And Manufacturing Company Photolabile blocked surfactants and compositions containing the same
US4444892A (en) * 1980-10-20 1984-04-24 Malmros Mark K Analytical device having semiconductive organic polymeric element associated with analyte-binding substance
IL61351A (en) * 1980-10-27 1983-12-30 Yeda Res & Dev Organometallic polymers,their preparation and compositions of co-ordination compounds containing them
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
EP0063810B1 (en) 1981-04-29 1986-03-05 Ciba-Geigy Ag New devices and kits for immunological analysis
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4339528A (en) * 1981-05-19 1982-07-13 Rca Corporation Etching method using a hardened PVA stencil
US4430299A (en) * 1981-06-18 1984-02-07 Coulter Electronics, Inc. Apparatus for monitoring chemical reactions
US4498774A (en) 1981-07-22 1985-02-12 Iowa State University Research Foundation, Inc. Micro-polarimeter for high performance liquid chromatography
US4395486A (en) 1981-08-19 1983-07-26 Medical College Of Ga. Research Inst., Inc. Method for the direct analysis of sickle cell anemia
USRE33064E (en) * 1981-09-18 1989-09-19 Prutec Limited Method for the determination of species in solution with an optical wave-guide
FI63596C (en) 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
US4444878A (en) * 1981-12-21 1984-04-24 Boston Biomedical Research Institute, Inc. Bispecific antibody determinants
US5073484A (en) * 1982-03-09 1991-12-17 Bio-Metric Systems, Inc. Quantitative analysis apparatus and method
US4500919A (en) 1982-05-04 1985-02-19 Massachusetts Institute Of Technology Color reproduction system
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
US4556643A (en) 1982-07-26 1985-12-03 Agracetus Assay method and probe for polynucleotide sequences
US4624915A (en) * 1982-07-29 1986-11-25 Board Of Trustees Of Michigan State University Positive selection sorting of cells
US4477556A (en) 1982-08-18 1984-10-16 E. I. Du Pont De Nemours And Company Acidic o-nitroaromatics as photoinhibitors of polymerization in positive working films
US4455089A (en) 1982-08-25 1984-06-19 Iowa State University Research Foundation, Inc. Refractive index and absorption detector for liquid chromatography based on Fabry-Perot interferometry
US5599720A (en) 1982-08-27 1997-02-04 Multilyte Limited Measurement of analyte concentration
US4973493A (en) * 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US4722906A (en) * 1982-09-29 1988-02-02 Bio-Metric Systems, Inc. Binding reagents and methods
US4588682A (en) 1982-12-13 1986-05-13 Integrated Genetics, Inc. Binding nucleic acid to a support
AU570425B2 (en) 1982-12-21 1988-03-17 Applied Research Systems Ars Holding N.V. Assay technique
US4516833A (en) 1982-12-27 1985-05-14 University Of Dayton Production of high performance optical spatial filters
DE3301833A1 (en) * 1983-01-20 1984-07-26 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig METHOD FOR SIMULTANEOUS SYNTHESIS OF SEVERAL OLIGONOCLEOTIDES IN A SOLID PHASE
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US4555491A (en) 1983-01-31 1985-11-26 Iowa State University Research Foundation, Inc. Sulfide chemiluminescence detection
US4634574A (en) 1983-01-31 1987-01-06 Iowa State Research Foundation, Inc. Apparatus for use in sulfide chemiluminescence detection
US4575433A (en) 1983-01-31 1986-03-11 Iowa State University Research Foundation, Inc. Method of generating chemiluminescent light
US4591570A (en) 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
US4537861A (en) 1983-02-03 1985-08-27 Elings Virgil B Apparatus and method for homogeneous immunoassay
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4584277A (en) 1983-04-05 1986-04-22 Syntex (U.S.A.) Inc. Fluorescent multiparameter particle analysis
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4533682A (en) 1983-04-29 1985-08-06 Desoto, Inc. Imidazolidine-blocked amine polymers
GB8314523D0 (en) * 1983-05-25 1983-06-29 Lowe C R Diagnostic device
US4517338A (en) * 1983-06-20 1985-05-14 Chiron Corporation Multiple reactor system and method for polynucleotide synthesis
US4542102A (en) * 1983-07-05 1985-09-17 Molecular Diagnostics, Inc. Coupling of nucleic acids to solid support by photochemical methods
US4987065A (en) 1983-07-05 1991-01-22 Enzo Biochem, Inc. In vivo labelling of polynucleotide sequences
US4713326A (en) * 1983-07-05 1987-12-15 Molecular Diagnostics, Inc. Coupling of nucleic acids to solid support by photochemical methods
US4626684A (en) * 1983-07-13 1986-12-02 Landa Isaac J Rapid and automatic fluorescence immunoassay analyzer for multiple micro-samples
US4677054A (en) 1983-08-08 1987-06-30 Sloan-Kettering Institute For Cancer Research Method for simple analysis of relative nucleic acid levels in multiple small samples by cytoplasmic dot hybridization
US4719615A (en) * 1983-08-22 1988-01-12 Optical Data, Inc. Erasable optical data storage medium
US4598049A (en) 1983-08-31 1986-07-01 Systec Inc. General purpose gene synthesizer
JP2548112B2 (en) 1983-09-02 1996-10-30 シンジェン,インコーポレイテッド Carrier and oligonucleotide synthesis
US4569967A (en) * 1983-10-24 1986-02-11 The Salk Institute For Biological Studies Synthesis of N-substituted peptide amides
US4580895A (en) * 1983-10-28 1986-04-08 Dynatech Laboratories, Incorporated Sample-scanning photometer
US4849513A (en) 1983-12-20 1989-07-18 California Institute Of Technology Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
US5821058A (en) 1984-01-16 1998-10-13 California Institute Of Technology Automated DNA sequencing technique
US5171534A (en) 1984-01-16 1992-12-15 California Institute Of Technology Automated DNA sequencing technique
US4613566A (en) 1984-01-23 1986-09-23 President And Fellows Of Harvard College Hybridization assay and kit therefor
JPS60155942A (en) 1984-01-25 1985-08-16 Fuji Photo Film Co Ltd Spot deposition apparatus of liquid specimen
FI71768C (en) 1984-02-17 1987-02-09 Orion Yhtymae Oy Enhanced nucleic acid reagents and process for their preparation.
GB8405437D0 (en) 1984-03-01 1984-04-04 Amersham Int Plc Detecting polynucleotide sequences
US4704353A (en) * 1984-04-27 1987-11-03 Molecular Devices Corporation Photoresponsive redox detection and discrimination
DE3565986D1 (en) 1984-05-02 1988-12-08 Brendan James Hamill An apparatus for the chemical synthesis of oligonucleotides
US4766062A (en) 1984-05-07 1988-08-23 Allied Corporation Displacement polynucleotide assay method and polynucleotide complex reagent therefor
JPS60248699A (en) * 1984-05-23 1985-12-09 Fujisawa Pharmaceut Co Ltd Preparation of urogastrone
US4670380A (en) 1984-05-23 1987-06-02 Molecular Diagnostics, Inc. Assays utilizing labeled nucleic acid probes
US4555490A (en) * 1984-06-08 1985-11-26 The United States Of America As Represented By The Department Of Health And Human Services Rapid visualization system for gel electrophoresis
IL75464A (en) 1984-06-12 1990-08-31 Orgenics Ltd Method and apparatus for multi-analyte assay
WO1986000991A1 (en) * 1984-07-24 1986-02-13 Commonwealth Serum Laboratories Commission Method for determining mimotopes
US4767927A (en) 1984-08-16 1988-08-30 Kabushiki Kaisha Toshiba Apparatus for reading radiation image information stored in imaging plate
US4755458A (en) 1984-08-30 1988-07-05 Enzo Biochem, Inc. Composition and method for the detection of the presence of a polynucleotide sequence of interest
US4563417A (en) * 1984-08-31 1986-01-07 Miles Laboratories, Inc. Nucleic acid hybridization assay employing antibodies to intercalation complexes
US4681859A (en) * 1984-09-21 1987-07-21 Ortho Diagnostic Systems Inc. Fluorescence polarization immunoassay for heavy antigens
US5258506A (en) 1984-10-16 1993-11-02 Chiron Corporation Photolabile reagents for incorporation into oligonucleotide chains
DE3440141A1 (en) * 1984-11-02 1986-05-07 Heiner Dipl.-Chem. Dr. 8000 München Eckert Use of bistrichloromethyl carbonate as a proreagent for phosgene
US4820630A (en) 1984-11-23 1989-04-11 Digene Diagnostics, Incorporated Assay for nucleic acid sequences, particularly genetic lesions, using interactive labels
US4719179A (en) 1984-11-30 1988-01-12 Pharmacia P-L Biochemicals, Inc. Six base oligonucleotide linkers and methods for their use
US5242794A (en) 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US5064754A (en) 1984-12-14 1991-11-12 Mills Randell L Genomic sequencing method
US4670379A (en) 1984-12-19 1987-06-02 E. I. Du Pont De Nemours And Company Polynucleotide hydridization assays employing catalyzed luminescence
US5026840A (en) * 1985-01-10 1991-06-25 Molecular Diagnostics, Inc. Photochemical nucleic acid-labeling reagent having a polyalklamine spacer
US4713347A (en) * 1985-01-14 1987-12-15 Sensor Diagnostics, Inc. Measurement of ligand/anti-ligand interactions using bulk conductance
US4767700A (en) 1985-02-15 1988-08-30 Beckman Research Institute Of The City Of Hope Detection of particular nucleotide sequences
EP0194132A3 (en) * 1985-03-06 1988-08-03 Murex Corporation Imaging immunoassay detection system and method
US5096807A (en) 1985-03-06 1992-03-17 Murex Corporation Imaging immunoassay detection system with background compensation and its use
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US6040166A (en) 1985-03-28 2000-03-21 Roche Molecular Systems, Inc. Kits for amplifying and detecting nucleic acid sequences, including a probe
DE3513168A1 (en) * 1985-04-12 1986-10-16 Thomas 8000 München Dandekar BIOSENSOR CONSISTING OF A SEMICONDUCTOR BASED ON SILICON OR CARBON-BASED (ELECTRONIC PART) AND NUCLEIN BASE (OR. OTHER BIOL. MONOMERS)
EP0199327B1 (en) * 1985-04-19 1992-03-04 Fuji Photo Film Co., Ltd. Signal processing method for determining base sequence of nucleic acids
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
WO1986006487A1 (en) * 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
US4797355A (en) * 1985-06-13 1989-01-10 Amgen Inc. Methods for attaching polynucleotides to supports
JPS61290311A (en) 1985-06-19 1986-12-20 Hitachi Ltd Apparatus and method for inspecting soldered zone
FR2583772B1 (en) 1985-06-20 1987-08-28 Roussel Uclaf NEW MEDIA, THE PREPARATION OF SUCH MEDIA, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION TO THE SYNTHESIS OF OLIGONUCLEOTIDES AND THE NEW NUCLEOSIDES AND OLIGONUCLEOTIDES RELATED TO THE MEDIA THUS OBTAINED
FR2584090B1 (en) 1985-06-27 1987-08-28 Roussel Uclaf NEW SUPPORTS, THEIR PREPARATION AND THE INTERMEDIATES OBTAINED, THEIR APPLICATION TO THE SYNTHESIS OF OLIGONUCLEOTIDES AND THE NEW NUCLEOSIDES AND OLIGONUCLEOTIDES RELATED TO THE SUPPORTS OBTAINED
US4719087A (en) * 1985-07-01 1988-01-12 Baxter Travenol Laboratories, Inc. Tray for analyzing system
EP0212807A3 (en) * 1985-07-15 1988-01-07 Imperial Chemical Industries Plc Coloured compound containing a cationic group and a reactive group
JPS6221151A (en) 1985-07-19 1987-01-29 Matsushita Electric Ind Co Ltd Formation of pattern
DD254998A1 (en) 1985-07-26 1988-03-16 Zeiss Jena Veb Carl ARRANGEMENT FOR THE IMAGE AND ANALYSIS OF FLUORESCENCE SIGNALS
DE3677364D1 (en) 1985-08-05 1991-03-07 Univ Leiden MARKED MACROMOLECULES; METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN IMMUNOLOGICAL OR IMMUNOCYTOCHEMICAL TESTS.
JPS6242057A (en) * 1985-08-19 1987-02-24 Fuji Photo Film Co Ltd Signal processing method for determining base sequence of nucleic acid
EP0213825A3 (en) 1985-08-22 1989-04-26 Molecular Devices Corporation Multiple chemically modulated capacitance
US4731335A (en) * 1985-09-13 1988-03-15 Fisher Scientific Company Method for treating thin samples on a surface employing capillary flow
SE450171B (en) 1985-10-18 1987-06-09 Carl Urban Ungerstedt DEVICE FOR AUTOMATIC COLLECTION OF SMALL LIQUID VOLUMES
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US4822566A (en) * 1985-11-19 1989-04-18 The Johns Hopkins University Optimized capacitive sensor for chemical analysis and measurement
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US4882269A (en) 1985-12-13 1989-11-21 Princeton University Amplified hybridization assay
US4637861A (en) * 1985-12-16 1987-01-20 Allied Corporation Stabilized, lipid membrane-based device and method of analysis
DE3785591T2 (en) 1986-01-10 1993-09-02 Amoco Corp COMPETITIVE HOMOGENEOUS TEST.
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US4855225A (en) 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US4758727A (en) 1986-02-12 1988-07-19 Ohio State University Research Foundation Method and apparatus for the measurement of low-level laser-induced fluorescence
JPH0685387B2 (en) 1986-02-14 1994-10-26 株式会社東芝 Alignment method
US4868103A (en) 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US5348855A (en) 1986-03-05 1994-09-20 Miles Inc. Assay for nucleic acid sequences in an unpurified sample
NO870613L (en) 1986-03-05 1987-09-07 Molecular Diagnostics Inc DETECTION OF MICROORGANISMS IN A SAMPLE CONTAINING NUCLEIC ACID.
EP0240729A3 (en) * 1986-03-05 1988-08-24 Fuji Photo Film Co., Ltd. Method of analyzing autoradiograph for determining base sequence of nucleic acid
US4925785A (en) 1986-03-07 1990-05-15 Biotechnica Diagnostics, Inc. Nucleic acid hybridization assays
US4728591A (en) * 1986-03-07 1988-03-01 Trustees Of Boston University Self-assembled nanometer lithographic masks and templates and method for parallel fabrication of nanometer scale multi-device structures
US5310893A (en) 1986-03-31 1994-05-10 Hoffmann-La Roche Inc. Method for HLA DP typing
CA1284931C (en) 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US5604099A (en) 1986-03-13 1997-02-18 Hoffmann-La Roche Inc. Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US4894796A (en) * 1986-03-17 1990-01-16 Westinghouse Electric Corp. Automatic transfer switch with programmable display
US5256549A (en) 1986-03-28 1993-10-26 Chiron Corporation Purification of synthetic oligomers
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US4875169A (en) 1986-04-11 1989-10-17 Iowa State University Research Foundation, Inc. Method for improving the limit of detection in a data signal
US4981783A (en) 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US4846552A (en) 1986-04-16 1989-07-11 The United States Of America As Represented By The Secretary Of The Air Force Method of fabricating high efficiency binary planar optical elements
US4857656A (en) * 1986-05-08 1989-08-15 Sanshin Kagaku Kogyo Co., Ltd. Active esters used for production of esters or amides and process for producing esters or amides
GB8612221D0 (en) * 1986-05-20 1986-06-25 Amersham Int Plc Assaying species in sample
US4811218A (en) 1986-06-02 1989-03-07 Applied Biosystems, Inc. Real time scanning electrophoresis apparatus for DNA sequencing
US4808508A (en) * 1986-07-01 1989-02-28 Hoechst Celanese Corporation Negative working color proofing process comprising diazo compound and polyvinyl acetal/polyvinyl alcohol/polyvinyl acetate resin
ATE86385T1 (en) 1986-08-06 1993-03-15 Multilyte Ltd DETERMINING ANALYTE CONCENTRATION WITH TWO LABELS.
US4786684A (en) * 1986-08-21 1988-11-22 The Mount Sinai School Of Medicine Of The City University Of New York Benzylthioether-linked solid support-bound thiol compounds and method for peptide synthesis
GB8621337D0 (en) * 1986-09-04 1986-10-15 Agricultural Genetics Co Non-radioactive nucleic acid hybridization probes
DE3631662A1 (en) * 1986-09-17 1988-03-24 Biotechnolog Forschung Gmbh METHOD FOR SIMULTANEOUS SYNTHESIS OF SEVERAL PEPTIDES ON A SOLID PHASE
JPS6384499A (en) * 1986-09-26 1988-04-15 Toho Yakuhin Kogyo Kk Production of delta sleep inducing peptide by enzyme
US5021550A (en) 1986-10-07 1991-06-04 Thomas Jefferson University Method for preventing deletion sequences in solid phase synthesis
GB8624637D0 (en) 1986-10-14 1986-11-19 Emi Plc Thorn Electrical device
US4979959A (en) * 1986-10-17 1990-12-25 Bio-Metric Systems, Inc. Biocompatible coating for solid surfaces
US4877745A (en) 1986-11-17 1989-10-31 Abbott Laboratories Apparatus and process for reagent fluid dispensing and printing
US5028525A (en) 1986-11-24 1991-07-02 Regents Of The University Of California Method of preparing and applying single stranded DNA probes to double stranded target DNAs in situ
EP0335902B1 (en) * 1986-12-15 1993-12-01 British Technology Group Usa Inc. Monomeric phthalocyanine reagents
JPS63167313A (en) 1986-12-27 1988-07-11 Hitachi Ltd Automatic focus control method
JPH0664057B2 (en) * 1987-01-06 1994-08-22 富士写真フイルム株式会社 Signal processing method for autoradiographic analysis
US4762881A (en) * 1987-01-09 1988-08-09 E. I. Du Pont De Nemours And Company Photoreactive benzoylphenylalanines and related peptides
US5077085A (en) 1987-03-06 1991-12-31 Schnur Joel M High resolution metal patterning of ultra-thin films on solid substrates
US5079600A (en) * 1987-03-06 1992-01-07 Schnur Joel M High resolution patterning on solid substrates
US4794150A (en) * 1987-03-11 1988-12-27 Samuel Steel Synthesis of peptide analogs
AU601021B2 (en) 1987-03-11 1990-08-30 Molecular Diagnostics, Inc. Assay for necleic acid sequences in a sample
US5026773A (en) 1987-03-11 1991-06-25 Samuel Steel Apparatus for a solid phase synthesis of peptide analogs
US5037882A (en) 1987-03-11 1991-08-06 Steel Samuel L Synthesis of oligonucleotide analogs
JPS63223557A (en) 1987-03-13 1988-09-19 Nec Corp Production of semiconductor biosensor
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) * 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
CA1315968C (en) * 1987-04-24 1993-04-13 David Colin Sherrington Substrate and process for making a substrate
US5100777A (en) 1987-04-27 1992-03-31 Tanox Biosystems, Inc. Antibody matrix device and method for evaluating immune status
US4833332A (en) * 1987-06-12 1989-05-23 E. I. Du Pont De Nemours And Company Scanning fluorescent detection system
SE458968B (en) 1987-06-16 1989-05-22 Wallac Oy BIOSPECIFIC ANALYTICAL PROCEDURE FOR MULTIPLE ANALYTICS WHICH DO NOT INCLUDE PARTICULAR COATING AND LABELING WITH FLUORESCING LABEL SUBSTANCES
US4874500A (en) 1987-07-15 1989-10-17 Sri International Microelectrochemical sensor and sensor array
US4921805A (en) 1987-07-29 1990-05-01 Life Technologies, Inc. Nucleic acid capture method
GB8803000D0 (en) 1988-02-10 1988-03-09 Ekins Roger Philip Determination of ambient concentrations of several analytes
US5149625A (en) 1987-08-11 1992-09-22 President And Fellows Of Harvard College Multiplex analysis of DNA
CA1321488C (en) * 1987-08-22 1993-08-24 Martin Francis Finlan Biological sensors
US4923901A (en) * 1987-09-04 1990-05-08 Millipore Corporation Membranes with bound oligonucleotides and peptides
US5011770A (en) 1987-09-04 1991-04-30 Molecular Devices, Inc. DNA detection method
US5006464A (en) 1987-10-01 1991-04-09 E-Y Laboratories, Inc. Directed flow diagnostic device and method
US4981985A (en) 1987-10-20 1991-01-01 Trustees Of The University Of Pennsylvania Synthesis of photolabile chelators for multivalent cations
ZA888978B (en) * 1987-12-04 1990-07-25 Du Pont Immobilized interleukin 2 and interleukin 2 containing a carboxylterminal extension
US4886741A (en) * 1987-12-09 1989-12-12 Microprobe Corporation Use of volume exclusion agents for the enhancement of in situ hybridization
CA1335721C (en) * 1987-12-24 1995-05-30 Patrick E. Guire Biomolecule attached to a solid surface by means of a spacer and methods of attaching biomolecules to surfaces
US4844617A (en) 1988-01-20 1989-07-04 Tencor Instruments Confocal measuring microscope with automatic focusing
EP0328256A1 (en) * 1988-01-21 1989-08-16 Owens-Corning Fiberglas Corporation Glass fibers coated with agarose for use as column packing or chromatographic media for bioseparations
US5082830A (en) 1988-02-26 1992-01-21 Enzo Biochem, Inc. End labeled nucleotide probe
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
FR2628530B1 (en) * 1988-03-08 1994-01-28 Chemunex Sa APPARATUS AND METHOD FOR DETECTION AND NUMERATION OF FLUORESCENT PARTICLES, CARRIED BY A SOLID SUPPORT
US4946942A (en) * 1988-03-11 1990-08-07 Bioresearch, Inc. Urethane-protected amino acid-N-carboxyanhydrides
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
IL89964A0 (en) 1988-04-15 1989-12-15 Montefiore Med Center Method for determining malignant progression,cdna,polypeptides encoded thereby and pharmaceutical compositions containing the same
US5002867A (en) * 1988-04-25 1991-03-26 Macevicz Stephen C Nucleic acid sequence determination by multiple mixed oligonucleotide probes
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
DE68928853T2 (en) * 1988-05-20 1999-08-05 Cetus Corp FASTENING OF SEQUENCE-SPECIFIC SAMPLES
US5013669A (en) 1988-06-01 1991-05-07 Smithkline Diagnostics, Inc. Mass producible biologically active solid phase devices
US5108576A (en) * 1988-06-13 1992-04-28 Ohmicron Corporation Pyroelectric thermometric device
DE3923165A1 (en) 1988-07-15 1990-01-18 Hitachi Ltd MAGNETIC DISK DEVICE
EP0425485B1 (en) * 1988-07-22 2000-10-04 SurModics, Inc. Preparation of polymeric surfaces
US5188963A (en) 1989-11-17 1993-02-23 Gene Tec Corporation Device for processing biological specimens for analysis of nucleic acids
US5281540A (en) * 1988-08-02 1994-01-25 Abbott Laboratories Test array for performing assays
US4992383A (en) 1988-08-05 1991-02-12 Porton Instruments, Inc. Method for protein and peptide sequencing using derivatized glass supports
US5225326A (en) 1988-08-31 1993-07-06 Research Development Foundation One step in situ hybridization assay
US5206137A (en) 1988-09-08 1993-04-27 Lifecodes Corporation Compositions and methods useful for genetic analysis
EP0358796B1 (en) 1988-09-14 1993-04-28 Siemens Aktiengesellschaft Diagnostic x-ray device with luminescent storage screen
GB8822228D0 (en) * 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
JP2897027B2 (en) 1988-10-27 1999-05-31 スズキ株式会社 Immunological agglutination detector
SE8804074D0 (en) * 1988-11-10 1988-11-10 Pharmacia Ab SENSOR UNIT AND ITS USE IN BIOSENSOR SYSTEM
US5200051A (en) * 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5869237A (en) 1988-11-15 1999-02-09 Yale University Amplification karyotyping
US5215889A (en) 1988-11-18 1993-06-01 The Regents Of The University Of California Catalytic and reactive polypeptides and methods for their preparation and use
US5489507A (en) 1988-11-30 1996-02-06 Perkin-Elmer Corporation DNA detection by color complementation
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US4992583A (en) 1989-01-06 1991-02-12 The Goodyear Tire & Rubber Company Process for synthesizing N-chlorothio-sulfonamides
US5077210A (en) 1989-01-13 1991-12-31 Eigler Frances S Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent
US4984857A (en) 1989-01-17 1991-01-15 Iowa State University Research Foundation, Inc. Linearization of scan velocity of resonant vibrating-mirror beam deflectors
US4921348A (en) 1989-01-26 1990-05-01 Iowa State University Research Foundation, Inc. Method and means for a spatial and temporal probe for laser-generated plumes based on density gradients
IT1232252B (en) 1989-02-22 1992-01-28 Rotta Research Lab DERIVATIVES OF N N PHENYL BENZAMIDE WITH ANTI-ULTER AND ANTIALLERIC ACTIVITY AND PROCEDURE FOR THEIR PREPARATION
US5081584A (en) 1989-03-13 1992-01-14 United States Of America Computer-assisted design of anti-peptides based on the amino acid sequence of a target peptide
JPH02299598A (en) 1989-04-14 1990-12-11 Ro Inst For Molecular Genetics & Geneteic Res Determination by means of hybridization, together with oligonucleotide probe of all or part of extremely short sequence in sample of nucleic acid connecting with separate particle of microscopic size
US5112962A (en) 1989-04-19 1992-05-12 Northwestern University Labile anchors for solid phase polynucleotide synthesis
US5219726A (en) 1989-06-02 1993-06-15 The Salk Institute For Biological Studies Physical mapping of complex genomes
US6379895B1 (en) * 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5547839A (en) * 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US5242974A (en) 1991-11-22 1993-09-07 Affymax Technologies N.V. Polymer reversal on solid surfaces
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
GB2233654A (en) 1989-07-07 1991-01-16 Nat Res Dev Immobilised polynucleotides
DE3924454A1 (en) 1989-07-24 1991-02-07 Cornelis P Prof Dr Hollenberg THE APPLICATION OF DNA AND DNA TECHNOLOGY FOR THE CONSTRUCTION OF NETWORKS FOR USE IN CHIP CONSTRUCTION AND CHIP PRODUCTION (DNA CHIPS)
US5061075A (en) 1989-08-07 1991-10-29 Alfano Robert R Optical method and apparatus for diagnosing human spermatozoa
US5141813A (en) 1989-08-28 1992-08-25 Clontech Laboratories, Inc. Multifunctional controlled pore glass reagent for solid phase oligonucleotide synthesis
US5196305A (en) * 1989-09-12 1993-03-23 Eastman Kodak Company Diagnostic and amplification methods using primers having thymine at 3' end to overcome primer-target mismatch at the 3' end
DE69032745T2 (en) * 1989-09-15 1999-04-01 Chiron Mimotopes Pty Ltd SOLID SUBSTRATE FOR PEPTID SYNTHESIS
US5232829A (en) 1989-09-29 1993-08-03 Hoffmann-La Roche Inc. Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
US5252743A (en) 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5297288A (en) * 1989-11-28 1994-03-22 United States Biochemical Corporation System for use with a high resolution scanner for scheduling a sequence of software tools for determining the presence of bands in DNA sequencing samples
US5215882A (en) 1989-11-30 1993-06-01 Ortho Diagnostic Systems, Inc. Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays
FI896202A (en) * 1989-12-22 1991-06-23 Ahlstroem Valmet METHOD OCH ANORDNING VID INLOPPSLAODAN AV EN PAPPERS-, KARTONG- ELLER TORKMASKIN.
US5091652A (en) 1990-01-12 1992-02-25 The Regents Of The University Of California Laser excited confocal microscope fluorescence scanner and method
US5192407A (en) 1990-01-30 1993-03-09 Iowa State University Research Foundation, Inc. Means and method of detection in chemical separation procedures
US6506558B1 (en) * 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5100626A (en) 1990-05-24 1992-03-31 Levin Andrew E Binding assay device with removable cassette and manifold
GB9014263D0 (en) 1990-06-27 1990-08-15 Dixon Arthur E Apparatus and method for spatially- and spectrally- resolvedmeasurements
GB9015793D0 (en) 1990-07-18 1990-09-05 Medical Res Council Confocal scanning optical microscope
US5306641A (en) 1990-07-27 1994-04-26 Saccocio Edward J Apparatus and method for determining gel rate of polymerizable compositions
US5235028A (en) 1990-08-31 1993-08-10 University Of Minnesota Polyethylene glycol derivatives for solid-phase applications
US5491224A (en) * 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
EP0834576B1 (en) * 1990-12-06 2002-01-16 Affymetrix, Inc. (a Delaware Corporation) Detection of nucleic acid sequences
ATE244065T1 (en) 1990-12-06 2003-07-15 Affymetrix Inc METHODS AND REAGENTS FOR VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS
RU1794088C (en) 1991-03-18 1993-02-07 Институт Молекулярной Биологии Ан@ Ссср Method of dna nucleotide sequence determination and a device for its realization
US5380489A (en) * 1992-02-18 1995-01-10 Eastman Kodak Company Element and method for nucleic acid amplification and detection using adhered probes
US5198871A (en) 1991-06-18 1993-03-30 Southwest Research Institute Laser-induced-fluorescence inspection of jet fuels
US5491570A (en) * 1991-07-26 1996-02-13 Accuwave Corporation Methods and devices for using photorefractive materials at infrared wavelengths
WO1993002992A1 (en) 1991-08-07 1993-02-18 H & N Instruments, Inc. Synthesis of chain chemical compounds
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5291763A (en) * 1991-09-18 1994-03-08 Cuisinot Charles P Universal lock for quick release mechanism
US5556961A (en) 1991-11-15 1996-09-17 Foote; Robert S. Nucleosides with 5'-O-photolabile protecting groups
US5846708A (en) 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
CA2124087C (en) * 1991-11-22 2002-10-01 James L. Winkler Combinatorial strategies for polymer synthesis
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
US5667667A (en) 1992-04-24 1997-09-16 Isis Innovation Limited Electrochemical treatment of surfaces
GB9218131D0 (en) 1992-08-26 1992-10-14 Slater James H A method of marking a liquid
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5386221A (en) * 1992-11-02 1995-01-31 Etec Systems, Inc. Laser pattern generation apparatus
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5382512A (en) * 1993-08-23 1995-01-17 Chiron Corporation Assay device with captured particle reagent
US5381224A (en) 1993-08-30 1995-01-10 A. E. Dixon Scanning laser imaging system
JPH0772378A (en) 1993-09-02 1995-03-17 Nikon Corp Focusing device
DK0725682T3 (en) 1993-10-28 2002-07-15 Houston Advanced Res Ct Micro-made, porous pass-through apparatus for discrete detection of bonding reactions
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5727098A (en) * 1994-09-07 1998-03-10 Jacobson; Joseph M. Oscillating fiber optic display and imager
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5776737A (en) 1994-12-22 1998-07-07 Visible Genetics Inc. Method and composition for internal identification of samples
US6673533B1 (en) * 1995-03-10 2004-01-06 Meso Scale Technologies, Llc. Multi-array multi-specific electrochemiluminescence testing
US5707806A (en) 1995-06-07 1998-01-13 Genzyme Corporation Direct sequence identification of mutations by cleavage- and ligation-associated mutation-specific sequencing
US5777888A (en) 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5698393A (en) 1995-08-18 1997-12-16 Abbott Laboratories Method for elimination of rheumatoid factor interference in diagnostic assays
US5871697A (en) 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
DE69942272D1 (en) * 1998-02-23 2010-06-02 Wisconsin Alumni Res Found DERANORDNUNGEN
US6306643B1 (en) * 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
US6346423B1 (en) * 1999-07-16 2002-02-12 Agilent Technologies, Inc. Methods and compositions for producing biopolymeric arrays
US6171797B1 (en) * 1999-10-20 2001-01-09 Agilent Technologies Inc. Methods of making polymeric arrays

Also Published As

Publication number Publication date
AU5837190A (en) 1991-01-07
US20030064391A1 (en) 2003-04-03
KR970001578B1 (en) 1997-02-11
US20050148027A1 (en) 2005-07-07
HK64195A (en) 1995-05-05
US20020192693A1 (en) 2002-12-19
US6747143B2 (en) 2004-06-08
US20030013100A1 (en) 2003-01-16
EP0476014A1 (en) 1992-03-25
NZ233886A (en) 1993-02-25
ATE175421T1 (en) 1999-01-15
NO914826L (en) 1991-12-06
JPH11315095A (en) 1999-11-16
WO1990015070A1 (en) 1990-12-13
ES2058921T3 (en) 1994-11-01
ATE110738T1 (en) 1994-09-15
DE69032888D1 (en) 1999-02-18
JP3759161B2 (en) 2006-03-22
EP0619321A1 (en) 1994-10-12
US6646243B2 (en) 2003-11-11
US5143854A (en) 1992-09-01
US5510270A (en) 1996-04-23
KR920701235A (en) 1992-08-11
CA2278878A1 (en) 1990-12-08
EP0476014B1 (en) 1994-08-31
US6630308B2 (en) 2003-10-07
GB9125996D0 (en) 1992-02-05
FI915723A0 (en) 1991-12-04
NO301233B1 (en) 1997-09-29
DE69032888T2 (en) 1999-07-29
CA2054706A1 (en) 1990-12-08
HUT59938A (en) 1992-07-28
HU223462B1 (en) 2004-07-28
EP0953835A1 (en) 1999-11-03
US6261776B1 (en) 2001-07-17
US6403957B1 (en) 2002-06-11
EP0902034A3 (en) 1999-05-26
US6491871B1 (en) 2002-12-10
DK0476014T3 (en) 1994-11-14
US6329143B1 (en) 2001-12-11
AU672723B2 (en) 1996-10-10
FI109130B (en) 2002-05-31
EP0902034A2 (en) 1999-03-17
ES2129101T3 (en) 1999-06-01
JP2005112867A (en) 2005-04-28
US20060210452A1 (en) 2006-09-21
AU651795B2 (en) 1994-08-04
CA2278883C (en) 2001-12-04
IL94551A (en) 1995-03-30
CA2278878C (en) 2002-09-17
JP2004002386A (en) 2004-01-08
US6225625B1 (en) 2001-05-01
IL94551A0 (en) 1991-03-10
GB2248840A (en) 1992-04-22
US6291183B1 (en) 2001-09-18
AU7765594A (en) 1995-05-04
DE69012119T2 (en) 1994-12-22
US20020064796A1 (en) 2002-05-30
US6660234B2 (en) 2003-12-09
KR970001577B1 (en) 1997-02-11
US5445934A (en) 1995-08-29
CA2278883A1 (en) 1990-12-08
DK0619321T3 (en) 1999-08-30
JPH04505763A (en) 1992-10-08
CA2054706C (en) 2001-08-28
HU904730D0 (en) 1992-02-28
TW434254B (en) 2001-05-16
NL191992B (en) 1996-08-01
NO914826D0 (en) 1991-12-06
US20050214828A1 (en) 2005-09-29
US20030235853A1 (en) 2003-12-25
DE953835T1 (en) 2002-06-13
BR9007425A (en) 1992-07-21
NL191992C (en) 1996-12-03
US5405783A (en) 1995-04-11
HK61395A (en) 1995-05-05
JPH1121293A (en) 1999-01-26
US20030082831A1 (en) 2003-05-01
GB2248840B (en) 1993-12-01
SG13595G (en) 1995-06-16
NL9022056A (en) 1992-03-02
DE69012119D1 (en) 1994-10-06
EP0619321B1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
CA2391491A1 (en) Very large scale immobilized peptide synthesis
US6406844B1 (en) Very large scale immobilized polymer synthesis
US5324633A (en) Method and apparatus for measuring binding affinity
RU2107072C1 (en) Method of preparing amino acid or nucleotide sequences on substrate, method of screening large number of amino acid sequences, and screening substrate

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued